WorldWideScience

Sample records for cancer current status

  1. Focal therapy for prostate cancer: The current status

    OpenAIRE

    Marshall, Susan; Taneja, Samir

    2015-01-01

    Purpose In an era of increasing prostate cancer incidence and earlier detection, the assessment of clinical significance of prostate cancer is critical. Minimally invasive therapies are increasingly being investigated in localized prostate cancer. Methods and results In this review, we discuss the current status of magnetic resonance imaging targeted fusion prostate biopsy and focal therapy for prostate cancer, its rationale, and techniques. Conclusion Focal therapy offers a promising outlook...

  2. Nanomedicines as cancer therapeutics: Current status

    NARCIS (Netherlands)

    Akhter, S.; Ahmad, M; Ramzani, F.; Singh, A..; Ahmad, I.; Rahman, Z.; Ahmad, F.J.; Storm, G.; Kok, R.J.

    2013-01-01

    As of 21st century, cancer is arguably the most complex and challenging disease known to mankind and an inevitable public health concern of this millennium. Nanotechnology, suitably amalgamated with cancer research, has ushered an era of highly personalized and safer medicines which can improve canc

  3. Chemoprevention of gastric cancer: current status

    Institute of Scientific and Technical Information of China (English)

    2003-01-01

    The development of gastric cancer is a multi-factor process. In addition to genetic factors, environmental factors including smoking, low gastric acidity, excessive intake of salt or salty food and low consumption of fresh fruits and vegetables all contribute to the development of gastric cancer. Of particular interest, epidemiological and experimental studies have demonstrated that Helicobacter pylori (H. pylori) infection is causally linked to gastric cancer. Most studies using micronutrient supplementation have failed to demonstrate any preventive effect against the development of gastric cancer. The use of non-steroidal anti-inflammatory drugs has been consistently observed to protect against the development of gastric cancer. Recently, eradication of H. pylori infection by a chemopreventative approach is being studied in a number of trials. Studies using precancerous lesions as an end point of the treatment have produced conflicting and mostly negative results. Trials using cancer as an end point are being cautiously carried out in high-risk populations, and will provide the definitive answer to this important question. In the end, vaccination may be proven to be the optimal strategy in human for the management of H. pylori infection and prevention of gastric cancer.

  4. Current status of oral cancer chemoprevention

    Institute of Scientific and Technical Information of China (English)

    Moni Abraham Kuriakose

    2008-01-01

    @@ Chemoprevention is the administration of agents to block or reverse carcinogenesis. Chemoprevention in oral cancer has been directed towards reversal of premalignant lesion and prevention of second primary tumor.

  5. Current Status and Challenges of Cancer Clinical Trials in Korea

    OpenAIRE

    Shim, Byoung Yong; Park, Se Hoon; Lee, Soonil; Kim, Jin-Soo; Lee, Kyoung Eun; Kang, Yoon-Koo; Ahn, Myung-Ju

    2015-01-01

    Purpose Cancer clinical trials in Korea have rapidly progressed in terms of quantity and quality during the last decade. This study evaluates the current status of cancer clinical trials in Korea and their associated problems. Materials and Methods We analyzed the clinical trials approved by the Korea Food and Drug Administration (KFDA) between 2007 and 2013. A nationwide on-line survey containing 22 questions was also performed with several cooperative study groups and individual researchers...

  6. [Immunooncology in Urologic Cancers: Current Status].

    Science.gov (United States)

    Grimm, M-O

    2016-09-01

    Immune checkpoint inhibitors are establishing itselves as a new systemic treatment option (in addition to chemotherapy and targeted therapy) for metastatic tumours. (Re)activating the immune system, these antibodies may lead to impressive remissions lasting for a long time in some patients. Regarding urological tumours, the anti-PD-1 antibody Nivolumab (Opdivo(®)) has been approved this year for advanced, previously treated renal cell carcinoma. In the United States, Atezolizumab (Tecentriq(®)) has been approved for metastatic urothelial carcinoma after platinum-based chemotherapy. In patients pre-treated with antiangiogenic drugs, Nivolumab has achieved a higher rate of remission (25 vs. 5%) and a 5.4-month increase in overall survival compared with Everolimus. An indirect comparison with chemotherapy demonstrates an increased remission rate (15%) and an increased 1-year survival rate (37%) for urothelial carcinoma after platinum-based chemotherapy with Atezolizumab. The frequency of side-effects resulting from these treatments is comparatively low. However, some patients experience what is called immune-mediated side-effects, which must be recognised and treated in a timely manner. Immune checkpoint inhibitors are being tested in numerous ongoing phase III clinical trials and have the potential to replace current first-line treatment options for metastatic tumours such as urothelial and renal cell carcinoma. These trials are also investigating anti-PD-1/anti-PD-L1 antibodies in combination with CTLA4 immune checkpoint inhibitors or antiangiogenic treatments. Approval trials are also investigating the role of immune checkpoint inhibitors in the adjuvant setting. PMID:27680188

  7. The current status of imaging diagnosis of breast cancer

    International Nuclear Information System (INIS)

    In recent years, the incidence and the mortality rate of female breast cancer in our country is increasing, Early diagnosis of breast cancer is particularly important. Precious preoperative staging in the breast cancer is advantageous for the treatment planning. Evaluating the efficacy of chemotherapy is beneficial for adjusting the follow-up plan. Imaging examination has become an important role in breast cancer management. At present, commonly used equipment include mammography, ultrasound, CT, and MRI, etc. This article reviews the present study status of these tools in diagnosis of breast cancer. A reasonable and effective choice of those tools can facilitate clinic diagnosis and treatment. (authors)

  8. [Current status of robotic surgery for gastric cancer].

    Science.gov (United States)

    Suda, Koichi; Ishida, Yoshinori; Uyama, Ichiro

    2014-11-01

    Robotic surgery was launched in Japan in 2000.In particular, the development of the da Vinci S Surgical System was a major breakthrough. It was introduced in Japan for the first time through our hospital in January 2009. Since then, the number of surgical robots used has been dramatically increasing, with up to approximately 160 robots all over the country. To date, we have performed more than 500 robotic surgeries, including 180 gastrectomies, at our hospital. Our data suggest that compared with the conventional laparoscopic approach, the use of the da Vinci Surgical System in minimally invasive gastrectomy for gastric cancer might improve short-term outcomes, particularly in terms of preventing postoperative local complications. Thus, we believe that use of surgical robots become increasingly beneficial for more extensive resections and operations that require more advanced skills, even though a couple of issues remain to be solved, such as long operative time, high cost, and limited experience and evidence. In this article, the current status and future perspectives regarding robotic gastrectomy for gastric cancer are presented based on our experience and a review of the literature. PMID:25434438

  9. Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

    International Nuclear Information System (INIS)

    Glioblastoma multiforme (GBM), an aggressive brain tumor of astrocytic/neural stem cell origin, represents one of the most incurable cancers. GBM tumors are highly heterogeneous. However, most tumors contain a subpopulation of cells that display neural stem cell characteristics in vitro and that can generate a new brain tumor upon transplantation in mice. Hence, previously identified molecular pathways regulating neural stem cell biology were found to represent the cornerstone of GBM stem cell self-renewal mechanism. GBM tumors are also notorious for their resistance to radiation therapy. Notably, GBM “cancer stem cells” were also found to be responsible for this radioresistance. Herein, we will analyze the data supporting or not the cancer stem cell model in GBM, overview the current knowledge regarding GBM stem cell self-renewal and radioresistance molecular mechanisms, and discuss the potential therapeutic application of these findings

  10. Current status of radiation therapy for prostate cancer

    Institute of Scientific and Technical Information of China (English)

    2007-01-01

    Radiotherapy for the treatment of prostate cancer has been extensively explored in the past. Along with the comprehensive understanding of the biology of prostate cancer and rapid advances in terms of technology, the outcome of treatment for the patients with prostate cancer has improved. The authors review radiotherapy as the primary treatment for the disease, with particular emphasis on the technological advances from both the radiobiological and radiophysics aspects. Nonconventional fractionated irradiation like hyper- or hypo-fractionation has been implemented in the clinic, the final results still need to be confirmed in the future. Technological advances like IMRT, IGRT,in the last two decades have significantly improved the delivery of external radiotherapy to the prostate. This has resulted in an overall increase in the total dose that can be safely delivered to the prostate, which has led to modest improvements in the biochemical outcome. However, establishing the standard therapy for prostate cancer remains controversial. It is hoped that the next decades will bring continued advances in the development of biologicals that will further improve current clinical outcomes.

  11. Current status and perspectives of brachytherapy for cervical cancer.

    Science.gov (United States)

    Toita, Takafumi

    2009-02-01

    Standard definitive radiotherapy for cervical cancer consists of whole pelvic external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICBT). In Japan, high-dose-rate ICBT (HDR-ICBT) has been utilized in clinical practice for more than 40 years. Several randomized clinical trials demonstrated that HDR-ICBT achieved comparative outcomes, both for pelvic control and incidences of late complications, to low-dose-rate (LDR) ICBT. In addition, HDR-ICBT has some potential advantages over LDR-ICBT, leading to further improvement in treatment results. Prior to the current computer planning systems, some excellent treatment planning concepts were established. At present, systems modified from these concepts, or novel approaches, such as image-guided brachytherapy (IGBT) are under investigation. One serious problem to be solved in HDR-ICBT for cervical cancer is that of the discrepancy in standard treatment schedules for combination HDR-ICBT and EBRT between the United States and Japan. Prospective studies are ongoing to assess the efficacy and toxicity of the Japanese schedule. PMID:19225920

  12. [Current status and perspectives of radiotherapy for esophageal cancer].

    Science.gov (United States)

    Wu, S X; Wang, L H

    2016-09-23

    Esophageal cancer is one of the most common cancers in China. More than 80% of esophageal cancer patients are diagnosed at a late stage and are not eligible for surgery. Radiotherapy is one of the most important modalities in esophageal cancer treatment. Here we reviewed the advances in esophageal cancer radiotherapy and radiotherapy-based combined-modality therapy, such as optimization of radiation dose and target volume, application of precise radiotherapy technique and the integration of radiotherapy with chemotherapy and targeted therapy.

  13. Research on cancer diagnosis in Malaysia: current status.

    Science.gov (United States)

    Looi, L M; Zubaidah, Z; Cheah, P L; Cheong, S K; Gudum, H R; Iekhsan, O; Ikram, S I; Jamal, R; Mak, J W; Othman, N H; Puteri, J N; Rosline, H; Sabariah, A R; Seow, H F; Sharifah, N A

    2004-06-01

    Cancer is a major morbidity and mortality concern in Malaysia. Based on National Cancer Registry data, the Malaysian population is estimated to bear a cancer burden of about 40,000 new cases per year, and a cumulative lifetime risk of about 1:4. Cancer research in Malaysia has to consider needs relevant to our population, and resources constraints. Hence, funding bodies prioritise cancers of high prevalence, unique to our community and posing specific clinical problems. Cancer diagnosis is crucial to cancer management. While cancer diagnosis research largely aims at improvements in diagnostic information towards more appropriate therapy, it also impacts upon policy development and other areas of cancer management. The scope of cancer diagnosis upon which this paper is based, and their possible impact on other R&D areas, has been broadly categorized into: (1) identification of aetiological agents and their linkages to the development of precancer and cancer (impact on policy development, cancer prevention and treatment), (2) cancer biology and pathogenesis (impact on cancer prevention, treatment strategies and product development), (3) improvements in accuracy, sensitivity and specificity in cancer detection, monitoring and classification (impact on technology development) and (4) prognostic and predictive parameters (impact on treatment strategies). This paper is based on data collected by the Working Group on Cancer Diagnosis Research for the First National Conference on Cancer Research Coordination in April 2004. Data was collated from the databases of Institutions/Universities where the authors are employed, the Ministry of Science, Technology and Innovation (MOSTI) and targeted survey feedback from key cancer researchers. Under the 7th Malaysia Plan, 76 cancer projects were funded through the Intensified Research in Priority Areas (IRPA) scheme of MOSTI, amounting to almost RM15 million of grant money. 47(61.8%) of these projects were substantially in cancer

  14. Current Status and Future Perspectives in Differentiated Thyroid Cancer

    OpenAIRE

    Kim, Tae Yong; Kim, Won Gu; Kim, Won Bae; Shong, Young Kee

    2014-01-01

    Thyroid cancer is increasing all over the world. The exact cause of this increase is still debated and there are conflicting reports. Sophisticated molecular studies suggest that environmental chemicals may have effects of thyroid carcinogenesis. The development of powerful molecular biology techniques has enabled targeted next-generation sequencing for detection of mutations in thyroid cancer, and this technique can make a specific diagnosis of thyroid cancer in cytologically indeterminate c...

  15. Adjuvant Therapy of Colon Cancer: Current Status and Future Developments

    OpenAIRE

    Morse, Michael A.

    2005-01-01

    Options for the adjuvant therapy of resected stage III colon cancer have expanded beyond the previously well-accepted standard of 5-fluorouracil (5-FU) combined with leucovorin. The Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) study confirmed that capecitabine (Xeloda) is at least as effective and is less toxic than a bolus 5-FU and leucovorin regimen for patients with stage III colon cancer. This study, in addition to National Surgical Adjuvant Breast and Bowel Project (NSABP) C-06, which...

  16. Research on cancer diagnosis in Malaysia: current status.

    Science.gov (United States)

    Looi, L M; Zubaidah, Z; Cheah, P L; Cheong, S K; Gudum, H R; Iekhsan, O; Ikram, S I; Jamal, R; Mak, J W; Othman, N H; Puteri, J N; Rosline, H; Sabariah, A R; Seow, H F; Sharifah, N A

    2004-06-01

    Cancer is a major morbidity and mortality concern in Malaysia. Based on National Cancer Registry data, the Malaysian population is estimated to bear a cancer burden of about 40,000 new cases per year, and a cumulative lifetime risk of about 1:4. Cancer research in Malaysia has to consider needs relevant to our population, and resources constraints. Hence, funding bodies prioritise cancers of high prevalence, unique to our community and posing specific clinical problems. Cancer diagnosis is crucial to cancer management. While cancer diagnosis research largely aims at improvements in diagnostic information towards more appropriate therapy, it also impacts upon policy development and other areas of cancer management. The scope of cancer diagnosis upon which this paper is based, and their possible impact on other R&D areas, has been broadly categorized into: (1) identification of aetiological agents and their linkages to the development of precancer and cancer (impact on policy development, cancer prevention and treatment), (2) cancer biology and pathogenesis (impact on cancer prevention, treatment strategies and product development), (3) improvements in accuracy, sensitivity and specificity in cancer detection, monitoring and classification (impact on technology development) and (4) prognostic and predictive parameters (impact on treatment strategies). This paper is based on data collected by the Working Group on Cancer Diagnosis Research for the First National Conference on Cancer Research Coordination in April 2004. Data was collated from the databases of Institutions/Universities where the authors are employed, the Ministry of Science, Technology and Innovation (MOSTI) and targeted survey feedback from key cancer researchers. Under the 7th Malaysia Plan, 76 cancer projects were funded through the Intensified Research in Priority Areas (IRPA) scheme of MOSTI, amounting to almost RM15 million of grant money. 47(61.8%) of these projects were substantially in cancer

  17. Use of bisphosphonates in prostate cancer: Current status

    OpenAIRE

    Nayyar, Rishi; Gupta, Narmada P

    2007-01-01

    Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.

  18. [Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer].

    Science.gov (United States)

    Toita, Takafumi; Ariga, Takuro; Kasuya, Goro; Hashimoto, Seiji; Maemoto, Hitoshi; Heianna, Joichi; Kakinohana, Yasumasa; Murayama, Sadayuki

    2015-10-01

    Fifteen years has passed since the NCI announced the clinical importance of concurrent chemoradiotherapy (CCRT) in radiotherapy for patients with locoregionally advanced uterine cervical cancer. Numerous clinical trials have been performed to further improve the outcomes of CCRT. In addition to investigations of chemotherapeutic regimens and schedules, adaptation of novel radiotherapy methods such as image-guided brachytherapy (IGBT) and intensity-modulated radiotherapy (IMRT) is encouraged in CCRT for cervical cancer. PMID:26489545

  19. Current status of bevacizumab in advanced ovarian cancer

    Directory of Open Access Journals (Sweden)

    Tomao F

    2013-07-01

    Full Text Available Federica Tomao,1,* Anselmo Papa,2,* Luigi Rossi,2 Davide Caruso,2 Pierluigi Benedetti Panici,1 Martina Venezia,2 Silverio Tomao21Department of Gynaecology and Obstetrics, "Sapienza" University of Rome, Policlinico "Umberto I," Rome, Italy; 2Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Oncology Unit, "ICOT," Latina, Italy*Authors contributed equally to this workAbstract: Ovarian cancer is the most lethal gynecological cancer, mainly because of the delay in diagnosis. Recently, much effort has been put into investigating and introducing novel targeted agents into clinical practice, with the aim of improving prognosis and quality of life. Angiogenesis is a possible target. The aim of this review is to investigate the most common molecular pathways of angiogenesis, which have provided novel targets for tailored therapy in patients with ovarian cancer. These therapeutic strategies include monoclonal antibodies and tyrosine-kinase inhibitors. These drugs have as molecular targets vascular endothelial growth factor, vascular endothelial growth factor receptors, platelet-derived growth factor, fibroblast growth factor, and angiopoietin. Bevacizumab was investigated in several Phase III studies, with interesting results. Today, there is strong evidence for introducing bevacizumab in the treatment of patients with advanced and recurrent ovarian cancer. Nevertheless, further investigations and large clinical trials are needed to understand the safety and effectiveness of bevacizumab, the optimal duration and timing of treatment, and activity in association with other chemotherapeutic and targeted agents. It also is necessary to identify biologic factors predictive of efficacy to choose the most appropriate antiangiogenic agent in the integrated treatment of epithelial ovarian cancer.Keywords: epithelial ovarian cancer, angiogenesis, bevacizumab, vascular endothelial growth factor, chemotherapy

  20. Current status and prospect of therapy with advanced cancer

    International Nuclear Information System (INIS)

    Symtomatic or palliative therapy of the patients with advanced cancer must be directed to the relief of specific distressing symptoms caused by or associated with neoplasm. The radiotherapy must have a clear concepts of the potential accomplishments of other treatment modalities, such as neurosurgery, anesthesiology, chemotherapy, pharmacology and psychotherapy, so that he may use his own method in proper perspective. I discussed following is an list of contents in this papers. Relief of pain, Psychotherapy, SVC obstruction, Obstructive jaundice, Brain and lung metastasis, prevention of fracture, Skin metastasis, Liver metastasis and treatment of advanced pediaric tumor etc. For the future: 1) Establishment of Stage and Grade of advanced cancer. 2) Development of new chemotherapeutic drug and immunotherapy. 3) Combination of multidisciplinary team and multidisciplinary treatment. (author)

  1. Prostate Cancer Registries: Current Status and Future Directions

    OpenAIRE

    Gandaglia, G; Bray, F.; Cooperberg, MR; Karnes, RJ; Leveridge, MJ; Moretti, K; Murphy, DG; Penson, DF; Miller, DC

    2016-01-01

    © 2015 European Association of Urology. Context: Disease-specific registries that enroll a considerable number of patients play a major role in prostate cancer (PCa) research. Objective: To evaluate available registries, describe their strengths and limitations, and discuss the potential future role of PCa registries in outcomes research. Evidence acquisition: We performed a literature review of the Medline, Embase, and Web of Science databases. The search strategy included the terms prostate...

  2. Imaging in primary penile cancer: current status and future directions

    Energy Technology Data Exchange (ETDEWEB)

    Kochhar, Rohit; Taylor, Ben [Christie, NHS Foundation Trust, Department of Radiology, Manchester (United Kingdom); Sangar, Vijay [Christie, NHS Foundation Trust, Department of Urology, Manchester (United Kingdom)

    2010-01-15

    Penile cancer is a rare neoplasm in the developed world. Clinical assessment often results in inaccurate staging and radiological techniques have a key role in staging and postoperative assessment. Magnetic resonance imaging (MRI) depicts penile anatomy in detail and is the most accurate technique for local staging and postoperative follow-up. MRI and ultrasound (US), although helpful for assessment of lymph nodes, are not reliable enough for accurate nodal staging. US-guided fine needle aspiration cytology (FNAC), however, remains a valuable tool to confirm metastases in suspicious inguinal nodes. Lymphoscintigraphy with dynamic sentinel node biopsy (DSNB) is a promising technique used to predict occult lymph node metastases. Novel imaging techniques such as positron emission tomography/computed tomography (PET-CT) and nanoparticle enhanced MRI have high sensitivity and specificity for lymph node metastases but their availability is limited and clinical utility is not fully established. The radiologist needs to be familiar with the normal penile anatomy, imaging appearances of pre- and post-treatment penile cancer, and the advantages and limitations of the available imaging techniques. This review highlights the above points and presents a systematic approach to make the best use of imaging in the management of patients with penile cancer. (orig.)

  3. Radionuclide liver cancer therapies: from concept to current clinical status.

    Science.gov (United States)

    Vente, Maarten A D; Hobbelink, Monique G G; van Het Schip, Alfred D; Zonnenberg, Bernard A; Nijsen, Johannes F W

    2007-07-01

    Primary and secondary liver cancer have longtime been characterized by an overall poor prognosis since the majority of patients are not candidates for surgical resection with curative intent, systemic chemotherapy alone has rarely resulted in long-term survival, and the role of conventional external beam radiation therapy has traditionally been limited due to the relative sensitivity of the liver parenchyma to radiation. Therefore, a host of new treatment options have been developed and clinically introduced, including radioembolization techniques, which are the main topic of this paper. In these locoregional treatments liver malignancies are passively targeted because, unlike the normal liver, the blood supply of intrahepatic tumors is almost uniquely derived from the hepatic artery. These internal radiation techniques consist of injecting either yttrium-90 ((90)Y) microspheres, or iodine-131 ((131)I) or rhenium-188 ((188)Re) labeled lipiodol into the hepatic artery. Radioactive lipiodol is used exclusively for treatment of primary liver cancer, whereas (90)Y microsphere therapy is applied for treatment of both primary and metastatic liver cancers. Favorable clinical results have been achieved, particularly when (90)Y microspheres were used in conjunction with systemic chemotherapy. The main advantages of radiolabeled lipiodol treatment are that it is relatively inexpensive (especially (188)Re-HDD-lipiodol) and that the administration procedure is somewhat less complex than that of the microspheres. Holmium-166 ((166)Ho) loaded poly(L-lactic acid) microspheres have also been developed and are about to be clinically introduced. Since (166)Ho is a combined beta-gamma emitter and highly paramagnetic as well, it allows for both (quantitative) scintigraphic and magnetic resonance imaging. PMID:17630919

  4. Berry fruits for cancer prevention: current status and future prospects.

    Science.gov (United States)

    Seeram, Navindra P

    2008-02-13

    Overwhelming evidence suggests that edible small and soft-fleshed berry fruits may have beneficial effects against several types of human cancers. The anticancer potential of berries has been related, at least in part, to a multitude of bioactive phytochemicals that these colorful fruits contain, including polyphenols (flavonoids, proanthocyanidins, ellagitannins, gallotannins, phenolic acids), stilbenoids, lignans, and triterpenoids. Studies show that the anticancer effects of berry bioactives are partially mediated through their abilities to counteract, reduce, and also repair damage resulting from oxidative stress and inflammation. In addition, berry bioactives also regulate carcinogen and xenobiotic metabolizing enzymes, various transcription and growth factors, inflammatory cytokines, and subcellular signaling pathways of cancer cell proliferation, apoptosis, and tumor angiogenesis. Berry phytochemicals may also potentially sensitize tumor cells to chemotherapeutic agents by inhibiting pathways that lead to treatment resistance, and berry fruit consumption may provide protection from therapy-associated toxicities. Although a wide variety of berry fruits are consumed worldwide, this paper focuses on those commonly consumed in North America, namely, blackberries, black raspberries, blueberries, cranberries, red raspberries, and strawberries. In addition, a large body of studies on singly purified berry bioactives is available, but this paper focuses on studies of "whole berries" per se, that is, as berry extracts and purified fractions, juices, and freeze-dried powders. Potential mechanisms of anticancer action and bioavailability of berry phenolics, as well as gaps in knowledge and recommendations for future berry research, are also briefly discussed. PMID:18211019

  5. Cytochrome P450-based cancer gene therapy: current status.

    Science.gov (United States)

    Kan, On; Kingsman, Susan; Naylor, Stuart

    2002-12-01

    Results from a number of preclinical studies have demonstrated that a P450-based gene-directed enzyme prodrug therapy (GDEPT) strategy for the treatment of cancer is both safe and efficacious. This strategy has now moved forward into the clinic. At least two different approaches using different delivery methods (retroviral vector MetXia [Oxford BioMedica] and encapsulated P450 expressing cells), different cytochrome P450 isoforms (human CYP2B6 versus rat CYP2B1) and different prodrugs (cyclophosphamide [CPA] versus ifosfamide [IFA]) have concluded Phase I/II clinical trial with encouraging results. In the future, P450-based GDEPT can potentially be further enhanced by improved vectors for P450 gene delivery and disease-targeted promoters for focused gene expression at the target site. In addition, there is scope for developing synthetic P450s and their respective prodrugs to improve both enzyme kinetics and the profile of the active moiety. PMID:12517265

  6. Gastric cancer: Current status of lymph node dissection.

    Science.gov (United States)

    Degiuli, Maurizio; De Manzoni, Giovanni; Di Leo, Alberto; D'Ugo, Domenico; Galasso, Erica; Marrelli, Daniele; Petrioli, Roberto; Polom, Karol; Roviello, Franco; Santullo, Francesco; Morino, Mario

    2016-03-14

    D2 procedure has been accepted in Far East as the standard treatment for both early (EGC) and advanced gastric cancer (AGC) for many decades. Recently EGC has been successfully treated with endoscopy by endoscopic mucosal resection or endoscopic submucosal dissection, when restricted or extended Gotoda's criteria can be applied and D1+ surgery is offered only to patients not fitted for less invasive treatment. Furthermore, two randomised controlled trials (RCTs) have been demonstrating the non inferiority of minimally invasive technique as compared to standard open surgery for the treatment of early cases and recently the feasibility of adequate D1+ dissection has been demonstrated also for the robot assisted technique. In case of AGC the debate on the extent of nodal dissection has been open for many decades. While D2 gastrectomy was performed as the standard procedure in eastern countries, mostly based on observational and retrospective studies, in the west the Medical Research Council (MRC), Dutch and Italian RCTs have been conducted to show a survival benefit of D2 over D1 with evidence based medicine. Unfortunately both the MRC and the Dutch trials failed to show a survival benefit after the D2 procedure, mostly due to the significant increase of postoperative morbidity and mortality, which was referred to splenopancreatectomy. Only 15 years after the conclusion of its accrual, the Dutch trial could report a significant decrease of recurrence after D2 procedure. Recently the long term survival analysis of the Italian RCT could demonstrate a benefit for patients with positive nodes treated with D2 gastrectomy without splenopancreatectomy. As nowadays also in western countries D2 procedure can be done safely with pancreas preserving technique and without preventive splenectomy, it has been suggested in several national guidelines as the recommended procedure for patients with AGC. PMID:26973384

  7. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

    Directory of Open Access Journals (Sweden)

    Zaman Mohd Saif

    2012-12-01

    Full Text Available Abstract Ovarian cancer is the fifth most common cancer among women and causes more deaths than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is based on the combination of surgery and chemotherapy. While recurrent ovarian cancer responds to additional chemotherapy treatments, the progression-free interval becomes shorter after each cycle, as chemo-resistance increases until the disease becomes incurable. There is, therefore, a strong need for prognostic and predictive markers to help optimize and personalize treatment in order to improve the outcome of ovarian cancer. An increasing number of studies indicate an essential role for microRNAs in ovarian cancer progression and chemo-resistance. MicroRNAs (miRNAs are small endogenous non-coding RNAs (~22bp which are frequently dysregulated in cancer. Typically, miRNAs are involved in crucial biological processes, including development, differentiation, apoptosis and proliferation. Two families of miRNAs, miR-200 and let-7, are frequently dysregulated in ovarian cancer and have been associated with poor prognosis. Both have been implicated in the regulation of epithelial-to-mesenchymal transition, a cellular transition associated with tumor aggressiveness, tumor invasion and chemo-resistance. Moreover, miRNAs also have possible implications for improving cancer diagnosis; for example miR-200 family, let-7 family, miR-21 and miR-214 may be useful in diagnostic tests to help detect ovarian cancer at an early stage. Additionally, the use of multiple target O-modified antagomirs (MTG-AMO to inhibit oncogenic miRNAs and miRNA replacement therapy for tumor suppressor miRNAs are essential tools for miRNA based cancer therapeutics. In this review we describe the current status of the role miRNAs play in ovarian cancer and focus on the possibilities of microRNA-based therapies and the use of microRNAs as diagnostic tools.

  8. Current status of methodology research on nuclear medicine on sentinel lymph node biopsy in breast cancer

    International Nuclear Information System (INIS)

    Breast cancer is the most common malignancy of the female,and axillary lymph node dissection has been considered as the basic method in breast cancer surgery. Sentinel lymph node biopsy (SLNB) in recent years is accepted gradually both at home and abroad because it not only can avoid complications but also has the advantages of safe and simple operation, high accuracy, and slight trauma. It has taken the place of axillary lymph node dissection in the treatment of axillary node-negative patients. Nuclear medicine inspection has played a crucial role in SLNB, and radiotracers, injecting techniques,detecting methods and standards have great influence upon the accuracy and false-negative rate of axillary lymph nodes and internal mammary lymph nodes detection. In this review, the current methodology status of nuclear medicine is summarized on SLNB in breast cancer at home and abroad. (authors)

  9. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears

    Institute of Scientific and Technical Information of China (English)

    ME de Noo; RAEM Tollenaar; AM Deelder; LH Bouwman

    2006-01-01

    Colorectal adenocarcinoma (CRC) is the third most common type of cancer and the fourth most frequent cause of death due to cancer worldwide. Given the natural history of CRC, early diagnosis appears to be the most appropriate tool to reduce disease-related mortality. A field of recent interest is clinical proteomics, which was reported to lead to high sensitivity and specificities for early detection of several solid tumors. This emerging field uses mass spectrometry-based protein profiles/patterns of easy accessible body fluids to distinguish cancer from non-cancer patients. These discrepancies may be a result of: (1) proteins being abnormally produced or shed and added to the serum proteome, (2) proteins clipped or modified as a consequence of the disease process, or (3) proteins subtracted from the proteome owing to disease-related proteolytic degradation pathways. Therefore, protein pattern diagnostics would provide easy and reliable tools for detection of cancer. This paper focuses on the current status of clinical proteomics research in oncology and in colorectal cancer especially,and will reflect on pitfalls and fears in this relatively new area of clinical medicine, which are reproducibility issues and pre-analytical factors, statistical issues, and identification and nature of discriminating proteins/peptides.

  10. Targeted therapy for advanced gastric cancer: A review of current status and future prospects

    Institute of Scientific and Technical Information of China (English)

    Ozkan; Kanat; Bert; O’Neil; Safi; Shahda

    2015-01-01

    In the West in particular, the vast majority of gastric cancer(GC) patients present with advanced-stage disease. Although combination chemotherapy is stillthe most important component of treatment for these patients, it confers a modest survival advantage. Recently, increased knowledge of the key molecular signaling pathways involved in gastric carcinogenesis has led to the discovery of specific molecular-targeted therapeutic agents. Some of these agents such as trastuzumab and ramucirumab have changed the treatment paradigm for this disease. In this paper, we will summarize the current clinical status of targeted drug therapy in the management of GC.

  11. HPV and Cervical Cancer Epidemiology - Current Status of HPV Vaccination in India.

    Science.gov (United States)

    Chatterjee, Sharmila; Chattopadhyay, Amit; Samanta, Luna; Panigrahi, Pinaki

    2016-01-01

    Cervical cancer (CaCx) is the second most fatal cancer contributing to 14% of cancers in Indian females, which account for 25.4% and 26.5% of the global burden of CaCx prevalence and mortality, respectively. Persistent infection with high-risk human papilloma virus (HPV- strains 16 and 18) is the most important risk factor for precursors of invasive CaCx. Comprehensive prevention strategies for CaCx should include screening and HPV vaccination. Three screening modalities for CaCx are cytology, visual inspection with acetic acid, and HPV testing. There is no Indian national policy on CaCx prevention, and screening of asymptomatic females against CaCx is practically non-existent. HPV vaccines can make a major breakthrough in the control of CaCx in India which has high disease load and no organized screening program. Despite the Indian Government's effort to introduce HPV vaccination in the National Immunization Program and bring down vaccine cost, challenges to implementing vaccination in India are strong such as: inadequate epidemiological evidence for disease prioritization, duration of vaccine use, parental attitudes, and vaccine acceptance. This paper reviews the current epidemiology of CaCx and HPV in India, and the current status of HPV vaccination in the country. This article stresses the need for more research in the Indian context, to evaluate interventions for CaCx and assess their applicability, success, scalability and sustainability within the constraints of the Indian health care system. PMID:27644600

  12. Current status and evolution of preclinical drug development models of epithelial ovarian cancer

    Directory of Open Access Journals (Sweden)

    Panagiotis A Konstantinopoulos

    2013-12-01

    Full Text Available Epithelial ovarian cancer (EOC is the most lethal gynecologic malignancy and the fifth most common cause of female cancer death in the United States. Although important advances in surgical and chemotherapeutic strategies over the last three decades have significantly improved the median survival of EOC patients, the plateau of the survival curve has not changed appreciably. Given that EOC is a genetically and biologically heterogeneous disease, identification of specific molecular abnormalities that can be targeted in each individual ovarian cancer on the basis of predictive biomarkers promises to be an effective strategy to improve outcome in this disease. However, for this promise to materialize, appropriate preclinical experimental platforms that recapitulate the complexity of these neoplasms and reliably predict antitumor activity in the clinic are critically important. In this review, we will present the current status and evolution of preclinical models of EOC, including cell lines, immortalized normal cells, xenograft models, patient-derived xenografts and animal models, and will discuss their potential for oncology drug development.

  13. Comparative Analysis of the Current Status, Own Body Perception and Positive Experience From Diagnosed Breast Cancer

    Directory of Open Access Journals (Sweden)

    Zornitza Ganeva

    2013-04-01

    Full Text Available Comparative analysis of the current status, own body perception and positive experience within a period of up to 1 year from diagnosing ofwomen with breast cancer (N = 41; mean age 35.25 in the 1st, 2nd and 3rd stages of the disease progress, of Bulgarian origin, was made.Reliability and validity of the scales were described. They were analysed with respect to: 1 medical characteristics (partial or total surgery,surgical removal of lymph nodes, presence or absence of metastases in them, 2 classical therapies (chemotherapy, radiation therapy andhormonal therapy administered or not and 3 application or not of alternative therapies (herbal medicine, physical load, administration ofmassage, lymph drainage, use of nutritional supplements, observance of diet. The results showed that the more therapies the personssurveyed were undergone the more unsatisfactory they assessed their current general status. The bigger the size of the surgery performedto remove the tumour the more positive idea of their own bodies they had. The more time after the surgical treatment passed the more thepositive experience accumulated from the oncologic diagnosis grew.

  14. Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges

    Institute of Scientific and Technical Information of China (English)

    Anil; Suri; Nirmala; Jagadish; Shikha; Saini; Namita; Gupta

    2015-01-01

    Colorectal cancer ranks third among the estimatedcancer cases and cancer related mortalities in United States in 2014. Early detection and efficient therapy remains a significant clinical challenge for this disease. Therefore, there is a need to identify novel tumor asso-ciated molecules to target for biomarker development and immunotherapy. In this regard, cancer testis antigens have emerged as a potential targets for developing novel clinical biomarkers and immunotherapy for various malignancies. These germ cell specific proteins exhibit aberrant expression in cancer cells and contribute in tumorigenesis. Owing to their unique expression profile and immunogenicity in cancer patients, cancer testis antigens are clinically referred as the most promising tumor associated antigens. Several cancer testis antigens have been studied in colorectal cancer but none of them could be used in clinical practice. This review is an attempt to address the promising cancer testis antigens in colorectal cancer and their possible clinical implications as biomarkers and immunotherapeutic targets with particular focus on challenges and future interventions.

  15. [Current status and prospect of treatment for esophageal cancer in the era of precision medicine].

    Science.gov (United States)

    Guo, X T; He, J

    2016-09-23

    Esophageal cancer (EC) is one of the most common malignant tumors around the world and has a high incidence in China. Chinese EC patients account for more than 50% in the world. The pathological subtype of EC shows a geographic distribution. Adenocarcinoma is the main pathological type in western countries, while squamous cell carcinoma is the dominant subtype in China. Thus specific diagnosis and treatment of EC are needed for Chinese patients. Although early diagnosis, progress in surgery and comprehensive treatment of EC have made remarkable achievements in China in recent years, yet the prognosis for resectable EC patients remains poor, with a 5-year survival of 30%. In addition, as the level of treatment varies significantly in different regions and centers around China, the current status of treatment for EC needs further improvement. This article reviews the advances in the treatment for EC in recent years, analyzes the present problems, and explores the perspective of the progress in esophageal cancer treatment in the era of precision medicine.

  16. Current status of radiation therapy. Evidence-based medicine (EBM) of radiation therapy. Current management of patients with esophageal cancer

    Energy Technology Data Exchange (ETDEWEB)

    Nemoto, Kenji [Tohoku Univ., Sendai (Japan). School of Medicine

    2002-03-01

    The best management for small mucosal esophageal cancer is generally endoscopic mucosal resection. However, for submucosal cancer and extensive mucosal caner, either radical surgery or radiation seems to be an equally efficacious option. Radiation therapy concurrent with chemotherapy is more effective than radiation therapy alone for patients with unresectable esophageal cancer. The key drugs are cisplatin and 5-fluorouracil. However, for patients with poor performance status or for aged patients, radiation therapy alone is still a choice of treatment. Surgery has generally been indicated for patients with resectable esophageal cancer. However, outcomes of concurrent chemoradiation therapy may be comparable with those of surgery. Therefore, a prospective randomized study should be performed to determine the best management for patients with resectable esophageal cancer. The usefulness of intra-cavitary irradiation for esophageal cancer has not been clarified. A prospective randomized trial with a large number of patients is necessary to determine the effectiveness of intra-cavitary irradiation. The best management for patients with loco-regionally recurrent esophageal cancer after surgery has not been determined. Intensive therapy should be considered if the site of recurrence is limited and the time interval from surgery to recurrence is long. Chemotherapy is essential in the management of patients with small cell esophageal cancer. However, the best local therapy has not been determined. (author)

  17. Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain

    Directory of Open Access Journals (Sweden)

    Prommer E

    2012-06-01

    Full Text Available Eric Prommer, Brandy FicekDivision of Hematology/Oncology, Mayo Clinic College of Medicine, Mayo Clinic Hospital, Scottsdale, AZ, USAAbstract: Breakthrough pain is a newly recognized pain category that was first described by Portenoy and Hagen in 1990. The term describes pain that increases in intensity to “break through” chronic pain that is being controlled by a scheduled opioid regimen. The development of fluctuations in pain intensity is challenging due to their unpredictable nature, rapid onset, and need for rapid treatment intervention. Breakthrough pain has been treated by using an extra opioid dose in addition to the scheduled opioid being used for pain. Recommendations for dose and frequency are based on expert opinion only, and have included dosing based on a percentage of the total opioid dose. Other recommendations include increasing the regularly scheduled opioid dose. Clinical trials have now focused on delivery of opioids that have both potency and a rapid onset of action. Lipophilic opioids have received a substantial amount of study due to their quick absorption and rapid onset of analgesia. Lipophilic opioids that have been studied to date include transmucosal fentanyl, sublingual fentanyl, intranasal sufentanil, and oral and sublingual methadone. Initial clinical trials have established the superiority of transmucosal fentanyl as a breakthrough analgesic when compared with immediate-release oral opioid formulations. Problems with bioavailability have led to a search for newer formulations of transmucosal delivery. Newer formulations, such as fentanyl transmucosal tablets, have been developed to ensure superior delivery for the patient suffering from breakthrough pain. The purpose of this paper is to discuss the current status of transmucosal tablet formulations for cancer breakthrough pain.Keywords: fentanyl, transmucosal, tablets, pain, breakthrough, cancer

  18. [Current status and prospect of perioperative thrombus management in gastrointestinal cancer].

    Science.gov (United States)

    Qin, X Y

    2016-03-01

    Thanks to the progress of surgical theory and skills, as well as the application of modern medical devices in general surgery, both the occurrence of perioperative complications and mortality of gastrointestinal surgery have significantly reduced recently. However, it is still far from optimal in terms of the perioperative venous thromboembolism (VTE) management in gastrointestinal cancer, and what is responsible for that? This paper aims at finding out the reasons contributing to the current status, giving suggestions for how to make improvement at both disease level and hospital management level. At the same time, while paying attention for the prophylaxis of VTE, there have been more and more patients receiving antithrombotic treatment require elective or emergent surgery in clinical practice, due to aging and increased incidence of cardiovascular disease year by year. How to balance the bleeding and thrombosis risk for these patients during perioperative periods is also a question we are going to discuss. In conclusion, as to the issue of the management of perioperative thrombosis, there will be a long way for Chinese doctors to go. Our peers should pay more attention to this problem and take more efforts, so that the thrombotic complications in surgical patients can be reduced. PMID:26932880

  19. Current Status of Poly(ADP-ribose Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer

    Directory of Open Access Journals (Sweden)

    David J. Hiller

    2012-01-01

    Full Text Available Triple-negative breast cancer (TNBC is an aggressive type of breast cancer that is clinically defined as lacking estrogen and progesterone receptors, as well as being ERBB2 (HER-2 negative. Without specific therapeutic targets, TNBC carries a worse prognosis than other types of breast cancer in the absence of therapy. Research has now further differentiated breast cancer into subtypes based on genetic expression patterns. One of these subtypes, basal-like, frequently overlaps with the clinical picture of TNBC. Additionally, both TNBC and basal-like breast cancer link to BRCA mutations. Recent pharmaceutical advances have created a class of drugs, poly(ADP-ribose polymerase (PARP inhibitors, which are showing potential to effectively treat these patients. The aim of this paper is to summarize the basis behind PARP inhibitors and update the current status of their development in clinical trials for the treatment of TNBC.

  20. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer

    Institute of Scientific and Technical Information of China (English)

    Norihisa; Uemura; Tadashi; Kondo

    2014-01-01

    Neoadjuvant therapy has been proven to be extremely valuable and is widely used for advanced esophageal cancer. However, a significant proportion of treated patients(60%-70%) does not respond well to neoadjuvant treatments and develop severe adverse effects. Therefore, predictive markers for individualization of multimodality treatments are urgently needed in esophageal cancer. Recently, molecular biomarkers that predict the response to neoadjuvant therapy have been explored in multimodal approaches in esophageal cancer and successful examples of biomarker identification have been reported. In this review, promising candidates for predictive molecular biomarkers developed by using multiple molecular approaches are reviewed. Moreover, treatment strategies based on the status of predicted biomarkers are discussed, while considering the international differences in the clinical background. However, in the absence of adequate treatment options related to the results of the biomarker test, the usefulness of these diagnostic tools is limited and new effective therapies for biomarker-identified nonresponders to cancer treatment should be concurrent with the progress of predictive technologies. Further improvement in the prognosis of esophageal cancer patients can be achieved through the introduction of novel therapeutic approaches in clinical practice.

  1. Current Status and Development of Traditional Chemotherapy in Non-small Cell Lung Cancer under the Background of Targeted Therapy

    OpenAIRE

    Zhang, Guowei; Wang, Huijuan; Mina ZHANG; Li, Peng; Ma, ZhiYong

    2015-01-01

    In recent years, along with rapid development of targeted therapy in non-small cell lung cancer, traditional chemotherapy get less and less attention. Yet it still can not be ignored in the current that how to locate and use traditional chemotherapy so patients could derive maximum benefit. For this purpose, through the literature review and analysis, we point out there are still many traditional chemotherapy irreplaceable places whatever patients’ driver gene status. And there are some new t...

  2. The status of current epidemiological knowledge of radiocarcinogenecity: other, miscellaneous cancers

    International Nuclear Information System (INIS)

    Currently available epidemiological data indicate low or intermediate levels of sensitivity for radiation-induced cancers of most tissues and organ systems other than lung, thyroid and female breast, and leukaemia. However, the estimated risks for these ''other, miscellaneous'' cancers may reflect deficiencies in the data as a result of small study populations, insufficient population dose to detect an effect, uncertainties in dosimetry or the confounding or modifying effects of unknown or unevaluated risk factors. Additional information is necessary to improve existing risk estimates for the malignancies in the other, miscellaneous category. This may be obtained by continued follow-up of the populations currently under study, application of new and developing molecular technologies to identify and quantify radiation exposures for individuals, and pooled or parallel analyses of multiple populations. Cancers of the following tissues are briefly discussed:- digestive system, genito-urinary system, brain or central nervous system, lymphoma, multiple myeloma, bone and skin. (Author)

  3. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.

    Science.gov (United States)

    Shiota, Masaki; Eto, Masatoshi

    2016-05-01

    Since 1941, androgen deprivation therapy has been the primary treatment for metastatic hormone-sensitive prostate cancer. Androgen deprivation therapy consists of several regimens that vary according to therapeutic modality, as well as treatment schedule. Androgen deprivation therapy initially shows excellent antitumor effects, such as relief of cancer-related symptoms, tumor marker decline and tumor shrinking. However, most metastatic hormone-sensitive prostate cancer cases eventually develop castration resistance and become lethal. Taxanes, such as docetaxel and cabazitaxel, as well as novel androgen receptor-targeting agents, such as abiraterone acetate and enzalutamide, have emerged for metastatic castration-resistant prostate cancer. The concept and principle of primary therapy for metastatic hormone-sensitive prostate cancer has remained unchanged for decades. Recently, upfront docetaxel chemotherapy has been shown to prolong overall survival in men with metastatic hormone-sensitive prostate cancer, and would lead to a paradigm shift in primary pharmacotherapy for metastatic hormone-sensitive prostate cancer. This raises the possibility of upfront use of taxanes, as well as novel androgen receptor-targeting agents combined with androgen deprivation therapy. The present review summarizes the current status of primary pharmacotherapy for metastatic hormone-sensitive prostate cancer, and discusses future perspectives in this field. PMID:27062039

  4. Concurrent chemo-radiotherapy in the treatment of early breast cancer: Current status

    Directory of Open Access Journals (Sweden)

    Nabil Ismaili

    2013-01-01

    Full Text Available Concurrent chemo-radiotherapy (CCRT in early breast cancer was investigated by few authors and remains controversial. This treatment is more commonly used for locally advanced breast cancer and showed high rate of complete pathological response. A search of articles published in English literature, between 1980 and November 2012, was conducted on Medline using the following terms: "breast cancer", "chemotherapy", "concurrent radiotherapy", and "Trastuzumab". We identified five phase I/II trials and three randomized phase three trials evaluating concurrent chemoradiotherapy in the adjuvant of breast cancer. In patients with early breast cancer having positive lymph nodes, phases III clinical trials showed that CCRT improved local control after conservative breast surgery. However, these randomized trials used non-standard regimen: Cyclophosphamide, methotrexate and fluorouracil (CMF or fluorouracil, mitoxantrone and cyclophosphamide (FNC. In addition, in phases II clinical trials, concurrent use of taxanes and anthracycline with standard whole-breast irradiation showed high rate of toxicity: Pulmonary toxicity with taxane; and cardiac and skin toxicity with anthracycline. Consequentely, CCRT is not be used in practice because of concerns of toxicity with the standard drugs (anthracyclines and taxanes and radiation. Anthracyclines with partial breast irradiation (PBI was feasible according to one phase I clinical trial, and should be investigated in randomized clinical trials. Concurrent Trastuzumab plus radiotherapy is safe and can be used in HER2-positive breast cancer; in this case, cardiac volume sparing and patient selections for internal mammary chain irradiation are highly recommended. The present paper aimed to review the current data evaluating the efficacy and safety of CCRT in early breast cancer.

  5. Current status of ultrasound-guided surgery in the treatment of breast cancer.

    Science.gov (United States)

    Volders, José H; Haloua, Max H; Krekel, Nicole Ma; Meijer, Sybren; van den Tol, Petrousjka M

    2016-02-10

    The primary goal of breast-conserving surgery (BCS) is to obtain tumour-free resection margins. Margins positive or focally positive for tumour cells are associated with a high risk of local recurrence, and in the case of tumour-positive margins, re-excision or even mastectomy are sometimes needed to achieve definite clear margins. Unfortunately, tumour-involved margins and re-excisions after lumpectomy are still reported in up to 40% of patients and additionally, unnecessary large excision volumes are described. A secondary goal of BCS is the cosmetic outcome and one of the main determinants of worse cosmetic outcome is a large excision volume. Up to 30% of unsatisfied cosmetic outcome is reported. Therefore, the search for better surgical techniques to improve margin status, excision volume and consequently, cosmetic outcome has continued. Nowadays, the most commonly used localization methods for BCS of non-palpable breast cancers are wire-guided localization (WGL) and radio-guided localization (RGL). WGL and RGL are invasive procedures that need to be performed pre-operatively with technical and scheduling difficulties. For palpable breast cancer, tumour excision is usually guided by tactile skills of the surgeon performing "blind" surgery. One of the surgical techniques pursuing the aims of radicality and small excision volumes includes intra-operative ultrasound (IOUS). The best evidence available demonstrates benefits of IOUS with a significantly high proportion of negative margins compared with other localization techniques in palpable and non-palpable breast cancer. Additionally, IOUS is non-invasive, easy to learn and can centralize the tumour in the excised specimen with low amount of healthy breast tissue being excised. This could lead to better cosmetic results of BCS. Despite the advantages of IOUS, only a small amount of surgeons are performing this technique. This review aims to highlight the position of ultrasound-guided surgery for malignant breast

  6. Current status of immunotherapy for non-small-cell lung cancer.

    Science.gov (United States)

    Imbimbo, Martina; Lo Russo, Giuseppe; Blackhall, Fiona

    2016-08-01

    In the last few years, the introduction of novel immunotherapeutic agents has represented a treatment shift for a subset of patients with non-small-cell lung cancer (NSCLC). Checkpoint inhibitors have been demonstrated to improve survival in advanced stage disease with very good tolerability. This success follows many years of scientific effort to manipulate the human immune system to attack cancer cells. With a variety of approaches ranging from vaccines to administration of interleukin or interferon-γ, the results in NSCLC were unsuccessful, with the view that it is a scarcely immunogenic cancer, unlike melanoma or renal cell carcinoma. The step change has come from understanding of immune checkpoints-cell surface molecules that regulate immune system activation and mediate coinhibitory signaling pathways that physiologically protect the body from autoimmunity. These pathways play an important role in tumors, including NSCLC, and are a mechanism of escape from immune surveillance. Several monoclonal antibodies have been developed in order to inhibit these molecules and unleash the brakes of the immune system. Currently in NSCLC, 7 different checkpoint inhibitors are under investigation: 2 anti-cytotoxic T-lymphocyte-associated antigen 4, 2 anti-programmed death (PD)-1, and 3 anti-PD-ligand 1 antibodies. Here we review the progress to date in developing immunotherapy for NSCLC, summarize results from published trials, highlight ongoing trials, and discuss progress in the question of how best to select patients for this treatment. PMID:27443896

  7. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer

    Energy Technology Data Exchange (ETDEWEB)

    Raja, J. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom)]. E-mail: jowadraja@gmail.com; Ramachandran, N. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom); Munneke, G. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom); Patel, U. [Department of Radiology, St George' s Hospital, Tooting, London (United Kingdom)

    2006-02-15

    In contemporary practice, most prostate cancers are either invisible on ultrasound or indistinguishable from concurrent benign prostatic hyperplasia. Diagnosis therefore rests on prostate biopsy. Biopsies are not simply directed at ultrasonically visible lesions, as these would miss many cancers; rather the whole gland is sampled. The sampling itself is systematic, using patterns based on prostate zonal anatomy and the geographical distribution and frequency of cancer. This review explains the evolution of the prostate biopsy technique, from the classical sextant biopsy method to the more recent extended biopsy protocols (8, 10, 12, >12 and saturation biopsy protocols). Extended protocols are increasingly being used to improve diagnostic accuracy, especially in those patients who require repeat biopsy. This trend has been facilitated by the ongoing improvement in safety and acceptability of the procedure, particularly with the use of antibiotic prophylaxis and local anaesthesia. The technical details of these extended protocols are discussed, as are the current data regarding procedure-related morbidity and how this may be minimized.

  8. Helicobacter pylori and gastric cancer: current status of the Austrian-Czech-German gastric cancer prevention trial (PRISMA-Study)

    Institute of Scientific and Technical Information of China (English)

    S. Miehlke; A. Leodolter; P. Malfertheiner; A. Neubauer; G. Ehninger; M. Stolte; E, Bayerdorffer; C. Kirsch; B. Dragosics; M. Gschwantler; G. Oberhuber; D. Antos; P. Dite; J. Lauter; J. Labenz

    2001-01-01

    AIM To test the hypothesis that Helicobacter pylori eradication alone can reduce the incidence of gastric cancer in a subgroup of individuals with an increased risk for this fatal disease.METHODS It is a prospective, randomized,double-blind, placebo-controlled multinational multicenter trial. Men between 55 and 65 years of age with a gastric cancer phenotype of Helicobacterpylori gastritis are randomized to receive a 7-day course of omeprazole 2 × 20 mg,clarithromycin 2 × 500 mg, and amoxicillin 2 ×lg for 7 days, or omeprazole2 × 20mg plusplacebo. Follow - up endoscopy is scheduled 3months after therapy, and thereafter in one-year intervals. Predefined study endpoints are gastric cancer, precancerous lesions (dysplasia, adenoma), other cancers, anddeath.RESULTS Since March 1998, 1524 target patients have been screened, 279 patients (18.3%) had a corpus-dominant type of H.pylori gastritis, and 167 of those were randomized (58.8%). In the active treatment group (n -- 86), H. pylori infection infection was cured in 88.9% of patients. Currently, thecumulative follow-up time is 3046 months (253.8patient-years, median follow-up 16 months). So far, none of the patients developed gastric cancer or any precancerous lesion. Three(1.8%) patients reached study endpoints other than gastric cancer.CONCLUSION Among men between 55 and 65years of age, the gastric cancer phenotype of H.pylori gastritis appears to be more common than expected. Further follow- up and continuing recruitment are necessary to fulfil the main aim of the study.

  9. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives

    OpenAIRE

    Chun-Wei Peng; Yan Li

    2010-01-01

    The semiconductor nanocrystal quantum dots (QDs) have excellent photo-physical properties, and the QDs-based probes have achieved encouraging developments in cellular and in vivo molecular imaging. More and more researches showed that QDs-based technology may become a promising approach in cancer research. In this review, we focus on recent application of QDs in cancer diagnosis and treatment, including early detection of primary tumor such as ovarian cancer, breast cancer, prostate cancer an...

  10. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives

    Directory of Open Access Journals (Sweden)

    Chun-Wei Peng

    2010-01-01

    Full Text Available The semiconductor nanocrystal quantum dots (QDs have excellent photo-physical properties, and the QDs-based probes have achieved encouraging developments in cellular and in vivo molecular imaging. More and more researches showed that QDs-based technology may become a promising approach in cancer research. In this review, we focus on recent application of QDs in cancer diagnosis and treatment, including early detection of primary tumor such as ovarian cancer, breast cancer, prostate cancer and pancreatic cancer, as well as regional lymph nodes and distant metastases. With the development of QDs synthesis and modification, the effect of QDs on tumor metastasis investigation will become more and more important in the future.

  11. Current Status on Stem Cells and Cancers of the Gastric Epithelium

    Directory of Open Access Journals (Sweden)

    Werner Hoffmann

    2015-08-01

    Full Text Available Gastric cancer is still a leading cause of cancer-related mortality worldwide in spite of declining incidence. Gastric cancers are, essentially, adenocarcinomas and one of the strongest risk factors is still infection with Helicobacter pylori. Within the last years, it became clear that gastric self-renewal and carcinogenesis are intimately linked, particularly during chronic inflammatory conditions. Generally, gastric cancer is now regarded as a disease resulting from dysregulated differentiation of stem and progenitor cells, mainly due to an inflammatory environment. However, the situation in the stomach is rather complex, consisting of two types of gastric units which show bidirectional self-renewal from an unexpectedly large variety of progenitor/stem cell populations. As in many other tumors, cancer stem cells have also been characterized for gastric cancer. This review focuses on the various gastric epithelial stem cells, how they contribute to self-renewal and which routes are known to gastric adenocarcinomas, including their stem cells.

  12. Current status of gene therapy for breast cancer: progress and challenges

    Directory of Open Access Journals (Sweden)

    McCrudden CM

    2014-11-01

    Full Text Available Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as cancer DNA vaccines. However, the bottleneck in creating such nucleic acid pharmaceuticals lies in the delivery. Deliverability of DNA is limited as it is prone to circulating nucleases; therefore, numerous strategies have been employed to aid with biological transport. This review will discuss some of the viral and nonviral approaches to breast cancer gene therapy, and present the findings of clinical trials of these therapies in breast cancer patients. Also detailed are some of the most recent developments in nonviral approaches to targeting in breast cancer gene therapy, including transcriptional control, and the development of recombinant, multifunctional bio-inspired systems. Lastly, DNA vaccines for breast cancer are documented, with comment on requirements for successful pharmaceutical product development.Keywords: breast cancer, gene therapy, nonviral, clinical trial

  13. Stem cell technology in breast cancer: current status and potential applications

    Directory of Open Access Journals (Sweden)

    Chiotaki R

    2016-04-01

    Full Text Available Rena Chiotaki, Hara Polioudaki, Panayiotis A Theodoropoulos Department of Biochemistry, School of Medicine, University of Crete, Heraklion, Greece Abstract: Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs. BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. Keywords: breast cancer stem cells, cancer stem cell heterogeneity, targeting cancer stem cells, circulating tumor cells, stem cell technology

  14. Stem cell technology in breast cancer: current status and potential applications.

    Science.gov (United States)

    Chiotaki, Rena; Polioudaki, Hara; Theodoropoulos, Panayiotis A

    2016-01-01

    Breast cancer, the leading cause of cancer among females, is supported by the presence of a rare subset of undifferentiated cells within the tumor, identified as breast cancer stem cells (BCSCs). BCSCs underlie the mechanisms of tumor initiation and sustenance and are implicated in the dissemination of the primary tumor to metastatic sites, as they have been found circulating in the blood of breast cancer patients. The discovery of BCSCs has generated a great amount of interest among the scientific community toward their isolation, molecular characterization, and therapeutic targeting. In this review, after summarizing the literature on molecular characterization of BCSCs and methodologies used for their isolation, we will focus on recent data supporting their molecular and functional heterogeneity. Additionally, following a synopsis of the latest approaches for BCSC targeting, we will specifically emphasize on the therapeutic use of naïve or engineered normal stem cells in the treatment of breast cancer and present contradictory findings challenging their safety. PMID:27217783

  15. Quantum Dots for Cancer Research: Current Status, Remaining Issues, and Future Perspectives

    International Nuclear Information System (INIS)

    Cancer is a major threat to public health in the 21st century because it is one of the leading causes of death worldwide. The mechanisms of carcinogenesis, cancer invasion, and metastasis remain unclear. Thus, the development of a novel approach for cancer detection is urgent, and real-time monitoring is crucial in revealing its underlying biological mechanisms. With the optical and chemical advantages of quantum dots (QDs), QD-based nanotechnology is helpful in constructing a biomedical imaging platform for cancer behavior study. This review mainly focuses on the application of QD-based nanotechnology in cancer cell imaging and tumor microenvironment studies both in vivo and in vitro, as well as the remaining issues and future perspectives

  16. Development and Current Status of National Cancer Center for Chinese Medicine

    Institute of Scientific and Technical Information of China (English)

    LI Jie; LIN Hong-sheng; HOU Wei; ZHANG Pei-tong; HUA Bao-jin

    2011-01-01

    @@ Chinese medicine (CM) is an important feature of cancer treatment in China.Especially in the last 10years, the effect of CM in cancer treatment has been of high concern and has been accepted by experts and patients locally and overseas.The oncology department (OD) of Guang'anmen Hospital (GAMH) of China Academy of Chinese Medical Sciences (CATCM),which will mark its 50th anniversary in 2013, is one of China's most-respected centers devoted exclusively to cancer patient care, research, education, and prevention through CM.It is located at the campus of GAMH,central Beijing.

  17. [Current status and future prospect of internal medicine treatment for advanced esophageal cancer].

    Science.gov (United States)

    Wang, F; Fan, Q X

    2016-09-23

    Esophageal cancer (EC) is one of common malignant tumors, and the incidence and mortality of EC in China rank the first place in the world. Because of the occult onset, the early atypical symptoms, and the lack of effective early diagnostic methods, most of patients are diagnosed at an advanced stage of the disease and lost the chance of surgery. Comprehensive treatment including palliative medical treatment, molecular targeted therapy, immunotherapy and so on is appropriate for these patients. How to choose the chemotherapy regimen and formulate reasonable treatment plan has become a hot spot in clinical research. Molecular targeted drugs have become a new developmental direction in cancer treatment because of their high specificity and antitumor activity, but the effects on esophageal cancer remain controversial. With the development of immune check point blockade treatment, breakthrough has been made in tumor immunotherapy, which has become an important means in cancer comprehensive treatment and shown a good prospect of treatment.

  18. Intensity-modulated radiotherapy for lung cancer: current status and future developments

    OpenAIRE

    Chan, C; Lang, S.; Rowbottom, C; Guckenberger, M.; Faivre-Finn, C

    2014-01-01

    Radiotherapy plays an important role in the management of lung cancer, with over 50% of patients receiving this modality at some point during their treatment. Intensity-modulated radiotherapy (IMRT) is a technique that adds fluence modulation to beam shaping, which improves radiotherapy dose conformity around the tumor and spares surrounding normal structures. Treatment with IMRT is becoming more widely available for the treatment of lung cancer, despite the paucity of high level evidence sup...

  19. Current status of gene therapy for breast cancer: progress and challenges

    OpenAIRE

    McCrudden CM; McCarthy HO

    2014-01-01

    Cian M McCrudden, Helen O McCarthySchool of Pharmacy, Queen’s University Belfast, Belfast, UKAbstract: Breast cancer is characterized by a series of genetic mutations and is therefore ideally placed for gene therapy intervention. The aim of gene therapy is to deliver a nucleic acid-based drug to either correct or destroy the cells harboring the genetic aberration. More recently, cancer gene therapy has evolved to also encompass delivery of RNA interference technologies, as well as c...

  20. Breast cancer screening in the working population. Current status and future issues in Tokyo

    International Nuclear Information System (INIS)

    We conducted a comparative study of breast cancer mass screening by the Tokyo Health Service Association for the regional and working population. The mammographic screening rate has been over 90% for all examinees since 2004, and the rate of inspection and palpation has been almost 0% in the regional population, although the rate was still 24% of all screenings among the working population even in 2006. In the working population the average age at which breast cancer screening was done was younger than in the regional population. The proportion of the population under 40 was 38.4% in 2003 and 35.7% in 2006, and in this population the rates of mammography, ultrasonography, and inspection and palpation were almost the same. This suggests a degree of confusion about breast cancer screening among younger women. The breast cancer detection rate was significantly better in the regional than in the working population. However, there was no significant difference in the rate between the two populations in the 40- to 59- year age range. In conclusion, the breast cancer screening system for the regional population has been improved as a result of the official notices of the Ministry of Health, Labour and Welfare. On the other hand, the data for the working population have not been favorable because of age-related factors and the methods used for screening. It will be necessary to refine the screening system for the working population to improve not only screening efficacy but also the breast cancer mortality rate. (author)

  1. Tasquinimod in the treatment of castrate-resistant prostate cancercurrent status and future prospects

    Science.gov (United States)

    Mehta, Amit R.; Armstrong, Andrew J.

    2016-01-01

    Treatment options have significantly expanded in recent years for men with metastatic castration-resistant prostate cancer (mCRPC), with the routine use of immunotherapy (sipuleucel-T) and novel hormonal agents such as enzalutamide and abiraterone acetate prior to taxane-based chemotherapy or radium-223 radiotherapy. A number of immune checkpoints limit the immune response of the host to metastatic tumor progression in prostate cancer, one of which is an immunosuppressive and pro-angiogenic cell called the myeloid-derived suppressor cell (MDSC). Tasquinimod is a small molecular oral inhibitor of S100A9, a key cell surface regulator of MDSC function, and has shown anti-angiogenic, antitumor and immune-modulatory properties in preclinical models of prostate cancer and other solid tumors. A large randomized phase II trial of tasquinimod in men with chemotherapy-naïve mCRPC demonstrated a significant prolongation in radiographic and symptomatic progression-free survival compared with placebo, which was also associated with improvements in overall survival. Tasquinimod was studied in a global phase III randomized trial in men with bone mCRPC and, while it significantly improved radiographic progression-free survival, this did not result in an overall survival benefit. However, tasquinimod is under evaluation as well as a combination therapy with other systemic agents in prostate cancer and as a single agent in other solid tumors. This review encompasses the preclinical and clinical development of tasquinimod as a therapy for men with prostate cancer. PMID:26834836

  2. The current status and future prospects of breast cancer screening using ultrasonography at our facility

    International Nuclear Information System (INIS)

    We report the results obtained by breast cancer screening of the general population using both ultrasonography and mammography conducted by the Tochigi Public Health Service Association. An investigation of breast cancer screening carried out on approximately 140,000 participants between 2000 and 2007 showed that ultrasonography and mammography are remarkably complementary for detection of breast cancer, particularly for women in their 40s and 50s, and that each modality improves the sensitivity of breast cancer detection by approximately 20%. The following issues are pivotal for establishing a breast cancer ultrasonography screening system that is able to maintain high precision and adequate efficiency: technical training of sonographers and physicians who must interpret the sonographic images, quality control of equipment, and an interpretation system that allows previous sonographs to be used as a reference. In independent combined screening systems using ultrasonography and mammography, the high recall rate becomes an issue. Comparative interpretation of sonographic images with previous sonographs is effective for resolving this. However, hopes abound for a comprehensive assessment system that allows simultaneous imaging and interpretation of both ultrasonography and mammography. (author)

  3. Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

    Directory of Open Access Journals (Sweden)

    Huiqin Guo

    2012-10-01

    Full Text Available The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp, ABCC1/multidrug resistance protein 1 (MRP1 and ABCG2/breast cancer resistance protein (BCRP. These transporters are part of the ATP-binding cassette (ABC superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be blocked by various drugs such as verapamil (calcium channel blocker and cyclosporin A (immunosuppressive agent, etc. These compounds are called MDR modulators or reversals. This review highlights several marine natural products with reversal effect on multidrug resistance in cancer, including agosterol A, ecteinascidin 743, sipholane triterpenoids, bryostatin 1, and welwitindolinones.

  4. Current Status on Marine Products with Reversal Effect on Cancer Multidrug Resistance

    OpenAIRE

    Huiqin Guo; Zhe-Sheng Chen; Khalid El Sayed; Ioana Abraham

    2012-01-01

    The resistance of tumor cells to a broad range of anticancer agents continues to be a problem for the success of cancer chemotherapy. Multidrug resistance (MDR) is due in part to three drug transporter proteins: ABCB1/P-glycoprotein (P-gp), ABCC1/multidrug resistance protein 1 (MRP1) and ABCG2/breast cancer resistance protein (BCRP). These transporters are part of the ATP-binding cassette (ABC) superfamily, whose members function as ATP-dependent drug-efflux pumps. Their activity can be block...

  5. Adeno-Associated Virus-Mediated Cancer Gene Therapy: Current Status

    OpenAIRE

    Luo, Jingfeng; Luo, Yuxuan; Sun, Jihong; Zhou, Yurong; Zhang, Yajing; Yang, Xiaoming

    2014-01-01

    Gene therapy is one of the frontiers of modern medicine. Adeno-associated virus (AAV)-mediated gene therapy is becoming a promising approach to treat a variety of diseases and cancers. AAV-mediated cancer gene therapies have rapidly advanced due to their superiority to other gene-carrying vectors, such as the lack of pathogenicity, the ability to transfect both dividing and non-dividing cells, low host immune response, and long-term expression. This article reviews and provides up to date kno...

  6. Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients

    Directory of Open Access Journals (Sweden)

    Per Pfeiffer

    2008-12-01

    Full Text Available Per Pfeiffer, Camilla Qvortrup, Jon K BjerregaardDepartment of Oncology, Odense University Hospital. Institute of Clinical Research, University of Southern Denmark. Odense C, DenmarkPurpose: Elderly cancer patients often have co-morbidities and other characteristics that make the selection of optimal treatment more complex. The introduction of targeted therapies in colorectal cancer has further complicated this problem. This review will focus on the role of the EGFR antibody cetuximab in elderly patients.Methods: We have reviewed the available evidence in the literature to evaluate the results of therapy with cetuximab, alone or in combination with chemotherapy, with a focus on elderly patients with metastatic colorectal cancer (mCRC.Results: In patients with mCRC, combination chemotherapy prolongs median survival to more than 18 months and even around 24 months in combination with cetuximab in selected patients. No prospective studies have evaluated cetuximab in elderly patients. However, subgroup analyses from randomized trials and retrospective analysis suggest that the efficacy of chemotherapy and cetuximab is maintained in fit elderly patients, but with slightly increased but acceptable toxicity.Conclusion: No prospective cetuximab studies have been conducted solely in a population of elderly patients. However, available data suggest that outcomes in the fit elderly mirror results observed in younger patients.Keywords: metastatic colorectal cancer, cetuximab, elderly patients

  7. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.

    Science.gov (United States)

    Roviello, Giandomenico; Polom, Karol; Petrioli, Roberto; Marano, Luigi; Marrelli, Daniele; Paganini, Giovanni; Savelli, Vinno; Generali, Daniele; De Franco, Lorenzo; Ravelli, Andrea; Roviello, Franco

    2016-01-01

    Gastric cancer (GC) is the second leading cause of cancer-related death, and despite having improved treatment modalities over the last decade, for most patients, only modest improvements have been seen in overall survival. Recent progress in understanding the molecular biology of GC and the related signaling pathways offers, from the clinical point of view, promising advances for selected groups of patients. In the past, targeted therapies have significantly impacted the treatment strategy of several common solid tumors such as breast, colorectal, and lung cancers. Unfortunately, translational and clinical research shows fewer encouraging targeted treatments with regards to the GC. To date, only two monoclonal antibodies (mAb), named trastuzumab and ramucirumab, are approved for the treatment of advanced GC, suggesting that in GC, maybe more than in other cancers, effective targeted therapy requires patient selection based on precise predictive molecular biomarkers. The aim of this review is to summarize the available data on the clinical advantages offered by the use of mAbs in the treatment of advanced/metastatic GC. Future perspective is also discussed. PMID:26566626

  8. Current status of high dose rate brachytherapy in cervical cancer in Korea and optimal treatment schedule

    Energy Technology Data Exchange (ETDEWEB)

    Huh, Seung Jae [College of Medicine, Sungkyunkwan Univ., Seoul (Korea, Republic of)

    1998-12-01

    Brachytherapy is an essential part of radiotherapy for uterine cervical cancer. The low dose rate (LDR) regimen has been the major technique of intracavitary therapy for cervical cancer. However, there has been an expansion in the last 20 years of high dose rate (HDR) machines using Ir-192 sources. Since 1979, HDR brachytherapy has been used for the treatment of uterine cervical cancer in Korea. The number of institutions employing HDR has been increasing, while the number of low dose rate system has been constant. In 1995, there was a total 27 HDR brachytherapy units installed and 1258 cases of patients with cervical cancer were treated with HDR. Most common regimens of HDR brachytherapy are total dose of 30-39 Gy at point A with 10-13 fractions in three fractions per week, 24-32 Gy with 6-8 fractions in two fractions per week, and 30-35 Gy with 6-7 fractions in two fractions per week. The average fractionation regimen of HDR brachytherapy is about 8 fractions of 4. 1 Gy each to point A. In Korea, treatment results for HDR brachytherapy are comparable with the LDR series and appears to be a safe and effective alternative to LDR therapy for the treatment of cervical carcinoma. Studies from the major centers report the five-year survival rate of cervical cancer as, 78-86% for Stage I, 68-85% for stage II, and 38-56% for Stage III. World-wide questionnaire study and Japanese questionnaire survey of multiple institutions showed no survival difference in any stages and dose-rate effect ratio (HDR/LDR) was calculated to be 0.54 to 0.58. However, the optimum treatment doses and fractionation schemes appropriate to generate clinical results comparable to conventional LDR schemes have yet to be standardized. In conclusion, HDR intracavitary radiotherapy is increasingly practiced in Korea and an effective treatment modality for cervical cancer. To determine the optimum radiotherapy dose and fractionation schedule, a nation-wide prospective study is necessary in Korea. In

  9. Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

    Directory of Open Access Journals (Sweden)

    Zhuo eZhang

    2015-09-01

    Full Text Available Circulating tumor cells (CTCs have garnered a lot of attention in the past few decades. Isolation of these rare cells form the billions of blood cells has been a challenge until recent times. With the advent of new sensitive technologies that permit live cell isolation and downstream genomic analysis, the existing paradigm of CTC research has evolved to explore clinical utility of these cells. CTCs have been identified as prognostic and pharmacodynamic biomarkers in many solid tumors, including lung cancer. As a means of liquid biopsy, CTCs could play a major role in the development of personalized medicine and targeted therapies. This review discusses the state of various isolation strategies, cell separation techniques and key studies that illustrate the application of liquid biopsy to lung cancer.

  10. Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives

    Institute of Scientific and Technical Information of China (English)

    Alberto; Biondi; Maria; C; Lirosi; Domenico; D’Ugo; Valeria; Fico; Riccardo; Ricci; Francesco; Santullo; Antonia; Rizzuto; Ferdinando; CM; Cananzi; Roberto; Persiani

    2015-01-01

    In the last 20 years, several clinical trials on neoadjuvant chemotherapy and chemo-radiotherapy as a therapeutic approach for locally advanced gastric cancer have been performed. Even if more data are necessary to define the roles of these approaches, the results of preoperative treatments in the combined treatment of gastric adenocarcinoma are encouraging because this approach has led to a higher rate of curative surgical resection. Owing to the results of most recent randomized phase III studies, neoadjuvant chemotherapy for locally advanced resectable gastric cancer has satisfied the determination of level I evidence. Remaining concerns pertain to the choice of the optimal therapy regimen, strict patient selection by accurate pre-operative staging, standardization of surgical procedures, and valid criteria for response evaluation. New well-designed trials will be necessary to find the best therapeutic approach in pre-operative settings and the best way to combine old-generation chemotherapeutic drugs with new-generation molecules.

  11. Proton beam therapy and localised prostate cancer: current status and controversies

    OpenAIRE

    Efstathiou, J. A.; Gray, P. J.; Zietman, A L

    2013-01-01

    Proton therapy is a promising, but costly, treatment for prostate cancer. Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shor...

  12. Current status of endoscopic submucosal dissection for the management of early gastric cancer: A Korean perspective

    Institute of Scientific and Technical Information of China (English)

    Hoon Jai Chun; Bora Keum; Ji Hyun Kim; Sang Young Seol

    2011-01-01

    The early diagnosis of gastric cancer allows patients and physicians to pursue the option of endoscopic resection, which is significantly less invasive than conventional surgical resection. In Korea, the use of endoscopic submucosal dissection (ESD) has been increasing, and many reports on ESD have been published. In addition, Korean gastroenterologists from several hospitals performing ESD have conducted formal meetings to discuss useful information regarding ESD. Here, we discuss the Korean experience with ESD, including outcomes and prospects of endoscopic treatments.

  13. [Current Status of Perioperative Rehabilitation in Patients who Undergo Esophagectomy for Cancer].

    Science.gov (United States)

    Oikawa, Masato; Hanada, Masatoshi; Hidaka, Shigekazu; Nagayasu, Takeshi; Kozu, Ryo

    2016-01-01

    The esophagectomy for esophageal cancer is major surgery and has the highest rate of postoperative pulmonary complications. Respiratory physiotherapy in patients undergoing esophagectomy has been applied to improve oxygenation and airway secretion clearance. Recently, the utility and effectiveness of enhanced recovery after surgery for gastroenterological surgery have been reported in Japan, and patients should be encouraged to participate in early mobilization. Perioperative rehabilitation which includes early mobilization reduces postoperative complications and improves fast-track recovery after esophagectomy. These interventions play important role in postoperative care. PMID:26975645

  14. Development path and current status of the NANIVID: a new device for cancer cell studies

    Science.gov (United States)

    Raja, Waseem Khan; Padgen, Michael R.; Williams, James K.; Wyckoff, Jeffrey; Condeelis, John; Castracane, James

    2011-02-01

    Cancer cells create a unique microenvironment in vivo which enables migration to distant organs. To better understand the tumor microenvironment, special tools and devices are required to monitor the interactions between different cell types and the effects of particular chemical gradients. This study presents the design and optimization of a new, versatile chemotaxis device called the NANIVID (NANo IntraVital Device). The device is fabricated using BioMEMS techniques and consists of etched and bonded Pyrex substrates, a soluble factor reservoir, fluorescent tracking beads and a microelectrode array for cell quantification. The reservoir contains a customized hydrogel blend loaded with EGF which diffuses out of the hydrogel to create a chemotactic gradient. This reservoir sustains a steady release of growth factor into the surrounding environment for many hours and establishes a concentration gradient that attracts specific cells to the device. In addition to a cell collection tool, the NANIVID can be modified to act as a delivery vehicle for the local generation of alternate soluble factor gradients to initiate controlled changes to the microenvironment such as hypoxia, ECM stiffness and etc. The focus of this study is to design and optimize the new device for wide ranging studies of breast cancer cell dynamics in vitro and ultimately, implantation for in vivo work.

  15. Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals

    International Nuclear Information System (INIS)

    Although the prognosis of differentiated thyroid cancer (DTC) is favorable, some histotypes show worst clinical outcome and higher risk of recurrence. Serum thyroglobulin (Tg) levels and 131I-whole-body-scan (WBS), together with neck ultrasound (US), represent the golden standard for DTC follow-up. Nevertheless, the relatively high frequency of patients with high Tg levels and negative WBS requires further investigations by using new imaging modalities. The availability of whole body positron emission tomography (PET) methods, in parallel with the advances in radiochemistry, offer a wide substrate for many solutions. To this day 18F-fluoro-deoxy-glucose (18F-FDG) PET/CT still represents the imaging of choice in follow-up of patients with high serum Tg and negative 131I-WBS but in the last decades the research has focused on finding “second generation” radiopharmaceuticals for PET imaging, with both diagnostic and prognostic purposes, aiming to change the way to image thyroid cancer. Moreover, the use of various PET radiopharmaceuticals, that offer the possibility to explore different pathways involved in thyroid cancer, could find important applications in the near future for clinical decision making in order to program tailored treatments and follow-up. It would be desirable to use the same radiopharmaceutical for both imaging and dosimetric purpose to achieve a tailored therapy. Many efforts are focused in this direction and 124I-PET/CT is now emerging as a valid tool in restaging and therapy management of DTC with promising results. Although the preliminary data available in literature require a confirmation in larger studies with longer follow-up, we think that in next future 124-PET/CT could gain an important role for management of DTC. The aim of this review was to perform a systematic analysis of literature describing the state of art of “second generation” PET-radiopharmaceuticals for imaging DTC. Discussion is focused on the utility of 124I

  16. Biosimilar drugs: Current status.

    Science.gov (United States)

    Kumar, Rajiv; Singh, Jagjit

    2014-07-01

    Biologic products are being developed over the past three decades. The expiry of patent protection for many biological medicines has led to the development of biosimilars in UK or follow on biologics in USA. This article reviews the literature on biosimilar drugs that covers the therapeutic status and regulatory guidelines. Appraisal of published articles from peer reviewed journals for English language publications, search from PubMed, and guidelines from European Medicines Agency, US Food Drug Administration (FDA) and India were used to identify data for review. Literature suggest that biosimilars are similar biological products, i.e., comparable but not identical to the reference product, are not generic version of innovator product and do not ensure therapeutic equivalence. Biosimilars present more challenges than conventional generics and marketing approval is also more complicated. To improve access, US Congress passed the Biologics Price Competition and Innovation act 2009 and US FDA allowed "abbreviated pathway" for their approval. U.S law has defined new standards and terms and EMA scientific guidelines have also set detailed approval standards. India being one of the most preferred manufacturing destinations of biosimilars, there is a need for stringent safety and regulatory guidelines. The New India Guidelines "Draft Guidelines on Similar Biologics were announced in June 2012, by Department of Biotechnology at Boston bio and available online. PMID:25143877

  17. The bivariate current status model

    OpenAIRE

    Groeneboom, P.

    2013-01-01

    For the univariate current status and, more generally, the interval censoring model, distribution theory has been developed for the maximum likelihood estimator (MLE) and smoothed maximum likelihood estimator (SMLE) of the unknown distribution function, see, e.g., [12], [7], [4], [5], [6], [10], [11] and [8]. For the bivariate current status and interval censoring models distribution theory of this type is still absent and even the rate at which we can expect reasonable estimators to converge...

  18. Bioartificial liver: current status.

    Science.gov (United States)

    Pless, G; Sauer, I M

    2005-11-01

    Liver failure remains a life-threatening syndrome. With the growing disparity between the number of suitable donor organs and the number of patients awaiting transplantation, efforts have been made to optimize the allocation of organs, to find alternatives to cadaveric liver transplantation, and to develop extracorporeal methods to support or replace the function of the failing organ. An extracorporeal liver support system has to provide the main functions of the liver: detoxification, synthesis, and regulation. The understanding that the critical issue of the clinical syndrome in liver failure is the accumulation of toxins not cleared by the failing liver led to the development of artificial filtration and adsorption devices (artificial liver support). Based on this hypothesis, the removal of lipophilic, albumin-bound substances, such as bilirubin, bile acids, metabolites of aromatic amino acids, medium-chain fatty acids, and cytokines, should be beneficial to the clinical course of a patient in liver failure. Artificial detoxification devices currently under clinical evaluation include the Molecular Adsorbent Recirculating System (MARS), Single-Pass Albumin Dialysis (SPAD), and the Prometheus system. The complex tasks of regulation and synthesis remain to be addressed by the use of liver cells (bioartificial liver support). The Extracorporeal Liver Assist Device (ELAD), HepatAssist, Modular Extracorporeal Liver Support system (MELS), and the Amsterdam Medical Center Bioartificial Liver (AMC-BAL) are bioartificial systems. This article gives a brief overview on these artificial and bioartificial devices and discusses remaining obstacles.

  19. ALMA Pipeline: Current Status

    Science.gov (United States)

    Shinnaga, H.; Humphreys, E.; Indebetouw, R.; Villard, E.; Kern, J.; Davis, L.; Miura, R. E.; Nakazato, T.; Sugimoto, K.; Kosugi, G.; Akiyama, E.; Muders, D.; Wyrowski, F.; Williams, S.; Lightfoot, J.; Kent, B.; Momjian, E.; Hunter, T.; ALMA Pipeline Team

    2015-12-01

    The ALMA Pipeline is the automated data reduction tool that runs on ALMA data. Current version of the ALMA pipeline produces science quality data products for standard interferometric observing modes up to calibration process. The ALMA Pipeline is comprised of (1) heuristics in the form of Python scripts that select the best processing parameters, and (2) contexts that are given for book-keeping purpose of data processes. The ALMA Pipeline produces a "weblog" that showcases detailed plots for users to judge how each step of calibration processes are treated. The ALMA Interferometric Pipeline was conditionally accepted in March 2014 by processing Cycle 0 and Cycle 1 data sets. From Cycle 2, ALMA Pipeline is used for ALMA data reduction and quality assurance for the projects whose observing modes are supported by the ALMA Pipeline. Pipeline tasks are available based on CASA version 4.2.2, and the first public pipeline release called CASA 4.2.2-pipe has been available since October 2014. One can reduce ALMA data both by CASA tasks as well as by pipeline tasks by using CASA version 4.2.2-pipe.

  20. Targeting breast cancer through its microenvironment : Current status of preclinical and clinical research in finding relevant targets

    NARCIS (Netherlands)

    Nienhuis, H. H.; Gaykema, S. B. M.; Timmer-Bosscha, H.; Jalving, M.; Brouwers, A. H.; Lub-de Hooge, M. N.; van der Vegt, B.; Overmoyer, B.; de Vries, E. G. E.; Schroder, C. P.

    2015-01-01

    It is increasingly evident that not only breast cancer cells, but also the tissue embedding these cells: the tumor microenvironment, plays an important role in tumor progression, metastasis formation and treatment sensitivity. This review focuses on the current knowledge of processes by which the mi

  1. Current status of the use of antiadhesive agents for gastric cancer surgery: a questionnaire survey in South Korea

    OpenAIRE

    Park, Ji-Ho; Jeong, Sang-Ho; Lee, Young-Joon; Choi, Sang-Kyung; Hong, Soon-Chan; Jung, Eun-Jung; Jeong, Chi-Young; Ju, Young-Tae; Ha, Woo-Song

    2013-01-01

    Purpose The aim of this study was to investigate the current status of the use of antiadhesive agents (AAdAs) via a questionnaire and to discuss the availability of AAdAs. Methods The survey was sent to a list of members that was approved by the Korean Gastric Association. The survey included questions on AAdA use by surgeons, the type of AAdAs used, and the reasons for not using AAdAs. Surgeons were also asked to describe complications related to AAdAs, and the reliability of its use. Result...

  2. EGFR-targeted drugs for colorectal cancer: current status and future challenges%EGFR靶向药物在结直肠癌中的研究进展

    Institute of Scientific and Technical Information of China (English)

    王丽; 余英豪

    2011-01-01

    Colorectal cancer is a common gastrointestinal malignancy. The effects of traditional chemotherapy and radiation therapy against colorectal cancer are not satisfactory. The epidermal growth factor receptor (EGFR) signaling pathway plays an important role in tumor proliferation, angiogenesis, invasion, and metastasis in colorectal cancer. EGFR-targeted drugs have been developed and applied to the treatment of colorectal cancer. This paper provides a literature review on the current status and future challenges of EGFR-targeted therapy of colorectal cancer.%结直肠癌是常见的消化系恶性肿瘤,传统的化疗和放疗效果均不甚理想.表皮生长因子受体(EGFR)q%号转导通路在结直肠癌细胞的增殖、血管生成、侵袭、转移等方面有重要作用.因此,针对EGFR的靶向药物已陆续开发,并应用于结直肠癌治疗的临床实践.本文就EGFR靶向药物在结直肠癌中的研究现状及其相关问题进行综述.

  3. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: Current status of vaginal brachytherapy

    International Nuclear Information System (INIS)

    Purpose: To survey the current postoperative recommendations for radiotherapy (RT) in patients with endometrial cancer, with an emphasis on vaginal brachytherapy (VBT). Methods and Materials: In August 2003, a 32-item questionnaire was mailed to a random sample of 2396 members of the American Society for Therapeutic Radiology and Oncology and the American Brachytherapy Society. The sample excluded members-in-training, physicists, and non-U.S. members. A follow-up mailing was conducted in November 2003. Those who had not treated any patient in the previous year for endometrial carcinoma were instructed to indicate so at the beginning of the questionnaire and return it without responding to any other item. Responses were tabulated to determine the relative frequency distribution. Results: of the 2396 surveys sent out, 757 were returned, for a response rate of 31.6%. Of those who responded, 551 (72.8%) had performed postoperative irradiation for endometrial cancer and were included in this study. Of the 551 respondents, 99.8% had delivered external beam RT to some endometrial cancer patients. An increasing trend was found toward referrals for VBT; 91.5% of those who treated endometrial cancer performed VBT. The vaginal target most often irradiated was the upper vagina in 40.7%, upper 4-5 cm in 54.5%, and the entire vagina in 4.9%; 21.3% placed clips at the vaginal apex for applicator verification. The maximal dose to the bladder and rectum was recorded in 78.3% and 80.2% of patients, respectively. Of the respondents, 40% did not use low-dose-rate (LDR) VBT. The two most common LDR applicators were Delclos cylinders (29.7%) and Fletcher colpostats (29.3%). The mean boost dose delivered with LDR VBT when prescribed to the surface was 29.9 Gy and when prescribed to 0.5 cm was 23.8 Gy. When LDR therapy was used without external beam RT, the mean dose when prescribed to the surface was 56.8 Gy and when prescribed to 0.5 cm was 47.9 Gy. In 2002, 69.1% of respondents treated

  4. Questionnaire survey of current status and reserve for breast cancer screening in Mie prefecture. Achievement of a 50% participation rate

    International Nuclear Information System (INIS)

    Mie Medical Network of Breast Cancer Screening, a NPO, was assigned the task of breast cancer screening in Mie prefecture in April, 2010. For breast cancer screening in Mie prefecture in 2009, a questionnaire survey was performed toward both consigner and consignee. Consigners were local public offices managing breast cancer screening for local inhabitants, and consignees were facilities offering breast cancer screening. The number of breast cancer screening was investigated toward all 29 of consigners in Mie prefecture. The questionnaire survey was conducted toward all 52 of the facilities possessing mammography systems (breast cancer screening being performed at 48 of them) in Mie prefecture in 2009. We investigated the predictive additional number of breast cancer screening and also investigated the requisite number of staff to achieve the predictive maximum number of breast cancer screening. As a result, the total number of breast cancer screenings was 93,525, and the participation rate was 27.5% which was calculated by reduction of continuator in Mie prefecture in 2009. The continuator accounted for over 30% of all breast cancer screenings. The predictive additional number was 126,950, this indicates that a possible participation rate of 75.2% after 2011. To achieve this high participation rate, active support is essential for short-handed facilities, and about 20% increase of medical staff is necessary. To achieve a participation rate of over 50% as a goal, new screenees should be recruited and breast cancer screening of every other year should be enlightened. (author)

  5. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

    Science.gov (United States)

    Barth, Rolf F; Vicente, M Graca H; Harling, Otto K; Kiger, W S; Riley, Kent J; Binns, Peter J; Wagner, Franz M; Suzuki, Minoru; Aihara, Teruhito; Kato, Itsuro; Kawabata, Shinji

    2012-08-29

    Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas, recurrent cancers of the head and neck region and either primary or metastatic melanoma. Neutron sources for BNCT currently have been limited to specially modified nuclear reactors, which are or until the recent Japanese natural disaster, were available in Japan, United States, Finland and several other European countries, Argentina and Taiwan. Accelerators producing epithermal neutron beams also could be used for BNCT and these are being developed in several countries. It is anticipated that the first Japanese accelerator will be available for therapeutic use in 2013. The major hurdle for the design and synthesis of boron delivery agents has been the requirement for selective tumor targeting to achieve boron concentrations in the range of 20 μg/g. This would be sufficient to deliver therapeutic doses of radiation with minimal normal tissue toxicity. Two boron drugs have been used clinically, a dihydroxyboryl derivative of phenylalanine, referred to as boronophenylalanine or "BPA", and sodium borocaptate or "BSH" (Na2B12H11SH). In this report we will provide an overview of other boron delivery agents that currently are under evaluation, neutron sources in use or under development for BNCT, clinical dosimetry, treatment planning, and finally a summary of previous and on-going clinical studies for high grade gliomas and recurrent tumors of the head and neck region. Promising results have been obtained with both groups of patients but these outcomes must be more rigorously evaluated in larger, possibly randomized clinical trials

  6. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

    Directory of Open Access Journals (Sweden)

    Barth Rolf F

    2012-08-01

    Full Text Available Abstract Boron neutron capture therapy (BNCT is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas, recurrent cancers of the head and neck region and either primary or metastatic melanoma. Neutron sources for BNCT currently have been limited to specially modified nuclear reactors, which are or until the recent Japanese natural disaster, were available in Japan, United States, Finland and several other European countries, Argentina and Taiwan. Accelerators producing epithermal neutron beams also could be used for BNCT and these are being developed in several countries. It is anticipated that the first Japanese accelerator will be available for therapeutic use in 2013. The major hurdle for the design and synthesis of boron delivery agents has been the requirement for selective tumor targeting to achieve boron concentrations in the range of 20 μg/g. This would be sufficient to deliver therapeutic doses of radiation with minimal normal tissue toxicity. Two boron drugs have been used clinically, a dihydroxyboryl derivative of phenylalanine, referred to as boronophenylalanine or “BPA”, and sodium borocaptate or “BSH” (Na2B12H11SH. In this report we will provide an overview of other boron delivery agents that currently are under evaluation, neutron sources in use or under development for BNCT, clinical dosimetry, treatment planning, and finally a summary of previous and on-going clinical studies for high grade gliomas and recurrent tumors of the head and neck region. Promising results have been obtained with both groups of patients but these outcomes must be more rigorously evaluated in larger

  7. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

    International Nuclear Information System (INIS)

    Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a constituent of natural elemental boron, is irradiated with low energy thermal neutrons to yield high linear energy transfer alpha particles and recoiling lithium-7 nuclei. Clinical interest in BNCT has focused primarily on the treatment of high grade gliomas, recurrent cancers of the head and neck region and either primary or metastatic melanoma. Neutron sources for BNCT currently have been limited to specially modified nuclear reactors, which are or until the recent Japanese natural disaster, were available in Japan, the United States, Finland and several other European countries, Argentina and Taiwan. Accelerators producing epithermal neutron beams also could be used for BNCT and these are being developed in several countries. It is anticipated that the first Japanese accelerator will be available for therapeutic use in 2013. The major hurdle for the design and synthesis of boron delivery agents has been the requirement for selective tumor targeting to achieve boron concentrations in the range of 20 μg/g. This would be sufficient to deliver therapeutic doses of radiation with minimal normal tissue toxicity. Two boron drugs have been used clinically, a dihydroxyboryl derivative of phenylalanine, referred to as boronophenylalanine or “BPA”, and sodium borocaptate or “BSH” (Na2B12H11SH). In this report we will provide an overview of other boron delivery agents that currently are under evaluation, neutron sources in use or under development for BNCT, clinical dosimetry, treatment planning, and finally a summary of previous and on-going clinical studies for high grade gliomas and recurrent tumors of the head and neck region. Promising results have been obtained with both groups of patients but these outcomes must be more rigorously evaluated in larger, possibly randomized clinical

  8. Current status of intrahepatic cholangiocarcinoma

    Institute of Scientific and Technical Information of China (English)

    Jian Yang; Lu-Nan Yan

    2008-01-01

    Intrahepatlc cholangiocarcinoma (ICC) is a rare primary liver cancer with a global increasing trend in recent years. Symptoms tend to be vague and insidious in development, often are diagnosed at an advanced stage when only palliative approaches can be used with a median survival rate of months. Comparing with HCC, ICC tends to spread to lymph nodes early, and is rarely limited to the regional lymph nodes, with a frequent postoperative recurrence. Surgery is the only choice of curative therapy for ICC, but recently no consensus has been established for operation. Thus, more data from multiple centers and more cases are needed. Generally speaking, current adjunctive therapy cannot clearly improve survival. Further research is needed to find more effective radio- and chemotherapeutic regimens.

  9. Sinoprobe Datacenter Development: Current Status

    Science.gov (United States)

    Guan, Y.; Dong, S.; Chen, Z.; Chen, G.; Cheng, M.

    2011-12-01

    The project of the Sinoprobe datacenter development is to build new IT infrastructures needed to store, visualize and manage all the data acquired by SinoProbe program.The SinoProbe data center is designed using service-oriented architecture (SOA) principles. More specifically, service component architecture (SCA) is used to implement sinoprobe data services. It also uses various advanced technologies such as Java/JEE for the platform, PostgresSQL/PostGIS for the data storage, ApacheDS for LDAP, CoachDB for the medadata storage, GeoServer for the GIS services, ExtJs and OpenLayer for the Ajax framework, and Apache Shiro for the security framework. Through the integration and development of various technologies used, the major services of the datacenter system are implemented including the security infrastructure services (user authentication and authorization), metadata services, data warehouse stores, data services, GIS services, and web portal. There are also visualization components including the development of a virtual globe to replace the currently used Google Earth. This poster presents the current status of the SinoProbe data center development, and the detailed discussion of the system.

  10. Current status of Japanese detectors

    CERN Document Server

    Tatsumi, Daisuke; Arai, Koji; Nakagawa, Noriyasu; Agatsuma, Kazuhiro; Yamazaki, Toshitaka; Fukushima, Mitsuhiro; Fujimoto, Masa-Katsu; Takamori, Akiteru; Bertolini, Alessandro; Sannibale, Virginio; DeSalvo, Riccardo; Marka, Szabolcs; Ando, Masaki; Tsubono, Kimio; Akutsu, Tomomi; Yamamoto, Kazuhiro; Ishitsuka, Hideki; Uchiyama, Takashi; Miyoki, Shinji; Ohashi, Masatake; Kuroda, Kazuaki; Awaya, Norichika; Kanda, Nobuyuki; Araya, Akito; Telada, Souichi; Tomaru, Takayuki; Haruyama, Tomiyoshi; Yamamoto, Akira; Sato, Nobuaki; Suzuki, Toshitaka; Shintomi, Takakazu

    2007-01-01

    Current status of TAMA and CLIO detectors in Japan is reported in this article. These two interferometric gravitational-wave detectors are being developed for the large cryogenic gravitational wave telescope (LCGT) which is a future plan for detecting gravitational wave signals at least once per year. TAMA300 is being upgraded to improve the sensitivity in low frequency region after the last observation experiment in 2004. To reduce the seismic noises, we are installing new seismic isolation system, which is called TAMA Seismic Attenuation System, for the four test masses. We confirmed stable mass locks of a cavity and improvements of length and angular fluctuations by using two SASs. We are currently optimizing the performance of the third and fourth SASs. We continue TAMA300 operation and R&D studies for LCGT. Next data taking in the summer of 2007 is planned. CLIO is a 100-m baseline length prototype detector for LCGT to investigate interferometer performance in cryogenic condition. The key features of...

  11. 副乳腺癌的诊治现状%Current status of diagnosis and treatment of accessory breast cancer

    Institute of Scientific and Technical Information of China (English)

    杨克酩; 冯雪园; 彭永强; 闫朝岐

    2015-01-01

    The age at onset of accessory breast cancer is around 40 ~ 60,which is closed to that of breast cancer. It usually presents a hard axillary mass with an obscure boundary as its first symptom. Histopathologic examination is the key point of its diagnosis and differential diagnosis. The main pathologic type of accessory breast cancer is the invasive carcino-ma. A comprehensive treatment based on operation is recommended,which is similar to that of breast cancer. The prognosis of accessory breast cancer is poor because it easily causes lymphatic metastasis.%副乳腺癌的发病年龄与乳腺癌相仿,多在40~60岁左右,常以腋下质硬、边界不清的肿块为首发症状;病理组织学检查是该疾病诊断与鉴别诊断重点,病理类型以浸润性癌居多,治疗方式与乳腺癌相同,宜行以手术为主的综合治疗;因其易发生淋巴结转移,预后较差。

  12. Research on the current status of breast cancer in males%男性乳腺癌研究现状

    Institute of Scientific and Technical Information of China (English)

    曹立; 常洪波; 巩丽丽

    2012-01-01

    男性乳癌临床罕见,但它在全球的发病率持续增长.由于样本量少,缺乏随机化临床试验,很多研究借鉴于女性乳癌,但男性乳癌与女性乳癌之间存在诸多差异.男性发病年龄比女性晚.对该病的关注及重视不够,使得就诊时肿块直径较大,进展期多见,多有腋窝淋巴结转移,预后不佳.男性乳癌以浸润型导管癌多见,小叶癌罕见,不同于女性乳癌.无痛性肿块常发生于乳晕下,局部浸润症状多见(累及皮肤及乳头),女性乳癌常发生于乳房外上象限.ER、PR受体阳性率高,他莫西芬是首选的一线激素治疗药物.%Male breast cancer is a rare disease, but the incidence has increased all over the world. Because absent of randomized clinical trials, many principles are derived from female breast cancer. But they are different from breast cancer in females. Men tend to be diagnosed at an older age than woman. The lack of awareness of this disease leads to its detection at a large size lump, advanced stage and several axillary nodes involved. All are associated with a worse outcome. Most of the male breast cancer presents with invasive ductal histology. In contrast to female breast cancer, lobular carcinoma is very seldom. The painless lump of male breast cancer is commonest located in the subareolar region, but female breast cancer is usually in the upper outer quadrant. More signs of part skin and/or nipple involvement are showed. Because generally has a higher rate of estrogen/progesterone hormone receptor positive than carcinoma of the female breast, and tamoxifen is the standard adjuvant therapy.

  13. Current status of converter steelmaking

    Energy Technology Data Exchange (ETDEWEB)

    Oghbasialasie, H.; Holappa, L.

    1995-12-31

    This literature work is mainly focusing on the mechanisms of modern converter steelmaking and related with the evaluation of converter technology applied during the last decades and further to the future. The history of steelmaking has been briefly reviewed from bloomeries and early-steelmaking processes to the progress of modern converter process. The pneumatic converter processes were developed in the 1850`s and thereafter the basis for the rapid growth of steel industries was established for the next 100 years. The world production of steel has not continuously grown but fluctuating quite much. It reached 723 Mt in 1994. The production is believed to grow the forecast for the year 2003 being approximately 800 Mt. Electric arc furnace production is estimated to reach 280 Mt by 2003, and BOFIOH will reach 520 Mt by 2003. The current status of the converter steelmaking process is briefly described both on its theoretical bases and practical technological progresses. Developments which significantly improve the process are briefly discussed. Several more recent developments such as combined oxygen blowing process, increased scrap melting, post combustion and hot metal pretreatment are discussed. The future progress will be in further development of these process characteristics as well as in eventual emerging of the continuous converter process. (author)

  14. The Current Status of Tumor Markers in Lung Cancer%肿瘤标志物在肺癌诊疗中的研究进展

    Institute of Scientific and Technical Information of China (English)

    郑名华; 孙国栋; 张郧樊; 杨建新

    2016-01-01

    肿瘤标志物的检测,对肺癌的早期诊断、临床分期、组织学分型、预后判断和疗效监测都具有重要价值。本文对癌胚抗原(CEA)、胃泌素释放肽前体(ProGRP)、细胞角蛋白19片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)、鳞状上皮细胞癌抗原(SCC)等肺癌肿瘤标志物的研究现状进行概述。%The determination of tumor markers is of great value for early diagnosis. It is not only helpful in clinical staging and classification of pathological types in patients with lung cancer, but also useful in evaluation of prognosis and response to treatment.This article reviews the current status of tumor markers in lung cancer,such as CEA,ProGRP,CYFRA21-1,NSE,SCC,and so on.

  15. [Current status and new applications of sentinel lymph node mapping in non-small cell lung cancer].

    Science.gov (United States)

    Minamiya, Yoshihiro; Ogawa, Jun-Ichi

    2009-03-01

    Sentinel lymph node (SLN) mapping has become a common procedure in the treatment of breast cancer and malignant melanoma. Its primary benefit is that it enables surgeons to avoid nontherapeutic lymph node dissection and the complications that may follow. All present evidence demonstrates the existence of SLNs in non-small cell lung cancer (NSCLC). However, SLN mapping is not widely used in the treatment of NSCLC for several reasons: first, special precautions are required to minimize exposure to radioisotopes; second, it is difficult to detect a dye within anthoracotic thoracic lymph nodes; and third, major complications comparable to the arm edema seen in breast cancer or the lymphedema and nerve injury seen in melanoma are not seen with mediastinal lymph node dissection. However, if the SLN mapping procedure were simplified, it could be used to avoid nontherapeutic mediastinal lymph node dissection in NSCLC. Recently, new applications of SLN mapping have been reported, such as the detection of lymph node micrometastases and segmentectomy for NSCLC. We expect SLN mapping to become a common clinical practice in the treatment of NSCLC in the near future PMID:19348199

  16. Quimioprevenção do câncer de mama Current status of breast cancer chemoprevention

    Directory of Open Access Journals (Sweden)

    Vilmar Marques de Oliveira

    2006-12-01

    defined as the use of natural or synthetic chemical agents to reverse, suppress or prevent carcinogenic progression of invasive cancer. Drugs that act as chemoprevention agents for breast cancer are divided into two major groups: drugs that prevent Estrogen Receptor (ER - positive breast cancers [selective estrogen receptor modulators (SERM, aromatase inhibitors GnKH agonists and phytoestrogens] and drugs that prevent ER - negative breast cancers [cyclooxygenase-2 (COX-2 inhibitors, retinoids, statins, receptor tyrosine, kinase inhibitors, monoclonal antibody against HER-2 and telomerase inhibitors]. Results from the NSABP Study of Tamoxifen and Raloxifene (STAR, which compared the risk-reducing efficacy as well as toxicity of these two SERMs in a similar high-risk for breast cancer population, showed that Raloxifene is as effective as Tamoxifen in reducing the risk of non-invasive breast cancer (p=.83. It has a statistically significant lower risk of thromboembolic events and cataracts, however a non- statistically significant higher risk of noninvasive breast cancer. Based on promising data involving reduction of contralateral breast cancer risk in adjuvant studies, several aromatase inhibitors, including letrozole, anastrozole and exemestane, are being included in trials to evaluate their efficacy in breast cancer prevention in both case-control and cohort studies As such randomized studies to confirm this efficacy are needed. Positive results of several recent clinical trials for preventing breast cancer in high-risk populations suggest that chemoprevention is a rational and attractive strategy.

  17. Current status of zirconia restoration.

    Science.gov (United States)

    Miyazaki, Takashi; Nakamura, Takashi; Matsumura, Hideo; Ban, Seiji; Kobayashi, Taira

    2013-10-01

    During the past decade, zirconia-based ceramics have been successfully introduced into the clinic to fabricate fixed dental prostheses (FDPs), along with a dental computer-aided/computer-aided manufacturing (CAD/CAM) system. In this article (1) development of dental ceramics, (2) the current status of dental CAD/CAM systems, (3) CAD/CAM and zirconia restoration, (4) bond between zirconia and veneering ceramics, (5) bond of zirconia with resin-based luting agents, (6) surface finish of zirconia restoration and antagonist enamel wear, and (7) clinical evaluation of zirconia restoration are reviewed. Yttria partially stabilized tetragonal zirconia polycrystalline (Y-TZP) showed better mechanical properties and superior resistance to fracture than other conventional dental ceramics. Furthermore, ceria-stabilized tetragonal zirconia polycrystalline and alumina nanocomposites (Ce-TZP/A) had the highest fracture toughness and had resistance to low-temperature aging degradation. Both zirconia-based ceramics have been clinically available as an alternative to the metal framework for fixed dental prostheses (FDPs). Marginal adaptation of zirconia-based FDPs is acceptable for clinical application. The most frequent clinical complication with zirconia-based FDPs was chipping of the veneering porcelain that was affected by many factors. The mechanism for the bonding between zirconia and veneering ceramics remains unknown. There was no clear evidence of chemical bonding and the bond strength between zirconia and porcelain was lower than that between metal and porcelain. There were two alternatives proposed that might avoid chipping of veneering porcelains. One was hybrid-structured FDPs comprising CAD/CAM-fabricated porcelain parts adhering to a CAD/CAM fabricated zirconia framework. Another option was full-contour zirconia FDPs using high translucent zirconia. Combined application of silica coating and/or silane coupler, and 10-methacryloyloxydecyl dihydrogen phosphate is

  18. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

    Directory of Open Access Journals (Sweden)

    Hasan Mukhtar

    2011-10-01

    Full Text Available The advent of nanotechnology has had a revolutionary impact on many aspects of 21st century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, prevention, and therapy of different diseases, and of cancer in particular. Entities in nanometer sizes are excellent platforms to incorporate various drugs or active materials that can be delivered effectively to the desired action site without compromising the activity of the incorporated drug or material. In particular, nanotechnology entities can be used to deliver conventional natural products that have poor solubility or a short half life. Conventional natural products used with entities in nanometer sizes enable us to solve many of the inherent problems (stability, solubility, toxicity associated with natural products, and also provide a platform for targeted delivery to tumor sites. We recently introduced the novel concept of using nanotechnology for enhancing the outcome of chemoprevention, which we called ‘nanochemoprevention’. This idea was subsequently exploited by several laboratories worldwide and has now become an advancing field in chemoprevention research. This review examines some of the applications of nanotechnology for cancer prevention and therapy using natural products.

  19. Current status and prospective of cancer immunotherapy%肿瘤免疫治疗的现状与展望

    Institute of Scientific and Technical Information of China (English)

    任军

    2012-01-01

    Increasing knowledge has increased awareness of roles of immunotherapy in cancer trealmenl. Such immunomodulation targeting specific immunopathways has risen the understandings that more and more methods could be incorporated into the clinical applications. The immunotherapy eliciting specific cellular immune response against cancer cells might result in tumor cell lysis and subsequently enhancing ability of antigen presenting cells and shows synergism with the cytotoxicity of chemotherapy.%目的 随着肿瘤学、免疫学以及分子生物学等相关学科的迅速发展和交叉渗透,肿瘤免疫治疗的研究突飞猛进.免疫治疗成为继手术、放射治疗和化学治疗之后又一种重要的抗肿瘤治疗手段,成为攻克恶性肿瘤的希望.进入21世纪,新型的特异性细胞免疫治疗技术得到迅速发展,为全世界成千上万肿瘤患者带来新的希望.化学治疗联合免疫治疗是肿瘤治疗的新模式.同时如何客观评价免疫治疗疗效也成为研究热点.

  20. Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

    Energy Technology Data Exchange (ETDEWEB)

    Bharali, Dhruba J. [The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144 (United States); Siddiqui, Imtiaz A.; Adhami, Vaqar M.; Chamcheu, Jean Christopher [Department of Dermatology, University of Wisconsin, Madison, WI 53706 (United States); Aldahmash, Abdullah M. [Stem Cell Unit, College of Medicine, King Saud University, Riyadh, 11461 (Saudi Arabia); University Hospital of Odense & Medical Biotechnology Center, Winslowsparken 25, DK-5000, Odense (Denmark); Mukhtar, Hasan [Department of Dermatology, University of Wisconsin, Madison, WI 53706 (United States); Mousa, Shaker A., E-mail: shaker.mousa@acphs.edu [The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY 12144 (United States); Stem Cell Unit, College of Medicine, King Saud University, Riyadh, 11461 (Saudi Arabia)

    2011-10-26

    The advent of nanotechnology has had a revolutionary impact on many aspects of 21{sup st} century life. Nanotechnology has provided an opportunity to explore new avenues that conventional technologies have been unable to make an impact on for diagnosis, prevention, and therapy of different diseases, and of cancer in particular. Entities in nanometer sizes are excellent platforms to incorporate various drugs or active materials that can be delivered effectively to the desired action site without compromising the activity of the incorporated drug or material. In particular, nanotechnology entities can be used to deliver conventional natural products that have poor solubility or a short half life. Conventional natural products used with entities in nanometer sizes enable us to solve many of the inherent problems (stability, solubility, toxicity) associated with natural products, and also provide a platform for targeted delivery to tumor sites. We recently introduced the novel concept of using nanotechnology for enhancing the outcome of chemoprevention, which we called ‘nanochemoprevention’. This idea was subsequently exploited by several laboratories worldwide and has now become an advancing field in chemoprevention research. This review examines some of the applications of nanotechnology for cancer prevention and therapy using natural products.

  1. [Current status of autism studies].

    Science.gov (United States)

    Kurita, H

    2001-01-01

    The current status of autism studies was reviewed based on English articles published during the 1990s. Although the concepts of autism and pervasive developmental disorders (PDD) are established, diagnostic criteria of PDDNOS or atypical autism, which is frequently difficult to differentiate from autism, need to be established. The prevalence of autism has been estimated as about 0.05% in the U.S and many European countries, while it was reported to be 0.1% or higher in Japan and some European countries, though the reasons for this difference are unclear. High-functioning (IQ > or = 70) autism may not be as rare a condition as previously thought and both its difference from and similarity to Asperger's syndrome, the highest functioning PDD subtype, need clarification. About 20 to 40% of children with autism lose meaningful words by the age of 2 years and display autistic symptoms thereafter. Such autism, called the setback type in Japan, has been demonstrated to have a poorer adolescent/adult outcome compared to autism without setback and its relationship with childhood disintegrative disorder, which displays a clearer regression after normal development for at least the first 2 years of life, needs to be addressed. The etiology of autism is now considered mostly genetic for reasons, such as the significantly higher concordance rate of autism in identical twin pairs (60-80%) than in fraternal twin pairs (0-10%) and an 3-5% incidence of autism among sibs of an autism proband, 30 to 100 times higher than that in the general population. The involvement of several genes is implicated to create susceptibility for autism, yet the responsible genes have not been identified. Although there is no medication to cure autism, some psychotropic drugs, such as antipsychotics and SSRIs, seem effective for behavior problems in autism patients. Psychosocial treatments are the main therapeutic approach to autism, though they are yet to be well systematized. It is important to

  2. Current status of pulmonary metastasectomy

    DEFF Research Database (Denmark)

    Hornbech, Kåre; Ravn, Jesper; Steinbrüchel, Daniel Andreas

    2011-01-01

    Malignant disease's ability to metastasize remains one of the major obstacles when treating patients with cancer. The change from loco-regional to systemic disease usually renders the patient beyond surgical treatment, as local treatment with surgery in a systemic disease is usually considered...

  3. Current status of MR colonography.

    LENUS (Irish Health Repository)

    Thornton, Eavan

    2010-01-01

    The search for an acceptable colorectal cancer screening examination has led to the development of virtual colonoscopy, which includes both computed tomographic (CT) colonography and magnetic resonance (MR) colonography. As indicated by the much larger number of published studies on CT colonography than on MR colonography, multidetector CT appears to be more suitable for colorectal screening than does MR colonography, in part reflecting the ease and speed of performing CT, as well as the increased spatial resolution, decreased cost, and wider availability of CT colonography. The main advantage of MR colonography over CT colonography is that it does not use ionizing radiation, which has important implications for colorectal cancer screening. The use of dark-lumen MR colonography to screen patients for colorectal cancer as well as other abdominopelvic disease could make it more attractive than CT. With the integration of 3.0-T MR colonography, fecal tagging, and parallel imaging into research and clinical settings, new MR colonography protocols must be optimized. Future MR colonography research should address issues such as image characteristics, presence of artifacts, management of specific absorption rate, and hardware-related modifications.

  4. Edible vaccines: Current status and future

    Directory of Open Access Journals (Sweden)

    Lal P

    2007-01-01

    Full Text Available Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.

  5. Status of current IPH applications

    Energy Technology Data Exchange (ETDEWEB)

    Kearney, D. W.

    1981-03-01

    The US Department of Energy has funded a series of field tests since 1977 to gain operational experience in the application of solar energy to industrial process heat requirements. To date, 34 design studies or actual installations have been funded utilizing technologies ranging from flat plates to line-focus concentrators to central receiver industrial systems. The types of solar systems include hot air, hot water, and steam production applied to a broad spectrum of industrial processes. The program elements are identified and put in perspective relative to transport fluid, temperature level, and size of the solar field. The status of these programs ranges from design studies to operational systems. Solar enhanced oil recovery and repowering have been studied. The chronological history of each program is tabulated. (LEW)

  6. Transungual drug delivery: current status.

    Science.gov (United States)

    Elkeeb, Rania; AliKhan, Ali; Elkeeb, Laila; Hui, Xiaoying; Maibach, Howard I

    2010-01-15

    Topical therapy is highly desirable in treating nail disorders due to its localized effects, which results in minimal adverse systemic events and possibly improved adherence. However, the effectiveness of topical therapies is limited by minimal drug permeability through the nail plate. Current research on nail permeation that focuses on altering the nail plate barrier by means of chemical treatments, penetration enhancers as well as physical and mechanical methods is reviewed. A new method of nail sampling is examined. Finally limitations of current ungual drug permeability studies are briefly discussed. PMID:19819318

  7. Transungual drug delivery: current status.

    Science.gov (United States)

    Elkeeb, Rania; AliKhan, Ali; Elkeeb, Laila; Hui, Xiaoying; Maibach, Howard I

    2010-01-15

    Topical therapy is highly desirable in treating nail disorders due to its localized effects, which results in minimal adverse systemic events and possibly improved adherence. However, the effectiveness of topical therapies is limited by minimal drug permeability through the nail plate. Current research on nail permeation that focuses on altering the nail plate barrier by means of chemical treatments, penetration enhancers as well as physical and mechanical methods is reviewed. A new method of nail sampling is examined. Finally limitations of current ungual drug permeability studies are briefly discussed.

  8. Current Status of RENO Experiment

    International Nuclear Information System (INIS)

    The RENO (Reactor Experiment for Neutrino Oscillation) is under construction to measure the value of the smallest and unknown neutrino mixing angle θ13. The experiment will compare the measured fluxes of electron antineutrinos at two detectors located at 290 m and 1.4 km distances from the center of the Yonggwang nuclear reactors in Korea, with world-second largest thermal power output of 16.4 GW. Construction of experimental halls and access tunnels for both near and far detector sites was completed in early 2009. The detectors are near completion, and data-taking is planned to start in mid 2010. An expected number of observed antineutrino is roughly 510 and 80 per day in the near detector and far detector, respectively. An estimated systematic uncertainty associated with the measurement is less than 0.6%, and an expected statistical error is about 0.3%. With three years of data, the experiment will search for the mixing angle values of sin2(2θ13) down to 0.02 in 90% C.L. limit. In this talk, the construction status will be presented. (author)

  9. Current status of rotavirus vaccines

    Institute of Scientific and Technical Information of China (English)

    Ching-Min Wang; Shou-Chien Chen; Kow-Tong Chen

    2015-01-01

    Background: Rotaviruses remain the major cause of childhood diarrheal disease worldwide and of diarrheal deaths of infants and children in developing countries. The huge burden of childhood rotavirus-related diarrhea in the world continues to drive the remarkable pace of vaccine development. Data sources: Research articles were searched using terms "rotavirus" and "rotavirus vaccine" in MEDLINE and PubMed. Articles not published in the English language, articles without abstracts, and opinion articles were excluded from the review. After preliminary screening, all articles were reviewed and synthesized to provide an overview of current vaccines and vaccination programs. Results: In this review of the global rotavirus vaccines and vaccination programs, the principles of rotavirus vaccine development and the efficacy of the currently licensed vaccines from both developed and developing countries were summarized. Conclusions: Rotavirus is a common cause of diarrhea in children in both developed and developing countries. Rotavirus vaccination is a cost-effective measure to prevent rotavirus diarrhea.

  10. The Current Status of Galaxy Formation

    OpenAIRE

    Silk, Joe; Mamon, Gary A.

    2012-01-01

    Understanding galaxy formation is one of the most pressing issues in cosmology. We review the current status of galaxy formation from both an observational and a theoretical perspective, and summarise the prospects for future advances.

  11. Current status of mini-gastric bypass

    Science.gov (United States)

    Mahawar, Kamal K.; Kumar, Parveen; Carr, William RJ; Jennings, Neil; Schroeder, Norbert; Balupuri, Shlok; Small, Peter K.

    2016-01-01

    Mini-gastric bypass (MGP) is a promising bariatric procedure. Tens of thousands of this procedure have been performed throughout the world since Rutledge performed the first procedure in the United States of America in 1997. Several thousands of these have even been documented in the published scientific literature. Despite a proven track record over nearly two decades, this operation continues to polarise the bariatric community. A large number of surgeons across the world have strong objections to this procedure and do not perform it. The risk of symptomatic (bile) reflux, marginal ulceration, severe malnutrition, and long-term risk of gastric and oesophageal cancers are some of the commonly voiced concerns. Despite these expressed fears, several advantages such as technical simplicity, shorter learning curve, ease of revision and reversal, non-inferior weight loss and comorbidity resolution outcomes have prompted some surgeons to advocate a wider adoption of this procedure. This review examines the current status of these controversial aspects in the light of the published academic literature in English. PMID:27251826

  12. Current status of mini-gastric bypass

    Directory of Open Access Journals (Sweden)

    Kamal K Mahawar

    2016-01-01

    Full Text Available Mini-gastric bypass (MGP is a promising bariatric procedure. Tens of thousands of this procedure have been performed throughout the world since Rutledge performed the first procedure in the United States of America in 1997. Several thousands of these have even been documented in the published scientific literature. Despite a proven track record over nearly two decades, this operation continues to polarise the bariatric community. A large number of surgeons across the world have strong objections to this procedure and do not perform it. The risk of symptomatic (bile reflux, marginal ulceration, severe malnutrition, and long-term risk of gastric and oesophageal cancers are some of the commonly voiced concerns. Despite these expressed fears, several advantages such as technical simplicity, shorter learning curve, ease of revision and reversal, non-inferior weight loss and comorbidity resolution outcomes have prompted some surgeons to advocate a wider adoption of this procedure. This review examines the current status of these controversial aspects in the light of the published academic literature in English.

  13. REACH and nanomaterials: current status

    International Nuclear Information System (INIS)

    New challenges for regulators are emerging about a specific assessment and appropriate management of the potential risks of nanomaterials. In the framework of European legislation on chemicals, Regulation (EC) No. 1907/2006 REACH aims to ensure the safety of human health and the environment through the collection of information on the physico-chemical characteristics of the substances and on their profile (eco) toxicological and the identification of appropriate risk management linked to 'exposure to these substances without impeding scientific progress and the competitiveness of industry. In order to cover the current shortage of information on the safety of nanomaterials and tackle the acknowledged legal vacuum, are being a rich activities, carried out both by regulators both by stake holders, and discussions on the proposals for adapting the European regulatory framework for chemicals . The European Commission is geared to strengthen the REACH Regulation by means of updates of its annexes. The importance of responding to the regulatory requirements has highlighted the need for cooperation between European organizations, scientists and industries to promote and ensure the safe use of nanomaterials.

  14. rasdaman Array Database: current status

    Science.gov (United States)

    Merticariu, George; Toader, Alexandru

    2015-04-01

    rasdaman (Raster Data Manager) is a Free Open Source Array Database Management System which provides functionality for storing and processing massive amounts of raster data in the form of multidimensional arrays. The user can access, process and delete the data using SQL. The key features of rasdaman are: flexibility (datasets of any dimensionality can be processed with the help of SQL queries), scalability (rasdaman's distributed architecture enables it to seamlessly run on cloud infrastructures while offering an increase in performance with the increase of computation resources), performance (real-time access, processing, mixing and filtering of arrays of any dimensionality) and reliability (legacy communication protocol replaced with a new one based on cutting edge technology - Google Protocol Buffers and ZeroMQ). Among the data with which the system works, we can count 1D time series, 2D remote sensing imagery, 3D image time series, 3D geophysical data, and 4D atmospheric and climate data. Most of these representations cannot be stored only in the form of raw arrays, as the location information of the contents is also important for having a correct geoposition on Earth. This is defined by ISO 19123 as coverage data. rasdaman provides coverage data support through the Petascope service. Extensions were added on top of rasdaman in order to provide support for the Geoscience community. The following OGC standards are currently supported: Web Map Service (WMS), Web Coverage Service (WCS), and Web Coverage Processing Service (WCPS). The Web Map Service is an extension which provides zoom and pan navigation over images provided by a map server. Starting with version 9.1, rasdaman supports WMS version 1.3. The Web Coverage Service provides capabilities for downloading multi-dimensional coverage data. Support is also provided for several extensions of this service: Subsetting Extension, Scaling Extension, and, starting with version 9.1, Transaction Extension, which

  15. Current research status of radioimmunotherapy monoclonal antibody drug

    International Nuclear Information System (INIS)

    Radioimmunotherapy (RIT) was one of the most important progresses in the field of cancer therapy over the past 20 years. It has been successfully applied in the treatment of blood system tumors such as NHL. For the utilization of RIT in therapy of solid tumors, however, development of more effective monoclonal antibodies, labeling methods and so on are needed. The current status of radionuclides, monoclonal antibodies and drugs commonly used in the RIT were briefly reviewed. (authors)

  16. Adventure Therapy: Current Status and Future Directions.

    Science.gov (United States)

    Berman, Dene

    1995-01-01

    Overviews articles in this issue that focus on the current status of adventure therapy and describe efforts aimed at defining a framework for conceptualizing adventure therapy. Notes changes in the field, including introduction of state laws requiring licensure of programs, the drive for program accreditation, and growing training opportunities in…

  17. Current Status of Radioisotope Applications in Defence

    Directory of Open Access Journals (Sweden)

    P. K. Bhatnagar

    1987-07-01

    Full Text Available Reviews the current status of radioisotope applications in Defence- R&D Establishments, Defence Inspectorates, Ordnance Factories, Public Sector Undertakings under the Defence Ministry, Army, Navy and Air Force Establishments and Military Hospitals. It also lists the users of film badge service in Defence. Training programmes in radioisotope applications in Defence conducted by DRDO organisations have also been highlighted.

  18. ATM in Europe: analysis of current status

    DEFF Research Database (Denmark)

    1999-01-01

    This deliverable provides an overview of the current status of the European market for ATM services. The offer of ATM services by principal operators in Belgium, Denmark, Finland, France, Germany, Greece, Italy, Norway, Portugal, Spain, Sweden and United Kingdom is described. In addition, a number...

  19. Current management of oral cancer

    Institute of Scientific and Technical Information of China (English)

    Robert Ord

    2008-01-01

    @@ This presentation will summarize some of the current areas of interest in the management of oral cancer. The presentation will be divided into a brief review of epidemiology and diagnosis, with a more extensive discussion regarding the controversial areas in surgery and a review of the adjuvant roles of radiation and chemotherapy.

  20. [Current Approaches in Cancer Immunotherapy].

    Science.gov (United States)

    Otáhal, P; Trněný, M

    2015-01-01

    Methods of cancer immunotherapy have finally entered clinical medicine after years of preclinical research. Currently, there are several methods, which have proven to be very effective even in cases of incurable cancer. Antitumor monoclonal antibodies are among major therapeutic anti-cancer drugs and have been successfully used for many ears. Novel group of antibodies are immunomodulatory antibodies which can break tumor -specific immune tolerance and induce regression of tumors by nonspecific activation of immune system. Bispecific antibodies represent a novel class of anticancer agents which can induce expansion of T cells in vivo, blinatumomab is an example of such agents and is currently available for the treatment of acute B -cell leukemia. Cellular immunotherapy is also very effective, especially the use of Chimeric receptor modified T-cells for the therapy of B- cell lymphoproliferative diseases. Although it is a very complicated and expensive method, it is highly effective approach which can induce remission even in previously hopeless conditions. The goal of this article is to explain the basic principles of cancer immunotherapy and summarize the newest findings in this field.

  1. Current status of the DARPA Quantum Network

    OpenAIRE

    Elliott, Chip; Colvin, Alexander; Pearson, David; Pikalo, Oleksiy; Schlafer, John; Yeh, Henry

    2005-01-01

    This paper reports the current status of the DARPA Quantum Network, which became fully operational in BBN's laboratory in October 2003, and has been continuously running in 6 nodes operating through telecommunications fiber between Harvard University, Boston University, and BBN since June 2004. The DARPA Quantum Network is the world's first quantum cryptography network, and perhaps also the first QKD systems providing continuous operation across a metropolitan area. Four more nodes are now be...

  2. Lung xenotransplantation: recent progress and current status.

    Science.gov (United States)

    Harris, Donald G; Quinn, Kevin J; Dahi, Siamak; Burdorf, Lars; Azimzadeh, Agnes M; Pierson, Richard N

    2014-01-01

    Xenotransplantation has undergone important progress in controlling initial hyperacute rejection in many preclinical models, with some cell, tissue, and organ xenografts advancing toward clinical trials. However, acute injury, driven primarily by innate immune and inflammatory responses, continues to limit results in lung xenograft models. The purpose of this article is to review the current status of lung xenotransplantation--including the seemingly unique challenges posed by this organ-and summarize proven and emerging means of overcoming acute lung xenograft injury.

  3. Current status of the DARPA Quantum Network

    CERN Document Server

    Elliott, C; Pearson, D; Pikalo, O; Schlafer, J; Yeh, H; Elliott, Chip; Colvin, Alexander; Pearson, David; Pikalo, Oleksiy; Schlafer, John; Yeh, Henry

    2005-01-01

    This paper reports the current status of the DARPA Quantum Network, which became fully operational in BBN's laboratory in October 2003, and has been continuously running in 6 nodes operating through telecommunications fiber between Harvard University, Boston University, and BBN since June 2004. The DARPA Quantum Network is the world's first quantum cryptography network, and perhaps also the first QKD systems providing continuous operation across a metropolitan area. Four more nodes are now being added to bring the total to 10 QKD nodes. This network supports a variety of QKD technologies, including phase-modulated lasers through fiber, entanglement through fiber, and freespace QKD. We provide a basic introduction and rational for this network, discuss the February 2005 status of the various QKD hardware suites and software systems in the network, and describe our operational experience with the DARPA Quantum Network to date. We conclude with a discussion of our ongoing work.

  4. Gravitational wave astronomy: the current status

    CERN Document Server

    Blair, David; Zhao, Chunnong; Wen, Linqing; Chu, Qi; Fang, Qi; Cai, RongGen; Gao, JiangRui; Lin, XueChun; Liu, Dong; Wu, Ling-An; Zhu, ZongHong; Reitze, David H; Arai, Koji; Zhang, Fan; Flaminio, Raffaele; Zhu, Xingjiang; Hobbs, George; Manchester, Richard N; Shannon, Ryan M; Baccigalupi, Carlo; Xu, Peng; Bian, Xing; Cao, Zhoujian; Chang, ZiJing; Dong, Peng; Gong, XueFei; Huang, ShuangLin; Ju, Peng; Luo, ZiRen; Qiang, Li'E; Tang, WenLin; Wan, XiaoYun; Wang, Yue; Xu, ShengNian; Zhang, YunLong; Zhang, HaiPeng; Lau, Yun-Kau; Ni, Wei-Tou

    2016-01-01

    In the centenary year of Einstein's General Theory of Relativity, this paper reviews the current status of gravitational wave astronomy across a spectrum which stretches from attohertz to kilohertz frequencies. Sect. 1 of this paper reviews the historical development of gravitational wave astronomy from Einstein's first prediction to our current understanding the spectrum. It is shown that detection of signals in the audio frequency spectrum can be expected very soon, and that a north-south pair of next generation detectors would provide large scientific benefits. Sect. 2 reviews the theory of gravitational waves and the principles of detection using laser interferometry. The state of the art Advanced LIGO detectors are then described. These detectors have a high chance of detecting the first events in the near future. Sect. 3 reviews the KAGRA detector currently under development in Japan, which will be the first laser interferometer detector to use cryogenic test masses. Sect. 4 of this paper reviews gravit...

  5. Current Status of Nuclear Physics Research

    OpenAIRE

    Bertulani, C.A.; Hussein, M. S.

    2015-01-01

    In this review we discuss the current status of research in nuclear physics which is being carried out in different centers in the World. For this purpose we supply a short account of the development in the area which evolved over the last 9 decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data become available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such a...

  6. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Ampornrat, Pantip [Nuclear Material Sciences Section, Physics Division, Office of Atomic Energy for Peace, Bangkok (Thailand)

    2000-10-01

    The neutron scattering experiments in Thailand have been done continuously since the start up of the reactor. In 1977, Thai research reactor was modified into TRIGA MARK III core. After that, the neutron spectrometer was installed again under a development program. Installation of upgrading spectrometer was delayed because of some problems involving the neutron intensity and instruments. However, these problems were solved and the setup is almost completed. The paper reports the current status of neutron spectrometer, the problems and plans for the experiments. (author)

  7. The current status of observational cosmology

    Indian Academy of Sciences (India)

    Jeremiah P Ostriker; Tarun Souradeep

    2004-10-01

    Observational cosmology has indeed made very rapid progress in recent years. The ability to quantify the universe has largely improved due to observational constraints coming from structure formation. The transition to precision cosmology has been spearheaded by measurements of the anisotropy in the cosmic microwave background (CMB) over the past decade. Observations of the large scale structure in the distribution of galaxies, high red-shift supernova, have provided the required complementary information. We review the current status of cosmological parameter estimates from joint analysis of CMB anisotropy and large scale structure (LSS) data. We also sound a note of caution on overstating the successes achieved thus far.

  8. The ENIQ pilot study: current status

    International Nuclear Information System (INIS)

    A pilot study is currently being carried out by ENIQ (European Network for Inspection Qualification) in order to explore the issues involved in inspection qualification applied along the general principles of the European methodology. The components selected for the pilot study are austenitic pipe to pipe and pipe to elbows welds typical of those in BWR recirculation loops. A range of defect parameters has been defined. A suitable inspection procedure designed to find the designated defects will be applied to geometrically representative test pieces. The procedure/equipment will be qualified through open trials and technical justification. The personnel qualification will be done in a blind way. Once all features of the inspection system will have been qualified an in-service inspection will be simulated in order to test the feasibility of the qualification approach followed. In this paper the current status of this pilot study is discussed. (orig.)

  9. The ENIQ pilot study: current status

    Energy Technology Data Exchange (ETDEWEB)

    Lemaitre, P.; Eriksen, B.; Crutzen, S. [European Commission, DG Joint Research Centre, Petten (Netherlands); Hansch, M. [Preussische Elektrizitaets-AG (Preussenelektra), Hannover (Germany); Whittle, J. [AEA Technology, Warrington (United Kingdom)

    1998-11-01

    A pilot study is currently being carried out by ENIQ (European Network for Inspection Qualification) in order to explore the issues involved in inspection qualification applied along the general principles of the European methodology. The components selected for the pilot study are austenitic pipe to pipe and pipe to elbows welds typical of those in BWR recirculation loops. A range of defect parameters has been defined. A suitable inspection procedure designed to find the designated defects will be applied to geometrically representative test pieces. The procedure/equipment will be qualified through open trials and technical justification. The personnel qualification will be done in a blind way. Once all features of the inspection system will have been qualified an in-service inspection will be simulated in order to test the feasibility of the qualification approach followed. In this paper the current status of this pilot study is discussed. (orig.)

  10. Cancer survival disparities by health insurance status.

    Science.gov (United States)

    Niu, Xiaoling; Roche, Lisa M; Pawlish, Karen S; Henry, Kevin A

    2013-06-01

    Previous studies found that uninsured and Medicaid insured cancer patients have poorer outcomes than cancer patients with private insurance. We examined the association between health insurance status and survival of New Jersey patients 18-64 diagnosed with seven common cancers during 1999-2004. Hazard ratios (HRs) with 95% confidence intervals for 5-year cause-specific survival were calculated from Cox proportional hazards regression models; health insurance status was the primary predictor with adjustment for other significant factors in univariate chi-square or Kaplan-Meier survival log-rank tests. Two diagnosis periods by health insurance status were compared using Kaplan-Meier survival log-rank tests. For breast, colorectal, lung, non-Hodgkin lymphoma (NHL), and prostate cancer, uninsured and Medicaid insured patients had significantly higher risks of death than privately insured patients. For bladder cancer, uninsured patients had a significantly higher risk of death than privately insured patients. Survival improved between the two diagnosis periods for privately insured patients with breast, colorectal, or lung cancer and NHL, for Medicaid insured patients with NHL, and not at all for uninsured patients. Survival from cancer appears to be related to a complex set of demographic and clinical factors of which insurance status is a part. While ensuring that everyone has adequate health insurance is an important step, additional measures must be taken to address cancer survival disparities.

  11. Current treatment of early breast cancer: adjuvant and neoadjuvant therapy [v1; ref status: indexed, http://f1000r.es/3l2

    Directory of Open Access Journals (Sweden)

    Elizabeth Miller

    2014-08-01

    Full Text Available Breast cancer is the most commonly diagnosed cancer in women. The latest world cancer statistics calculated by the International Agency for Research on Cancer (IARC revealed that 1,677,000 women were diagnosed with breast cancer in 2012 and 577,000 died. The TNM classification of malignant tumor (TNM is the most commonly used staging system for breast cancer. Breast cancer is a group of very heterogeneous diseases. The molecular subtype of breast cancer carries important predictive and prognostic values, and thus has been incorporated in the basic initial process of breast cancer assessment/diagnosis. Molecular subtypes of breast cancers are divided into human epidermal growth factor receptor 2 positive (HER2 +, hormone receptor positive (estrogen or progesterone +, both positive, and triple negative breast cancer. By virtue of early detection via mammogram, the majority of breast cancers in developed parts of world are diagnosed in the early stage of the disease. Early stage breast cancers can be completely resected by surgery. Over time however, the disease may come back even after complete resection, which has prompted the development of an adjuvant therapy. Surgery followed by adjuvant treatment has been the gold standard for breast cancer treatment for a long time. More recently, neoadjuvant treatment has been recognized as an important strategy in biomarker and target evaluation. It is clinically indicated for patients with large tumor size, high nodal involvement, an inflammatory component, or for those wish to preserve remnant breast tissue. Here we review the most up to date conventional and developing treatments for different subtypes of early stage breast cancer.

  12. Aurora kinase inhibitors: current status and outlook

    Directory of Open Access Journals (Sweden)

    Vassilios eBavetsias

    2015-12-01

    Full Text Available The Aurora kinase family comprises of cell cycle-regulated serine/threonine kinases important for mitosis. Their activity and protein expression are cell cycle regulated, peaking during mitosis to orchestrate important mitotic processes including centrosome maturation, chromosome alignment, chromosome segregation and cytokinesis. In humans, the Aurora kinase family consists of three members; Aurora-A, Aurora-B and Aurora-C, that each share a conserved C-terminal catalytic domain but differ in their sub-cellular localization, substrate specificity and function during mitosis. In addition, Aurora-A and Aurora-B have been found to be overexpressed in a wide variety of human tumors. These observations led to a number of programs among academic and pharmaceutical organizations to discovering small molecule Aurora kinase inhibitors as anti-cancer drugs. This review will summarize the known Aurora kinase inhibitors currently in the clinic and the current and future directions.

  13. Gravitational wave astronomy: the current status

    Science.gov (United States)

    Blair, David; Ju, Li; Zhao, ChunNong; Wen, LinQing; Chu, Qi; Fang, Qi; Cai, RongGen; Gao, JiangRui; Lin, XueChun; Liu, Dong; Wu, Ling-An; Zhu, ZongHong; Reitze, David H.; Arai, Koji; Zhang, Fan; Flaminio, Raffaele; Zhu, XingJiang; Hobbs, George; Manchester, Richard N.; Shannon, Ryan M.; Baccigalupi, Carlo; Gao, Wei; Xu, Peng; Bian, Xing; Cao, ZhouJian; Chang, ZiJing; Dong, Peng; Gong, XueFei; Huang, ShuangLin; Ju, Peng; Luo, ZiRen; Qiang, Li'E.; Tang, WenLin; Wan, XiaoYun; Wang, Yue; Xu, ShengNian; Zang, YunLong; Zhang, HaiPeng; Lau, Yun-Kau; Ni, Wei-Tou

    2015-12-01

    In the centenary year of Einstein's General Theory of Relativity, this paper reviews the current status of gravitational wave astronomy across a spectrum which stretches from attohertz to kilohertz frequencies. Sect. 1 of this paper reviews the historical development of gravitational wave astronomy from Einstein's first prediction to our current understanding the spectrum. It is shown that detection of signals in the audio frequency spectrum can be expected very soon, and that a north-south pair of next generation detectors would provide large scientific benefits. Sect. 2 reviews the theory of gravitational waves and the principles of detection using laser interferometry. The state of the art Advanced LIGO detectors are then described. These detectors have a high chance of detecting the first events in the near future. Sect. 3 reviews the KAGRA detector currently under development in Japan, which will be the first laser interferometer detector to use cryogenic test masses. Sect. 4 of this paper reviews gravitational wave detection in the nanohertz frequency band using the technique of pulsar timing. Sect. 5 reviews the status of gravitational wave detection in the attohertz frequency band, detectable in the polarisation of the cosmic microwave background, and discusses the prospects for detection of primordial waves from the big bang. The techniques described in sects. 1-5 have already placed significant limits on the strength of gravitational wave sources. Sects. 6 and 7 review ambitious plans for future space based gravitational wave detectors in the millihertz frequency band. Sect. 6 presents a roadmap for development of space based gravitational wave detectors by China while sect. 7 discusses a key enabling technology for space interferometry known as time delay interferometry.

  14. Current status of neutron capture therapy

    International Nuclear Information System (INIS)

    There are about 6000 new glioblastoma multiform brain tumours diagnosed each year in the United States of America alone. This cancer is usually fatal within six months of diagnosis even with current standard treatments. Research on boron neutron capture therapy (BNCT) has been considered as a method of potentially curing such cancers. There is a great interest at under-utilised research reactors institutions to identify new medical utilization, attractive to the general public. Neutron capture therapy is a true multidisciplinary topic with a large variety of individuals involved. This publication attempts to provide current information for all those thinking about being involved with NCT, based on the knowledge and experience of those who have pioneered the treatment. It covers the whole range of NCT from designing reactor conversions or new facilities, through to clinical trials and their effectiveness. However, since most work has been done with boron capture therapy for brain tumours using modified thermal research reactors, this tends to be the focus of the report. One of the factors which need to be addressed at the beginning is the timing of the further development of NCT facilities. It should be emphasised that all current work is still at the research stage. Many of those now involved believe that there is little need for many more research facilities until such time as the treatment shows more promising results. For this and other reasons discussed in the report, very serious consideration should be given by research reactor owners and operators before spending large sums of money converting their facilities for NCT

  15. [Renaissance of immuno-oncology for urological tumors : Current status].

    Science.gov (United States)

    Grimm, M-O; Winkler, Y; Fetter, I; Oppel-Heuchel, H

    2016-05-01

    With the advent of immune checkpoint inhibitors, immunotherapy has gained new importance in oncology. Current research is focused on the cytotoxic T‑lymphocyte antigen 4 (CTLA4), programmed cell death 1 (PD-1) and programmed death ligand 1 (PD-L1) immune checkpoints. The CTLA4 antibody ipilimumab (melanoma) as well as the PD-1 antibodies nivolumab (melanoma, non-small cell lung cancer and renal cell carcinoma) and pembrolizumab (melanoma) are approved for the treatment of metastatic disease in Europe. Immune checkpoint inhibitors (re)activate the immune system against cancer cells and appear to be more effective than current standards for many tumors. The toxicity profile is favorable but involves new so-called immune-related side effects, which need to be recognized and treated in time. Immune checkpoint inhibitors are also currently being tested in uro-oncology in phase 3 trials relevant for approval status. Based on this it is to be expected that immune checkpoint inhibitors will become a new standard (as monotherapy or as part of combination therapy) in the early lines of therapy in the near future and replace the previous standard therapies, particularly for metastasized renal cell carcinoma and urothelial cancer.

  16. Current status of Pohang Neutron Facility

    Energy Technology Data Exchange (ETDEWEB)

    Kim, G.N.; Lee, Y.S.; Cho, M.H. [Pohang Accelerator Laboratory, POSTECH, Pohang (KR)] [and others

    2000-03-01

    We present the current status of Pohang Neutron Facility, which is the pulsed neutron facility, based on the 70-MeV electron linear accelerator completed on Dec.1997. We have prepared the 15-m time-of-flight path, a Ta-target system, and the Data Acquisition System. Meanwhile we have measured the total cross-sections of Dy and Hf samples at the Research Reactor Institute, Kyoto University and the neutron capture cross-sections of {sup 164}Dy isotope at Research Laboratory for Nuclear Reactors, Tokyo Institute of Technology both in Japan. We also were participated the experiment at the 122-m flight path of the IBR-30 pulsed neutron source of Joint Institute of Nuclear Research in Dubna, Russia. (author)

  17. Interventional Radiology of Male Varicocele: Current Status

    Energy Technology Data Exchange (ETDEWEB)

    Iaccarino, Vittorio, E-mail: vittorio.iaccarino@unina.it; Venetucci, Pietro [University of Naples ' Federico II' , Diagnostic Imaging Department-Cardiovascular and Interventional Radiology, School of Medicine (Italy)

    2012-12-15

    Varicocele is a fairly common condition in male individuals. Although a minor disease, it may cause infertility and testicular pain. Consequently, it has high health and social impact. Here we review the current status of interventional radiology of male varicocele. We describe the radiological anatomy of gonadal veins and the clinical aspects of male varicocele, particularly the physical examination, which includes a new clinical and ultrasound Doppler maneuver. The surgical and radiological treatment options are also described with the focus on retrograde and antegrade sclerotherapy, together with our long experience with these procedures. Last, we compare the outcomes, recurrence and persistence rates, complications, procedure time and cost-effectiveness of each method. It clearly emerges from this analysis that there is a need for randomized multicentre trials designed to compare the various surgical and percutaneous techniques, all of which are aimed at occlusion of the anterior pampiniform plexus.

  18. Current status of toxoplasmosis vaccine development.

    Science.gov (United States)

    Kur, Józef; Holec-Gasior, Lucyna; Hiszczyńska-Sawicka, Elzbieta

    2009-06-01

    Toxoplasmosis, caused by an intracellular protozoan parasite, Toxoplasma gondii, is widespread throughout the world. The disease is of major medical and veterinary importance, being a cause of congenital disease and abortion in humans and domestic animals. In addition, recently it has gained importance owing to toxoplasma encephalitis in AIDS patients. In the last few years, there has been considerable progress towards the development of a vaccine for toxoplasmosis, and a vaccine based on the live-attenuated S48 strain was developed for veterinary uses. However, this vaccine is expensive, causes side effects and has a short shelf life. Furthermore, this vaccine may revert to a pathogenic strain and, therefore, is not suitable for human use. Various experimental studies have shown that it may be possible to develop a vaccine against human toxoplasmosis. Recent progress in knowledge of the protective immune response generated by T. gondii and the current status of development of a vaccine for toxoplasmosis are highlighted.

  19. Current Status of the KSTAR Engineering

    Institute of Scientific and Technical Information of China (English)

    J. S. Bak; K. Kim; C. H. Choi; Y. K. Oh; B. C. Kim; N. I. Her; H. L. Yang; G. S. Lee; the KSTAR Team

    2004-01-01

    As there is substantial progress in the KSTAR tokamak engineering, all the major structures and sub-systems are under fabrication and in procurement phase. The vacuum vessel,port, cryostat cylinder, lid, and bellows are being rigorously fabricated in the factory. The lower part of the KSTAR such as cryostat base and gravity support has been almost finished in its fabrication. There are also great progresses and significant results in manufacturing of the superconducting magnet, including four Toroidal Field (TF) coils, lower and upper PF7 coils which are the largest Poloidal Field (PF) coils. The TF00 coil, which has been made for test and back-up of the TF magnet system, was successfully tested in the cool-down and current charging. As the fabrications and procurements of major structures have been actively proceeded, assembly works were also launched from Aug. 2003. More detailed description on these status, results, and plans will be described in this paper.

  20. Current status of NDC fuel hot laboratory

    Energy Technology Data Exchange (ETDEWEB)

    Yamaguchi, Youichirou; Matsuoka, Takanori; Shiraishi, Satoshi [Nuclear Development Corp., Tokai, Ibaraki (Japan); Sugano, Mitsuteru

    1999-09-01

    Nuclear Development Corporation (NDC) fuel hot laboratory was established to investigate the causes for leaked rods and to confirm the integrity of the precedence irradiation fuels, in 1986. After that, it obtained a license to conduct PIE of the structural materials, such as stainless steels, inside the reactor in addition to fuels. So far we have conducted PIE of fuels and metallic materials including fuel assembly components and reactor internal components irradiated in Japanese PWR plants or some test reactors. To meet these PIE needs, we are making efforts to improve facilities and to install high advanced equipments. This paper describes current status of the facilities and PIE techniques in NDC fuel hot laboratory. (author)

  1. Current surgical status of thyroid diseases.

    Science.gov (United States)

    Touzopoulos, Panagiotis; Karanikas, Michael; Zarogoulidis, Paul; Mitrakas, Alexandros; Porpodis, Konstantinos; Katsikogiannis, Nikolaos; Zervas, Vasilis; Kouroumichakis, Ioannis; Constantinidis, Theodoros C; Mikroulis, Dimitrios; Tsimogiannis, Konstantinos E

    2011-01-01

    Thyroid nodules are a common clinical problem for surgeons. The clinical importance of nodules is the need to exclude thyroid cancer, which occurs in 5%-15% of patients. If fine needle aspiration cytology is positive, or suspicious for malignancy, surgery is recommended. During the past decade, with the tendency to develop smaller incisions, an endoscopic approach has been applied to thyroid surgery, called minimally invasive video-assisted thyroidectomy. This approach was immediately followed by other minimally invasive or scarless neck techniques, such as the breast approach, axillary-breast approach, and robot-assisted method. All these techniques follow the same principles of surgery and oncology. This review presents the current surgical management of the thyroid gland, including the surgical techniques and compares them by describing benefits and drawbacks of each one. PMID:22247619

  2. Role of radiation therapy in the management of stage III non-small cell lung cancers:current status and controversies

    Institute of Scientific and Technical Information of China (English)

    Wen Feng; Xiaolong Fu

    2015-01-01

    The treatment of stage III non-smal cel lung cancer (NSCLC) consisting of the heterogeneous stage subsets remains a chal enge. Overal , it has been gradual y recognized that radiation therapy (RT) plays a crucial role in the management of stage III NSCLC. One superior sulcus tumors are the subset for which the trimodality treatments are clearly preferred. One subset of stage III NSCLC has a minimal disease burden with microscopic pN2 disease or with discrete pN2 involvement identified preoperatively, thus technical y could undergo a surgical resection. For the incidental y found pN2 disease after complete surgery (IIIA-1, IIIA-2), the value of postoperative radiotherapy (PORT) has been recognized by a reassessment based on new data. However, doubt persists regarding how to define the clinical target volume for PORT. For the discrete pN2 involvement identified preoperatively (a selected part of IIIA-3), induction chemoradiation therapy (CRT) before surgery may yield a survival advantage, although the phase III randomized trials in this issue are not conclusive. The other major subset of stage III NSCLC is the infiltrative stage III NSCLC with N2 or N3 nodal disease (IIIA-3, IIIA-4, and IIIB), for which concurrent CRT is considered as the current standard of care. The potential role of radiation dose escalation/acceleration has been proposed;however, the optimal dose fractionation remains an important unresolved question. Additional y, the role of prophylac-tic cranial irradiation for stage III patients with high risk of brain metastasis is worth of further assessment. Moreover, how to integrate molecular targeted therapy with RT, as wel as whether they had a role in stage III diseases, are other controversies actively under study in ongoing trials. This review specifical y describes the updated role of RT in multimodal approach to treat stage III NSCLC and the controversies regarding these results in various situations.

  3. Current status of pig liver xenotransplantation.

    Science.gov (United States)

    Ekser, Burcin; Markmann, James F; Tector, A Joseph

    2015-11-01

    The shortage of organs from deceased human donors is a major problem limiting the number of organs transplanted each year and results in the death of thousands of patients on the waiting list. Pigs are currently the preferred species for clinical organ xenotransplantation. Progress in genetically-engineered (GE) pig liver xenotransplantation increased graft and recipient survival from hours with unmodified pig livers to up to 9 days with normal to near-normal liver function. Deletion of genes such as GGTA1 (Gal-knockout pigs) or adding genes such as human complement regulatory proteins (hCD55, hCD46 expressing pigs) enabled hyperacute rejection to be overcome. Although survival up to 9 days was recorded, extended pig graft survival was not achieved due to lethal thrombocytopenia. The current status of GE pig liver xenotransplantation with world experience, potential factors causing thrombocytopenia, new targets on pig endothelial cells, and novel GE pigs with more genes deletion to avoid remaining antibody response, such as beta1,4-N-acetyl galactosaminyl transferase 2 (β4GalNT2), are discussed.

  4. Current surgical status of thyroid diseases

    Directory of Open Access Journals (Sweden)

    Touzopoulos P

    2011-12-01

    Full Text Available Panagiotis Touzopoulos1, Michael Karanikas1, Paul Zarogoulidis2, Alexandros Mitrakas1, Konstantinos Porpodis2, Nikolaos Katsikogiannis3, Vasilis Zervas2, Ioannis Kouroumichakis4, Theodoros C Constantinidis5, Dimitrios Mikroulis6, Konstantinos E Tsimogiannis71First Surgery Department, University General Hospital of Alexandroupolis, Democritus University of Alexandroupolis, Greece; 2Pulmonary Department, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Greece; 3Surgery Department (NHS, University General Hospital of Alexandroupolis, Greece; 4Second Internal Medicine Department, University General Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece; 5Medical School, Laboratory of Hygiene and Environmental Protection, Democritus University of Thrace, Regional Laboratory of Public Health, Eastern Macedonia-Thrace, Greece; 6Cardiothoracic Surgery Department, General University Hospital of Alexandroupolis, Democritus University of Thrace, Greece; 7Surgery Department, "G. Hatzikosta" General Hospital of Ioannina, GreeceAbstract: Thyroid nodules are a common clinical problem for surgeons. The clinical importance of nodules is the need to exclude thyroid cancer, which occurs in 5%–15% of patients. If fine needle aspiration cytology is positive, or suspicious for malignancy, surgery is recommended. During the past decade, with the tendency to develop smaller incisions, an endoscopic approach has been applied to thyroid surgery, called minimally invasive video-assisted thyroidectomy. This approach was immediately followed by other minimally invasive or scarless neck techniques, such as the breast approach, axillary-breast approach, and robot-assisted method. All these techniques follow the same principles of surgery and oncology. This review presents the current surgical management of the thyroid gland, including the surgical techniques and compares them by describing benefits and drawbacks of

  5. Radiopharmaceuticals in China. Current status and prospects

    International Nuclear Information System (INIS)

    The review provides an overview of the current status of radiopharmaceuticals in China for in vivo clinical use and also describes some important advances in the past three decades. Development of the diagnostic and therapeutic radiopharmaceuticals as well as basic research on radiopharmaceutical chemistry are being introduced. The radiotracers developed in China include: (1) Brain perfusion imaging agents and CNS radiotracers for β-amyloid plaques, σ1 receptors, and dopamine D2 or D4 receptors; (2) 99mTc- and 18F-labeled myocardial perfusion imaging agents; (3) tumor imaging agents including integrin-targeting radiotracer, novel sentinel lymph node imaging agents, hypoxia imaging agents, 99mTc-labeled glucose derivatives, σ2 receptor imaging agents, folate receptor imaging agents, and potential radiotracers for imaging of human telomerase reverse transcriptase expression; (4) Potential infection imaging agents; (5) Potential asialoglycoprotein receptor imaging agents; (6) Other imaging agents. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed. (orig.)

  6. Radiopharmaceuticals in China. Current status and prospects

    Energy Technology Data Exchange (ETDEWEB)

    Jia, Hong-Mei; Liu, Bo-Li [Beijing Normal Univ. (China). Key Laboratory of Radiopharmaceuticals

    2014-04-01

    The review provides an overview of the current status of radiopharmaceuticals in China for in vivo clinical use and also describes some important advances in the past three decades. Development of the diagnostic and therapeutic radiopharmaceuticals as well as basic research on radiopharmaceutical chemistry are being introduced. The radiotracers developed in China include: (1) Brain perfusion imaging agents and CNS radiotracers for β-amyloid plaques, σ{sub 1} receptors, and dopamine D{sub 2} or D{sub 4} receptors; (2) {sup 99m}Tc- and {sup 18}F-labeled myocardial perfusion imaging agents; (3) tumor imaging agents including integrin-targeting radiotracer, novel sentinel lymph node imaging agents, hypoxia imaging agents, {sup 99m}Tc-labeled glucose derivatives, σ{sub 2} receptor imaging agents, folate receptor imaging agents, and potential radiotracers for imaging of human telomerase reverse transcriptase expression; (4) Potential infection imaging agents; (5) Potential asialoglycoprotein receptor imaging agents; (6) Other imaging agents. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed. (orig.)

  7. Current status of JENDL-3.3

    Energy Technology Data Exchange (ETDEWEB)

    Hasegawa, Akira [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-03-01

    Current status of JENDL-3.3 is presented. Reevaluation work toward JENDL-3.3 has started last April for three years project to supply a consolidated new versions of JENDL by JAERI NDC (Nuclear Data center) with the cooperation of JNDC (Japanese Nuclear Data Committee). The working schedule has been fixed by the careful review of the summary report, `The problems of JENDL-3.2`, submitted to JNDC last March after one year discussions by a small advisory group: `Identifying the problems of JENDL-3.2`. To cope with the problems, two new subgroups are set up in the Subcommittee of Nuclear Data of JNDC. One is Heavy Mass Elements Evaluation Working Group for the re-evaluation of major actinides (Th-232, U-233,235,236,238, Pu-236,239,241,242). The other is Intermediate Mass Elements Evaluation Working Group for solving the inconsistencies between calculations and integral experiments relating to the fields of fusion neutronics and shielding applications as well as new evaluations such as Er elements. Supplying covariance data for important nuclides are one of the main feature of JENDL-3.3. Re-evaluated data will be released as JENDL-3.3 in the individual bases after the reviewing process by the experts. (author)

  8. Current status in diabetic macular edema treatments

    Institute of Scientific and Technical Information of China (English)

    Pedro; Romero-Aroca

    2013-01-01

    Diabetes is a serious chronic condition,which increase the risk of cardiovascular diseases,kidney failure and nerve damage leading to amputation.Furthermore the ocular complications include diabetic macular edema,is the leading cause of blindness among adults in the industrialized countries.Today,blindness from diabetic macular edema is largely preventable with timely detection and appropriate interventional therapy.The treatment should include an optimized control of glycemia,arterial tension,lipids and renal status.The photocoagulation laser is currently restricted to focal macular edema in some countries,but due the high cost of intravitreal drugs,the use of laser treatment for focal and diffuse diabetic macular edema(DME),can be valid as gold standard in many countries.The intravitreal anti vascular endothelial growth factor drugs(ranibizumab and bevacizumab),are indicated in the treatment of all types of DME,but the correct protocol for administration should be defined for the different Retina Scientific Societies.The corticosteroids for diffuse DME,has a place in pseudophakic patients,but its complications restricted the use of these drugs for some patients.Finally the intravitreal interface plays an important role and its exploration is mandatory in all DME patients.

  9. Tackling dengue fever: Current status and challenges.

    Science.gov (United States)

    Nedjadi, Taoufik; El-Kafrawy, Sherif; Sohrab, Sayed S; Desprès, Philippe; Damanhouri, Ghazi; Azhar, Esam

    2015-01-01

    According to recent statistics, 96 million apparent dengue infections were estimated worldwide in 2010. This figure is by far greater than the WHO prediction which indicates the rapid spread of this disease posing a growing threat to the economy and a major challenge to clinicians and health care services across the globe particularly in the affected areas.This article aims at bringing to light the current epidemiological and clinical status of the dengue fever. The relationship between genetic mutations, single nucleotide polymorphism (SNP) and the pathophysiology of disease progression will be put into perspective. It will also highlight the recent advances in dengue vaccine development.Thus far, a significant progress has been made in unraveling the risk factors and understanding the molecular pathogenesis associated with the disease. However, further insights in molecular features of the disease and the development of animal models will enormously help improving the therapeutic interventions and potentially contribute to finding new preventive measures for population at risk. PMID:26645066

  10. Current Status of Nuclear Physics Research

    CERN Document Server

    Bertulani, C A

    2015-01-01

    In this review we discuss the current status of research in nuclear physics which is being carried out in different centers in the World. For this purpose we supply a short account of the development in the area which evolved over the last 9 decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data become available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as $^4$He, $^7$Li, $^9$Be etc. and up the ladder to heavier bound nuclei co...

  11. Chinese Soybean Industry: Current Status and Outlook

    Institute of Scientific and Technical Information of China (English)

    Dachuan Liu; Shaojun Tian

    2002-01-01

    This paper focus on the soybeanresources and their industry development inChina. Due to the high demand in domesticmarket, it is necessary to expand the cultivationarea and improve the production yields.Meanwhile, to inc e the export of soybeansfrom overseas is also important. China has along history in producing traditional soyfoods. After recent fifty years, the developmentof Chinese soybean industry has reached to areasonable level. The current status of Chinesesoybean industry has been included in thepaper. It has been expected that in next fiveyears, there will be a rapid increase in theprocessing of soybeans; it will become morereasonable in the scale and distribution ofsoybean oil factories. Emphasis will be put onthe improvement of the functionalities ofsoybean products. Different kinds of functionalsoybean foods, especially the soybean proteinsfor particular uses will be developed by the useof modification technologies. Concern is alsogiven to the multi -utilizn of soybeanresources, which not only the extractionof oil from soybean and the processingof protein products from the meal; but alsoincludes the recovery of the naturalchemicals from soybeans which could then beexploited to novel products with more profits.

  12. Cancer immunotherapy: moving beyond current vaccines

    OpenAIRE

    Rosenberg, Steven A.; Yang, James C.; Restifo, Nicholas P

    2004-01-01

    Great progress has been made in the field of tumor immunology in the past decade, but optimism about the clinical application of currently available cancer vaccine approaches is based more on surrogate endpoints than on clinical tumor regression. In our cancer vaccine trials of 440 patients, the objective response rate was low (2.6%), and comparable to the results obtained by others. We consider here results in cancer vaccine trials and highlight alternate strategies that mediate cancer regre...

  13. Semiconductor plasmonic nanolasers: current status and perspectives

    Science.gov (United States)

    Gwo, Shangjr; Shih, Chih-Kang

    2016-08-01

    Scaling down semiconductor lasers in all three dimensions holds the key to the development of compact, low-threshold, and ultrafast coherent light sources, as well as integrated optoelectronic and plasmonic circuits. However, the minimum size of conventional semiconductor lasers utilizing dielectric cavity resonators (photonic cavities) is limited by the diffraction limit. To date, surface plasmon amplification by stimulated emission of radiation (spaser)-based plasmonic nanolaser is the only photon and plasmon-emitting device capable of this remarkable feat. Specifically, it has been experimentally demonstrated that the use of plasmonic cavities based on metal-insulator-semiconductor (MIS) nanostructures can indeed break the diffraction limit in all three dimensions. In this review, we present an updated overview of the current status for plasmonic nanolasers using the MIS configuration and other related metal-cladded semiconductor microlasers. In particular, by using composition-varied indium gallium nitride/gallium nitride core–shell nanorods, it is possible to realize all-color, single-mode nanolasers in the full visible wavelength range with ultralow continuous-wave (CW) lasing thresholds. The lasing action in these subdiffraction plasmonic cavities is achieved via a unique auto-tuning mechanism based on the property of weak size dependence inherent in plasmonic nanolasers. As for the choice of metals in the plasmonic structures, epitaxial silver films and giant colloidal silver crystals have been shown to be the superior constituent materials for plasmonic cavities due to their low plasmonic losses in the visible and near-infrared (NIR) spectral regions. In this review, we also provide some perspectives on the challenges and opportunities in this exciting new research frontier.

  14. Current status of JMTR refurbishment project

    International Nuclear Information System (INIS)

    The JMTR is a light water moderated and cooled, beryllium reflected tank- type reactor using LUE silicide plate-type fuels. Its thermal power is 50 MW, maximum thermal and fast neutron flux is 4x1018 m-2s-1. First criticality was achieved in March 1968, and its operation was stopped from August, 2006 for the refurbishment. The refurbishment is scheduled from the beginning of FY2007 to the end of FY2010. The renewed and upgraded JMTR will be re-started from FY2011. An investigation on aged components (aged-investigation) was carried out for concrete structures of the JMTR reactor building, exhaust stack, etc., and for tanks in the primary cooling system, heat exchangers, pipes in the secondary cooling system, cooling tower, emergency generators and so on, in order to identify their integrity. The aged-investigation was carried out at the beginning of FY2007. As a result, some components were decided to replace from viewpoints of future maintenance and improvement of reliability, and some components or structures were decided to repair. A visual inspection of inner side of the pressure vessel was carried out using an underwater camera in FY2008, and no serious damage was observed. Up to now, refurbishment works are in progress according to the planned schedule. In FY2009, motors of primary cooling pumps, secondary cooling pumps, motors of drain pumps, pump in the primary water transfer line to the water purification system, beryllium reflector frame, low-voltage motor control centers are to be replaced. A nuclear instrumentation system, process control system, safety protection system and so on are to be replaced in FY2010. In this paper, current status of JMTR refurbishment project is presented. (author)

  15. Counseling in Turkey: Current Status and Future Challenges

    OpenAIRE

    Suleyman Dogan

    1998-01-01

    In this article a special emphasis is placed on the current status and the future challenges of counseling in Turkey. A brief history of counseling in Turkey, current developments, and the basic issues in this field are pointed out. Finally, the future challenges and recommendations to improve the current status of counseling are discussed.

  16. Torque teno virus (TTV): current status.

    Science.gov (United States)

    Hino, Shigeo; Miyata, Hironori

    2007-01-01

    Torque teno virus (TTV), currently classified into the family Circoviridae, genus Anellovirus, was first found in a patient with non-A-E hepatitis. TTV has a single stranded circular DNA of approximately 3.8 kb. TTVs are extraordinarily diverse, spanning five groups including SANBAN and SEN viruses. Torque teno mini virus (TTMV) with approximately 2.9 kb genome also has wide variants. Recently, two related 2.2- and 2.6-kb species joined this community. Recombinations between variants are frequent. This extensive TTV diversity remains unexplained; it is unclear how TTVs could be viable, and why they require such genetic variation. An unequivocal culture system is still not available. TTVs are ubiquitous in > 90% of adults worldwide but no human pathogenicity of TTV has been fully established. Epidemiological surveys need to specify the variants being studied and clinical targets, and must calibrate the sensitivity of the assay used. Potentially interesting observations include a higher viral load in patients with severe idiopathic inflammatory myopathies, cancer and lupus. Active replication was also found in infants with acute respiratory diseases. TTV/TTMV-related viruses were found in chimpanzees, apes, African monkeys and tupaias, and also in chickens, pigs, cows, sheep and dogs. Experimentally, rhesus monkeys were persistently infected by TTV, but only 1/53 chimpanzees. TTV transcribes three species of mRNAs, 3.0-, 1.2- and 1.0-kb in the ratio of 60:5:35. Recently, at least three mRNAs were shown in chicken anaemia virus. The genomic region -154/-76 contains a critical promoter. TTV seems to have at least three proteins; however, the definite functions of these proteins await further research work. PMID:17146841

  17. [Current status of hyperthermia for deep-seated tumors].

    Science.gov (United States)

    Hiraoka, M; Abe, M

    1989-03-01

    The current status of hyperthermia for deep-seated tumor is reviewed. Heating methods include external heating, intraluminal heating and interstitial heating, all of which have inherent advantages and disadvantages. Hyperthermia alone has significant effects on deep-seated tumors. The combination of hyperthermia and radiotherapy has been widely applied, resulting in 10-15% complete regression and 10-40% partial regression in the treatment of locally advanced tumors. The response rate of thermoradiotherapy was higher than that of radiotherapy for tumors in the brain, rectum and esophagus in the non-randomized study. The clinical application of thermochemotherapy is increasing and its effect is demonstrated in the prevention and treatment of peritoneal dissemination of gastric cancers. Reports of serious complications are rare. The technology for deep-heating and thermometry, and the new criteria for the assessment of thermotherapy for deep-seated tumors seems a promising new treatment modality.

  18. Current status of nuclear physics research

    Energy Technology Data Exchange (ETDEWEB)

    Bertulani, Carlos A. [Department of Physics and Astronomy, Texas A and M University-Commerce (United States); Hussein, Mahir S., E-mail: hussein@if.usp.br [Instituto Tecnologico de Aeronautica (ITA), Sao Jose dos Campos, SP (Brazil). Dept. de Fisica

    2015-12-15

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as {sup 4}He, {sup 7}Li, {sup 9}Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate

  19. Current status of nuclear physics research

    International Nuclear Information System (INIS)

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as 4He, 7Li, 9Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate students interested in

  20. Current Status of Nuclear Physics Research

    Science.gov (United States)

    Bertulani, Carlos A.; Hussein, Mahir S.

    2015-12-01

    In this review, we discuss the current status of research in nuclear physics which is being carried out in different centers in the world. For this purpose, we supply a short account of the development in the area which evolved over the last nine decades, since the discovery of the neutron. The evolution of the physics of the atomic nucleus went through many stages as more data became available. We briefly discuss models introduced to discern the physics behind the experimental discoveries, such as the shell model, the collective model, the statistical model, the interacting boson model, etc., some of these models may be seemingly in conflict with each other, but this was shown to be only apparent. The richness of the ideas and abundance of theoretical models attests to the important fact that the nucleus is a really singular system in the sense that it evolves from two-body bound states such as the deuteron, to few-body bound states, such as 4He, 7Li, 9Be, etc. and up the ladder to heavier bound nuclei containing up to more than 200 nucleons. Clearly, statistical mechanics, usually employed in systems with very large number of particles, would seemingly not work for such finite systems as the nuclei, neither do other theories which are applicable to condensed matter. The richness of nuclear physics stems from these restrictions. New theories and models are presently being developed. Theories of the structure and reactions of neutron-rich and proton-rich nuclei, called exotic nuclei, halo nuclei, or Borromean nuclei, deal with the wealth of experimental data that became available in the last 35 years. Furthermore, nuclear astrophysics and stellar and Big Bang nucleosynthesis have become a more mature subject. Due to limited space, this review only covers a few selected topics, mainly those with which the authors have worked on. Our aimed potential readers of this review are nuclear physicists and physicists in other areas, as well as graduate students interested in

  1. Non-small cell lung cancer: current status of chemoradiation for locally advanced disease and an update on susceptibility and prevention

    International Nuclear Information System (INIS)

    Locally advanced, inoperable non-small cell lung cancer (NSCLC) afflicts 40,000 patients yearly. The traditional treatment has been radiation therapy (RT) alone with 5 year survival rates averaging around 5%. Recent reports of randomized clinical trials using combined radiochemotherapy suggest significant improvement in survival compared to RT alone. These trials are difficult to evaluate because of differences in dose, timing and sequencing of both the chemotherapy (CT) and the RT. Dr. Byhardt will give an overview of the significant chemoradiation trials, especially with respect to the factors associated with reduction of local failure and distant metastasis. Dr. Tishler will review the biologic rationale of these regimens and make some prognostications about the potential role of new chemotherapy agents, new developments in RT dose-time-fractionation, and new RT technology in future radiochemotherapy trials. While progress continues to be made using the more traditional cancer treatment modalities, investigations in NSCLC epidemiology and prevention are providing new insights regarding susceptibility, etiology, failure risk stratification, and potential avenues of therapeutic intervention. Dr. Spitz will discuss NSCLC as a paradigm of an environmentally induced disease in which host susceptibility may be determined by genetically determined modulation of environmental exposures. A mutagen sensitivity assay can determine individuals at high risk for developing NSCLC if exposed to carcinogens such as those in cigarette smoke. This susceptibility may have prognostic implications that could influence choice of therapy. Highly susceptible individuals can also be selected for special counseling, smoking cessation, with consideration given to chemoprevention. Dr. Gritz will review major work done in this area

  2. A balanced review of the status T cell-based therapy against cancer

    Directory of Open Access Journals (Sweden)

    Marincola Francesco M

    2005-04-01

    Full Text Available Abstract A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.

  3. Qualitative Study of Current Status and Needs of Caregivers of Terminal Cancer Patient%晚期癌症患者照顾者照护现状和需求的质性研究

    Institute of Scientific and Technical Information of China (English)

    许君; 叶文琴; 江萍

    2014-01-01

    目的:了解晚期癌症患者照顾者的照护现状和需求,为提供适合照顾者需求的护理服务提供依据。方法采用目的抽样法,选择2013年8-12月上海市浦东新区人民医院收治的晚期癌症患者的照顾者10名,对其进行面对面、半结构式的深入访谈,并采用内容分析法对资料进行分析。结果分析出关于照顾者照护现状和需求的主要主题共8个。结论晚期癌症患者照顾者承担着一定的压力,面临着不同程度的问题,护理人员应为照顾者提供专业和个性化的培训,同时建议医院联动社会资源,为患者提供全方位服务。此外,对照顾者适时进行临终辅导,提供有效的情感支持。%Objective To understand the current status and needs of caregivers of terminal cancer patient , in order to provide evidence for fulfilling the caregiver’s needs and nursing service .Methods By using pur‐pose sampling method ,10 participants were applied face to face ,semi‐structured in‐depth interview ,and use content analyze method to analysis the material .Results Eight themes were analyzed about caregiver’s care current status and needs .Conclusion Caregivers of terminal cancer patients are under the pressure , and facing the different kinds of problem .Nursing staff should provide caregivers with professional and personalized training ,and hospital should alliance with social resources to provide all around service for pa‐tients .Besides ,it is important to offer caregivers end of life assistant with effective emotional support .

  4. Counselling International Students in Turkish Universities: Current Status and Recommendations

    Science.gov (United States)

    Bektas, Dilek Yelda

    2008-01-01

    In the present study, the current status of international students and counselling services provided at Turkish universities is addressed. Firstly, a brief history of counselling and counselling services in Turkish universities is examined, leading to a consideration of the current status of international students and counselling services.…

  5. Palliative radiotherapy: current status and future directions.

    Science.gov (United States)

    Sharma, Sonam; Hertan, Lauren; Jones, Joshua

    2014-12-01

    For nearly 100 years, palliative radiotherapy has been a time-efficient, effective treatment for patients with metastatic or advanced cancer in any area where local tumors are causing symptoms. Short courses including a single fraction of radiotherapy may be effective for symptom relief with minimal side effects and maximization of convenience for patient and family. With recent advances in imaging, surgery, and other local therapies as well as systemic cancer therapies, palliative radiotherapy has been used frequently in patients who may not yet have symptoms of advanced or metastatic cancer. In this setting, more prolonged radiotherapy courses and advanced radiotherapy techniques including intensity-modulated radiotherapy (IMRT) or stereotactic radiotherapy (SRT) may be useful in obtaining local control and durable palliative responses. This review will explore the use of radiotherapy across the spectrum of patients with advanced and metastatic cancer and delineate an updated, rational approach for the use of palliative radiotherapy that incorporates symptoms, prognosis, and other factors into the delivery of palliative radiotherapy. PMID:25499634

  6. The Current Status of STEM Education Research

    Science.gov (United States)

    Brown, Josh

    2012-01-01

    This paper explores the current Science, Technology, Engineering and Mathematics (STEM) education research base through an analysis of articles from eight journals focused on the STEM disciplines. Analyzed are both practitioner and research publications to determine the current scope of STEM education research, where current STEM education…

  7. Current status of the Brazilian AMS program

    Energy Technology Data Exchange (ETDEWEB)

    Gomes, P.R.S. E-mail: paulogom@if.uff.br; Anjos, R.M.; Acquadro, J.C.; Santos, G.M.; Macario, K.D.; Liguori Neto, R.; Added, N.; Coimbra, M.M.; Appoloni, C.R.; Castro Faria, N.V. de; Magalhaes, S.D.; Donangelo, R

    2000-10-01

    The status and the near future plans for the Brazilian AMS program are described. The 8 MV Tandem accelerator at the University of Sao Paulo (USP) is ready to measure standard AMS samples. A recently installed 1.7 MV Tandem at the University of Rio de Janeiro will have a {sup 14}C AMS line. Together with external laboratories, we developed some projects on paleoclimatic and maritime geology. During these studies we have also learned sample preparation procedures.

  8. Current status of fast reactor physics

    Energy Technology Data Exchange (ETDEWEB)

    Hummel, H.H.

    1979-01-01

    The subject of calculation of reactivity coefficients for fast reactors is developed, starting with a discussion of the status of relevant nuclear data and proceeding to the subjects of group cross section generation and of methods of obtaining reactivity coefficients from group cross sections. Reactivity coefficients measured in critical experiments are compared with calculated values. Dependence of reactivity coefficients on reactor design is discussed. Finally, results of the recent international comparison of calculated reactivity coefficients are presented.

  9. Current status of VHTR development in Japan

    International Nuclear Information System (INIS)

    The status of the program at the beginning of fiscal 1982 is reviewed. Special emphasis is placed on the altering of the output helium temperature of the experimental VHTR to 9500. The modification is aimed at establishing the technical basis for post-experimental VHTR output helium temperature of 10000C. Notes are given on the design of the VHTR as well as various research and development efforts in Japan on multi-purpose nuclear heat applications and HTGR technology

  10. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Ampornrat, Pantip [Physics Division, Office of Atomic Energy for Peace, Chatuchak, Bangkok (Thailand)

    1999-10-01

    Thailand's neutron spectrometer has been installed soon after the startup of the reactor. The neutron scattering experiments have been done continuously, although there were some problems involving the neutron intensity and instruments. Development program has been planned for better experimental result. This paper reports the past and present status of neutron scattering equipment and experiments in Thailand. In addition, installation of a HRPD (High Resolution Powder Diffraction) system is included within the scope of the Ongkharak Nuclear Research Center project. (author)

  11. Current status of photovoltaic research at SERI

    Science.gov (United States)

    Deb, S. K.

    1987-02-01

    The purpose of the Solar Energy Research Institute's photovoltaic cell development program is to conduct high risk, potentially high-payoff R&D leading to a more substantial knowledge base for exploitation by private concerns interested in the electrical energy market. Attention is presently given to the status of research and development for crystalline and amorphous silicon, polycrystalline CuInSe2 and CdTe thin-film, and high efficiency III-V compound solar cells. Comparative efficiencies and economies are presented in tabular form, together with schematics of promising solar cell layer structures.

  12. Spent fuel management: Current status and prospects

    International Nuclear Information System (INIS)

    The main objective of the Advisory Group on Spent Fuel Management is to review the world-wide situation in Spent Fuel Management, to define the most important directions of national efforts and international cooperation in this area, to exchange information on the present status and progress in performing the back-end of Nuclear Fuel Cycle and to elaborate the general recommendations for future Agency programmes in the field of spent fuel management. This report which is a result of the third IAEA Advisory Group Meeting (the first and second were held in 1984 and 1986) is intended to provide the reader with an overview of the status of spent fuel management programmes in a number of leading countries, with a description of the past and present IAEA activities in this field of Nuclear Fuel Cycle and with the Agency's plans for the next years, based on the proposals and recommendations of Member States. A separate abstract was prepared for each of 14 papers presented at the advisory group meeting. Refs, figs and tabs

  13. 我国胃癌患者生活质量研究现状的文献分析%Literature Analysis of Current Status of Studies on Quality of Life of Gastric Cancer Patients in China

    Institute of Scientific and Technical Information of China (English)

    周燕燕; 席淑华

    2012-01-01

    目的 了解近10年来我国胃癌患者生活质量的研究现状.方法 检索并分析Sinomed中国生物医学文献数据库近10年有关胃癌患者生活质量的相关文献.结果 共检索出近10年的133篇相关文献,其中核心期刊文献79篇.虽然胃癌患者生活质量的相关文献总体数量呈逐年增加的趋势,但核心期刊文献所占比例存在下降趋势,而且存在选题思路较窄(主要集中于药物、手术和护理干预对生活质量的影响)、研究欠深入、选用量表不一致等问题.结论 在增加胃癌患者生活质量研究数量的同时,还应提高研究质量.由于缺乏大量的大样本、随机对照研究,使得对已有的相关研究系统分析存在困难.因此,一方面相关部门需重视相关科研,另一方面医护人员也应提高相关科研意识,拓展研究思路,提高研究质量,以寻找切实有效的措施提升胃癌患者生活质量.%Objective To investigate the current status of studies on quality of life (QOL) of gastric cancer patients in China in the past decade. Methods The Sinomed CBM was searched in the past decade and the studies on QOL of gastric cancer patients were collected for further analysis. Results A total of 133 literatures were identified, of which 79 studies were published in core journals. Although the number of literatures in past two decades had an increasing tendency,the quality of studies had a decreasing tendency which was characterized by humdrum and narrow selection of a topic (mainly on the effect of different pharmaco-therapy,or surgical methods and nursing strategies on QOL) ,superficial focus,and significant difference in scales for evaluation of QOL. Conclusion It is necessary to not only conduct more studies on QOL of gastric cancer patients and but increase the quality of these studies. Currently, the studies with large sample size and randomized-controlled design are lacking,which poses difficulties in further systemic review

  14. 乳腺癌术后上肢淋巴水肿危险因素的研究现状%Current status of research on the risk of breast cancer-related lymphedema

    Institute of Scientific and Technical Information of China (English)

    王玲; 李惠萍; 王本忠

    2012-01-01

    OBJECTIVE: To sump up current status of research on the risk of breast cancer-related lymphedema. METHODS: "breast cancer, lymphedema, risk factor" were searched as key words in the database of PubMed, CNKI and CBM. A total of 216 literatures were obtained from PubMed, 6 literatures from CNKI and 2 literatures from CBM during the period of 2005 to 2012. Including criteria; 1. the features of breast cancer-related lymphedema; 2. risks reported risk ratioCRR or OR) estimates. By extraction according to the inclusion criteria, 114 literatures were finaly analyzed. RESULTS: The risk factors for breast cancer-related lymphedema including four aspects : physiological factors, disease factors, treatment factors, and behavioral factors. Physiological factors include: age, weight, whether the surgical side of the main hand, history of hypertension; Disease factors: tumor stage and location, local tumor recurrence and metastasis, the number of axillary lymph nodes; Therapeutic factors include: surgical method, incision type, postoperative complications, axillary lymph node dissection and postoperative adjuvant therapy; Behavioral factors include: the exercise of limb function, limb activity frequency and intensity, and limb infection and injury. CONCLUSIONS: Breast cancer-related lymphedema is a chronic, incurable sick ness. Prevention should focus on major risk factors and to avoid or reduce exposure to risk factors, in order to reduce the incidence of lymphedema.%目的:总结国内外关于乳腺癌术后淋巴水肿危险因素的研究现状.方法:以“乳腺癌或乳腺肿瘤(breast cancer)、淋巴水肿(lymphedema)、危险因素(risk factor)”为关键词,检索PubMed、CNK1期刊全文数据库和CBM数据库中2005-01-2011-12的相关文献,共检索216篇英文文献,8篇中文文献.纳入标准:1)乳腺癌术后淋巴水肿;2)危险因素中报告RR或OR值.根据纳入标准,共纳入114篇文献.结果:乳腺癌术后淋巴水肿的危险因素包括4个

  15. Current status of tumor radiogenic therapy

    Institute of Scientific and Technical Information of China (English)

    Feng-Ling Min; Hong Zhang; Wen-Jian Li

    2005-01-01

    Although tumor gene therapy falls behind its clinical use, the combination of irradiation and gene therapy is full ofpromise in cancer therapy based on traditional radiotherapy, chemotherapy and surgery. We have termed it as radiogenic therapy. This review focuses on the following aspects of radiogenic therapy in recent years: improvement of gene transfer efficiency by irradiation, radiotherapy combined with cytokine gene delivery or enhancement of the immunity of tumor cells by transgene, direct stimulation by radiation toproduce cytotoxic agents, increase of tumor cell radiosensitivity in gene therapy by controlling the radiosensitivity genes and adjusting the fraction dose and interval of radiation so as to achieve the optimum antitumor effect while reducing the normal tissue damage, radioprotective gene therapy enhancing radiation tumor killing effect while protecting the normal tissue and organs with transgene using transfer vectors.

  16. Current status of flexible ureteroscopy in urology.

    Science.gov (United States)

    Cho, Sung Yong

    2015-10-01

    Retrograde intrarenal surgery (RIRS) is being performed for the surgical management of upper urinary tract pathology. With the development of surgical instruments with improved deflection mechanisms, visuality, and durability, the role of RIRS has expanded to the treatment of urinary calculi located in the upper urinary tract, which compensates for the shortcomings of shock wave lithotripsy and percutaneous nephrolithotomy. RIRS can be considered a conservative treatment of upper urinary tract urothelial cancer (UTUC) or for postoperative surveillance after radical treatment of UTUC under an intensive surveillance program. RIRS has a steep learning curve and various surgical techniques can be used. The choice of instruments during RIRS should be based on increased surgical efficiency, decreased complications, and improved cost-benefit ratio. PMID:26495068

  17. Current status of neutron scattering in Thailand

    International Nuclear Information System (INIS)

    The current neutron powder diffractometer at the Thai Research Reactor-1/M1 (TRR-1/M1) has been modified from the obsolete neutron diffractometer which had been used during 1968-1975. The upgraded diffractometer has medium resolution and is appropriate for studying samples with small unit cell dimensions and training university students in the field of neutron scattering. This paper describes the current activities of neutron scattering research in Thailand as well as a new research reactor for enlarging the perspectives of its utilization in the future. (author)

  18. Current status of neutron scattering in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Kornduangkaeo, Areeratt; Pongkasem, Somchai; Putchar, Suriya; Ampornrat, Pantip; Kajornrith, Varavuth; Sangariyavanich, Archara [Office of Atomic Energy for Peace, Bangkok (Thailand)

    2003-03-01

    The current neutron powder diffractometer at the Thai Research Reactor-1/M1 (TRR-1/M1) has been modified from the obsolete neutron diffractometer which had been used during 1968-1975. The upgraded diffractometer has medium resolution and is appropriate for studying samples with small unit cell dimensions and training university students in the field of neutron scattering. This paper describes the current activities of neutron scattering research in Thailand as well as a new research reactor for enlarging the perspectives of its utilization in the future. (author)

  19. Energy sector in Ecuador: Current status

    International Nuclear Information System (INIS)

    This paper describes the current energy sector in Ecuador, its present structure, the oil industry, subsidies, and renewable energy, focusing on the evolution and reform of the electricity sector. Currently, 86% of the primary energy originates from nonrenewable sources. In 2005, the gross electricity generation was 15 127 GWh (45.5% hydropower, 43.11% thermal, and 11.39% imported). Ecuador is the fifth largest oil producer in South America but lacks sufficient oil refining capacity. Reserves of natural gas (NG) are small, and most of NG is produced from oil fields without energy recovery. Several projects are underway to increase the utilization of NG and renewable energies to meet Ecuador commitments to the Kyoto Protocol

  20. Energy sector in Ecuador: Current status

    Energy Technology Data Exchange (ETDEWEB)

    Pelaez-Samaniego, M.R. [University of Cuenca (Ecuador). Faculty of Chemical Sciences; Energy Systems Planning, FEM, UNICAMP (Brazil); Garcia-Perez, M. [Monash University, Melbourne (Australia); Cortez, L.A.B. [Energy Systems Planning, FEM, UNICAMP (Brazil); Oscullo, J. [National Center for Energy Control - CENACE (Ecuador); Olmedo, G. [Polytechnic School of the Army - ESPE (Ecuador)

    2007-08-15

    This paper describes the current energy sector in Ecuador, its present structure, the oil industry, subsidies, and renewable energy, focusing on the evolution and reform of the electricity sector. Currently, 86% of the primary energy originates from nonrenewable sources. In 2005, the gross electricity generation was 15 127 GWh (45.5% hydropower, 43.11% thermal, and 11.39% imported). Ecuador is the fifth largest oil producer in South America but lacks sufficient oil refining capacity. Reserves of natural gas (NG) are small, and most of NG is produced from oil fields without energy recovery. Several projects are underway to increase the utilization of NG and renewable energies to meet Ecuador commitments to the Kyoto Protocol. (author)

  1. The current status of grazing incidence optics

    International Nuclear Information System (INIS)

    The developments in the area of grazing incidence optics with emphasis on telescopes for use in X-ray astronomy are reviewed. The performance of existing high-resolution telescopes is outlined and compared with those expected from future missions like ROSAT and AXAF. Starting from the basic principles of X-ray reflection and scattering, an attempt is made to highlight the current understanding of X-ray mirror physics using new theoretical ideas as well as experimental laboratory results. (author)

  2. Multislice CT colonography: current status and limitations

    Energy Technology Data Exchange (ETDEWEB)

    Ji, Hoon; Rolnick, Joshua A.; Haker, Steven E-mail: mabarish@partners.org; Barish, Matthew A

    2003-08-01

    CT colonography (CTC) is a promising method for colorectal screening providing a full structural evaluation of the entire colon and gaining in popularity due to a superior safety profile, a low rate of complications, and high patient acceptance. Multislice CT (MSCT) has further improved the diagnostic potential of CTC by generating high-resolution CT images of the abdomen and pelvis in shorter acquisition times than was previously possible. Over the past year, multiple studies have been published on every aspect of CTC including techniques, image display, image reconstruction, and clinical trial results assessing the feasibility of CTC as a screening tool. Yet despite increasing clinical use, the appropriate role of CTC in colorectal cancer screening remains undefined and barriers to widespread adoption remain. In particular, though the test is generally regarded as easy to perform, accurate interpretation requires a steep learning curve. While several large studies have found high sensitivity and specificity, the accuracy of CTC in a screening population has yet to be verified and almost no health insurance plans reimburse for its use in colorectal screening. Ongoing research in computer-aided detection and new software tools, however, have the potential to increase accuracy and ease of interpretation significantly, accelerating its acceptance as a colorectal screening tool.

  3. The current status and influencing factors of quality of life in patients with cervical cancer%宫颈癌患者生存质量状况及其影响因素研究

    Institute of Scientific and Technical Information of China (English)

    徐昊; 丁焱

    2011-01-01

    Objective To investigate the status and influencing factors of quality of life(QOL) in patients with cervical cancer. Methods A total of 473 patients with cervical cancer were investigated with the Functional Assessment of Cancer Therapy scale-Cervix (FACT-Cx). Results The mean score.of QOL was 118.65±19.72. Marital status,perceived family relationship, performance status and perceived financial burden were influencing factors of patients' QOL. Conclusions The quality of life in patients with cervical cancer is in middle to high level. It is suggested to provide interventions to improve the quality of life for patients with heavy financial burden,poor family relationship,worse performance status and single.%目的 调查宫颈癌患者生存质量状况,分析其影响因素。方法 采用宫颈癌生存质量评估量表(FACT-Cx)对473例宫颈癌患者进行调查。结果 患者生存质量总分均值为(118.65±19.72)分。单身、家庭关系一般、活动状况较差和经济负担重是生存质量的影响因素。结论 宫颈癌患者生存质量得分处于较好水平。应加强对经济负担较量、家庭关系较差、单身和活动状态较差患者的干预,以提高其生存质量。

  4. Avian influenza in Croatia - Current status

    International Nuclear Information System (INIS)

    Full text: Wild birds can carry a wide range of viral and other zoonotic agents, which may be transmitted to humans. From October 2005 to March 2006 HPAI H5N1 virus was isolated from wild birds (mute swans, black-headed gulls and a mallard duck) in Croatia at five locations. After isolation of H5N1 virus at 2006 from mallard duck near City of Zagreb (capital of Croatia) Department of Poultry Diseases with Clinic at the Faculty of Veterinary Medicine, has conducted monitoring of avian viruses that could endanger human health. Samples (999 pharyngeal and cloacal swabs) from 23 wild bird species were taken. After year 2006 Croatia has regular monitoring for avian influenza in wild birds and poultry (especially in the backyard flocks). During 2007 (6,928 wild birds and 18,000 blood samples from poultry) and 2008 (2,486 wild birds; 20,000 blood samples and 1,500 cloacal swabs from poultry) were taken. Isolation was performed with classical virus detection method by inoculation of 10 day old chicken embryos, and molecular methods by conventional PCR and Real Time PCR (M gene, H5, H7 and N1 genes), and serological methods by antibody detection from blood samples (inhibition hemagglutination and ELISA). All samples were HPAI virus negative but investigators from the Poultry Centre of the Croatian Veterinary Institute isolated from wild birds LPAI viruses: H2N3, H3N8, H5N3 and H10N7. The results obtained by these investigations and monitoring revealed the need for permanent monitoring of wild bird's health status, especially the water birds species. Vaccination against AI is never practiced in Croatia. Quick and accurate detection of wild migratory birds infected with the H5N1 virus prevented the spread of the virus to the domestic poultry in Croatia which would have had enormous consequences. (author)

  5. Prostate Cancer: Current Treatment and Prevention Strategies

    OpenAIRE

    Chen, Fang-zhi; Zhao, Xiao-kun

    2013-01-01

    Abstract Prostate cancer is one of the life threatening disorders of male. Although, over the last two decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of prostate cancer, the treatment or prevention strategies are not enough to control the high rate of disease related mortality. Current medical treatment approaches include surgery, radiation therapy, chemotherapy, hormonal therapy, cryosurgery and other methods. These approaches are more or less effecti...

  6. Current status of family health in Mexico

    Directory of Open Access Journals (Sweden)

    Apolinar Membrillo Luna

    2013-01-01

    Full Text Available Family Health (FH has three main elements: individual health, life material conditions and family functioning. Its main actors are the individual, the family and society. A common framework is the basis of FH, as each one of these elements is extremely important. Currently, in Mexico two aspects are considered: epidemiological studies and those inherent to the family medicine specialty. That latter has a residency and an integrated specialty curriculum, as well as certification from the corresponding board. All of this allows us to apply the HF approach to each and every family and individual that is cared for.

  7. Current status and trends of radiation technology

    International Nuclear Information System (INIS)

    Radiation technology(RT) is more intimate than the other nuclear technologies and closely related to the public. The present conditions of radiation and radioisotope utilization and economic scales of radiation and radioisotope application in USA, Japan and Korea were examined, and the current trends and prospects of radiation technology were investigated. For planning of extended uses of the technology, the programs of the USA Office of Isotope for Medicine and Science, and the privatization activities of commercial isotopes of DOE were observed. The 2nd 'Comprehensive Nuclear Energy Promotion Plan(CNEPP)' of MOST includes utilization of radiation and radioisotopes, the suggestions for the practice of it were made

  8. RBMK fuel assemblies: Current status and perspectives

    International Nuclear Information System (INIS)

    The safety enhancement measures implemented since 1986 have led to substantial burnup reduction in the RBMK fuel assemblies and consequently to economical losses. With the purpose to compensate the losses, computer analysis and experiments were performed during the last decade. The works were aimed at the RBMK fuel charge perfection to reduce void reactivity effect and to increase fuel burnup. The paper presents principle results of the studies which are currently under implementation or are supposed to be implemented in the nearest future. (author)

  9. Current status of the implantable LVAD.

    Science.gov (United States)

    Kadakia, Sagar; Moore, Ryan; Ambur, Vishnu; Toyoda, Yoshiya

    2016-09-01

    With the ongoing shortage of available organs for heart transplantation, mechanical circulatory support devices have been increasingly utilized for managing acute and chronic heart failure that is refractory to medical therapy. In particular, the introduction of the left ventricular assist devices (LVAD) has revolutionized the field. In this review, we will discuss a brief history of the LVAD, available devices, current indications, patient selection, complications, and outcomes. In addition, we will discuss recent outcomes and advancements in the field of noncardiac surgery in the LVAD patient. Finally, we will discuss several topics for surgical consideration during LVAD implantation. PMID:27270581

  10. Family therapy in Brazil: current status.

    Science.gov (United States)

    Picon, Felipe

    2012-04-01

    In the last three decades there has been a noticeable trend in the redefinition of the nuclear family in Brazil. A recent increase in the rates of divorces and paradoxically also in the rates of marriages, the legalization of same-sex unions and adoption by these couples, and the phenomenon of teenage pregnancy are some of the aspects that reflect on the current Brazilian family. This review highlights these changes and describes how family therapists in Brazil are facing the challenge of assisting these families, in a continental-sized country with uneven distribution of training courses and healthcare assistance. PMID:22515454

  11. The STIS MAMA status: Current detector performance

    Science.gov (United States)

    Danks, A. C.; Joseph, C.; Bybee, R.; Argebright, V.; Abraham, J.; Kimble, R.; Woodgate, B.

    1992-01-01

    The STIS (Space Telescope Imaging Spectrograph) is a second generation Hubble instrument scheduled to fly in 1997. Through a variety of modes, the instrument will provide spectral resolutions from R approximately 50 in the objective spectroscopy mode to 100,000 in the high resolution echelle mode in the wavelength region from 115 to 1000 nm. In the UV the instrument employs two MAMA (Multimode Anode Microchannel plate Arrays) 1024 by 1024 pixel detectors, which provide high DQE (Detective Quantum Efficiency), and good dynamic range and resolution. The current progress and performance of these detectors are reported, illustrating that the technology is mature and that the performance is very close to flight requirements.

  12. [Current status of anthrax or black fever].

    Science.gov (United States)

    Chantal, J

    1997-01-01

    Although anthrax is one of the oldest recognized infectious diseases in the world, it remains widespread particularly in tropical zones such as Africa. The impact of this major zoonoses is further enhanced by the fact that the pulmonary form can be used for biological warfare. Recently there has been a revival of interest in anthrax and research has benefited greatly from advances in molecular biology. The main factors accounting for the virulence of Bacillus anthracis have been elucidated. The author reports current data concerning pathogenesis, epidemiology and diagnosis and reviews progress made in the field of prophylaxis especially with regard to vaccines. PMID:9513179

  13. Current status of nanotechnology in urology

    Directory of Open Access Journals (Sweden)

    Suresh K. Goyal

    2016-08-01

    Full Text Available Nanotechnology has been investigated for its applications in medicine. The objective of this review was to summarize the current applications of nanotechnology in Urology. A systematic search of literature was performed and relevant articles were analyzed with specific reference to applications in Urology. Nanotechnology has applications in diagnostic urology like in uroimaging using nanoparticles and nanosensors. It has therapeutic applications in infections, malignancies, genetic disease using targeted drug delivery, gene transfers, nano device-based manipulations etc. Nanotechnology has many applications in Urology. More efforts are required to make these applications practically feasible and affordable. [Int J Res Med Sci 2016; 4(8.000: 3114-3120

  14. Sensing technology current status and future trends

    CERN Document Server

    Mukhopadhyay, Subhas; Jayasundera, Krishanthi; Bhattacharyya, Nabarun

    2014-01-01

    This book is written for academic and industry professionals working in the field of sensing, instrumentation and related fields, and is positioned to give a snapshot of the current state of the art in sensing technology, particularly from the applied perspective.  The book is intended to give a broad overview of the latest developments, in addition to discussing the process through which researchers go through in order to develop sensors, or related systems, which will become more widespread in the future.  

  15. Esophageal tissue engineering: Current status and perspectives.

    Science.gov (United States)

    Poghosyan, T; Catry, J; Luong-Nguyen, M; Bruneval, P; Domet, T; Arakelian, L; Sfeir, R; Michaud, L; Vanneaux, V; Gottrand, F; Larghero, J; Cattan, P

    2016-02-01

    Tissue engineering, which consists of the combination and in vivo implantation of elements required for tissue remodeling toward a specific organ phenotype, could be an alternative for classical techniques of esophageal replacement. The current hybrid approach entails creation of an esophageal substitute composed of an acellular matrix and autologous epithelial and muscle cells provides the most successful results. Current research is based on the use of mesenchymal stem cells, whose potential for differentiation and proangioogenic, immune-modulator and anti-inflammatory properties are important assets. In the near future, esophageal substitutes could be constructed from acellular "intelligent matrices" that contain the molecules necessary for tissue regeneration; this should allow circumvention of the implantation step and still obtain standardized in vivo biological responses. At present, tissue engineering applications to esophageal replacement are limited to enlargement plasties with absorbable, non-cellular matrices. Nevertheless, the application of existing clinical techniques for replacement of other organs by tissue engineering in combination with a multiplication of translational research protocols for esophageal replacement in large animals should soon pave the way for health agencies to authorize clinical trials. PMID:26711880

  16. Landsat sensor performance: history and current status

    Science.gov (United States)

    Markham, B.L.; Storey, James C.; Williams, Darrel L.; Irons, J.R.

    2004-01-01

    The current Thematic Mapper (TM) class of Landsat sensors began with Landsat-4, which was launched in 1982. This series continued with the nearly identical sensor on Landsat-5, launched in 1984. The final sensor in the series was the Landsat-7 Enhanced Thematic Mapper Plus (ETM+), which was carried into orbit in 1999. Varying degrees of effort have been devoted to the characterization of these instruments and data over the past 22 years. Extensive short-lived efforts early in the history, very limited efforts in the middle years, and now a systematic program for continuing characterization of all three systems are apparent. Currently, both the Landsat-5 TM and the Landsat-7 ETM+ are operational and providing data. Despite 20+ years of operation, the TM on Landsat-5 is fully functional, although downlinks for the data are limited. Landsat-7 ETM+ experienced a failure of its Scan Line Corrector mechanism in May 2003. Although there are gaps in the data coverage, the data remain of equivalent quality to prefailure data. Data products have been developed to fill these gaps using other ETM+ scenes.

  17. Current Status of Biosimilar Growth Hormone

    Directory of Open Access Journals (Sweden)

    Saenger Paul

    2009-08-01

    Full Text Available As the first wave of biopharmaceuticals is set to expire, biosimilars or follow-on protein products (FOPPs have emerged. The regulatory foundation for these products is more advanced and better codified in Europe than in the US. Recent approval of biosimilar Somatropin (growth hormone in Europe and the US prompted this paper. The scientific viability of biosimilar growth hormone is reviewed. Efficacy and safety data (growth rates, IGF-1 generation for up to 7 years for pediatric indications measure up favorably to previously approved growth hormones as reference comparators. While the approval in the US is currently only for treatment of growth hormone deficiency (GHD in children and adults, the commercial use of approved biosimilar growth hormones will allow in the future for in-depth estimation of their efficacy and safety in non-GH deficient states as well.

  18. Current Status of Biosimilar Growth Hormone

    Directory of Open Access Journals (Sweden)

    Paul Saenger

    2009-01-01

    Full Text Available As the first wave of biopharmaceuticals is set to expire, biosimilars or follow-on protein products (FOPPs have emerged. The regulatory foundation for these products is more advanced and better codified in Europe than in the US. Recent approval of biosimilar Somatropin (growth hormone in Europe and the US prompted this paper. The scientific viability of biosimilar growth hormone is reviewed. Efficacy and safety data (growth rates, IGF-1 generation for up to 7 years for pediatric indications measure up favorably to previously approved growth hormones as reference comparators. While the approval in the US is currently only for treatment of growth hormone deficiency (GHD in children and adults, the commercial use of approved biosimilar growth hormones will allow in the future for in-depth estimation of their efficacy and safety in non-GH deficient states as well.

  19. Current Status of Biliary Metal Stents.

    Science.gov (United States)

    Nam, Hyeong Seok; Kang, Dae Hwan

    2016-03-01

    Many advances have been achieved in biliary stenting over the past 30 years. Endoscopic stent placement has become the primary management therapy to relieve obstruction in patients with benign or malignant biliary tract diseases. Compared with plastic stents, a self-expandable metallic stent (SEMS) has been used for management in patients with malignant strictures because of a larger lumen and longer stent patency. Recently, SEMS has been used for various benign biliary strictures and leaks. In this article, we briefly review the characteristics of SEMS as well as complications of stent placement. We review the current guidelines for managing malignant and benign biliary obstructions. Recent developments in biliary stenting are also discussed. PMID:26911896

  20. Current Status of Biliary Metal Stents

    Science.gov (United States)

    Nam, Hyeong Seok; Kang, Dae Hwan

    2016-01-01

    Many advances have been achieved in biliary stenting over the past 30 years. Endoscopic stent placement has become the primary management therapy to relieve obstruction in patients with benign or malignant biliary tract diseases. Compared with plastic stents, a self-expandable metallic stent (SEMS) has been used for management in patients with malignant strictures because of a larger lumen and longer stent patency. Recently, SEMS has been used for various benign biliary strictures and leaks. In this article, we briefly review the characteristics of SEMS as well as complications of stent placement. We review the current guidelines for managing malignant and benign biliary obstructions. Recent developments in biliary stenting are also discussed. PMID:26911896

  1. Current status of optical coherence tomography.

    Science.gov (United States)

    Inami, Shigenobu; Wang, Zuoyan; Ming-Juan, Zhang; Takano, Masamichi; Mizuno, Kyoichi

    2011-09-01

    Optical coherence tomography (OCT) is a novel imaging technology based on low-coherence interferometry that use near-infrared light in real-time, and allows cross-sectional in-situ visualization of the vessel wall at the microscopic level. OCT provides 10-fold higher resolution than intravascular ultrasound which is currently the most used modality for intra-coronary imaging. OCT offers the obvious advantages when characterizing precise plaque microstructure and distinguishing various type of plaques. OCT is also being assessed for its potential role in the understanding of neointimal coverage, vascular healing and the progression of atherosclerosis in coronary vasculature after stenting on the micron scale. These unique capabilities could be helpful in guiding coronary management and interventions. Recent improvement in next generation OCT technology, such as frequency-domain OCT, will allow for a simple imaging procedure, providing more useful information and complementing other modalities on both clinical and research applications for the cardiologists. PMID:24122583

  2. Anaerobic biorefinery: Current status, challenges, and opportunities.

    Science.gov (United States)

    Sawatdeenarunat, Chayanon; Nguyen, Duc; Surendra, K C; Shrestha, Shilva; Rajendran, Karthik; Oechsner, Hans; Xie, Li; Khanal, Samir Kumar

    2016-09-01

    Anaerobic digestion (AD) has been in use for many decades. To date, it has been primarily aimed at treating organic wastes, mainly manures and wastewater sludge, and industrial wastewaters. However, with the current advancements, a more open mind is required to look beyond these somewhat restricted original applications of AD. Biorefineries are such concepts, where multiple products including chemicals, fuels, polymers etc. are produced from organic feedstocks. The anaerobic biorefinery concept is now gaining increased attention, utilizing AD as the final disposal step. This review aims at evaluating the potential significance of anaerobic biorefineries, including types of feedstocks, uses for the produced energy, as well as sustainable applications of the generated residual digestate. A comprehensive analysis of various types of anaerobic biorefineries has been developed, including both large-scale and household level applications. Finally, future directives are highlighted showing how anaerobic biorefinery concept could impact the bioeconomy in the near future. PMID:27005786

  3. [Evaluating the current status of anthropologic psychiatry].

    Science.gov (United States)

    Schmidt-Degenhard, M

    1997-10-01

    Phenomenological psychiatry examines the variety of psychiatric diseases as regular modifications of human feeling tone experience and behaviour, which can be derived approximately from the nature of man as defined philosophically, Interdisciplinary self-conception of phenomenological psychiatry as a science calls for a constant critical dialogue with the philosophy of man and other disciplines of the humanities. The point of departure of phenomenological psychiatry is the mental or affective illness of the individual patient, with which the psychiatrist is acquainted, and reflects in interpersonal encounters in such a way that individual case studies are of central importance in this area of studies. From a methodological point of view two approaches are to be differentiated within the field of research in phenomenological psychiatry: 1. The phenomenological approach is concerned with the analysis of specific patterns of disturbance of the transcendental organisation of psychotic subjectivity. 2. The interpretative approaches are again divided into the so called "Daseinsanalyse" as a hermeneutic access to the inner biography and "Weltanschauung" of the psychiatric patient as well as the attempts of understanding the meaning of psychotic forms of experience. In this context a survey of the current fields of research of phenomenological psychiatry is given which aims at a deeper understanding of the situation of psychiatric patients and which claims to have a strong relevance for therapy. The relevance of such a phenomenological approach for current psychiatry lies in a broadening and sophistication of our experience in clinic and practice. Its main interest lies in the concentration on the patient as an individual and on the existential dimension of forms of mental and emotional diseases. PMID:9445840

  4. Advanced radiation chemistry research: Current status

    International Nuclear Information System (INIS)

    Radiation chemistry is a branch of chemistry that studies chemical transformations in materials exposed to high-energy radiations. It is based on the use of ionizing radiation as the initiator or catalyst in chemical reactions. The most significant advantage of radiation chemistry lies in its ability to be used in the production and study of almost any reactive atomic and molecular species playing a part in chemical reaction, synthesis, industrial processes, or in biological systems. Over the the last few years a number of meetings have taken place, under the auspices of the IAEA, in order to evaluate recent developments in radiation chemistry as well as the trends indicated by the results obtained. Radiation chemists from different countries have participated at these meetings. The present publication, a companion to the previous publication - New Trends and Development in Radiation Chemistry, IAEA-TECDOC-527 (1989) - includes some of the important contributions presented at these meetings. It is hoped that it will provide a useful overview of current activities and of emerging trends in this field, thus promoting better understanding of potential contributions of radiation chemistry to other fields of knowledge as well as to practical applications in industry, medicine and agriculture. Refs, figs and tabs

  5. Current status of the LBNE neutrino beam

    CERN Document Server

    Moore, Craig Damon; Crowley, Cory Francis; Hurh, Patrick; Hylen, James; Lundberg, Byron; Marchionni, Alberto; McGee, Mike; Mokhov, Nikolai V; Papadimitriou, Vaia; Plunkett, Rob; Reitzner, Sarah Diane; Stefanik, Andrew M; Velev, Gueorgui; Williams, Karlton; Zwaska, Robert Miles

    2015-01-01

    The Long Baseline Neutrino Experiment (LBNE) will utilize a neutrino beamline facility located at Fermilab. The facility is designed to aim a beam of neutrinos toward a detector placed in South Dakota. The neutrinos are produced in a three-step process. First, protons from the Main Injector hit a solid target and produce mesons. Then, the charged mesons are focused by a set of focusing horns into the decay pipe, towards the far detector. Finally, the mesons that enter the decay pipe decay into neutrinos. The parameters of the facility were determined by an amalgam of the physics goals, the Monte Carlo modeling of the facility, and the experience gained by operating the NuMI facility at Fermilab. The initial beam power is expected to be ~700 kW, however some of the parameters were chosen to be able to deal with a beam power of 2.3 MW. The LBNE Neutrino Beam has made significant changes to the initial design through consideration of numerous Value Engineering proposals and the current design is described.

  6. Current Status of VHTR Technology Development

    Energy Technology Data Exchange (ETDEWEB)

    David Petti; Hans Gougar; Richard Wright; William Windes; Steve Herring; Richard Schultz; Paul Humrickhouse

    2010-10-01

    Abstract – High Temperature Gas-cooled Reactors (HTGRs) featuring particle fuel reached the stage of commercial deployment in the mid-1980s with the Fort St.Vrain and Thorium HochTemperatur Reaktor feeding electricity to the grids in the United States and West Germany, respectively. The technology was then adopted by Japan and China with the operation of the High Temperature Test Reactor in Oarai, Japan and the High Temperature Reactor (HTR-10) in China. Increasing the outlet temperature of the HTGR to even higher temperatures above 900°C will improve the thermodynamic efficiency of the system and enable application of a new class of gas reactor, the very high temperature reactor, to provide process heat, electricity, and hydrogen to chemical industries with the attendant benefits of improved energy security and reduced CO2 emissions. However, the increase in coolant outlet temperature presents a number of technical challenges associated with fuel, materials, power conversion, and analysis methods for the reactor and hydrogen production. The U.S. Department of Energy is sponsoring a broad program of research and development with a goal of addressing the technical challenges over a broad range of outlet temperatures as part of the Next Generation Nuclear Plant Project. This paper describes the research and development activities that are currently underway to realize the technologies needed for an HTGR that features outlet temperatures of 750 to 950°C.

  7. Current status of tritium calorimetry at TLK

    International Nuclear Information System (INIS)

    Inside a tritium facility, calorimetry is an important analytical method as it is the only reference method for accountancy (it is based on the measurement of the heat generated by the radioactive decay). Presently, at Tritium Laboratory Karlsruhe (TLK), 4 calorimeters are in operation, one of isothermal type and three of inertial guidance control type (IGC). The volume of the calorimeters varies between 0.5 and 20.6 liters. About two years ago we started an extensive work to improve our calorimeters with regard to reliability and precision. We were forced to upgrade 3 of our 4 calorimeters due to the outdated interfaces and software. This work involved creating new LabView programs driving the devices, re-tuning control loops and replacing obsolete hardware components. In this paper we give a review on the current performance of our calorimeters, comparing it to recently available devices from the market and in the literature. We also show some ideas for a next generation calorimeter based on experiences with our IGC calorimeters and other devices reported in the literature. (authors)

  8. Current status of fusion reactor blanket thermodynamics

    International Nuclear Information System (INIS)

    Recent studies of liquid lithium have concentrated on its sorption characteristics for hydrogen isotopes and its interaction with common impurity elements. Hydrogen isotope sorption data (P-C-T relations, activity coefficients, Sieverts' constants, plateau pressures, isotope effects, free energies of formation, phase boundaries etc.) are presented in a tabular form that can be conveniently used to extract thermodynamic information for the α-phase of the Li-LiH, Li-LiD, and Li-LiT systems and to construct complete phase diagrams. Recent solubility data for Li3N, Li2O, and Li2C2 in liquid lithium are discussed with emphasis on the prospects for removing these species by cold-trapping methods. Current studies on the sorption of hydrogen in solid lithium alloys (e.g., Li--Al and Li--Pb), made using a new technique (the hydrogen titration method), have shown that these alloys should lead to smaller blanket-tritium inventories than are attainable with liquid lithium and that the P-C-T relationships for hydrogen in Li--M alloys can be estimated from lithium activity data for these alloys

  9. Current Status of VHTR Technology Development

    International Nuclear Information System (INIS)

    High Temperature Gas-cooled Reactors (HTGRs) featuring particle fuel reached the stage of commercial deployment in the mid-1980s with the Fort St.Vrain and Thorium HochTemperatur Reaktor feeding electricity to the grids in the United States and West Germany, respectively. The technology was then adopted by Japan and China with the operation of the High Temperature Test Reactor in Oarai, Japan and the High Temperature Reactor (HTR-10) in China. Increasing the outlet temperature of the HTGR to even higher temperatures above 900 C will improve the thermodynamic efficiency of the system and enable application of a new class of gas reactor, the very high temperature reactor, to provide process heat, electricity, and hydrogen to chemical industries with the attendant benefits of improved energy security and reduced CO2 emissions. However, the increase in coolant outlet temperature presents a number of technical challenges associated with fuel, materials, power conversion, and analysis methods for the reactor and hydrogen production. The U.S. Department of Energy is sponsoring a broad program of research and development with a goal of addressing the technical challenges over a broad range of outlet temperatures as part of the Next Generation Nuclear Plant Project. This paper describes the research and development activities that are currently underway to realize the technologies needed for an HTGR that features outlet temperatures of 750 to 950 C.

  10. Current status of the CLIO project

    CERN Document Server

    Yamamoto, K; Miyoki, S; Ohashi, M; Kuroda, K; Ishitsuka, H; Akutsu, T; Telada, S; Tomaru, T; Suzuki, T; Sato, N; Saitô, Y; Higashi, Y; Haruyama, T; Yamamoto, A; Shintomi, T; Tatsumi, D; Ando, M; Tagoshi, H; Kanda, N; Awaya, N; Yamagishi, S; Takahashi, H; Araya, A; Takamori, A; Takemoto, S; Higashi, T; Hayakawa, H; Morii, W; Akamatsu, J

    2008-01-01

    CLIO (Cryogenic Laser Interferometer Observatory) is a Japanese gravitational wave detector project. One of the main purposes of CLIO is to demonstrate thermal-noise suppression by cooling mirrors for a future Japanese project, LCGT (Large-scale Cryogenic Gravitational Telescope). The CLIO site is in Kamioka mine, as is LCGT. The progress of CLIO between 2005 and 2007 (room- and cryogenic-temperature experiments) is introduced in this article. In a room-temperature experiment, we made efforts to improve the sensitivity. The current best sensitivity at 300 K is about $6 \\times 10^{-21} /\\sqrt{\\rm Hz}$ around 400 Hz. Below 20 Hz, the strain (not displacement) sensitivity is comparable to that of LIGO, although the baselines of CLIO are 40-times shorter (CLIO: 100m, LIGO: 4km). This is because seismic noise is extremely small in Kamioka mine. We operated the interferometer at room temperature for gravitational wave observations. We obtained 86 hours of data. In the cryogenic experiment, it was confirmed that the...

  11. Photoacoustic imaging: current status and future development

    Science.gov (United States)

    Lu, Tao; Jiang, Jingying; Su, Yixiong; Wang, Ruikang K.; Zhang, Fan; Yao, Jianquan

    2006-09-01

    Photo-acoustic tomography(PAT) is a new ultrasound-mediated biomedical imaging technology which combines the advantages of high optical contrast and high ultrasonic resolution. In theory, PAT can image object embedded several centimeters under the surface of sample with the resolution of tens of microns. In this paper, several representative image reconstruction algorithms are discussed. Because the PA signal is wide band signal, it is hard to get the whole frequency spectrum due to the tremendous calculation needed. Therefore, the most applicable reconstruction algorithms are all performed in time domain such as "delay-and-sum" and "back projection". The current research methods have been focused on optical detecting and piezoelectric detecting. The optical method has the advantage of high spatial sensitivity due to the short wavelength of the probe laser beam. PA signal detecting using piezoelectric sensor has two main modes i.e. using unfocused transducer or transducer array or using focused transducer array or linear transducer array. When a focused transducer array is used, the "delay-and-sum" method is often used for image reconstruction. The advantage of the method is that its data acquisition time can be reduced to several minutes or even several seconds by employing the phase control linear scan technique. The future development in PAT research and its potential clinic application is also presented.

  12. Current status of tritium calorimetry at TLK

    Energy Technology Data Exchange (ETDEWEB)

    Buekki-Deme, A.; Alecu, C.G.; Kloppe, B.; Bornschein, B. [Institute of Technical Physics, Tritium Laboratory Karsruhe - TLK, Karlsruhe Institute of Technology - KIT, Karlsruhe (Germany)

    2015-03-15

    Inside a tritium facility, calorimetry is an important analytical method as it is the only reference method for accountancy (it is based on the measurement of the heat generated by the radioactive decay). Presently, at Tritium Laboratory Karlsruhe (TLK), 4 calorimeters are in operation, one of isothermal type and three of inertial guidance control type (IGC). The volume of the calorimeters varies between 0.5 and 20.6 liters. About two years ago we started an extensive work to improve our calorimeters with regard to reliability and precision. We were forced to upgrade 3 of our 4 calorimeters due to the outdated interfaces and software. This work involved creating new LabView programs driving the devices, re-tuning control loops and replacing obsolete hardware components. In this paper we give a review on the current performance of our calorimeters, comparing it to recently available devices from the market and in the literature. We also show some ideas for a next generation calorimeter based on experiences with our IGC calorimeters and other devices reported in the literature. (authors)

  13. Current status of laser applications in urology

    Science.gov (United States)

    Knipper, Ansgar; Thomas, Stephen; Durek, C.; Jocham, Dieter

    1993-05-01

    The overall development of laser use in urology is recessing. The reasons are the refinement of methods of radical surgery and the continuing development of alternative technologies involving electric current. Taking the cost factor into account, are lasers still opportune in medicine? The answer is definitely yes. Cost reduction in medical practice without quality loss is only possible with effective methods of minimally invasive surgery. Continuing investigation of cutting, welding, coagulating and ablating instruments is justified. Competition of lasers to other technologies can only be beneficial to the cause. But where are the highlights of laser applications? The unsurpassed utilization of optical properties of lasers lie in the concept of photodynamic therapies and in optical feedback mechanisms for laser applications. The combination of lasers with three dimensional visualization of the treatment area by ultrasound (TULIP-procedure for benign prostatic hyperplasia) is a novel approach in laser application. The further development of these treatment modalities will reveal the true benefit of laser technology in urological applications.

  14. Piezoelectric microgenerators--current status and challenges.

    Science.gov (United States)

    Kim, Hyun-Uk; Lee, Woo-Ho; Dias, H V Rasika; Priya, Shashank

    2009-08-01

    This manuscript reviews the developments made in design and fabrication of piezoelectric microgenerators and presents a method for making a comparative study within various vibration energy harvesting mechanisms. Current generation vibration energy harvesters have power density in the range of 0.8 microW/mm3. The manuscript also reports our results on synthesis of barium titanate (BT) thin films for MEMS (micro-electromechanical systems) based energy harvester. BT sol-gel was synthesized by aqueous process using barium acetate and titanium bis (ammonium lacto) dihydroxide with PVP (Polyvinylpyrrolidone). After optimizing the annealing temperature and time, textured BT films with 600 nm thickness were obtained on (111) Pt/Ti/SiO2 wafer. A MEMS fabrication process flow was designed to produce microcantilever chips from BT films constituting 6 cantilevers connected in series with an interdigital electrode pattern. We also present some concepts for further improvement of the power density of vibration energy harvesters by incorporating 3-D structure, magnetoelectric material, and a multimodal scheme. PMID:19686971

  15. International Shock-Wave Database: Current Status

    Science.gov (United States)

    Levashov, Pavel

    2013-06-01

    Shock-wave and related dynamic material response data serve for calibrating, validating, and improving material models over very broad regions of the pressure-temperature-density phase space. Since the middle of the 20th century vast amount of shock-wave experimental information has been obtained. To systemize it a number of compendiums of shock-wave data has been issued by LLNL, LANL (USA), CEA (France), IPCP and VNIIEF (Russia). In mid-90th the drawbacks of the paper handbooks became obvious, so the first version of the online shock-wave database appeared in 1997 (http://www.ficp.ac.ru/rusbank). It includes approximately 20000 experimental points on shock compression, adiabatic expansion, measurements of sound velocity behind the shock front and free-surface-velocity for more than 650 substances. This is still a useful tool for the shock-wave community, but it has a number of serious disadvantages which can't be easily eliminated: (i) very simple data format for points and references; (ii) minimalistic user interface for data addition; (iii) absence of history of changes; (iv) bad feedback from users. The new International Shock-Wave database (ISWdb) is intended to solve these and some other problems. The ISWdb project objectives are: (i) to develop a database on thermodynamic and mechanical properties of materials under conditions of shock-wave and other dynamic loadings, selected related quantities of interest, and the meta-data that describes the provenance of the measurements and material models; and (ii) to make this database available internationally through the Internet, in an interactive form. The development and operation of the ISWdb is guided by an advisory committee. The database will be installed on two mirrored web-servers, one in Russia and the other in USA (currently only one server is available). The database provides access to original experimental data on shock compression, non-shock dynamic loadings, isentropic expansion, measurements of sound

  16. Current status of thoracic dorsal sympathectomy.

    Science.gov (United States)

    Welch, E; Geary, J

    1984-01-01

    This article summarizes over 20 years of experience (1962 to 1982) with cervical sympathectomy (thoracic dorsal sympathectomy) in 46 patients undergoing 68 sympathectomies. All operations were performed through an anterior supraclavicular approach. Indications for surgery were intractable Raynaud's disease (26 patients), atherosclerotic obliterative arterial disease (five), causalgia (five), posttraumatic sympathetic dystrophy (seven), collagen vascular disorders (eight), hyperhidrosis (12), occupational-related digital thrombosis (four), and thrombosis secondary to intra-arterial injection (one). The incidence of complications and side effects, both temporary and permanent, including Horner's syndrome, is reviewed in detail. Particular reference is made to the various surgical techniques of managing the stellate ganglion; four patients had two-third to three-fourth resection of the stellate ganglion down to and including the T-3 thoracic ganglion, two had preservation of the stellate ganglion and resection of the T-2 through T-4 ganglia, seven had excision of the entire stellate ganglion down to and including the T-4 ganglion, seven had resection of the lower third of the stellate ganglion down to and including the T-4 ganglion, and 48 had removal of the lower half of the stellate ganglion down to and including the T-3 ganglion. The study reviews the literature germane to anatomic considerations and suggests revisions in current texts and atlases. By retrospective analysis of the records and a follow-up questionnaire, which provided an 86% follow-up (average 8.4 years), the paper points to the distinctive clinical characteristics of the different groups within the population undergoing the operation and provides guidelines for patient selection and conclusions on the place for this operation in the management of vascular diseases involving the upper extremity. PMID:6481864

  17. Current radiological status of Utirik Atoll

    Energy Technology Data Exchange (ETDEWEB)

    Robison, W L

    1998-08-01

    A preliminary radiological survey was conducted at Utirik Atoll in 1978 as part of the Northern Marshall Islands Radiological Survey (NMIRS). A dose assessment based on these limited data indicated a relatively low dose of about 0.12 mSv to people living on Utirik in 1978 (Robison et al., 1982). A much more detailed radiological survey was conducted in April of both 1993 and 1994. Aerial photos of the islands of Utirik Atoll were taken as part of the 1978 NMIRS. The sampling grids for the 1993 and 1994 surveys are shown overlaid on these aerial photos in Figures 1, 2, 3, and 4. External gamma measurements and a collection of either drinking coconuts or copra coconuts were made at each location. Pandanus, breadfruit, lime, and banana were collected where available. Ground water was collected in 1993/94 from four wells on Utirik Island and two wells on Aon Island. Surface soil and soil profiles were collected at some of the grid points on each of the islands at the atoll in 1993/94. A comparison of the number of samples collected in 1978 and 1993/94 are shown in Table 1. A detailed listing of the samples collected in the 1993/94 radiological survey at Utirik Atoll is given in Table 2. The number of vegetation samples collected in 1993/94 is nearly a factor of 7 greater than in 1978. Soil samples collected in 1993/94 exceeded the number collected in 1978 by more than a factor of 4. Consequently, extensive data are now available for the islands at Utirik Atoll and form the basis for the current dose assessment for the atoll.

  18. Current practice of gastric cancer treatment

    Institute of Scientific and Technical Information of China (English)

    Yoon Young Choi; Ji Yeong An; Hyung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh

    2014-01-01

    Objective The aim of this review was to overview the current practice of gastric cancer treatment including surgery and other adjuvant modalities.Data sources The review was based on data obtained from the published articles and main guidelines in the East and West.Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed.Results Although varied adjuvant modalities have been proved to be benefit for treating gastric cancer,surgery is still the most important treatment strategy against gastric cancer.Actively adapting to new technology is important but it should be balanced with an effort to establish sound scientific rationale that adheres to oncologic principles.Conclusions Future treatment of gastric cancer will be focused on tailored,personalized therapy.For achieving it,collaboration across disciplines is essential.Also the philosophy of caring for the patients with gastric cancer should be rooted in the realization of true patient benefit regardless of who is providing the care.With these philosophies,we can shift the scientific and technological advances toward triumph over gastric cancer.

  19. Exercise after breast cancer treatment: current perspectives

    Directory of Open Access Journals (Sweden)

    Dieli-Conwright CM

    2015-10-01

    Full Text Available Christina M Dieli-Conwright, Breanna Z Orozco Division of Biokinesiology and Physical Therapy, Women's Health and Exercise Laboratory, University of Southern California, Los Angeles, CA, USA Abstract: Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offset treatment-related side effects. Noticeable reductions in physical fitness (ie, cardiopulmonary fitness and muscular strength, negative changes in body composition (ie, increase in body mass, decrease in lean body mass, and increase in fat mass, increased fatigue, depression, or anxiety are some of the common side effects of cancer treatments that negatively impact overall quality of life and increase the risk for the development of comorbidities. Exercise plays a vital role in improving cardiopulmonary function, psychological events, muscular strength, and endurance in breast cancer survivors, and thus should be considered as a key factor of lifestyle intervention to reverse negative treatment-related side effects. The purpose of this review is to address current perspectives on the benefits of aerobic and resistance exercise after breast cancer treatments. This review is focused on the well-established benefits of exercise on physical and emotional well-being, bone health, lymphedema management, and the postulated benefits of exercise on risk reduction for recurrence of breast cancer. Keywords: breast cancer, exercise, physical well-being

  20. Exercise after breast cancer treatment: current perspectives.

    Science.gov (United States)

    Dieli-Conwright, Christina M; Orozco, Breanna Z

    2015-01-01

    Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offset treatment-related side effects. Noticeable reductions in physical fitness (ie, cardiopulmonary fitness and muscular strength), negative changes in body composition (ie, increase in body mass, decrease in lean body mass, and increase in fat mass), increased fatigue, depression, or anxiety are some of the common side effects of cancer treatments that negatively impact overall quality of life and increase the risk for the development of comorbidities. Exercise plays a vital role in improving cardiopulmonary function, psychological events, muscular strength, and endurance in breast cancer survivors, and thus should be considered as a key factor of lifestyle intervention to reverse negative treatment-related side effects. The purpose of this review is to address current perspectives on the benefits of aerobic and resistance exercise after breast cancer treatments. This review is focused on the well-established benefits of exercise on physical and emotional well-being, bone health, lymphedema management, and the postulated benefits of exercise on risk reduction for recurrence of breast cancer.

  1. Current status of endoscopic ultrasound for the upper gastrointestinal tract in Asia.

    Science.gov (United States)

    Yoshinaga, Shigetaka; Hilmi, Ida Normiha; Kwek, Boon Eu Andrew; Hara, Kazuo; Goda, Kenichi

    2015-04-01

    We summarize the current status of endoscopic ultrasound (EUS) for the upper gastrointestinal (GI) tract solely in Asia, focusing on the staging of superficial cancers and the diagnosis of submucosal tumors (SMT), by analysis of questionnaire responses and a literature review. EUS for assessing the depth of superficial cancers of the upper GI tract is useful; however, evidence is lacking to support that EUS is superior to other modalities. The current status of EUS varies across different Asian countries, and standardization of the methods used both during the procedure and for depth subclassification is necessary to evaluate the diagnostic accuracy. Although EUS alone is limited in the diagnosis of SMT, EUS-guided fine-needle aspiration is an effective and safe diagnostic tool. Although there is a role for EUS, there are still many limitations both technically and in terms of accessibility. PMID:25537645

  2. Nuclear Power for Sustainable Development : Current Status and Future Prospects

    OpenAIRE

    Adamantiades, A.; Kessides, I.

    2009-01-01

    Interest in nuclear power has been revived as a result of volatile fossil fuel prices, concerns about the security of energy supplies, and global climate change. This paper describes the current status and future plans for expansion of nuclear power, the advances in nuclear reactor technology, and their impacts on the associated risks and performance of nuclear power. Advanced nuclear reactors have been designed to be simpler and safer, and to have lower costs than currently operating reactor...

  3. Counseling in Malaysia: History, Current Status, and Future Trends

    Science.gov (United States)

    See, Ching Mey; Ng, Kok-Mun

    2010-01-01

    This article presents an overview of the history of counseling in Malaysia, provides an update of its current status, and discusses some anticipated future trends for the profession in light of recent developments in the country. Counseling in Malaysia began with school guidance in the 1960s and has now achieved recognition as a profession in…

  4. Colonography: current status, research directions and challenges. Update 2002

    International Nuclear Information System (INIS)

    With the introduction of multislice CT technology and faster gradients in MRI, CT and MR colonography are increasingly becoming attractive alternatives for colorectal mass screening. In this article we summarise the current status, research directions, and challenges in CT and MR colonography. (orig.)

  5. Special Education History, Current Status and Future: India

    Science.gov (United States)

    Antony, Pavan John

    2013-01-01

    Education of all children in public schools, including those with disabilities, continues to be an unresolved issue in many countries around the globe. While education of all children is mandated by law and considered a basic human right in many countries, the current status of implementation varies. India, for example, is an ancient country that…

  6. Current Status and Future Prospects of Hydroelectricity Standardization

    Institute of Scientific and Technical Information of China (English)

    2010-01-01

    Technical standardization is very essential to electricity industry, which plays an active role in many aspects including technology standardization, secure and economic operation of power systems, environment protection, technological progress, and improvement of enterprises' management. This paper introduces the current status of hydroelectricity standardization, summarizes the progress and achievements, and then points out the development direction and working target in the future.

  7. Current Status and Future Prospects of Hydroelectricity Standardization

    Institute of Scientific and Technical Information of China (English)

    Liu Yongdong

    2010-01-01

    @@ Technical standardization is very essential to electricity industry, which plays an active role in many aspects including technology standardization, secure and economic operation of power systems, environment protection, technological progress, and improvement of enterprises' management. This paper introduces the current status of hydroelectricity standardization, summarizes the progress and achievements, and then points out the development direction and working target in the future.

  8. Current status of quantitative rotational spectroscopy for atmospheric research

    Science.gov (United States)

    Drouin, Brian J.; Wlodarczak, Georges; Colmont, Jean-Marcel; Rohart, Francois

    2004-01-01

    Remote sensing of rotational transitions in the Earth's atmosphere has become an important method for the retrieval of geophysical temperatures, pressures and chemical composition profiles that requires accurate spectral information. This paper highlights the current status of rotational data that are useful for atmospheric measurements, with a discussion of the types the rotational lineshape measurements that are not generally available in either online repository.

  9. Refugee Issues: Current Status and Directions for the Future.

    Science.gov (United States)

    Rubin, Gary; And Others

    A comprehensive review of current refugee policy and program issues is provided in this paper, which is intended to serve both as a status report and a guide to developing an agenda for the future. Chapter I deals with early warning as to potential refugee movements, mass asylum, and interim assistance. Chapter II discusses and analyzes four types…

  10. The World Space Observatory (WSO-UV) - Current status

    CERN Document Server

    Uslenghi, Michela; Pontoni, Cristian; Scuderi, Salvatore; Shustov, Boris

    2008-01-01

    This paper reports on the current status of the World Space Observatory WSO-UV, a space mission for UV astronomy, planned for launch at the beginning of next decade. It is based on a 1.7 m telescope, with focal plane instruments including high resolution spectrographs, long slit low resolution spectrographs and imaging cameras.

  11. Current status and future research in motion planning

    Energy Technology Data Exchange (ETDEWEB)

    Hwang, Y.K.

    1995-07-01

    There have been numerous research efforts in the field of motion planning, resulting in many theoretical and practical results. We review the current status of existing motion planning algorithms, evaluate their completeness and efficiencies on modern computers, and suggest fruitful future research directions.

  12. Epidermal growth factor receptor inhibition in lung cancer: status 2012.

    Science.gov (United States)

    Hirsch, Fred R; Jänne, Pasi A; Eberhardt, Wilfried E; Cappuzzo, Federico; Thatcher, Nick; Pirker, Robert; Choy, Hak; Kim, Edward S; Paz-Ares, Luis; Gandara, David R; Wu, Yi-Long; Ahn, Myung-Ju; Mitsudomi, Tetsuya; Shepherd, Frances A; Mok, Tony S

    2013-03-01

    Lung cancer is the most common cause of cancer deaths. Most patients present with advanced-stage disease, and the prognosis is generally poor. However, with the understanding of lung cancer biology, and development of molecular targeted agents, there have been improvements in treatment outcomes for selected subsets of patients with non-small-cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have demonstrated significantly improved tumor responses and progression-free survival in subsets of patients with advanced NSCLC, particularly those with tumors harboring activating EGFR mutations. Testing for EGFR mutations is a standard procedure for identification of patients who will benefit from first-line EGFR TKIs. For patients with advanced NSCLC and no activating EGFR mutations (EGFR wild-type) or no other driving oncogenes such as ALK-gene rearrangement, chemotherapy is still the standard of care. A new generation of EGFR TKIs, targeting multiple receptors and with irreversible bindings to the receptors, are in clinical trials and have shown encouraging effects. Research on primary and acquired resistant mechanisms to EGFR TKIs are ongoing. Monoclonal antibodies (e.g. cetuximab), in combination with chemotherapy, have demonstrated improved outcomes, particularly for subsets of NSCLC patients, but further validations are needed. Novel monoclonal antibodies are combined with chemotherapy, and randomized comparative studies are ongoing. This review summarizes the current status of EGFR inhibitors in NSCLC in 2012 and some of the major challenges we are facing. PMID:23370315

  13. Macromolecular contrast agents for MR mammography: current status

    International Nuclear Information System (INIS)

    Macromolecular contrast media (MMCM) encompass a new class of diagnostic drugs that can be applied with dynamic MRI to extract both physiologic and morphologic information in breast lesions. Kinetic analysis of dynamic MMCM-enhanced MR data in breast tumor patients provides useful estimates of tumor blood volume and microvascular permeability, typically increased in cancer. These tumor characteristics can be applied to differentiate benign from malignant lesions, to define the angiogenesis status of cancers, and to monitor tumor response to therapy. The most immediate challenge to the development of MMCM-enhanced mammography is the identification of those candidate compounds that demonstrate the requisite long intravascular distribution and have the high tolerance necessary for clinical use. Potential mammographic applications and limitations of various MMCM, defined by either experimental animal testing or clinical testing in patients, are reviewed in this article. (orig.)

  14. Colonoscopy in Colorectal Cancer Screening: Current Aspects.

    Science.gov (United States)

    Triantafillidis, John K; Vagianos, Constantine; Malgarinos, George

    2015-09-01

    Colonoscopy represents a very important diagnostic modality for screening for colorectal cancer, because it has the ability to both detect and effectively remove pro-malignant and malignant lesions. It is recommended by almost all international and national gastroenterology and cancer societies, as an initial screening modality or, following a positive fecal occult blood test, to be performed every 10 years in individuals of average risk starting from the age of 50. However, a significant problem is the so-called post-screening (interval) polyps and cancers found some years after the index colonoscopy. In order to reduce the rate of interval cancers it is extremely necessary to optimize the quality and effectiveness of colonoscopy. Bowel preparation is of paramount importance for both accurate diagnosis and subsequent treatment of lesions found on colonoscopy. The quality of bowel preparation could be significantly improved by splitting the dose regimens, a strategy that has been shown to be superior to single-dose regimen. A good endoscopic technique and optimal withdrawal time offering adequate time for inspection, would further optimize the rate of cecal intubation and the number of lesions detected. During the last years, sophisticated devices have been introduced that would further facilitate cecal intubation. The percentage of total colonoscopies is now super-passing the level of 95 % allowing the adenoma detection rate to be greater than the suggestive level of 25 % in men and 15 % in women. This review aims to provide the reader with the current knowledge concerning indications, usefulness, limitations and future perspectives of this probably most important screening technique for colorectal cancer available today. PMID:27217671

  15. Health Insurance Status May Affect Cancer Patients' Survival

    Science.gov (United States)

    ... https://medlineplus.gov/news/fullstory_160304.html Health Insurance Status May Affect Cancer Patients' Survival 2 studies highlight disparities in outcomes for uninsured and Medicaid patients To use the sharing features on this ...

  16. MRI for breast cancer: Current indications

    International Nuclear Information System (INIS)

    Mammography is the only imaging study that has been proven in multiple large randomized trials to decrease breast cancer mortality. Mammography, however, has its limitations and, as such, other modalities that can complement it are being studied. One of these is dynamic contrast-enhanced breast MRI, which has emerged as an important adjunctive modality and is at present the most sensitive modality that we have to evaluate the breast. The American College of Radiology, in its 2004 practice guidelines, has outlined the 12 current indications for breast MRI. This manuscript reviews and provides examples of each of these

  17. Current imaging strategies for the evaluation of uterine cervical cancer.

    Science.gov (United States)

    Bourgioti, Charis; Chatoupis, Konstantinos; Moulopoulos, Lia Angela

    2016-04-28

    Uterine cervical cancer still remains an important socioeconomic issue because it largely affects women of reproductive age. Prognosis is highly depended on extent of the disease at diagnosis and, therefore, accurate staging is crucial for optimal management. Cervical cancer is clinically staged, according to International Federation of Gynecology and Obstetrics guidelines, but, currently, there is increased use of cross sectional imaging modalities [computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-CT (PET-CT)] for the study of important prognostic factors like tumor size, parametrial invasion, endocervical extension, pelvic side wall or adjacent/distal organs involvement and lymph node status. Imaging indications also include cervical cancer follow-up, evaluation of tumor response to treatment and selection of suitable candidates for less radical surgeries like radical trachelectomy for fertility preservation. The preferred imaging method for local cervical cancer evaluation is MRI; CT is equally effective for evaluation of extrauterine spread of the disease. PET-CT shows high diagnostic performance for the detection of tumor relapse and metastatic lymph nodes. The aim of this review is to familiarize radiologists with the MRI appearance of cervical carcinoma and to discuss the indications of cross sectional imaging during the course of the disease in patients with cervical carcinoma.

  18. Current status of the LHCf experiment and future plan

    Directory of Open Access Journals (Sweden)

    Tamura T.

    2013-06-01

    Full Text Available The Large Hadron Collider forward (= LHCf experiment has successfully finished the first phase of data taking at LHC √s = 0.9 and 7 TeV proton-proton collisions in 2010. As current status, we concentrate on analyzing the obtained data. As the first result, the energy spectra of photon measured by LHCf during = 7 TeV p-p collision has been published recently. Also the study of the upgraded version of LHCf detector for future = 14TeV run scenario is developed with the GSO scintillator. Another possible plan of p-A(nuclear collision in LHC is also studied. In this paper, as the current status of the experiment, analyses, and works for foreseen detector upgrade are summarized.

  19. Review of the current status of radiation risk estimates

    International Nuclear Information System (INIS)

    This report reviews the current status of radiation risk estimation for low linear energy transfer radiation. Recent statements by various national and international organisations regarding risk estimates are critically discussed. The recently published revised population risk estimates from the study of Japanese bomb survivors are also reviewed and used with some unpublished data from Japan to calculate risk figures for a general work force. (author)

  20. Current Status of Deltabaculoviruses, Cypoviruses and Chloriridoviruses Pathogenic for Mosquitoes

    Institute of Scientific and Technical Information of China (English)

    James J. Becnel

    2007-01-01

    There are a variety of viral pathogens that cause disease in mosquitoes with most belonging to three major groups. The most common viruses of mosquitoes are the baculoviruses (DBVs) (Baculoviridae: Deltabaculovirus), cytoplasmic polyhedrosis viruses (CPVs) (Reoviridae: Cypovirus) and the iridoviruses (MIVs) (Iridoviridae: Chloriridovirus). Baculoviruses and iridoviruses are DNA viruses while cypoviruses are the main RNA viruses in mosquitoes. This review presents an overview of the current status and recent advancements in understanding the biology and molecular features of mosquito pathogenic viruses.

  1. Current status of acupuncture and moxibustion in China

    OpenAIRE

    Lim, Min Yee; Huang, Jian; Zhao, Baixiao; Ha, Lue

    2015-01-01

    Acupuncture and moxibustion are more integrated in the Chinese healthcare system than in the national healthcare systems of other countries. Development of acupuncture and moxibustion in China is making progress in this field. For overseas researchers, this commentary offers perspectives on the current status of acupuncture and moxibustion in China and examines relevant opportunities and challenges in healthcare reforms. There has been a steady increase in the number of undergraduates and pos...

  2. Current Status and Development of National Grid in China

    Institute of Scientific and Technical Information of China (English)

    2005-01-01

    With most primary energy resources far from load centers, the voltage level of power system in China has imperatively been upgraded to meet the demand of long-distance power transmission. The successful commissioning of the 750-kV HVAC line in Northwest Power Grid has opened an era of national grid devel opment and brought about a series of technical problems to be faced. This report introduces briefly the current status and policies of UHV development in China.

  3. Corporate Social Responsibility : Benefit, Current Status and Future Trend

    OpenAIRE

    Ahmed, Sarwar U.; Uchida, Shigeru

    2006-01-01

    The objective of this paper is to review the current status and future trend of corporate social responsibility concept practiced by companies. In doing so, the term corporate social responsibility is defined with the regulations governing it. Then the benefits of performing such responsibilities are elaborated. Finally, the role of the public sector is discussed in assisting the business firms for practicing social responsibility. The examination of various available literatures revealed tha...

  4. Current Status and Prospects of Biodiesel Production from Microalgae

    Directory of Open Access Journals (Sweden)

    Yuhuan Liu

    2012-07-01

    Full Text Available Microalgae represent a sustainable energy source because of their high biomass productivity and ability to remove air and water born pollutants. This paper reviews the current status of production and conversion of microalgae, including the advantages of microalgae biodiesel, high density cultivation of microalgae, high-lipid content microalgae selection and metabolic control, and innovative harvesting and processing technologies. The key barriers to commercial production of microalgae biodiesel and future perspective of the technologies are also discussed.

  5. Current Status and Prospects of Biodiesel Production from Microalgae

    OpenAIRE

    Yuhuan Liu; Rongsheng Ruan; Zhenyi Du; Xiaodan Wu

    2012-01-01

    Microalgae represent a sustainable energy source because of their high biomass productivity and ability to remove air and water born pollutants. This paper reviews the current status of production and conversion of microalgae, including the advantages of microalgae biodiesel, high density cultivation of microalgae, high-lipid content microalgae selection and metabolic control, and innovative harvesting and processing technologies. The key barriers to commercial production of microalgae biodie...

  6. Current status of orthodontic professionals in the Asian Pacific region

    Directory of Open Access Journals (Sweden)

    Kazuo Tanne

    2016-01-01

    Full Text Available Asian Pacific Orthodontic Society (APOS was developed in Tokyo on October 1, 2001. Currently, APOS has grown up to a scientific association specified to orthodontics with 18 affiliated societies. However, the status of orthodontic professionals in each society remains unclear beyond our understanding. To this end, I have recently conducted an internet interview to the representatives of affiliated societies. The questionnaire includes the educational system for dentists and orthodontists, the number of orthodontic departments with post-graduate programs, the number of orthodontists or members of each society, orthodontic treatment fee on average, the prevalence of CLP and the treatment, orthodontic treatment for jaw deformity patients, current status of orthodontic treatment with lingual appliances and TADs, important issues for orthodontic specialists, future plans of each society. It is hopefully anticipated that the current status of orthodontic professionals in the Asian Pacific region are well understood by all the APOS members and will become a great benefit for the development of all the affiliate societies.

  7. The current status of Zika virus in Southeast Asia

    Science.gov (United States)

    2016-01-01

    OBJECTIVES: Zika virus currently poses a global threat and is a major public health issue throughout Latin America and the Caribbean. However, Zika virus infections in humans have also been observed in other regions, including Southeast Asia, where arboviral diseases are very common. In this study, we summarize the current status of Zika virus in Southeast Asia. This review aims to provide an overview of the current situation and also to suggest ways of adequately managing the emergence of Zika virus in Southeast Asia. METHODS: The literature searching for the reports on Zika virus in Southeast Asia was done using standard database PubMed and the re-analysis and summarization on the reports was done. RESULTS: A limited number of reports have addressed Zika virus disease in Southeast Asia, but it is has been confirmed that a problem already exists. Individual case reports and outbreaks of Zika virus have been confirmed in Southeast Asia. Several reports have also described patients becoming infected after visiting Southeast Asia. In addition, the concurrent circulation of Zika virus with other arboviruses has been confirmed. CONCLUSIONS: As a tropical region with a high prevalence of arboviral diseases, the emergence of Zika virus in Southeast Asia is a major concern. It is essential for local medical personnel to recognize this disease. Given the status of Southeast Asia as a globally important tourist destination, continuous updates on the status of Zika virus in Southeast Asia are required and should be incorporated into global health advisories regarding travel. PMID:27336445

  8. Ukrainian network of permanent geodynamic stations: Current status and perspective

    Science.gov (United States)

    Yatskiv, Y.; Bolotin, S.; Bolotina, O.; Khoda, O.; Medvedsky, M.; Sydorenko, G.; Stopkhay, Y.; Volvach, O.

    Current status and perspective of establishing the Ukrainian network of permanent geodynamic stations (UKRGEONETWORK) is reviewed in connection with Integrated Space Geodetic Systems project. The UKRGEONETWORK consists of several stations which form GPS, SLR, and VLBI subnetworks as well as Gravimetry subsystem. Some information concerned with current activity of the UKRGEONETWORK in particular precise orbit determination in software complex Kiev-Geodynamic, ionospheric modelling in Klio program, and EOP determination on SteelBreeze software is given. Plan for upgrading the hardware of stations and for increasing the number of collocation sites is considered.

  9. Current Status of LHC Physics: Precision Theory View

    CERN Document Server

    Ward, B F L

    2014-01-01

    We discuss the current status of LHC physics from the perspective of precision theory predictions for the attendant QCD and EW higher order corrections. We focus on the interplay between the available data and the predictions for these data viewed in the context of the establishment of baselines for what is needed to exploit fully the discovery potential of the existing LHC data and the data expected by the end of the second LHC run (i.e., 300fb$^{-1}$). We conclude that significant improvement in the currently used theoretical predictions will be mandatory. Possible strategies to achieve such improvement are indicated.

  10. Current status of percutaneous coronary intervention of chronic total occlusion

    Institute of Scientific and Technical Information of China (English)

    Jun-bo GE

    2012-01-01

    This paper describes the current status of percutaneous coronary intervention (PCI) for totally occluded coronary arteries.Chronic total occlusion is associated with 10%-20% of all PCI procedures.Results show that opening an occluded vessel,especially one supplying a considerable area of myocardium,may be beneficial for a patient's angina relief and heart function.We describe the devices used currently in re-canalization such as new wires,microcatheters (including Tonus and Cosair) and intravascular ultrasound guidance.Different techniques to improve the success rate and reduce complications are discussed in detail.

  11. Investigation analysis of current exercise status and its obstacle factors in patients with cancer-related fatigue%癌因性疲乏患者运动现状及障碍因素的调查分析

    Institute of Scientific and Technical Information of China (English)

    王晓庆; 段培蓓; 杨丽华; 梅思娟

    2015-01-01

    目的 了解患有癌因性疲乏的胃肠道肿瘤患者的运动情况,分析其障碍因素,为临床护理工作提供依据. 方法 采用自行设计的一般资料调查问卷及肿瘤患者运动障碍问卷对江苏省中医院消化肿瘤外科的216例胃肠道肿瘤并具有不同程度癌因性疲乏的患者进行问卷调查. 结果 216例患者中有155例进行运动,但只有66例运动强度达到了美国肿瘤学会2012年发布的运动指南推荐的标准."不知道运动能够减轻疲乏程度""害怕运动对疾病及治疗带来负面影响""疲乏""缺乏运动技能"及"无运动习惯"等是影响癌因性疲乏患者实施运动疗法的主要障碍因素. 结论 医护人员应意识到癌因性疲乏对肿瘤患者生活质量的严重影响,规范化评估和管理疲乏,进行睡眠干预和行为指导,科学地评价疲乏的管理效果.%Objective To probe into the exercise status of digestive tumor patients in cancer-related fatigue, analyze its obstacle factors, in order to provide evidence for clinical nursing care. Methods Self designed general information questionnaire and tumor patient′s cinesipathy questionnaire in 216 digestive tumor patients of Digestive Tumor Surgery Department in Jiangsu Chinese Medicine Hospital for investigation of different degree cancer-related fatigue. Results A total of 155 of 216 patients had excises, but 66 cases reached the excises intensity of American Cancer Society in 2012 published guidelines recommend movement standards;"do not know that exercise can reduce fatigue degree", "fear campaign negative impact on disease and treatment","tired", "lack of motor skills" and "no exercise habits" were the obstacle factors for cancer-related fatigue carrying out exercise therapy. Conclusions Medical personnel should be aware of the impact of cancer-related fatigue on the quality of life in the cancer patients, regulate assessment and manage fatigue, carry out sleep interventions and guide

  12. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

    Science.gov (United States)

    Smith, Robert A; Andrews, Kimberly; Brooks, Durado; DeSantis, Carol E; Fedewa, Stacey A; Lortet-Tieulent, Joannie; Manassaram-Baptiste, Deana; Brawley, Otis W; Wender, Richard C

    2016-01-01

    Each year the American Cancer Society (ACS) publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, we summarize current ACS cancer screening guidelines, including the update of the breast cancer screening guideline, discuss quality issues in colorectal cancer screening and new developments in lung cancer screening, and provide the latest data on utilization of cancer screening from the National Health Interview Survey.

  13. Current trends in staging rectal cancer

    Institute of Scientific and Technical Information of China (English)

    Abdus Samee; Chelliah Ramachandran Selvasekar

    2011-01-01

    Management of rectal cancer has evolved over the years.In this condition preoperative investigations assist in deciding the optimal treatment.The relation of the tumor edge to the circumferential margin (CRM) is an important factor in deciding the need for neoadjuvant treatment and determines the prognosis.Those with threatened or involved margins are offered long course chemoradiation to enable R0 surgical resection.Endoanal ultrasound (EUS) is useful for tumor (T) staging;hence EUS is a useful imaging modality for early rectal cancer.Magnetic resonance imaging (MRI) is useful for assessing the mesorectum and the mesorectal fascia which has useful prognostic significance and for early identification of local recurrence.Computerized tomography (CT) of the chest,abdomen and pelvis is used to rule out distant metastasis.Identification of the malignant nodes using EUS,CT and MRI is based on the size,morphology and internal characteristics but has drawbacks.Most of the common imaging techniques are suboptimal for imaging following chemoradiation as they struggle to differentiate fibrotic changes and tumor.In this situation,EUS and MRI may provide complementary information to decide further treatment.Functional imaging using positron emission tomography (PET) is useful,particularly PET/CT fusion scans to identify areas of the functionally hot spots.In the current state,imaging has enabled the multidisciplinary team of surgeons,oncologists,radiologists and pathologists to decide on the patient centered management of rectal cancer.In future,functional imaging may play an active role in identifying patients with lymph node metastasis and those with residual and recurrent disease following neoadjuvant chemoradiotherapy.

  14. Current status and challenge of Human Parasitology teaching in China.

    Science.gov (United States)

    Peng, Hong-Juan; Zhang, Chao; Wang, Chun-Mei; Chen, Xiao-Guang

    2012-11-01

    Parasitic infection profile in China has been changed greatly with the rapid economic development in China since the 1980s, such as the tremendous decreased infection rate of the soil-borne helminthiasis, the elimination of filariasis, the control of malaria, and the initiation to eradicate malaria in 2020. Some food-borne parasitic infections have increased such as Clonorchiasis, Cysticercosis, and Echinococcosis, probably because of the increased chances of eating out. This trend directly affected the status of Human Parasitology teaching in medical universities, such as the shorten length of this course, re-adjusted contents structure and teaching manners, even the change of the name of this course. In this paper, we analyzed the current status and challenges of Human Parasitology teaching in medical universities, and discussed the requisite contents and manners in course delivery and measures to improve the quality of Human Parasitology teaching in China.

  15. Current role of surgical therapy in gastric cancer

    Institute of Scientific and Technical Information of China (English)

    Ryan Swan; Thomas J Miner

    2006-01-01

    Surgery is currently the only potentially curative treatment for gastric cancer. Since the inception of the gastrectomy for cancer of the stomach, there has been debate over the bounds of surgical therapy, balancing potential long-term survival with perioperative morbidity and mortality. This review delineates the current role of surgery in preoperative staging, curative resection, and palliative treatment for gastric cancer.

  16. Indirect dark matter searches: current status and perspectives

    CERN Document Server

    CERN. Geneva

    2016-01-01

    Many theoretical ideas for the particle nature of dark matter exist. The  most popular models often predict that dark matter particles self-annihilate or decay, giving rise to potentially detectable signatures in astronomical observations.  I will summarize the current status of searches for such signatures and critically reassess recent claims for dark matter signals.  I will further provide an outlook on anticipated developments in the next 10 years, and discuss new methods to facilitate strategy development.

  17. Current Status and Prospects of Natural Gas Utilization in China

    Institute of Scientific and Technical Information of China (English)

    Shi Xin

    2002-01-01

    @@ 1 Overview and Current Status of Utilization of China's Natural Gas Resources Natural gas as a green fuel with low carbon content can comply with the trend in the epoch for development of non carbonaceous energy source, and has a lot of advantages such as its abundance in resources, convenience in applica tion and cost competitiveness. The application of natural gas as a premium fuel has become a focus pursued aggres sively by international players, and the perspectives for gas demand growth will be better than that for oil globally.

  18. MicroRNAs of parasites: current status and future perspectives.

    Science.gov (United States)

    Liu, Quan; Tuo, Wenbin; Gao, Hongwei; Zhu, Xing-Quan

    2010-08-01

    MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs regulating gene expression in eukaryotes at the post-transcriptional level. The complex life cycles of parasites may require the ability to respond to environmental and developmental signals through miRNA-mediated gene expression. Over the past 17 years, thousands of miRNAs have been identified in the nematode Caenorhabditis elegans and other parasites. Here, we review the current status and potential functions of miRNAs in protozoan, helminths, and arthropods, and propose some perspectives for future studies.

  19. Current research status of immunology in the genomic era

    Institute of Scientific and Technical Information of China (English)

    LI HaoWen; LI dinZhi; ZHAO GuoPing; WANG Ying

    2009-01-01

    This review updates the current status of immunology research under the influence of genomics, both conceptually and technologically. It particularly highlights the advantages of employing the high-throughput and large-scale technology, the large genomic database, and bioinformatic power in the immunology research. The fast development in the fields of basic immunology, clinical immunology (tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy. We also speculate the future research directions of immunology in the era of genomics and post-genomics.

  20. Current status and challenges in PEMFC stacks, systems and commercialization

    Institute of Scientific and Technical Information of China (English)

    任远; 曹广益; 朱新坚

    2006-01-01

    The current status of worldwide developments of polymer electrolyte membrane fuel cell (PEMFC) stacks and system,research activities in resent years to analyze the cost of PEMFC stacks and systems, the remaining research and development issues that should be resolved before the PEMFC available for commercial application were discussed. The two main problems that challenge the PEMFC commercialization were cost and fuel supply infrastructure. The ways to lower the cost, to choose the fuel and improve the efficiency and reliability were described. To research the cost target of 125 kW and stack lifetime of 40 000 ~ 100 000h, basic research in PEMFC was indispensable.

  1. Current status and future of Mo-99 supply

    Energy Technology Data Exchange (ETDEWEB)

    Ponsard, Bernard [Belgian Nuclear Research Center (SCK.CEN), Mol (Belgium). AIPES Reactors and Isotopes Working Group

    2016-01-15

    The global supply of Mo-99 relies on a limited number of research reactors and processing facilities. Its production is essential as medical diagnostic imaging techniques using Tc-99m account for approximately 80% of all nuclear medicine procedures worldwide. The short half-life's of the radioisotopes requires a continuous supply. Several severe disruptions have been experienced over the past decade. Fortunately, the situation encouraged the industry to develop new projects and new production routes. The current status of Mo-99 supply is described and the efforts made to achieve a reliable Tc-99m availability for nuclear medicine is summarized.

  2. The current status of women in physics in Tanzania

    Science.gov (United States)

    Mohammed, Najat K.; Kazmili, Brenda

    2015-12-01

    Women's representation in physics in Tanzania is generally low. Various studies have shown that Tanzanian girls face obstacles to realizing their educational and intellectual capabilities. The situation is even worse in the field of physics because of the perception that the subject is too difficult. The number of women in physics at the university level is highly associated with their number in secondary school level as well as their performance. This paper analyzes the current status of women engaged in physics in Tanzania in the academic and research institutions.

  3. Mobile Ad Hoc Networks Current Status and Future Trends

    CERN Document Server

    Loo, Jonathan

    2011-01-01

    Guiding readers through the basics of these rapidly emerging networks to more advanced concepts and future expectations, Mobile Ad hoc Networks: Current Status and Future Trends identifies and examines the most pressing research issues in Mobile Ad hoc Networks (MANETs). Containing the contributions of leading researchers, industry professionals, and academics, this forward-looking reference provides an authoritative perspective of the state of the art in MANETs. The book includes surveys of recent publications that investigate key areas of interest such as limited resources and the mobility o

  4. CT myocardial perfusion imaging: current status and future directions.

    Science.gov (United States)

    Williams, M C; Newby, D E

    2016-08-01

    Computed tomography (CT) imaging of the heart has advanced rapidly, and it is now possible to perform a comprehensive assessment at a low radiation dose. CT myocardial perfusion imaging can provide additive information to CT coronary angiography, and is particularly useful in patients with heavily calcified coronary arteries or coronary artery stents. A number of protocols are now available for CT myocardial perfusion including static, dynamic, and dual-energy techniques. This review will discuss the current status of CT myocardial perfusion imaging, its clinical application, and future directions for this technology.

  5. On the current status of Phakopsora pachyrhizi genome sequencing

    Directory of Open Access Journals (Sweden)

    Marco eLoehrer

    2014-08-01

    Full Text Available Recent advances in the field of sequencing technologies and bioinformatics allow a more rapid access to genomes of non-model organisms at sinking costs. Accordingly, draft genomes of several economically important cereal rust fungi have been released in the last three years. Aside from the very recent flax rust and poplar rust draft assemblies there are no genomic data available for other dicot-infecting rust fungi. In this article we outline rust fungus sequencing efforts and comment on the current status of Phakopsora pachyrhizi (Asian soybean rust genome sequencing.

  6. Current Status of Integral Medical Study on Endometriosis

    Institute of Scientific and Technical Information of China (English)

    YU Chao-qin (俞超芹); YU Jin (俞瑾)

    2003-01-01

    @@ Endometriosis (EM), an estrogen dependent disease that comes from the planting of endometrial gland and stroma outside the uterine cavity, is characterized by invasiveness, wide planting and liability to relapse. It has been proved by recent studies that the pathogenesis of EM has its genetic background and is closely related with neuro-, endocrino- and immuno-factors. There has been great progress in the treatment of EM, but the clinical effect is not yet satisfactory. Traditional Chinese medicine (TCM) has definitely played its role in EM treatment. In this article, the current status of integral medical study on EM is reviewed.

  7. Current research status of immunology in the genomic era

    Institute of Scientific and Technical Information of China (English)

    2009-01-01

    This review updates the current status of immunology research under the influence of genomics,both conceptually and technologically.It particularly highlights the advantages of employing the high-throughput and large-scale technology,the large genomic database,and bioinformatic power in the immunology research.The fast development in the fields of basic immunology,clinical immunology(tumor and infectious immunology) and vaccine designing is illustrated with respect to the successful usage of genomic strategy.We also speculate the future research directions of immunology in the era of genomics and post-genomics.

  8. MONK and MCBEND: Current status and recent developments

    International Nuclear Information System (INIS)

    Highlights: • We describe recent developments to the Monte Carlo codes MONK and MCBEND. • MONK is a Monte Carlo code for nuclear criticality and reactor physics analyses. • MCBEND is a Monte Carlo code for radiation shielding and dosimetry analyses. • Improvements include input; physics; scoring; variance reduction; and visualisation. • Parallelisation of MONK and multi-physics coupling are described. - Abstract: MONK® and MCBEND are Monte Carlo software packages for: nuclear criticality and reactor physics; and radiation shielding and dosimetry applications, respectively. The codes are actively developed, maintained and supported by AMEC’s ANSWERS® Software Service in line with the ANSWERS vision of providing easy-to-use software that meets the current and emerging needs of the user community. This paper summarises the current status of MONK and MCBEND and the recent developments which have been carried out to the codes, and their supporting nuclear data libraries and visualisation package

  9. Review of the current status of linear hybrid reactor concepts

    International Nuclear Information System (INIS)

    A review was made of the current status of linear fusion-fission hybrid reactor design studies in the USA. The linear hybrid reactor concepts reviewed include the linear theta-pinch hybrid reactor being studied at Los Alamos Scientific Laboratory, the electron beam-heated solenoid hybrid reactor under development at Physics International Co., the laser-heated solenoid hybrid reactor being investigated at Mathematical Sciences Northwest, Inc., and the linear fusion waste burning reactor being studied at General Atomic Company. The discussion addresses confinement and heating mechanisms for each concept, as well as the hybrid blanket designs. The current state of the four reactor designs is summarized and the performance of the various concepts compared

  10. Product ecodesign and materials: current status and future prospects

    CERN Document Server

    Mathieux, Fabrice; Zwolinski, Peggy

    2007-01-01

    The aim of this paper is to discuss the current status of ecodesign in the industry and its future implications for materials. There is today more and more focus on the environmental impacts of products during their whole life cycle. In particular, ecodesign aims at integrating environmental aspects during the product's design process as any other criterion, in order to reduce the life cycle impacts. Although a lot of product environmental impact assessment and Design for Environment tools already exist, environmental aspects are unfortunately rarely routinely integrated into product development process in the industry. This is mainly due to the fact that current ecodesign tools are little adapted to designers' practices, requirements and competencies. After the sequential and DfX paradigms, design of products is today maturing into Integrated Design, where multiple points of views and expertise have to be considered at the same time to progressively define the product.

  11. Current status of surrogacy in Japan and uterine transplantation research.

    Science.gov (United States)

    Kisu, Iori; Banno, Kouji; Mihara, Makoto; Iida, Takuya; Yoshimura, Yasunori

    2011-10-01

    Recent advances in assisted reproductive technology (ART) have made it possible to circumvent many causes of male and female infertility. The right to have a child by ART has been respected for infertile couples. However, there are currently no legal regulations concerning ART in Japan, and this has resulted in social and ethical problems. Surrogacy involves particularly complex medical, ethical, social, and legal issues, and is frequently focused on as a major social concern. Uterine transplantation (UTx) is a potential alternative for young women with uterine factor infertility due to hysterectomy for treatment of a malignant uterine tumor or massive blood loss after delivery, or because of a congenital disease such as Mayer-Rokitansky-Küster syndrome. UTx has been examined in experimental animals as a basis for establishment of fecundity for young women with uterine factor infertility. In this review, we focus on surrogacy in Japan and UTx research, and discuss the current status and concerns in this field. PMID:21632170

  12. Current status of Paragonimus and paragonimiasis in Ecuador.

    Science.gov (United States)

    Calvopiña, Manuel; Romero, Daniel; Castañeda, Byron; Hashiguchi, Yoshihisa; Sugiyama, Hiromu

    2014-11-01

    A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.

  13. Current status of Paragonimus and paragonimiasis in Ecuador

    Directory of Open Access Journals (Sweden)

    Manuel Calvopiña

    2014-11-01

    Full Text Available A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.

  14. Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

    International Nuclear Information System (INIS)

    In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report

  15. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.

    Science.gov (United States)

    Wallner, Paul E; Anscher, Mitchell S; Barker, Christopher A; Bassetti, Michael; Bristow, Robert G; Cha, Yong I; Dicker, Adam P; Formenti, Silvia C; Graves, Edward E; Hahn, Stephen M; Hei, Tom K; Kimmelman, Alec C; Kirsch, David G; Kozak, Kevin R; Lawrence, Theodore S; Marples, Brian; McBride, William H; Mikkelsen, Ross B; Park, Catherine C; Weidhaas, Joanne B; Zietman, Anthony L; Steinberg, Michael

    2014-01-01

    In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.

  16. Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

    Energy Technology Data Exchange (ETDEWEB)

    Wallner, Paul E., E-mail: pwallner@theabr.org [21st Century Oncology, LLC, and the American Board of Radiology, Bethesda, Maryland (United States); Anscher, Mitchell S. [Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia (United States); Barker, Christopher A. [Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York (United States); Bassetti, Michael [Department of Human Oncology, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin (United States); Bristow, Robert G. [Departments of Radiation Oncology and Medical Biophysics, Princess Margaret Cancer Center/University of Toronto, Toronto, Ontario (Canada); Cha, Yong I. [Department of Radiation Oncology, Norton Cancer Center, Louisville, Kentucky (United States); Dicker, Adam P. [Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania (United States); Formenti, Silvia C. [Department of Radiation Oncology, New York University, New York, New York (United States); Graves, Edward E. [Departments of Radiation Oncology and Radiology, Stanford University, Stanford, California (United States); Hahn, Stephen M. [Department of Radiation Oncology, University of Pennsylvania (United States); Hei, Tom K. [Center for Radiation Research, Columbia University, New York, New York (United States); Kimmelman, Alec C. [Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (United States); Kirsch, David G. [Department of Radiation Oncology, Duke University, Durham, North Carolina (United States); Kozak, Kevin R. [Department of Human Oncology, University of Wisconsin (United States); Lawrence, Theodore S. [Department of Radiation Oncology, University of Michigan (United States); Marples, Brian [Department of Radiation Oncology, Oakland University, Oakland, California (United States); and others

    2014-01-01

    In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.

  17. Active Debris Removal: Current Status of Activities in CNES

    Science.gov (United States)

    Bonnal, Christophe; Ruault, Jean-Marc; Desjean, Marie-Christine

    2013-08-01

    Most of the ongoing studies led at worldwide level, mainly through IADC Actions, conclude that in order to keep a stable Low Earth Orbit environment in the coming decades, it may be necessary to retrieve some 5 to 10 large objects annually. These operations, known as Active Debris Removal (ADR), raise a huge amount of difficulties in numerous domains: political, legal, insurance, defense, financing and, last but not least, technical questions. The current paper aims at reviewing the current status of the ADR activities led by CNES both at National and Multi-lateral level. The first question which is raised is that of the high level requirements to be applied. What are the requirements coming from the operators; do we want to stabilize the environment, decrease it or could we accept some increase over the years; when do we have to act; can we baseline random reentry of such large objects or do we have to stick to controlled destructive reentries?… There may not yet be clear answers to these points, so efforts at international level are required. The second part of the paper deals with the potential solutions at system level. Numerous possibilities can be identified, depending on the size of the launcher and of the strategy selected to de-orbit the debris. Large space tugs visiting some 10 debris or small dedicated chasers launched as piggyback are among the solutions which have been traded. The currently preferred solution is described in details. The third part of the paper is devoted to the chaser-debris operations themselves, following five key functions; - the long range rendezvous, - the short range rendezvous up to contact, - the mechanical interfacing of the debris, - its control by the chaser, when required, - the de-orbiting maneuver itself. For each of these functions, the current status of available technologies is described, enabling the identification of the most critical ones requiring additional R&T effort and subsequent demonstrations. Among them

  18. Current progress in immunotherapy for pancreatic cancer.

    Science.gov (United States)

    Foley, Kelly; Kim, Victoria; Jaffee, Elizabeth; Zheng, Lei

    2016-10-10

    Pancreatic cancer remains one of the most lethal cancers with few treatment options. Immune-based strategies to treat pancreatic cancer, such as immune checkpoint inhibitors, therapeutic vaccines, and combination immunotherapies, are showing promise where other approaches have failed. Immune checkpoint inhibitors, including anti-CTLA4, anti-PD-1, and anti-PD-L1 antibodies, are effective as single agents in immune sensitive cancers like melanoma, but lack efficacy in immune insensitive cancers including pancreatic cancer. However, these inhibitors are showing clinical activity, even in traditionally non-immunogenic cancers, when combined with other interventions, including chemotherapy, radiation therapy, and therapeutic vaccines. Therapeutic vaccines given together with immune modulating agents are of particular interest because vaccines are the most efficient way to induce effective anti-tumor T cell responses, which is required for immunotherapies to be effective. In pancreatic cancer, early studies suggest that vaccines can induce T cells that have the potential to recognize and kill pancreatic cancer cells, but the tumor microenvironment inhibits effective T cell trafficking and function. While progress has been made in the development of immunotherapies for pancreatic cancer over the last several years, additional trials are needed to better understand the signals within the tumor microenvironment that are formidable barriers to T cell infiltration and function. Additionally, as more pancreatic specific antigens are identified, immunotherapies will continue to be refined to provide the most significant clinical benefit.

  19. Photodynamic therapy using 5-aminolevulinic acid-induced photosensitization: current clinical status

    Science.gov (United States)

    Marcus, Stuart L.; Golub, Allyn L.; Shulman, D. Geoffrey

    1995-03-01

    Photodynamic therapy using 5-aminolevulinic acid-induced photosensitization (ALA PDT) via endogenous protoporphyrin IX (PpIX) synthesis has been reported as efficacious, using topical formulations, in the treatment of a variety of dermatologic diseases including superficial basal cell carcinoma, Bowen's disease, and actinic (solar) keratoses. Application of ALA PDT to the detection and treatment of both malignant and non-malignant diseases of internal organs has recently been reported. Local internal application of ALA has been used for the detection, via PpIX fluorescence, of pathological conditions of the human urinary bladder and for selective endometrial ablation in animal model systems. Systemic, oral administration of ALA has been used for ALA PDT of superficial head and neck cancer and of colorectal cancer. This paper reviews the current clinical status of ALA PDT.

  20. [Current status and future prospect of robot-assisted radical prostatectomy].

    Science.gov (United States)

    Miyake, Hideaki; Fujisawa, Masato

    2016-01-01

    Although radical retropubic prostatectomy had long been the mainstay as the surgical treatment for patients with localized prostate cancer, robot-assisted radical prostatectomy (RARP) has recently been achieving increasing acceptance, resulting in the leading option for treating such patients in the United States, and it has been progressively expanding in other countries, including Japan. To date, however, there have been limited data concerning prospective studies or randomized trials showing the superiority of RARP over other surgical approaches. In this review, we attempted to summarize the current status of RARP based on available evidence as well as the experience at our institution, and to discuss the future prospect of this novel system as a major surgical technique for localized prostate cancer.

  1. Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

    Directory of Open Access Journals (Sweden)

    Chanan-Khan Asher A

    2010-01-01

    Full Text Available Abstract Background Survivin is known playing a role in drug resistance. However, its role in bortezomib-mediated inhibition of growth and induction of apoptosis is unclear. There are conflicting reports for the effect of bortezomib on survivin expression, which lacks of a plausible explanation. Methods: In this study, we tested cancer cells with both p53 wild type and mutant/null background for the relationship of bortezomib resistance with survivin expression and p53 status using MTT assay, flow cytometry, DNA fragmentation, caspase activation, western blots and RNAi technology. Results We found that cancer cells with wild type p53 show a low level expression of survivin and are sensitive to treatment with bortezomib, while cancer cells with a mutant or null p53 show a high level expression of survivin and are resistant to bortezomib-mediated apoptosis induction. However, silencing of survivin expression utilizing survivin mRNA-specific siRNA/shRNA in p53 mutant or null cells sensitized cancer cells to bortezomib mediated apoptosis induction, suggesting a role for survivin in bortezomib resistance. We further noted that modulation of survivin expression by bortezomib is dependent on p53 status but independent of cancer cell types. In cancer cells with mutated p53 or p53 null, bortezomib appears to induce survivin expression, while in cancer cells with wild type p53, bortezomib downregulates or shows no significant effect on survivin expression, which is dependent on the drug concentration, cell line and exposure time. Conclusions Our findings, for the first time, unify the current inconsistent findings for bortezomib treatment and survivin expression, and linked the effect of bortezomib on survivin expression, apoptosis induction and bortezomib resistance in the relationship with p53 status, which is independent of cancer cell types. Further mechanistic studies along with this line may impact the optimal clinical application of bortezomib in

  2. Trends and current status of general thoracic surgery in Japan revealed by review of nationwide databases.

    Science.gov (United States)

    Okumura, Meinoshin

    2016-08-01

    Nationwide databases of cases treated for thoracic disease have been established by several academic associations in Japan, which contain information showing trends and current status in regard to surgical treatment. The Japanese Association of Thoracic Surgery (JATS), Japanese Association of Chest Surgery (JACS), Japan Lung Cancer Society (JLCS), Japanese Respiratory Society (JRS), and Japan Society for Respiratory Endoscopy (JSRE) have maintained databases of lung cancer cases treated in Japan. In 1986, the number of general thoracic surgery cases was 15,544, which increased to 75,306 in 2013. Furthermore, the number of lung cancer operations performed in 2013 was 37,008, occupying 49.1% of all general thoracic operations. Also, the proportions of adenocarcinoma, female patients, aged patients, stage I disease, and limited resection procedures are increasing in lung cancer surgery cases. While the 5-year overall post-operative survival rate of lung cancer patients was 47.8% in those undergoing surgery in 1989, it was 69.6% in those of 2004, which means 22% increase during 15 years. JATS, JACS, and the Japanese Association for Research of the Thymus (JART) have maintained retrospective databases of thymic epithelial tumor cases. The number of mediastinal tumors surgically treated is also increasing and was 4,780 in 2013, among which thymoma was the most prevalent. The Japanese Association for Lung and Heart-Lung Transplantation has developed a prospective nationwide database of lung transplantation cases in Japan, which contains clinical data for 466 patients who received lung transplantation or heart-lung transplantation from 1998 to 2015. Nationwide databases are currently being utilized for clinical studies and will also contribute to international projects related to the Union for International Cancer Control (UICC) tumor, node, and metastasis (TNM) classification system.

  3. Current Soil Nutrient Status of Intensively Managed Greenhouses

    Institute of Scientific and Technical Information of China (English)

    HU Yun-Cai; SONG Zhi-Wen; LU Wen-Long; C.POSCHENRIEDER; U.SCHMIDHALTER

    2012-01-01

    Nine districts covering the main greenhouse vegetable areas in Tianjin Municipality of the North China Plain were selected for the soil investigation in 2010 to survey the current soil nutrient status (soil available N,P and K),acidification and salinization due to excessive input of fertilizers in greenhouses in Tianjin. The study showed that,in particular,soil available P content increased with the age of greenhouses.In contrast,our results did not reveal higher K accumulation and lowered pH in the greenhouse soils compared with cultivation in open fields.Over-fertilization,causing high NO3- accumulation,most likely resulted in salinity problems in the greenhouses.Ninety percent of the investigated greenhouse soils had electrical conductivity values of saturated paste extracts of 2-10 d S m-1,which might affect the yields of vegetable crops like green bean,pepper,cabbage,carrot,eggplant,lettuce,spinach,celery,cucumber and tomato. The findings of our survey of the current fertility and salinity problems in greenhouse soils suggest that there is an urgent need to improve the farmers' practices and strategies in fertilization management in greenhouses of China.Because education and the agricultural technical extension services may play a more important role in avoiding overuse of fertilizers,we suggest that current nutrient management practices should be improved in the near future through training of local farmers in farmers' schools and through strengthening the agricultural extension services with practical techniques.

  4. Current status of severe acute respiratory syndrome in China

    Institute of Scientific and Technical Information of China (English)

    Qing-He Nie; Xin-Dong Luo; Jian-Zhong Zhang; Qin Su

    2003-01-01

    Severe acute respiratory syndrome (SARS), also called infectious atypical pneumonia, is an emerging infectious disease caused by a novel variant of coronavirus (SARS associated coronavirus, SARS-CoV). It is mainly characterized by pulmonary infection with a high infectivity and fatality.SARS is swept across almost all the continents of the globe, and has currently involved 33 countries and regions, including the mainland China, Hong Kong, Taiwan, North America and Europe. On June 30, 2003, an acumulative total reached 8450 cases with 810 deaths. SARS epidemic was very rampant in March, April and May 2003 in the mainland of China and Hong Kong. Chinese scientists and healthcare workers cooperated closely with other scientists from all over the world to fight the disease. On April 16, 2003, World Health Organization (WHO) formally declared that SARSCoV was an etiological agent of SARS. Currently, there is no specific and effective therapy and prevention method for SARS. The main treatments include corticosteroid therapy,antiviralagents, anti-infection, mechanical ventilation and isolation. This disease can be prevented and controlled, and it is also curable. Under the endeavor of the Chinese Government, medical staffs and other related professionals,SARS has been under control in China, and Chinese scientists have also made a great contribution to SARS research.Otherstudies in developing new detection assays and therapies, and discovering new drugs and vaccines are in progress. In this paper, we briefly review the current status of SARS in China.

  5. Current status of minimally invasive endoscopicmanagement for Zenker diverticulum

    Institute of Scientific and Technical Information of China (English)

    Alberto Aiolfi; Federica Scolari; Greta Saino; Luigi Bonavina

    2015-01-01

    Surgical resection has been the mainstay of treatment ofpharyngoesophageal (Zenker) diverticula over the pastcentury. Developments in minimally invasive surgeryand new endoscopic devices have led to a paradigmchange. The concept of dividing the septum betweenthe esophagus and the pouch rather than resecting thepouch itself has been revisited during the last threedecades and new technologies have been investigatedto make the transoral operation safe and effective. Theinternal pharyngoesophageal myotomy accomplished through the transoral stapling approach has been shown to effectively relieve outflow obstruction and restore physiological bolus transit in patients with medium size diverticula. Transoral techniques, either through a rigid device or by flexible endoscopy, are gaining popularity over the open surgical approach due the low morbidity, the fast recovery time and the fact that the procedure can be safely repeated. We provide an analysis of the the current status of minimally invasive endoscopic management of Zenker diverticulum.

  6. Contrast-enhanced endoscopic ultrasonography: advance and current status

    Directory of Open Access Journals (Sweden)

    Sung Ill Jang

    2014-07-01

    Full Text Available Endoscopic ultrasonography (EUS technology has undergone a great deal of progress along with the color and power Doppler imaging, three-dimensional imaging, electronic scanning, tissue harmonic imaging, and elastography, and one of the most important developments is the ability to acquire contrast-enhanced images. The blood flow in small vessels and the parenchymal microvasculature of the target lesion can be observed non-invasively by contrast-enhanced EUS (CE-EUS. Through a hemodynamic analysis, CE-EUS permits the diagnosis of various gastrointestinal diseases and differential diagnoses between benign and malignant tumors. Recently, mechanical innovations and the development of contrast agents have increased the use of CE-EUS in the diagnostic field, as well as for the assessment of the efficacy of therapeutic agents. The advances in and the current status of CE-EUS are discussed in this review.

  7. The Current Status of World Protection for Mangrove Forest

    Institute of Scientific and Technical Information of China (English)

    张征云; 苏智先; 张桥英; 申爱英

    2003-01-01

    Mangrove forests occur extensively in the tropic areas rich in wildlife and other non-forestry resources and provide a wide array of raw materials for livelihood and production processes and have been a major source of income generation and subsistence for the local people.Exploitation of timber, fuel wood, poles, industrial raw material, and many other non-wood products from the nangrove forests give rise to large scale economic activity and income generation. At present, mangrove forests are facing great peril. Reckless exploitation and swampland reclamation result in their gradual degradation. This article deals with the world's mangrove forest resources and their benefit to people; describes the current status, points out the main causes of the destruction of these forests, presents proposals for protecting mangrove forests, and discusses international cooperation in protecting the world's mangrove forests.

  8. Indian fast reactor technology: Current status and future programme

    Indian Academy of Sciences (India)

    S C Chetal; P Chellapandi

    2013-10-01

    The paper brings out the advantages of fast breeder reactor and importance of developing closed nuclear fuel cycle for the large scale energy production, which is followed by its salient safety features. Further, the current status and future strategy of the fast reactor programme since the inception through 40 MWt/13 MWe Fast Breeder Test Reactor (FBTR), is highlighted. The challenges and achievements in science and technology of FBRs focusing on safety are described with the particular reference to 500 MWe capacity Prototype Fast Breeder Reactor (PFBR), being commissioned at Kalpakkam. Roadmap with comprehensive R&D for the large scale deployment of Sodium Cooled Fast Reactor (SFRs) and timely introduction of metallic fuel reactors with emphasis on breeding gain and enhanced safety are being brought out in this paper.

  9. The lion in Ghana: its historical and current status

    Directory of Open Access Journals (Sweden)

    Angelici, F. M.

    2015-07-01

    Full Text Available Historically, the lion (Panthera leo population in Ghana has been little studied and its status is poorly documented. Currently, after recent unsuccessful attempts to find signs of the presence of the species, many authors believe that the Ghanaian lion population is most likely extinct. In an attempt to gather more data, since 2005 we have been carrying out lion surveys in the most important parks and other protected areas of Ghana, mainly focusing on Mole National Park (MNP. We have also been extensively reviewing the literature in an attempt to reconstruct the history of the presence of the lion in the country. Although our research has not provided unequivocal evidence of the presence of the lion, we have collected circumstantial evidence that suggests that a small lion population might still be present in MNP and its surrounding areas.

  10. The current status and future of granular media

    International Nuclear Information System (INIS)

    The current status of CoPtCr-SiO2 granular media is briefly reviewed, and challenges relative to media technology exceeding 1 Tb/in2 are discussed. It is effective to enhance grain isolation using oxide materials that easily precipitate at the grain boundary, and this technique is adopted in commercially available perpendicular recording media. Although some difficulties such as reduction of the grain size retaining the switching field remain, 1 Tb/in2 could be achieved by using granular exchange-coupled composite-type media or related technologies. Discrete track media could be used for more than 1 Tb/in2 recording. It could also take several years to further develop nano-processing technology and establish a cost-effective infrastructure. BPM offers great potential in achieving high recording density, although some necessary technologies are still too primitive to consider commercial production

  11. Current status of SK-Gd project and EGADS

    Science.gov (United States)

    Xu, Chenyuan; Super-Kamiokande Collaboration

    2016-05-01

    Supernova Relic Neutrino (SRN) has not been observed yet because of its low event rate and high background. By adding gadolinium into water Cherenkov detector, inverse beta decay will have two signals, the prompt one is positron signal and the delayed one is a ~8 MeV gamma cascade from neutron capture on gadolinium. By this way, background for SRN can be largely reduced by detecting prompt and delayed signals coincidently, and Super-K will also have the ability to distinguish neutrino and anti-neutrino. SK-Gd is a R&D project proposed to dissolve gadolinium into Super-K. As a part of it, EGADS, a 200 ton water Cherenkov detector was built in Kamioka mine. Current status of SK-Gd project and the physics work being performed in EGADS will be presented here.

  12. Current status of high energy nucleon-meson transport code

    Energy Technology Data Exchange (ETDEWEB)

    Takada, Hiroshi; Sasa, Toshinobu [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    1998-03-01

    Current status of design code of accelerator (NMTC/JAERI code), outline of physical model and evaluation of accuracy of code were reported. To evaluate the nuclear performance of accelerator and strong spallation neutron origin, the nuclear reaction between high energy proton and target nuclide and behaviors of various produced particles are necessary. The nuclear design of spallation neutron system used a calculation code system connected the high energy nucleon{center_dot}meson transport code and the neutron{center_dot}photon transport code. NMTC/JAERI is described by the particle evaporation process under consideration of competition reaction of intranuclear cascade and fission process. Particle transport calculation was carried out for proton, neutron, {pi}- and {mu}-meson. To verify and improve accuracy of high energy nucleon-meson transport code, data of spallation and spallation neutron fragment by the integral experiment were collected. (S.Y.)

  13. Current Status of Mechanical Circulatory Support: A Systematic Review

    Directory of Open Access Journals (Sweden)

    Kyriakos Spiliopoulos

    2012-01-01

    Full Text Available Heart failure is a major public health problem and its management requires a significant amount of health care resources. Even with administration of the best available medical treatment, the mortality associated with the disease remains high. As therapeutical strategies for heart failure have been refined, the number of patients suffering from the disease has expanded dramatically. Although heart transplantation still represents the gold standard therapeutical approach, the implantation of mechanical circulatory support devices (MCSDs evolved to a well-established management for this disease. The limited applicability of heart transplantation caused by a shortage of donor organs and the concurrent expand of the patient population with end-stage heart failure led to a considerable utilization of MCSDs. This paper outlines the current status of mechanical circulatory support.

  14. Current status of the Mallard population in the Nordic countries

    DEFF Research Database (Denmark)

    Dalby, Lars; Söderquist, Pär; Clausen, Preben;

    Dabbling ducks (Anas ssp.) are cornerstone species in wetland bird communities and yet in many cases we lack sufficient data to judge the conservation status of the flyway population. In a first step to remedy this we here compile all available data on Mallard in the Nordic countries. We find...... increasing numbers of wintering Mallards and stable to increasing breeding populations. Data on breeding success is scarce but the available data show an increasing trend. In recent years the overall trend in hunting bag sizes is relatively stable even though there is some variation among countries. Thus all...... indicators suggest that the Nordic Mallard population is currently in good condition. However major knowledge gaps were identified with regard to release of hand-reared Mallards and the effect of short stopping for the trends observed locally. A detailed assessment of the effect of releases is urgently...

  15. Contrast-enhanced endoscopic ultrasonography: advance and current status

    Energy Technology Data Exchange (ETDEWEB)

    Jang, Sung Il [Dept. of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul (Korea, Republic of); Lee, Dong Ki [Dept. of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul (Korea, Republic of)

    2014-10-15

    Endoscopic ultrasonography (EUS) technology has undergone a great deal of progress along with the color and power Doppler imaging, three-dimensional imaging, electronic scanning, tissue harmonic imaging, and elastography, and one of the most important developments is the ability to acquire contrast-enhanced images. The blood flow in small vessels and the parenchymal microvasculature of the target lesion can be observed non-invasively by contrast-enhanced EUS (CE-EUS). Through a hemodynamic analysis, CE-EUS permits the diagnosis of various gastrointestinal diseases and differential diagnoses between benign and malignant tumors. Recently, mechanical innovations and the development of contrast agents have increased the use of CE-EUS in the diagnostic field, as well as for the assessment of the efficacy of therapeutic agents. The advances in and the current status of CE-EUS are discussed in this review.

  16. The current status of the Korean student health examination

    Directory of Open Access Journals (Sweden)

    Hye-Jung Shin

    2013-08-01

    Full Text Available Recent trends place an emphasis on school health care, the ultimate goal of which is to protect,maintain, and promote students’ health. School health care is a program that integrates health careservices, health education, health counseling, and local social health services. The student healthexamination (SHE system is a part of school health care and schools and communities must beavailable to provide professional health services. Pediatricians also have important roles as experts inboth school health care and the SHE system. In this article, the history of school health care, its legalbasis, and the current status of the SHE system in Korea are reviewed. Furthermore, sample surveysfrom the past few years are reviewed. Through this holistic approach, future directions are proposed forthe improvement of SHE and school health care.

  17. Current research status, databases and application of single nucleotide polymorphism.

    Science.gov (United States)

    Javed, R; Mukesh

    2010-07-01

    Single Nucleotide Polymorphisms (SNPs) are the most frequent form of DNA variation in the genome. SNPs are genetic markers which are bi-allelic in nature and grow at a very fast rate. Current genomic databases contain information on several million SNPs. More than 6 million SNPs have been identified and the information is publicly available through the efforts of the SNP Consortium and others data bases. The NCBI plays a major role in facillating the identification and cataloging of SNPs through creation and maintenance of the public SNP database (dbSNP) by the biomedical community worldwide and stimulate many areas of biological research including the identification of the genetic components of disease. In this review article, we are compiling the existing SNP databases, research status and their application. PMID:21717869

  18. Current Backpack Weight Status for Primary Schoolchildren in Colima, Mexico.

    Science.gov (United States)

    Olmedo-Buenrostro, Bertha Alicia; Delgado-Enciso, Iván; Sánchez-Ramírez, Carmen Alicia; Cruz, Sergio Adrián Montero; Vásquez, Clemente; Mora-Brambila, Ana Bertha; Rodríguez-Sánchez, Iram P; Martínez-Fierro, Margarita L

    2016-06-01

    The purpose of the study was to identify the current status of backpack weight in primary schoolchildren in Colima, Mexico, in relation to gender, school grade level, and body mass index. A cross-sectional study was conducted on 240 randomly selected children from 20 primary schools. The participating children's parents signed statements of informed consent. Descriptive statistics, the χ(2) test, Student's t-test, and Kruskal-Wallis test were used. The mean age was 8.55 ± 2 years (range: 5-12 years). Seventy-eight percent of the schoolchildren presented with a backpack overload that was greater than 10% of their body weight. No significant differences were found in relation to gender. Four out of every five schoolchildren presented with backpack overload, exposing them to a potential health problem. Education and public policy prevention strategies for this situation should be implemented in Mexico and other regions of the world with the same problem. PMID:26416767

  19. Current status of thermoluminescence studies on minerals and rocks

    International Nuclear Information System (INIS)

    The usefulness of thermoluminescence (TL) in geological studies is being increasingly recognized, as may be judged from the considerable volume of literature accumulated over the past couple of decades; besides, a number of seminars, conferences and specialists' meetings have also been held on the subject of applied TL. However, these publications lie scattered over several periodicals and conference proceedings and an interested worker finds it difficult to obtain the gist of the contributions in one place. The present authors felt a need for this and have, therefore, attempted to bring together in this Report the current status of TL research about different minerals; applications in the fields of geochronology, ore-prospecting, stratigraphic correlation, geothermometry and other useful areas are also included. (author)

  20. Running Vacuum in the Universe: current phenomenological status

    CERN Document Server

    Sola, Joan

    2016-01-01

    I review the excellent phenomenological status of a class of dynamical vacuum models in which the vacuum energy density, $\\rho_{\\Lambda}=\\rho_{\\Lambda}(H)$, as a function of the Hubble rate, evolves through its interaction with dark matter and/or through the accompanying running of the gravitational coupling $G$, including the possibility of being self-conserved with a nontrivial effective equation of state. Some of these models have been used to incorporate into a single vacuum structure the rapid stage of inflation, followed by the standard radiation and cold dark matter epochs all the way down until the dark energy era. Remarkably, the running vacuum models (RVM's) render an outstanding phenomenological description of the main cosmological data at a level that is currently challenging the concordance $\\Lambda$CDM model, thereby implying that present observations seem to point to a running vacuum rather than to a rigid cosmological constant $\\Lambda$ in our Universe.

  1. Advanced Gas Tungsten Arc Weld Surfacing Current Status and Application

    Directory of Open Access Journals (Sweden)

    Stephan Egerland

    2015-09-01

    Full Text Available Abstract Gas Shielded Tungsten Arc Welding (GTAW – a process well-known providing highest quality weld results joined though by lower performance. Gas Metal Arc Welding (GMAW is frequently chosen to increase productivity along with broadly accepted quality. Those industry segments, especially required to produce high quality corrosion resistant weld surfacing e.g. applying nickel base filler materials, are regularly in consistent demand to comply with "zero defect" criteria. In this conjunction weld performance limitations are overcome employing advanced 'hot-wire' GTAW systems. This paper, from a Welding Automation perspective, describes the technology of such devices and deals with the current status is this field – namely the application of dual-cathode hot-wire electrode GTAW cladding; considerably broadening achievable limits.

  2. Current status and future tendency of lake eutrophication in China

    Institute of Scientific and Technical Information of China (English)

    JIN; Xiangcan

    2005-01-01

    Current trophic status and trend of Chinese freshwater lakes were investigated in this study. The results showed that all lakes studied were commonly undergoing the eutrophication process, water quality decreased and lake's ecosystem is being declined. Most of the urban lakes are facing serious eutrophication. Many medium-sized lakes are in metrophic or eutrophic status, some local water are even approaching the hypertrophic level. The famous five freshwater lakes in China have entered into eutrophication in the condition of higher nutrient load. Lake Taihu, Hongze and Caohu are already in eutrophic state. Eutrophic lakes are mainly distributed in the middle and lower reaches of Yangtze River and Yungui plateau. Lake eutrophication developed rapidly. Among the 34 lakes studied in 1970's, most of lakes were in the mesotrophic status,mesotrophic water area accounted for 91.8%. With the nine year of 1978-1987 the area percentage of oligotrophic lakes decreased from 3.2% to 0.53%, and that of eutrophic lakes increased from 5.0% to 55.01%. Recent data showed 57.5% lakes were in eutrophic and hypertrophic status of the 40 surveyed lakes.Eutrophic trend of Lake Taihu, Chaohu and Xuanwu in the region of the middle and lower reaches of Yangtze River was predicated using the ecological stress model. The results showed that in 2008 Lake Taihu, Chaohu and Xuanwu might be of eutrophication, eutrophication and hypertrophication, respectively if no control measurement is taken. Provided the pollution water treatment rate is 60% in 2030, approximately 30 billion ton pollution water would still be discharged directly in the lakes. Therefore, in 2030 the urban lakes in China might be eutrophication or hypertrophication, and most of the medium-sized lakes at the urban-rural fringe might be in eutrophication or hypertrophication. The famous five biggest freshwater lakes in China might be eutrophication if control countermeasures are taken as now.Lake eutrophication has become a

  3. Current Status and Prevention Strategy for Coal-arsenic Poisoning in Guizhou, China

    Science.gov (United States)

    An, Dong; Zhou, Yunsu; Liu, Jie; Waalkes, Michael P.

    2006-01-01

    Arsenic exposure from burning coal with high arsenic contents occurs in southwest Guizhou, China. Coal in this region contains extremely high concentrations of inorganic arsenic. Arsenic exposure from coal-burning is much higher than exposure from arsenic-contaminated water in other areas of China. The current status and prevention strategies for arsenic poisoning from burning high-arsenic coal in southwest Guizhou, China, is reported here. Over 3,000 arsenic-intoxicated patients were diagnosed based on skin lesions and urinary arsenic excretion. Non-cancerous toxicities and malignancies were much more common and severe in these patients than in other arsenic-affected populations around the world. The high incidence of cancer and arsenic-related mortality in this cohort is alarming. Chelation therapy was performed but the long-term therapeutic effects are not satisfactory. The best prevention strategy is to eliminate arsenic exposure. Funds from the Chinese Government are currently available to solve this arsenic exposure problem. Strategies include the installation of vented stoves, the use of marsh gas to replace coal, health education, the improvement of nutritional status, and the use of various therapies to treat arsenic-induced skin and liver diseases. PMID:17366768

  4. Current status and prevention strategy for coal-arsenic poisoning in Guizhou, China.

    Science.gov (United States)

    Li, Dasheng; An, Dong; Zhou, Yunsu; Liu, Jie; Waalkes, Michael P

    2006-09-01

    Arsenic exposure from burning coal with high arsenic contents occurs in southwest Guizhou, China. Coal in this region contains extremely high concentrations of inorganic arsenic. Arsenic exposure from coal-burning is much higher than exposure from arsenic-contaminated water in other areas of China. The current status and prevention strategies for arsenic poisoning from burning high-arsenic coal in southwest Guizhou, China, is reported here. Over 3,000 arsenic-intoxicated patients were diagnosed based on skin lesions and urinary arsenic excretion. Non-cancerous toxicities and malignancies were much more common and severe in these patients than in other arsenic-affected populations around the world. The high incidence of cancer and arsenic-related mortality in this cohort is alarming. Chelation therapy was performed but the long-term therapeutic effects are not satisfactory. The best prevention strategy is to eliminate arsenic exposure. Funds from the Chinese Government are currently available to solve this arsenic exposure problem. Strategies include the installation of vented stoves, the use of marsh gas to replace coal, health education, the improvement of nutritional status, and the use of various therapies to treat arsenic-induced skin and liver diseases.

  5. Viewpoint on the current status of researches on sepsis

    Directory of Open Access Journals (Sweden)

    Zheng-guo WANG

    2012-11-01

    Full Text Available Sepsis is a common complication after severe trauma and burn, and also one of the main causes of death. Recently, although some new progresses were seen in antibiotic therapy, the mortality of sepsis is still on the rise, and the death rate as a result of sepsis is higher than a total of that of prostate cancer, breast cancer and AIDS. Therefore, sepsis has obviously become one of the serious ailments threatening human health. The present paper introduced the international definition of sepsis, severe sepsis and septic shock, the current researches on diagnosis and therapy, and proposed that we should not only pay attention to pathogenesis and treatment, but also to sepsis prevention in sepsis researches, and we should try to find out the breakthrough in the interaction and dynamic balance between human being and pathogenic factors. Researches on the strategies to revert strong toxicity of infectious agents to non-toxic or weak pathogenic factors, and to conduct further research concerning biological characteristics of microorganisms and mechanism of drug resistance in order to render them to lose the drug resistance ability, or to increase its sensitivity to the drugs. The above suggested approaches might form the future strategies for preventing and controlling sepsis.

  6. Status of selenium in cancer prevention

    Science.gov (United States)

    An abundance of data indicate that selenium (Se) can be antitumorigenic. Those data, mostly from controlled studies using animal tumor models and some from clinical studies in free-living people, indicate that treatment with Se in the absence of nutritional Se-deficiency, can reduce cancer risk. T...

  7. Current Research and Management of Ovarian Cancer in China

    Institute of Scientific and Technical Information of China (English)

    GUMeijiao; SHIWei

    2002-01-01

    Ovarian cancer is ne of the most lethal malignant tumors in China,represents the third most common cancer after cervical cancer and endometrial cancer,and the first leading cause of death from hynaecological cancers.Due to the lack of effective screening strategies and the absence of symptoms in early-stage of disease,over 70% of patients present at an advanced stage.Despite the advances in surgical techniques and conventional chemotheraphy,the prognosis of ovarian cancer has not been improved significantly,and indeed the long-term survival for patients with advanced disease does not exceed 20%.The aetiology of ovarian cancer temains poorly understood.In China,the major focus of research is to clarify the mechanism underlying ovarian cancer,develop more effective life-saving diagnostic and therapeutic measures,and undertake more population-based studies.This article summarizes current research,diagnosis and management of ovarian cancer in China.

  8. A Survey of the Status of Awareness of Lymphedema in Breast Cancer Patients in Busan-Gyeongnam, Korea

    OpenAIRE

    Choi, Jong Kyoung; Kim, Hui Dong; Sim, Young Joo; Kim, Ghi Chan; Kim, Dong Kyu; Yu, Byeng Chul; Park, Si-Sung; Jeong, Ho Joong

    2015-01-01

    Objective To support the establishment of lymphedema education plans and the actual practice of education by investigating the current lymphedema awareness status of Korean breast cancer patients. Methods cross-sectional population survey was conducted in 116 breast cancer patients in the Busan-Gyeongnam area. The survey included questions regarding demographic characteristics, breast cancer-related lymphedema (BCRL) risk factors, and characteristics and treatments of the disease. Some of the...

  9. Radio Astronomy in Malaysia: Current Status and Outreach Activities

    Science.gov (United States)

    Hashim, N.; Abidin, Z. Z.; Ibrahim, U. F. S. U.; Umar, R.; Hassan, M. S. R.; Rosli, Z.; Hamidi, Z. S.; Ibrahim, Z. A.

    2011-12-01

    In this paper, we will present the current status of radio astronomical research and outreach in Malaysia. We will also present a short history of our research group, which is currently the only radio astronomical facility in Malaysia. Our group is called the Radio Cosmology Research Lab and was established in 2005 by Dr Zamri Zainal Abidin and Prof Dr Zainol Abidin Ibrahim. We will discuss the future plans for this group including our keen interest in being part of a more global network of radio astronomers. We are already an active member of the South-East Asia Astronomy Network (SEAAN) and aims to have a radio astronomical facility in order to join the Global Very Long Baseline Interferometer (VLBI) as well becoming a research hub for the future Square Kilometer Array (SKA) project. We will also present some of the scientific goals of our group including providing a platform for radio astronomers to be able to do observations of weak and high red-shifted radio objects such as galaxy clusters and supernovae.

  10. IAA multilingual space dictionary, current status and future prospects

    Science.gov (United States)

    Yoshimitsu, Tetsuo; McKenna-Lawlor, Susan; Candel, Danielle; Ninomiya, Keiken; Contant, Jean-Michel

    2015-12-01

    Terminology is a key issue for a better understanding among people using various languages. Since 1986, when the International Academy of Astronautics (IAA) multilingual terminology database committee on astronautics was formed, the committee and its successor IAA study groups on the IAA multilingual space dictionary have made a continuous effort to construct a multilingual dictionary database on astronautical terms. In 2002, the dictionary was computerized using a database server and some recent internet technologies. The database is accessible from all over the world via the internet. You can search for terms at your home and office using a web browser installed on the computer with an internet connection. Since then, the number of terms and languages included in the database has increased. The current version includes about 3500 terms in 22 languages. The flexibility of the database enables the addition and the revision of new terms without much effort. The computerization has also demonstrated another possibility to utilize the database. When total of four paper books about the multilingual space terminology were published on the 50th anniversary of IAA in 2010, one of the lexicon books was edited by a computer program which accessed to the database. In this paper, the authors present the current status of the IAA multilingual database as well as the future possibilities on the utilization of the database.

  11. Current status of preoperative drainage for distal biliary obstruction

    Institute of Scientific and Technical Information of China (English)

    Harutoshi; Sugiyama; Toshio; Tsuyuguchi; Yuji; Sakai; Rintaro; Mikata; Shin; Yasui; Yuto; Watanabe; Dai; Sakamoto; Masato; Nakamura; Reina; Sasaki; Jun-ichi; Senoo; Yuko; Kusakabe; Masahiro; Hayashi; Osamu; Yokosuka

    2015-01-01

    Preoperative biliary drainage(PBD) was developed to improve obstructive jaundice, which affects a number of organs and physiological mechanisms in patients waiting for surgery. However, its role in patients who will undergo pancreaticoduodenectomy for biliary obstruction remains controversial. This article aims to review the current status of the use of preoperative drainage for distal biliary obstruction. Relevant articles published from 1980 to 2015 were identified by searching MEDLINE and Pub Med using the keywords "PBD", "pancreaticoduodenectomy", and "obstructive jaundice". Additional papers were identified by a manual search of the references from key articles. Current studies have demonstrated that PBD should not be routinely performed because of the postoperative complications. PBD should only be considered in carefully selected patients, particularly in cases where surgery had to be delayed. PBD may be needed in patients with severe jaundice, concomitant cholangitis, or severe malnutrition. The optimal method of biliary drainage has yet to be confirmed. PBD should be performed by endoscopic routes rather than by percutaneous routes to avoid metastatic tumor seeding. Endoscopic stenting or nasobiliary drainage can be selected. Although more expensive, the use of metallic stents remains a viable option to achieve effective drainage without cholangitis and reintervention.

  12. Uas for Geo-Information Current Status and Perspectives

    Science.gov (United States)

    Haarbrink, R. B.

    2011-09-01

    Recent and ongoing developments of state-of-the-art sensor technologies have resulted in smaller and lighter photogrammetric cameras with IMU, lidar scanners and other sensors that can now be integrated with and mounted on the larger Light UAS. This paper describes as an example the successful automatic flight of the 50-megapixel DigiCAM with AEROcontrol IMU developed by IGI flown on Geocopter's GC-201 unmanned helicopter system. The operational and technical requirements of UAS defined in new legislation remain however the safeguard to protect people and costly sensor payload assets. The current prospects of UAS-g face additional challenges related to end-user awareness and the return on investment. The current status of UAS legislation is given in this paper. This legislation justifies UAS-g operations of mapping coastal zones, forests, agricultural fields, and open mines. Sooner return on investment happens when the UAS legislation will be opening up airspace over urban areas (Class 2 approved UAS-g), to longer distances (BLOS operations), and to higher altitudes. UAS-g flights then become feasible to the maximum extent for cadastral mapping of larger areas, oil and gas pipeline monitoring, power line surveys, dike inspection, and highway and railway mapping.

  13. Current Status and Research into Overcoming Limitations of Capsule Endoscopy.

    Science.gov (United States)

    Kwack, Won Gun; Lim, Yun Jeong

    2016-01-01

    Endoscopic investigation has a critical role in the diagnosis and treatment of gastrointestinal (GI) diseases. Since 2001, capsule endoscopy (CE) has been available for small-bowel exploration and is under continuous development. During the past decade, CE has achieved impressive improvements in areas such as miniaturization, resolution, and battery life. As a result, CE is currently a first-line tool for the investigation of the small bowel in obscure gastrointestinal bleeding and is a useful alternative to wired enteroscopy. Nevertheless, CE still has several limitations, such as incomplete examination and limited diagnostic and therapeutic capabilities. To resolve these problems, many groups have suggested several models (e.g., controlled CO2 insufflation system, magnetic navigation system, mobile robotic platform, tagging and biopsy equipment, and targeted drug-delivery system), which are in development. In the near future, new technological advances will improve the capabilities of CE and broaden its spectrum of applications not only for the small bowel but also for the colon, stomach, and esophagus. The purpose of this review is to introduce the current status of CE and to review the ongoing development of solutions to address its limitations. PMID:26855917

  14. Current Status of Pd- Reference Electrode Development Work

    International Nuclear Information System (INIS)

    Accurate and stable in-core reference electrodes are needed in long-term corrosion potential measurements when water chemistry effects on corrosion of construction materials under radiation fields are studied. The experimental difficulties of measuring ECP inside the reactor pressure vessel are basically related to the high pressure, high temperature environments, which give significant problems connected with bringing electrochemical information across the pressure boundaries. Additionally, the sensors have to withstand exposure to high radiation and neutron flux. Currently, the most widely used in-core reference electrodes are either internal silver/silver chloride electrodes or zirconia membrane based pH sensors. A novel approach is to use a cathodically charged palladium (Pd) hydrogen electrode. This type of sensor is a suitable reference electrode for in-core corrosion potential measurements in constant pH solutions, because the potential determining components (H2,H+) are stable over the temperatures of interest and do not contaminate the measurement environment. In addition, the mechanisms of hydrogen reactions on palladium and platinum (Pt) surfaces have been extensively studied and are now reasonably well understood. A new Pd reference electrode has been tested in an out-of-core test loop in Halden. The electrode was installed into the flow through cell containing external pressure balanced silver/silver chloride reference electrodes, a high temperature conductivity sensor and a temperature probe. This report discusses the current status of the in-core Pd reference electrode development work being performed at the OECD Halden Project. (author)

  15. The current status and future perspectives of the combined chemo-radiotherapy for locoregionally advanced squamous cell head and neck cancer%局部或区域晚期头颈鳞癌放化疗联合治疗现状和展望

    Institute of Scientific and Technical Information of China (English)

    李志勇; 张艳清; 郑艳群; 朱步东

    2013-01-01

    头颈部鳞状细胞癌的全身治疗包括细胞毒药物治疗(简称化疗)、靶向治疗和支持治疗;而局部治疗主要包括放射治疗和手术。放化疗联合是局部晚期或区域晚期头颈部鳞癌主要治疗模式,包括同步化放疗、诱导化疗、序贯化放疗。本文综述了原发于口腔、口咽、下咽、喉的鳞癌的化放疗联合治疗现状和进展。%The systemic treatments of locoregionally advanced squamous cell head and neck cancer include cytotoxic therapy (referred to chemotherapy), targeted therapies and supportive care, in addition to local therapy consisted of surgery and/or radiation therapy (RT). Approaches combining chemotherapy and radiation therapy is primarily treatment modalities in patients with locoregionally advanced head and neck cancer, comprising of concurrent chemoradiotherapy, induction chemotherapy and sequential chemoradiotherapy. This article reviews the current status and progress in the combined chemo-radiotherapy approaches to patients with locoregionally advanced head and neck cancer arising in the oral cavity, oropharynx, hypopharynx, and larynx.

  16. Current Immunotherapeutic Approaches in Pancreatic Cancer

    Directory of Open Access Journals (Sweden)

    Shigeo Koido

    2011-01-01

    Full Text Available Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. Thus, new therapeutic approaches are needed. Pancreatic cancer cells that develop gemcitabine resistance would still be suitable targets for immunotherapy. Therefore, one promising treatment approach may be immunotherapy that is designed to target pancreatic-cancer-associated antigens. In this paper, we detail recent work in immunotherapy and the advances in concept of combination therapy of immunotherapy and chemotherapy. We offer our perspective on how to increase the clinical efficacy of immunotherapies for pancreatic cancer.

  17. Personal dosimetric monitoring in Ukraine: current status and further development

    International Nuclear Information System (INIS)

    Presently Ukraine has mixed system for dosimetric monitoring. Nuclear power plants and some major nuclear facilities have their own dosimetry services, which are responsible for regular dosimetric monitoring of workers. Rest of occupationally exposed persons is monitored by dosimetry laboratories affiliated to the territorial authorities for sanitary and epidemiology supervision. In 2002-2003 Ukrainian Ministry of Health performed survey of the status of dosimetric monitoring and inventory of critical groups requiring such monitoring. Dosimetry services in Ukraine cover about 38,000 occupationally exposed workers, including 9,100 medical professionals, 16,400 employees of 5 nuclear power plants and ca.12,400 workers dealing with other sources of occupational exposure (industry, research). Territorial dosimetry services operate in 13 of 24 regions of Ukraine, using DTU-01 manual TLD readers produced with one exception in 1988-1990. The coverage of critical groups by dosimetric monitoring is variable and ranges from 38% to 100% depending on the region. Personnel of nuclear power plants (about 16,400 workers) is monitored by their own dosimetry services achieving absolute coverage of the main staff and temporary workers. Current inadequate status of dosimetric monitoring infrastructure in Ukraine demands an urgent elaboration of the united state system for monitoring and recording of individual doses. The proposed plan would allows to bring dosimetry infrastructure in Ukraine to the modern state which would be compatible with existing and future European and international radiation protection networks. Unitary structure of Ukraine, strong administrative command and good communications between regions of the country are positive factors in favour of efficient implementation of the proposed plan. Deficiencies are associated with limited funding of this effort. (authors)

  18. Current status of cerebral glioma surgery in China

    Institute of Scientific and Technical Information of China (English)

    WU Jin-song; ZHANG Jie; ZHUANG Dong-xiao; YAO Cheng-jun; QIU Tian-ming; LU Jun-feng; ZHU Feng-ping; MAO Ying; ZHOU Liang-fu

    2011-01-01

    The treatment of gliomas is highly individualized.Surgery for gliomas is essentially for histological diagnosis,to alleviate mass effect,and most importantly,to favor longer survival expectancy.During the past two decades,many surgical techniques and adjuvants have been applied to glioma surgery in China,which lead to a rapid development in the field of cerebral glioma surgery.This article broadly and critically reviewed the existing studies on cerebral glioma surgery and to portrait the current status of glioma surgery in China.A literature search was conducted covering major innovative surgical techniques and adjuvants for glioma surgery in China.The following databases were searched:the Pubmed (January 1995 to date);China Knowledge Resource Integrated Database (January 1995 to date) and VIP Database for Chinese Technical Periodicals (January 1995 to date).A selection criterion was established to exclude duplicates and irrelevant studies.The outcome measures were extracted from included studies.A total of 3307 articles were initially searched.After excluded by abstracts and full texts,69 studies conducted in the mainland of China were included and went through further analysis.The philosophy of surgical strategies for cerebral gliomas in China is undergoing tremendous change.Nowadays Chinese neurosurgeons pay more attention to the postoperative neurofunctional status of the patients.The aim of the glioma surgery is not only the more extensive tumor resection but also the maximal safety of intervention.The well balance of longer overall survival and higher quality of life should be judged with respect to each individual patient.

  19. Current Immunotherapeutic Approaches in Pancreatic Cancer

    OpenAIRE

    Jianlin Gong; Shigeo Koido; Hisao Tajiri; Hideo Komita; Masaki Ito; Kan Uchiyama; Kenichi Satoh; Keisuke Nagatsuma; Hiroshi Matsudaira; Toyokazu Yukawa; Shunichi Odahara; Jimi Mitobe; Yoshihisa Namiki; Shintaro Tsukinaga; Akitaka Takahara

    2011-01-01

    Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. Thus, new therapeutic approaches are needed. Pancreatic cancer cells that develop gemcitabine resistance would still be suitable targets for immuno...

  20. Exercise after breast cancer treatment: current perspectives

    OpenAIRE

    Dieli-Conwright CM; Orozco BZ

    2015-01-01

    Christina M Dieli-Conwright, Breanna Z Orozco Division of Biokinesiology and Physical Therapy, Women's Health and Exercise Laboratory, University of Southern California, Los Angeles, CA, USA Abstract: Over the past 2 decades, great strides have been made in the field of exercise-oncology research, particularly with breast cancer. This area of research is particularly important since there are >2.8 million breast cancer survivors who are in need of an intervention that can offs...

  1. Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.

    Science.gov (United States)

    Kim, Mi-Gyeong; Kim, Dongyoon; Suh, Soo-Kyung; Park, Zewon; Choi, Min Joung; Oh, Yu-Kyoung

    2016-04-01

    Chimeric antigen receptor-modified T cells (CAR-T) have emerged as a new modality for cancer immunotherapy due to their potent efficacy against terminal cancers. CAR-Ts are reported to exert higher efficacy than monoclonal antibodies and antibody-drug conjugates, and act via mechanisms distinct from T cell receptor-engineered T cells. These cells are constructed by transducing genes encoding fusion proteins of cancer antigen-recognizing single-chain Fv linked to intracellular signaling domains of T cell receptors. CAR-Ts are classified as first-, second- and third-generation, depending on the intracellular signaling domain number of T cell receptors. This review covers the current status of CAR-T research, including basic proof-of-concept investigations at the cell and animal levels. Currently ongoing clinical trials of CAR-T worldwide are additionally discussed. Owing to the lack of existing approved products, several unresolved concerns remain with regard to safety, efficacy and manufacturing of CAR-T, as well as quality control issues. In particular, the cytokine release syndrome is the major side-effect impeding the successful development of CAR-T in clinical trials. Here, we have addressed the challenges and regulatory perspectives of CAR-T therapy. PMID:26895243

  2. [Cervical cancer screening in Switzerland - current practice and future challenges].

    Science.gov (United States)

    Untiet, Sarah; Schmidt, Nicole; Low, Nicola; Petignat, Patrick

    2013-04-01

    At the beginning of the 20th Century, cervical cancer was the leading cause of death from cancer in women. A marked decline in cervical cancer has been observed since the 1960s, in parallel with the introduction of the Papanicolau (Pap) test as a cytological screening method. Today, Pap smear screening is still the most widely used tool for cervical cancer prevention. Testing for human papillomavirus (HPV) in cervical specimens or a combination of Pap and HPV testing are also now available. In this article we compare current guidelines for cervical cancer screening in Switzerland with those in other European countries. In view of the opportunities offered by HPV testing and, since 2008, HPV vaccination, current guidelines for cervical cancer screening should be updated. Both the choice of screening tests and general organization of cervical cancer screening should be reviewed.

  3. Acute stroke magnetic resonance imaging: current status and future perspective.

    Science.gov (United States)

    Kloska, Stephan P; Wintermark, Max; Engelhorn, Tobias; Fiebach, Jochen B

    2010-03-01

    Cerebral stroke is one of the most frequent causes of permanent disability or death in the western world and a major burden in healthcare system. The major portion is caused by acute ischemia due to cerebral artery occlusion by a clot. The minority of strokes is related to intracerebral hemorrhage or other sources. To limit the permanent disability in ischemic stroke patients resulting from irreversible infarction of ischemic brain tissue, major efforts were made in the last decade. To extend the time window for thrombolysis, which is the only approved therapy, several imaging parameters in computed tomography and magnetic resonance imaging (MRI) have been investigated. However, the current guidelines neglect the fact that the portion of potentially salvageable ischemic tissue (penumbra) is not dependent on the time window but the individual collateral blood flow. Within the last years, the differentiation of infarct core and penumbra with MRI using diffusion-weighted images (DWI) and perfusion imaging (PI) with parameter maps was established. Current trials transform these technical advances to a redefined patient selection based on physiological parameters determined by MRI. This review article presents the current status of MRI for acute stroke imaging. A special focus is the ischemic stroke. In dependence on the pathophysiology of cerebral ischemia, the basic principle and diagnostic value of different MRI sequences are illustrated. MRI techniques for imaging of the main differential diagnoses of ischemic stroke are mentioned. Moreover, perspectives of MRI for imaging-based acute stroke treatment as well as monitoring of restorative stroke therapy from recent trials are discussed.

  4. 腹腔镜结直肠癌手术的应用现状与进展%Current status of and advance in laparoscopic surgery for colorectal cancer

    Institute of Scientific and Technical Information of China (English)

    郑民华

    2008-01-01

    Laparoscopic surgery for colorectal cancer has the advantages of minimal impairment of gastrointestinal and pulmonary function, less immunosuppression and shorter hospital stay, which had been appoved by evidence-based medicine. With the development of concepts and techniques of minimally invasive surgery, the combination of laparoscope and endoscope in the treatment of colorectal cancer has attracted surgeons' attention, and some conventional surgery techniques of colorectal-anal anastomosis have been adopted during laparoscopic colorectal resection, which make ultra-low anastomosis feasible. The aspects mentioned above will promote the further development of laparoscopic surgery for colorectal cancer.

  5. Current status and potential perspectives in classical radiotherapy technology

    Directory of Open Access Journals (Sweden)

    Dabić-Stanković Kata M.

    2004-01-01

    Full Text Available Introduction and potentials of classical radiotherapy After purchase of radiotherapy equipment in 2003, classic radiation therapy in Serbia will reach the highest world level. In order to define the highest standards in radiation technology, we analyzed the current status and potential perspectives of radiation therapy. Technological levels of radiotherapy in developed countries An analysis of present situation in the USA, assumed as the most developed in the world, was done. Available data, collected in the last 3 years (equipment assortment, therapy modalities, workload and manpower for 284 radiotherapy centers, out of potential 2050, were analyzed. Results were presented as crude percentage and mached to point current status. Results of analysis and discussion The analysis showed that CLINAC accelerators are the most popular (82.7%, as well as, ADAC (43.7% and Focus (CMS (27.4% systems for therapy planning. Movement towards virtual simulation is evident (59.3%, although classic ”simulation” is not fully eliminated from the radiotherapy chain. The most popular brachytherapy afterloader is Microselectron HDR (71%. About 64.4% centers use IMPAC communication/verification/record system that seems more open than Varis. All centers practice modern radiotherapy modalities and techniques (CFRT, IMRT, SRS/SRT, TBI, IORT, IVBHRT, HDR BHRT, etc.. CT and MRI availability is out of question, but PET is available in 3% of centers, however this percentage is rapidly growing. Up to 350 new patients per year are treated by one accelerator (about 35 pts. a day. Centers are relatively small and utilize 2-3 accelerators on average. Average FTE staffing norm is 4 radiation oncologists, 2-3 medical radiotherapy physicists, about 3 certified medical dosimetrists and about 6 radiotherapy technologists. Technological aspects and conclusion In the past 5 years relative stagnation in classic radiotherapy has been observed. In spite of substantial investments in

  6. Relaxation: its effect on the nutritional status and performance status of clients with cancer.

    Science.gov (United States)

    Campbell, D F; Dixon, J K; Sanderford, L D; Denicola, M A

    1984-02-01

    Relaxation was used to promote normal food consumption patterns among persons with cancer. As part of a larger study, 22 persons with cancer were randomly assigned to receive instruction and reinforcement in a relaxation technique to be used preprandially. The relaxation procedure included four components: (a) deep abdominal breathing, (b) tensing and relaxing of various body parts, (c) relaxation by autosuggestion, and (d) voluntary image control. Twelve clients complied with relaxation instructions in part, and 10 did not. Among compliers, 75% experienced desirable weight change over a six-week period. Performance status, measured by the Karnofsky scale, improved for 33% and worsened for 17% over eight weeks. Research has shown relaxation to be an effective measure in relation to pain, hypertension, and other conditions. These preliminary results now suggest that relaxation may also be effective in treating the eating problems of the person with cancer, leading to improvement in weight and performance status.

  7. Nutritional status of cancer patients given different treatment modalities.

    Science.gov (United States)

    Usharani, K; Roy, R K; Vijayalakshmi; Prakash, Jamuna

    2004-08-01

    The nutritional status of 91 cancer patients was assessed at the time of diagnosis and follow-up assessments were carried out at the third and sixth week after initiating different treatment modalities to study the effect of type and duration of treatment on nutritional status. Parameters assessed were anthropometry, biochemical status and clinical signs and symptoms of nutritional deficiencies. Treatment modalities studied were radiotherapy, chemotherapy, chemotherapy+radiotherapy, and combined treatment modality (surgery+radiotherapy+chemotherapy). The nutritional status of male patients was affected most by chemotherapy+radiotherapy while females were affected most with radiotherapy. Biochemical parameters showed a marginal decline in total serum protein and serum albumin concentrations. Haemoglobin concentrations declined substantially with radiotherapy and chemotherapy. The lymphocyte count decreased substantially irrespective of the treatment modality. Clinical examination revealed increased incidences of deficiency signs and symptoms in all patients during follow-up irrespective of treatment modality.

  8. Current Status of the DPOSS Effort at Caltech

    Science.gov (United States)

    Odewahn, S. C.

    1998-05-01

    We discuss the current status of a three-color survey of fields of the digitized Second Palomar Observatory Sky Survey (DPOSS). Eventually, the DPOSS catalogs will be released to the astronomical community. The final catalog will contain an estimated minimum of 50,000,000 (50 million) galaxies, and over 2,000,000,000 (2 billion) stars, down to the equivalent blue limiting magnitude of 22., and with star-galaxy classifications accurate to 90% or better down to the equivalent blue magnitude of 21. An important addition is a program to collect extensive CCD calibration data in the Gunn gri system with the Palomar 60". This represents a considerable advance over other, currently existing optical sky surveys based on large-format photographic plates. A great variety of scientific projects should become possible using this major data set, including the following: studies of galaxy clustering and of the large-scale structure in the low-redshift universe, as tests of structure formation models; galaxy counts at moderate depth, as a function of magnitudes, colors, and morphology, to be used in tests of galaxy evolution over the past few Gigayears; a search for high redshift (z > 4) quasars, and active galactic nuclei at lower redshifts; mass optical identifications of radio, IR, and x-ray sources; generation of objectively defined catalogs of clusters and groups of galaxies; a search for previously unknown sparse globular clusters and dwarf spheroidal galaxies; cataloging of low surface brightness galaxies; a search for objects with peculiar colors or variability; and many others. In particular, we review efforts to perform automatic galaxy classification using artificial neural network image classifiers. This powerful technique is used to map a multivariate photometric parameter space to the revised Hubble system of galaxy classification. We present a new morphological classification approach using Fourier image models to identify barred and ringed spiral systems.

  9. CURRENT STATUS, CHALLENGES AND OPPORTUNITIES OF RABBIT PRODUCTION IN BOTSWANA

    Directory of Open Access Journals (Sweden)

    J.C. MOREKI

    2012-03-01

    Full Text Available This review highlights the current status of rabbit production, challenges facing the industry and opportunities available. Rabbit farming in Botswana is in its infancy and the rabbit population is estimated to be less than 1000. However, this value is a gross underestimate due to poor monitoring by government extension services. In Botswana, rabbits are mainly kept in the backyards, indicating that intensive systems have not yet been developed. Rabbits have small body size, short gestation period, high reproductive potential, rapid growth rate and ability to utilize forages. Compared to beef, chicken, mutton, chevon and chicken, rabbit meat has low cholesterol, high protein and low fat contents. Rabbit production can be integrated into small farming systems, with the rabbits being fed on crop residues, weeds, poultry droppings, and kitchen and garden wastes. The manure can be used to fertilize soils. The major challenges in rabbit production are inadequacy of breeding stock, inadequate rabbit feeds, poor management (feeding, housing and health care, lack of research support, lack of technical support from extension services, lack of access to credit and inadequate supply of equipment. The major opportunity available to the rearers is that the market is vast due to the small rabbit population in the country. The attributes of rabbits suggest that rabbit farming is likely to play an important role in nutrition, poverty alleviation and food security, especially in countries with higher unemployment levels and HIV/AIDS prevalence rates such as Botswana.

  10. The JT-60SA Cryoplant Current Design Status

    Science.gov (United States)

    Henry, D.; Michel, F.; Roussel, P.; Reynaud, P.; Journeaux, J. Y.; Maréchal, J. L.; Balaguer, D.; Roux, C.; Matsukawa, M.; Yoshida, K.

    2008-03-01

    In the framework of the ITER Broader Approach, CEA is carrying out the procurement of the Cryogenic System to the JA-EU Satellite Tokamak JT-60SA, which should be operated in Japan at JAEA, Naka in 2014. According to the Conceptual Design Report, JT-60SA is to operate for periods of at least 6 months per year, with major shutdown periods in between for maintenance and further installation upgrades. For this operation scenario, the cryoplant and the cryodistribution have to cope with different heat loads which depend on the different JT-60SA operating states. The cryoplant consists of one 4.5 K refrigerator and one 80 K helium loop, each pre-cooled by LN2. These cryogenic subsystems have to operate simultaneously in order to remove the heat loads from the superconducting magnets, 80 K shields and the divertor cryopumps. The first part of this study is based on the Process Flow Diagram (PFD) and presents the current design status of the JT-60SA cryogenic system. The second part is dedicated to the analysis of the cryoplant normal operation modes including the regeneration mode of the divertor cryopumps. Thanks to this analysis, the architecture of the present PFD is proposed in order to match the technical specifications of the cryoplant with the JT-60SA operation requirements.

  11. Current status of animal welfare and animal rights in China.

    Science.gov (United States)

    Lu, Jiaqi; Bayne, Kathryn; Wang, Jianfei

    2013-11-01

    In the past few years, new social passions have sparked on the Chinese mainland. At the centre of these burgeoning passions is a focus on animal welfare, animal treatment, and even animal rights, by the public and academic sectors. With China's rapid economic changes and greater access to information from around the world, societal awareness of animal issues is rising very fast. Hastening this paradigm shift were several highly public incidents involving animal cruelty, including exposés on bear bile harvesting for traditional Chinese medicine, the thousands of dogs rescued from China's meat trade, and the call to boycott shark fin soup and bird nest soup. This article outlines the current status of campaigning by animal advocates in China (specifically the animal rights movement) from three interlinked perspectives: wildlife conservation, companion animal protection, and laboratory animal protection. By reviewing this campaigning, we attempt to present not only the political and social impact of the concept of animal rights, but also the perceptions of, and challenges to, animal rights activities in China.

  12. Medical telerobotic systems: current status and future trends.

    Science.gov (United States)

    Avgousti, Sotiris; Christoforou, Eftychios G; Panayides, Andreas S; Voskarides, Sotos; Novales, Cyril; Nouaille, Laurence; Pattichis, Constantinos S; Vieyres, Pierre

    2016-01-01

    Teleoperated medical robotic systems allow procedures such as surgeries, treatments, and diagnoses to be conducted across short or long distances while utilizing wired and/or wireless communication networks. This study presents a systematic review of the relevant literature between the years 2004 and 2015, focusing on medical teleoperated robotic systems which have witnessed tremendous growth over the examined period. A thorough insight of telerobotics systems discussing design concepts, enabling technologies (namely robotic manipulation, telecommunications, and vision systems), and potential applications in clinical practice is provided, while existing limitations and future trends are also highlighted. A representative paradigm of the short-distance case is the da Vinci Surgical System which is described in order to highlight relevant issues. The long-distance telerobotics concept is exemplified through a case study on diagnostic ultrasound scanning. Moreover, the present review provides a classification into short- and long-distance telerobotic systems, depending on the distance from which they are operated. Telerobotic systems are further categorized with respect to their application field. For the reviewed systems are also examined their engineering characteristics and the employed robotics technology. The current status of the field, its significance, the potential, as well as the challenges that lie ahead are thoroughly discussed. PMID:27520552

  13. Management of reprocessed uranium. Current status and future prospects

    International Nuclear Information System (INIS)

    There is worldwide interest in developing advanced and innovative technologies for nuclear fuel cycles, minimizing waste and environmental impacts. As of the beginning of 2003, about 171000 tonnes heavy metal spent nuclear fuel is in storage, while smaller amounts have been reprocessed. In several countries, including France, India, Japan and the Russian Federation, spent fuel has been viewed as a national energy resource. Some countries hold reprocessed uranium as the result of their commercial reprocessing service contracts for reprocessing the spent fuel of others. Reprocessed uranium has a potential value for recycling either directly or after appropriate treatment. This report analyses the existing options, approaches and developments in the management of reprocessed uranium. It includes the technical issues involved in managing reprocessed uranium which are RepU arisings, storage, chemical conversion, re-enrichment, fuel fabrication, transport, reactor irradiation, subsequent reprocessing and disposal options, as well as assessment of holistic environmental impacts. The objective of this document is to overview the information on the current status and future trends in the management of RepU and to identify major issues to be considered for future projects

  14. Solar Power – Current Status, Challenges and Policies in India

    Directory of Open Access Journals (Sweden)

    Rachit S

    2016-06-01

    Full Text Available The demand for energy is growing day by day in the whole world. The Conventional energy sources like coal and petroleum are limited. Renewable energy resources will play an important role in the future. India is situated in sunny belt India is endowed with vast solar energy potential. Government of India had launched Jawaharlal Nehru National Solar Mission (JNNSM in 2009. The target was to start Grid connected Solar Projects of 20 GW by 2022. In May 2015 government increases the target to 100 GW by 2022. This paper provides an overview on solar energy in India. It reviews the current status of solar energy in terms of existing capacity, along with historical trends of solar energy. The paper also focuses on the technical and economical barriers and challenges for development and utilization of solar energy technology. The paper reviews existing government act and regulatory policies to support solar energy development in India. Indicating how these policies are helping in achieving their goals. Finally, a review based on of the future target of solarenergy supply has been presented.

  15. Current status and future trends of medical physics in Mexico

    Science.gov (United States)

    Azorin Nieto, J.

    2015-01-01

    Medical Physics is an area that applies the principles of physics to medicine, particularly in the prevention, diagnosis and treatment of diseases using ionizing and nonionizing radiation. The main attractive of medical physics is that it has a direct impact on the quality and safety of medical care in humans; this social component with direct implications for the population is of high value for Mexico. This paper describes the concepts of medical physics, trends and the current status of this discipline as a profession, which is directly related to the efforts of clinical research. It is also described what is, in my opinion, the future of medical physics in Mexico, emphasizing the fact that this field requires a substantial boost from universities and hospitals to recruit highly qualified young medical physicists and the support from government agencies such as Secretaria de Salud, Instituto Mexicano del Seguro Social and Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado through clinical research projects that allow the necessary evolution of medical physics into the hospital setting.

  16. Current status and scientific capabilities of the Rosetta lander payload

    Science.gov (United States)

    Biele, J.; Ulamec, S.; Feuerbacher, B.; Rosenbauer, H.; Mugnuolo, R.; Moura, D.; Bibring, J. P.

    ESA's cornerstone mission "ROSETTA" to comet 46P/Wirtanen will bring a 100 kg Lander (provided by an international European consortium) with a scientific payload of about 27 kg to the surface of the comet's nucleus. After a first scientific sequence it will operate for a considerable fraction of the cometary orbit around the sun (between 3 AU and 2 AU). The Lander is an autonomous spacecraft, powered with solar cells and using the ROSETTA Orbiter as a telemetry relais to Earth. The main scientific objectives are the in-situ investigation of the chemical, elemental, isotopic and mineralogical composition of the comet, study of the physical properties of the surface material, analyze the internal structure of the nucleus, observe temporal variations (day/night cycle, approach to sun), study the relationship between the comet and the interplanetary matter and provide ground reference data for Orbiter instruments. Ten experiments with a number of sub-experiments are foreseen to fulfil these objectives. In this paper we present the current status of the instrumental development and the scientific capabilities of each of the experiments.

  17. Collagen Cross-Linking: Current Status and Future Directions

    Directory of Open Access Journals (Sweden)

    Marine Hovakimyan

    2012-01-01

    Full Text Available Collagen cross-linking (CXL using UVA light and riboflavin (vitamin B2 was introduced as a clinical application to stabilize the cornea by inducing cross-links within and between collagen fibers. CXL has been investigated extensively and has been shown clinically to arrest the progression of keratoconic or post-LASIK ectasia. With its minimal cost, simplicity, and proven positive clinical outcome, CXL can be regarded as a useful approach to reduce the number of penetrating keratoplasties performed. Small case series have also indicated that CXL is beneficial in corneal edema by reducing stromal swelling behavior and in keratitis by inhibiting pathogen growth. Despite these encouraging results, CXL remains a relatively new method that is potentially associated with complications. Aspects such as side effects and recurrence rates have still to be elucidated. In light of the growing interest in CXL, our paper summarizes present knowledge about this promising approach. We have intentionally endeavored to include the more relevant studies from the recent literature to provide an overview of the current status of CXL.

  18. High-density matter: current status and future challenges

    Directory of Open Access Journals (Sweden)

    Stone J. R.

    2015-01-01

    Full Text Available There are many fascinating processes in the Universe which we observe in more and more in detail thanks to increasingly sophisticated technology. One of the most interesting phenomena is the life cycle of stars, their birth, evolution and death. If the stars are massive enough, they end their lives in the core-collapse supernova explosion, the one of the most violent events in the Universe. As the result, the densest objects in the Universe, neutron stars and/or black holes are created. Naturally, the physical basis of these events should be understood in line with observation. The current status of our knowledge of processes in the life of stars is far from adequate for their true understanding. We show that although many models have been constructed their detailed ability to describe observations is limited or non-existent. Furthermore the general failure of all models means that we cannot tell which are heading in the right direction. A possible way forward in modeling of high-density matter is outlined, exemplified by the quark-meson-coupling model (QMC. This model has a natural explanation for the saturation of nuclear forces and depends on very few adjustable parameters, strongly constrained by the underlying physics. Latest QMC results for compact objects and finite nuclei are presented.

  19. High-density matter: current status and future challenges

    Science.gov (United States)

    Stone, J. R.

    2015-05-01

    There are many fascinating processes in the Universe which we observe in more and more in detail thanks to increasingly sophisticated technology. One of the most interesting phenomena is the life cycle of stars, their birth, evolution and death. If the stars are massive enough, they end their lives in the core-collapse supernova explosion, the one of the most violent events in the Universe. As the result, the densest objects in the Universe, neutron stars and/or black holes are created. Naturally, the physical basis of these events should be understood in line with observation. The current status of our knowledge of processes in the life of stars is far from adequate for their true understanding. We show that although many models have been constructed their detailed ability to describe observations is limited or non-existent. Furthermore the general failure of all models means that we cannot tell which are heading in the right direction. A possible way forward in modeling of high-density matter is outlined, exemplified by the quark-meson-coupling model (QMC). This model has a natural explanation for the saturation of nuclear forces and depends on very few adjustable parameters, strongly constrained by the underlying physics. Latest QMC results for compact objects and finite nuclei are presented.

  20. Current Status of Carl Sagan Observatory in Mexico

    Science.gov (United States)

    Sanchez-Ibarra, A.

    The current status of Observatory "Carl Sagan" (OCS) of University of Sonora is presented. This project was born in 1996 focused to build a small solar-stellar observatory completely operated by remote control. The observatory will be at "Cerro Azul", a 2480 m peak in one of the best regions in the world for astronomical observation, at the Sonora-Arizona desert. The OCS, with three 16 cm solar telescopes and a 55 cm stellar telescope is one of the cheapest observatories, valuated in US200,000 Added to its scientific goals to study solar coronal holes and Supernovae Type 1A, the OCS has a strong educative and cultural program in Astronomy to all levels. At the end of 2001, we started the Program "Constelacion", to build small planetariums through all the countries with a cost of only US80,000. Also, the webcast system for transmission of the solar observations from the prototype OCS at the campus, was expanded to webcast educational programs in Astronomy since July of this year, including courses and diplomats for Latin American people. All of these advances are exposed here.

  1. Current status and prospects for development of thermometry

    International Nuclear Information System (INIS)

    The paper deals with results of an analysis carried out at the VNIIM with the purpose to ascertain the current status of thermometry as well as to make an attempt to determine a line of development of this field of measurements in future. The analysis was based on a survey of 150 industrial enterprises and scientific organizations. The results of the survey showed that during two last decades the accuracy of measuring instruments used in science and industry was increased almost tenfold. However, advances in the improvement of temperature measuring instruments were achieved not owing to new principles of designing thermometers, but due to rapid development of electronics, which allowed to solve the problem of accurate measurements of resistance and electromotive force and automatize measurement information processing. In most cases the contemporary measuring instruments perfectly meet the requirements to the measurement accuracy claimed by the enterprises surveyed and are provided with a necessary metrological assurance. Although there is a general understanding of the necessity to use the thermodynamic scale rather than the conditional one, we have no objective evidence with regard to how close we have to bring the international scale used in our everyday practice to the thermodynamic scale and what will be a benefit for development of science and industry. Increasing the accuracy of national standards does not affect, as a rule, the accuracy of temperature measurements in industry and scientific research since the main contribution to a total measurement error is made by components caused by an improper measurement procedure

  2. The current status of radiological protection infraestructures in Tanzania

    International Nuclear Information System (INIS)

    Without adequate and sustainable radiation protection infrastructure, the benefits associated with safe use of nuclear technology and atomic energy might be jeopardized. In the United Republic of Tanzania, the Atomic Energy Act No. 7 of 2003 established the Tanzania Atomic Energy Commission as sole regulatory body responsible for regulating and controlling the safe and peaceful utilization of nuclear technology in the country. The Atomic Energy (Protection from ionizing radiation) Regulations, 2004 further specifies practices designed to ensure that unnecessary exposure of persons to ionizing radiation is avoided, that all exposures are kept as low as reasonably achievable and that all the dose limits specified in the radiation protection standards are not exceeded. This is achieved through the systems of notification, authorizations through registration and licensing, safety and security of radiation sources as well as regulatory inspections and enforcements. These activities are performed by the Commission with operational funds allocated by the Government of Tanzania. The Commission further provides other services namely individual monitoring; calibration services; education and training to radiation workers, public as well as law enforcers; and safe management of radioactive waste. Despite such achievement, still there are a lot to be done in order to strengthen the radiation protection infrastructure in Tanzania. These include issues such as gaps in our legislations, regulations and guidance, security of sources, enforcement of laws, etc. This paper describes and discusses the current status of the regulatory control activities and radiation protection services provided by the Commission and suggestions for further improvement of radiological protection infrastructure in Tanzania. (author)

  3. The Current Status and Future Prospects for the GRACE Mission

    Science.gov (United States)

    Tapley, Byron; Flechtner, Frank; Watkins, Michael; Bettadpur, Srinivas; Boening, Carmen

    2016-04-01

    The twin satellites of the Gravity Recovery and Climate Experiment (GRACE) were launched on March 17, 2002 and have operated for over 13 years. The mission objectives are to sense the spatial and temporal variations of the Earth's mass through its effects on the gravity field at the GRACE satellite altitude. The major cause of the time varying mass is water motion and the GRACE mission has provided a continuous decade long measurement sequences which characterizes the seasonal cycle of mass transport between the oceans, land, cryosphere and atmosphere; its inter-annual variability; and the climate driven secular, or long period, mass transport signals. In 2012, the RLO5 solution, based on a complete reanalysis of the mission data, data release, was initiated. The monthly solutions from this effort were released in mid-2013 with the mean fields following in 2014 and 2015. The mission is entering the final phases of operations. The current mission operations strategy emphasizes extending the mission lifetime to achieve mission overlap with the GRACE Follow On Mission. This presentation will review the mission status and the projections for mission lifetime, summarize plans for the RL 06 data re-analysis, describe the issues that influence the operations philosophy and discuss the impact the operations may have on the scientific data products.

  4. Computational modeling of cardiac hemodynamics: Current status and future outlook

    Science.gov (United States)

    Mittal, Rajat; Seo, Jung Hee; Vedula, Vijay; Choi, Young J.; Liu, Hang; Huang, H. Howie; Jain, Saurabh; Younes, Laurent; Abraham, Theodore; George, Richard T.

    2016-01-01

    The proliferation of four-dimensional imaging technologies, increasing computational speeds, improved simulation algorithms, and the widespread availability of powerful computing platforms is enabling simulations of cardiac hemodynamics with unprecedented speed and fidelity. Since cardiovascular disease is intimately linked to cardiovascular hemodynamics, accurate assessment of the patient's hemodynamic state is critical for the diagnosis and treatment of heart disease. Unfortunately, while a variety of invasive and non-invasive approaches for measuring cardiac hemodynamics are in widespread use, they still only provide an incomplete picture of the hemodynamic state of a patient. In this context, computational modeling of cardiac hemodynamics presents as a powerful non-invasive modality that can fill this information gap, and significantly impact the diagnosis as well as the treatment of cardiac disease. This article reviews the current status of this field as well as the emerging trends and challenges in cardiovascular health, computing, modeling and simulation and that are expected to play a key role in its future development. Some recent advances in modeling and simulations of cardiac flow are described by using examples from our own work as well as the research of other groups.

  5. Current status and future trends of medical physics in Mexico

    International Nuclear Information System (INIS)

    Medical Physics is an area that applies the principles of physics to medicine, particularly in the prevention, diagnosis and treatment of diseases using ionizing and nonionizing radiation. The main attractive of medical physics is that it has a direct impact on the quality and safety of medical care in humans; this social component with direct implications for the population is of high value for Mexico. This paper describes the concepts of medical physics, trends and the current status of this discipline as a profession, which is directly related to the efforts of clinical research. It is also described what is, in my opinion, the future of medical physics in Mexico, emphasizing the fact that this field requires a substantial boost from universities and hospitals to recruit highly qualified young medical physicists and the support from government agencies such as Secretaria de Salud, Instituto Mexicano del Seguro Social and Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado through clinical research projects that allow the necessary evolution of medical physics into the hospital setting

  6. Bonded permanent magnets: Current status and future opportunities (invited)

    Science.gov (United States)

    Ormerod, John; Constantinides, Steve

    1997-04-01

    Permanent magnets play a vital role in modern society as a component in a wide range of devices utilized by many industries and consumers. In 1995, the world production of permanent magnets was estimated to be valued at 3.6 billion and growing at an annual rate of 12%. Bonded permanent magnets are the fastest growing segment of this market. Bonded magnet technology enables a wide variety of magnetic powders to be combined with several polymer and binder systems to produce magnetic components utilizing several processing options. In this article, we review the development of bonded magnet technology. The major classes of magnetic powders, binder systems, and processing technologies are described. Recent developments in magnetic material grades, e.g., anisotropic NdFeB, rare earth lean NdFeB, SmFe(N,C) are outlined. The current status of processing and binder options aimed at increasing the upper application temperature limit of these materials is highlighted. Finally, the improvements and future opportunities for bonded magnets are discussed.

  7. The current status of percutaneous vertebroplasty in Canada

    Energy Technology Data Exchange (ETDEWEB)

    Heffernan, E.J.; O' Sullivan, P.J.; Alkubaidan, F.O.; Heran, M.K.S.; Legiehn, G.M.; Munk, P.L. [Dept. of Radiology, Vancouver General Hospital, Univ. of British Columbia, Vancouver, British Columbia (Canada)], E-mail: ejheffernan@eircom.net

    2008-04-15

    To provide an overview of the current status of percutaneous vertebroplasty (PVP) practice in Canada, including the preprocedure work up operative technique and follow-up practice of physicians performing the procedure in this county. Questionnaires were emailed to 31 institutions performing percutaneous vertebroplasty across Canada. Twenty-three (74.2%) completed surveys were returned, representing data from 1,516 vertebroplasties performed by 66 radiologists and surgeons. Preoperative routine imaging and screening practice varies widely. The majority of respondents perform PVP under conscious sedation; however, an anaesthetist is present in only 22% of institutions. Biplane fluoroscopy is used in 43.5% of practices. The preference for unipedicular or bipedicular injection varies: in 7 institutions, a unipedicular approach is used in at least 80% of cases. Patients receive a follow-up by the screening physician in 65.2% of institutions. There were 4 complications requiring treatment. Venous and intradiscal extravasation rates were 20.8% and 25.3%, respectively; however, the vast majority of these were clinically insignificant. PVP complication rates reported in our Canadian survey compare favourably with those in the published literature. The number of PVPs performed annually in the institutions surveyed appears small, relative to the figures from the United States. The prevalence of osteoporosis and incidence of vertebral compression fractures in Canada is increasing as the population ages, and demand for PVP is likely to rise significantly in the coming years. (author)

  8. Current Status of Manufacturing Hazardous Waste in Shanghai

    Institute of Scientific and Technical Information of China (English)

    Liu Changqing; Zhang Jiangshan; Zhao Youcai

    2007-01-01

    It is difficult to manage the manufacturing hazardous waste(MHW)whichis generated from a huge amount of complicated sources and causes very serious pollution.Therefore more and more attention has been paid to MHW pollution.shanghai,as an industrial and economic center and an intemational metropolis in China,has a vast industrial system spanning a multitude of sectors,which generates MHW not only in a huge magnitude but also in a large variety of types from complicated sourrces,resulting in severe pollution.In 2003,the production of MHW in Shanghai is about 3.96 x 10ton,involving 33 indices.Most of MHW in Shanghai is treated and disposed of,but a significant portion is not handled properly and effectively.This paper carries out in-field investigation on the current status of MHW production and treat ment in Shanghai,and puts forward scientific proposals that Shanghai should facilitate cleaner production and minimize haz ardous waste;strictly enforce hazardous waste registration system, strengthen monitoring the certified enterprises;strengthen intent disposal center construction and realize hazardous waste reclamation;accelerate establishing tlle technical criteria and the management policy,promote the research and development on the treatment and disposal technology,and strengthen information management,thus realizing integrated management on MHW pollution.

  9. Thorium-based nuclear fuel: current status and perspectives

    International Nuclear Information System (INIS)

    Until the present time considerable efforts have already been made in the area of fabrication, utilization and reprocessing of Th-based fuels for different types of reactors, namely: by FRG and USA - for HTRs; FRG and Brazil, Italy - for LWRs; India - for HWRs and FBRs. Basic research of thorium fuels and thorium fuel cycles are also being undertaken by Australia, Canada, China, France, FRG, Romania, USSR and other countries. Main emphasis has been given to the utilization of thorium fuels in once-through nuclear fuel cycles, but in some projects closed thorium-uranium or thorium-plutonium fuel cycles are also considered. The purpose of the Technical Committee on the Utilization of Thorium-Based Nuclear Fuel: Current Status and Perspective was to review the world thorium resources, incentives for further exploration, obtained experience in the utilization of Th-based fuels in different types of reactors, basic research, fabrication and reprocessing of Th-based fuels. As a result of the panel discussion the recommendations on future Agency activities and list of major worldwide activities in the area of Th-based fuel were developed. A separate abstract was prepared for each of the 9 papers in this proceedings series

  10. Neuroendoscopy in Kuwait: Evolution, Current Status, and Future Directions.

    Science.gov (United States)

    Azab, Waleed A; Abdelrahman, Ahmed Y; Alsheikh, Tarik M; Najibullah, Mostafa M

    2016-08-01

    An overview of the development of neuroendoscopy at the neurosurgery department, Ibn Sina Hospital in Kuwait, is presented with an outline of difficulties and obstacles faced by the field until it reached its current status. The factors and solutions that helped us overcome these problems are also elaborated on. After a modest beginning few years ago, endoscopic skull base procedures, intraventricular neuroendoscopy, and spinal endoscopy are regularly performed in the department. Although neuroendoscopy is not per se a neurosurgical subspecialty, it is an area that requires special training. Achieving an appropriate level of care necessitates these highly trained neurosurgeons to collaborate together and with other specialties to create teamsgeared towards offering such treatment options topatients. Importantly, a multitude of essential facilities should be available to make such a pattern of practice possible. In our experience, this was made possible through continued efforts that have finally paid off and gradually led to a complete shift of the face of neuroendoscopic practice in our department. Our future endeavors aim at further development of neuroendoscopy in the department to create a center of excellence. PMID:27188640

  11. Plague in Iran: its history and current status

    Science.gov (United States)

    2016-01-01

    OBJECTIVES: Plague remains a public health concern worldwide, particularly in old foci. Multiple epidemics of this disease have been recorded throughout the history of Iran. Despite the long-standing history of human plague in Iran, it remains difficult to obtain an accurate overview of the history and current status of plague in Iran. METHODS: In this review, available data and reports on cases and outbreaks of human plague in the past and present in Iran and in neighboring countries were collected, and information was compiled regarding when, where, and how many cases occurred. RESULTS: This paper considers the history of plague in Persia (the predecessor of today’s Iran) and has a brief review of plague in countries in the World Health Organization Eastern Mediterranean Region, including a range of countries in the Middle East and North Africa. CONCLUSIONS: Since Iran has experienced outbreaks of plague for several centuries, neighboring countries have reported the disease in recent years, the disease can be silent for decades, and the circulation of Yersinia pestis has been reported among rodents and dogs in western Iran, more attention should be paid to disease monitoring in areas with previously reported human cases and in high-risk regions with previous epizootic and enzootic activity. PMID:27457063

  12. Pig islets for islet xenotransplantation: current status and future perspectives

    Institute of Scientific and Technical Information of China (English)

    Hu Qinghua; Liu Zhongwei; Zhu Haitao

    2014-01-01

    Objective To review the current status and progress on pig islet xenotransplantation.Data sources Data used in this review were mainly from English literature of Pubmed database.The search terms were "pig islet" and "xenotransplantation".Study selection The original articles and critical reviews selected were relevant to this review's theme.Results Pigs are suggested to be an ideal candidate for obtaining available islet cells for transplantation.However,the potential clinical application of pig islet is still facing challenges including inadequate yield of high-quality functional islets and xenorejection of the transplants.The former can be overcome mainly by selection of a suitable pathogen-free source herd and the development of isolation and purification technology.While the feasibility of successful preclinical pig islet xenotranplantation provides insights in the possible mechanisms of xenogeneic immune recognition and rejection to overwhelm the latter.In addition,the achievement of long-term insulin independence in diabetic models by means of distinct islet products and novel immunotherapeutic strategies is promising.Conclusions Pig islet xenotransplantation is one of the prospective treatments to bridge the gap between the needs of transplantation in patients with diabetes and available islet cells.Nonetheless,further studies and efforts are needed to translate obtained findings into tangible applications.

  13. Neural synchrony in cortical networks: history, concept and current status

    Directory of Open Access Journals (Sweden)

    Peter Uhlhaas

    2009-07-01

    Full Text Available Following the discovery of context-dependent synchronization of oscillatory neuronal responses in the visual system, the role of neural synchrony in cortical networks has been expanded to provide a general mechanism for the coordination of distributed neural activity patterns. In the current paper, we present an update of the status of this hypothesis through summarizing recent results from our laboratory that suggest important new insights regarding the mechanisms, function and relevance of this phenomenon. In the first part, we present recent results derived from animal experiments and mathematical simulations that provide novel explanations and mechanisms for zero and nero-zero phase lag synchronization. In the second part, we shall discuss the role of neural synchrony for expectancy during perceptual organization and its role in conscious experience. This will be followed by evidence that indicates that in addition to supporting conscious cognition, neural synchrony is abnormal in major brain disorders, such as schizophrenia and autism spectrum disorders. We conclude this paper with suggestions for further research as well as with critical issues that need to be addressed in future studies.

  14. Chinese Soybean Industry:Current Status and Outlook

    Institute of Scientific and Technical Information of China (English)

    DachuanLiu; ShaojunTian

    2002-01-01

    This paper focus on the soybean resources and their industry development in China.Due to the high demand in domestic market,it is necessary to expand the cultivation area and improve the production yields.Meanwhile,to increase the export of soybeans from overseas is also important.China has a long history in producing traditional soybean foods.After recent fifty years,the development of Chinese soybean industry has reached to a reasonable level.The current status of Chinese soybean industry has been included in the paper.It has been expected that in next five years,there will be a rapid increase in the processing of soybeans;it will become more reasonable in the scale and distribution of soybean oil factories.Emphasis will be put on the improvement of the functionalities of soybean products.Different kinds of functional soybean foods,especially the soybean proteins for particular uses will be developed by the use of modification technologies.Concern is also given to the multi-utilization of soybean resources,which not only covers the extraction of oil from soybean seeds and the processing of protein products from the meal;but also includes the recovery of the natural phyto-chemicals from soybeans which could then be exploited to novel products with more profits.

  15. An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.

    Science.gov (United States)

    Sun, Lei; Quan, Xiao-Qing; Yu, Shiying

    2015-01-01

    Recently, an international consensus diagnostic criterion for cancer cachexia was proposed. The aim of the study is to assess the prevalence of cachexia in patients with advanced cancer and to assess the current status of the diagnosis and management of cancer cachexia. A total of 390 patients with advanced cancer were included. There were 140 patients with cachexia and the prevalence was 35.9%. The prevalence was highest in pancreatic cancer (88.9%), followed by gastric cancer (76.5%) and esophageal cancer (52.9%). Sixty-three patients with cancer cachexia have CT scans available for muscle mass evaluation and 98.4% were sarcopenic. Cachectic patients have a significantly lower overall quality of life and a higher symptom burden. According to oncology physicians, only 33 patients were considered to have cancer cachexia. The false negative rate amounted to 76.4%. The positive rate was related to the body mass index and Eastern Cooperative Oncology Group performance status of the patients. There were few types of pharmacological approaches for cancer cachexia and more than half of cachectic patients did not receive any anticachexia treatment. These results indicate that the prevalence of cachexia in advanced cancer patients was high. However, cancer cachexia was rarely recognized and clinical management for cancer cachexia was very inadequate. PMID:26317149

  16. Current management of locally recurrent rectal cancer

    DEFF Research Database (Denmark)

    Nielsen, Mette Bak; Laurberg, Søren; Holm, Thorbjörn

    2011-01-01

    ABSTRACT Objective: A review of the literature was undertaken to provide an overview of the surgical management of locally recurrent rectal cancer (LRRC) after the introduction of total mesorectal excision (TME). Method: A systematic literature search was undertaken using PubMed, Embase, Web...

  17. Nanotechnology in neurology: Genesis, current status, and future prospects.

    Science.gov (United States)

    Ambesh, Paurush; Angeli, Daniel Gregory

    2015-01-01

    Nanotechnology is a promising, novel field of technological development. There is great potential in research and clinical applications for neurological diseases. Here we chronicle the inception of nanotechnology, discuss its integration with neurology, and highlight the challenges in current application. Some of the problems involving practical use of neuronanotechnology are direct biological toxicity, visualization of the nanodevice, and the short life expectancy of nanomachinery. Neuron cell therapy is an upcoming field for the treatment of challenging problems in neurology. Peptide nanofibers based on amphiphilic molecules have been developed that can autoregulate their structure depending on the conditions of the surrounding milieu. Such frameworks are promising for serving as drug delivery systems or communication bridges between damaged neurons. For common disabling diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), recent developments have seen revolutionary nanotech-based novelties, which are discussed here in detail. Bioimaging integrated with nanoneuromedicine has opened up new doors for cancer and infection therapeutics. PMID:26713006

  18. Nanotechnology in neurology: Genesis, current status, and future prospects

    Directory of Open Access Journals (Sweden)

    Paurush Ambesh

    2015-01-01

    Full Text Available Nanotechnology is a promising, novel field of technological development. There is great potential in research and clinical applications for neurological diseases. Here we chronicle the inception of nanotechnology, discuss its integration with neurology, and highlight the challenges in current application. Some of the problems involving practical use of neuronanotechnology are direct biological toxicity, visualization of the nanodevice, and the short life expectancy of nanomachinery. Neuron cell therapy is an upcoming field for the treatment of challenging problems in neurology. Peptide nanofibers based on amphiphilic molecules have been developed that can autoregulate their structure depending on the conditions of the surrounding milieu. Such frameworks are promising for serving as drug delivery systems or communication bridges between damaged neurons. For common disabling diseases such as Alzheimer′s disease (AD, Parkinson′s disease (PD, amyotrophic lateral sclerosis (ALS, and multiple sclerosis (MS, recent developments have seen revolutionary nanotech-based novelties, which are discussed here in detail. Bioimaging integrated with nanoneuromedicine has opened up new doors for cancer and infection therapeutics.

  19. The current status of robot-assisted radical prostatectomy

    Institute of Scientific and Technical Information of China (English)

    Prokar Dasgupta; Roger S.Kirby

    2009-01-01

    Robot-assisted radical prostatectomy (RARP) is a rapidly evolving technique for the treatment of localized prostate cancer.In the United States,over 65% of radical prostatectomies are robot-assisted,although the acceptance of this technology in Europe and the rest of the world has been somewhat slower.This article reviews the current literature on RARP with regard to oncological,continence and potency outcomes-the so-called 'trifecta'.Preliminary data appear to show an advantage of RARP over open prostatectomy,with reduced blood loss,decreased pain,early mobilization,shorter hospital stay and lower margin rates.Most studies show good postoperative continence and potency with RARP;however,this needs to be viewed in the context of the paucity of randomized data available in the literature.There is no definitive evidence to show an advantage over standard laparoscopy,but the fact that this technique has reached parity with laparoscopy within 5 years is encouraging.Finally,evolving techniques of single-port robotic prostatectomy,laserguided robotics,catheter-free prostatectomy and image-guided robotics are discussed.

  20. [Current status of palliative care in medical oncology].

    Science.gov (United States)

    Sasaki, Tsubasa; Ohta, Syuji; Seki, Nobuhiko; Eguchi, Kenji

    2010-06-01

    A team approach is efficient in palliative care for cancer patients. People suffered from cancer have a right to receive high-quality palliative care earlier in cancer treatment. In Japan the National Act for Strategy against Cancer was enacted in 2007. Systematic educational programs supported by the Ministry of Health Labor and Welfare has been conducted for medical staffs, home care staffs, local pharmacists, care managers etc. at core institutes in each district. Pain control is still major target for cancer palliative medicine. Recently various types of opioids can be used routinely in daily clinical setting for Japanese cancer patients. Complementary and alternative medicine (CAM) may also effective in some patients but further study for proving scientific evidence in CAM should be warranted. Tailor-maid pain control will be established in the near future with molecular based pharmacogenomics.

  1. Internal radionuclide therapy in pancreatic cancer:current status and progress%胰腺癌放射性核素内照射治疗现状及进展

    Institute of Scientific and Technical Information of China (English)

    王颖(综述); 李亚明(审校)

    2015-01-01

    Pancreatic cancer is a digestive system tumor with high degree of malignancy, rapid progress and poor prognosis. The early detection of pancreatic cancer is difficult, so that most patients are diagnosed at an advanced stage, have lost the opportunity for surgical therapy, and can only receive adjuvant chemoradiotherapy to help relieve symptoms and control the disease. In recent years, internal radionuclide therapy, with its constant development along with the continuous renewal of treatment strategy, has been increasingly noted in treatment of pancreatic cancer. In this paper, the authors address the advances of internal radionuclide therapy in pancreatic cancer.%胰腺癌是恶性程度高、进展迅速、预后极差的消化系统肿瘤,早期诊断困难,多数患者发现时已属晚期,失去手术治疗的机会,只能采取放化疗等辅助治疗手段来缓解症状及控制疾病。近年来随着放射性核素内照射治疗的不断发展,治疗策略的不断更新,其在胰腺癌的治疗中的作用越来越受到重视,笔者就其在胰腺癌治疗中的进展进行综述。

  2. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

    NARCIS (Netherlands)

    Hughes, David J.; Duarte-Salles, Talita; Hybsier, Sandra; Trichopoulou, Antonia; Stepien, Magdalena; Aleksandrova, Krasimira; Overvad, Kim; Tjønneland, Anne; Olsen, Anja; Affret, Aurélie; Fagherazzi, Guy; Boutron-Ruault, Marie Christine; Katzke, Verena; Kaaks, Rudolf; Boeing, Heiner; Bamia, Christina; Lagiou, Pagona; Peppa, Eleni; Palli, Domenico; Krogh, Vittorio; Panico, Salvatore; Tumino, Rosario; Sacerdote, Carlotta; Bueno de Mesquita, Hendrik Bastiaan; Peeters, Petra H.; Engeset, Dagrun; Weiderpass, Elisabete; Lasheras, Cristina; Agudo, Antonio; Sánchez, Maria José; Navarro, Carmen; Ardanaz, Eva; Dorronsoro, Miren; Hemmingsson, Oskar; Wareham, Nicholas J.; Khaw, Kay Tee; Bradbury, Kathryn E.; Cross, Amanda J.; Gunter, Marc; Riboli, Elio; Romieu, Isabelle; Schomburg, Lutz; Jenab, Mazda

    2016-01-01

    Selenium status is suboptimal in many Europeans and may be a risk factor for the development of various cancers, including those of the liver and biliary tract. Objective: We wished to examine whether selenium status in advance of cancer onset is associated with hepatobiliary cancers in the EPIC (Eu

  3. Current and emerging breast cancer biomarkers

    Directory of Open Access Journals (Sweden)

    Maryam Sana

    2015-01-01

    Full Text Available Breast cancer treatment has experienced several advancements in the past few decades with the discovery of specific predictive and prognostic biomarkers that make possible the application of individualized therapies. In addition to traditional prognostic factors of breast carcinoma, molecular biomarkers have played a significant role in tumor prediction and treatment. The most frequent genetic alterations of breast cancer are gained along chromosome 1q, 8q, 17q, 20q, and 11q and losses along 8p, 13q, 16q, 18q, and 11q. Interestingly, many of these chromosomal fragments harbor known proto oncogenes or tumor suppressor genes such as BRCA1, BRCA2, p53, HER2-neu, cyclin D1, and cyclin E, which are briefly described in this review.

  4. Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

    Institute of Scientific and Technical Information of China (English)

    Guo-Yan Liu; Wei Zhang

    2012-01-01

    In Western countries,the mutation status of the BRCA1 and BRCA2 genes is commonly determined for genetic counseling among members of families with a history of breast or ovarian cancer,especially for women of the Ashkenazi Jewish ethnicity.Recent studies in the Cancer Genome Atlas project have demonstrated that BRCA2 mutation carriers are more responsive to platinum-based chemotherapy among high-grade serous ovarian cancer patients.Thus,in Western countries,the mutation status of BRCA1 and BRCA2 is recognized to have an important value with which to assess cancer risk and therapeutic response.However,very limited studies of BRCA1 and BRCA2 mutations and their implications for counseling and therapeutic prediction have been conducted in China.Therefore,a potentially important genetic test that is technically simple has not benefited Chinese women with an increased risk of breast or ovarian cancer.This article summarizes the current progress in the study of BRCA1/2 mutation in China and recommends an increased effort in applying advances in genetic testing to the clinical management of Chinese patients with ovarian cancer.

  5. HER2 status and disparities in luminal breast cancers.

    Science.gov (United States)

    Holowatyj, Andreana N; Ruterbusch, Julie J; Ratnam, Manohar; Gorski, David H; Cote, Michele L

    2016-08-01

    National Comprehensive Care Network guidelines for adjuvant treatment of invasive breast cancer are based on HER2 and hormone receptor (HR) status, where HR+ disease encompasses all estrogen receptor (ER)+ and/or progesterone receptor (PR)+ tumors. We sought to explore clinical and demographic differences among patients with HR+ breast cancer subtypes, and the role of HER2 status, age, race/ethnicity, and socioeconomic status (SES) in disease risk. We evaluated breast cancer subtype distribution, defined by HR and HER2 status, using patient clinical, demographic, and socioeconomic characteristics. Differences in HR categories by demographic and tumor characteristics were examined using chi-squared tests. Multinomial logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) to quantify associations between breast cancer HR status and demographic factors. We found that differences in HR+ (ER-/PR+ vs. ER+/PR- or ER+/PR+) tumor biology are likely clinically significant and may play a role in breast cancer, regardless of HER2 status. While clinical and patient characteristics differed within each luminal subtype, we found disparities in SES only among Luminal A (HR+/HER2-) tumors. Among HR+/HER2- cases, we observed that ER-/PR+ patients tend to live in areas of higher poverty (OR = 1.20, 95% CI = 1.03-1.40) and are 70% more likely to be aged 50 years or older. However, this pattern was not found in women with Luminal B (HR+/HER2+) disease (Poverty OR = 0.98, 95% CI = 0.76-1.27; Age OR = 1.01, 95% CI = 0.81-1.26). Racial/ethnic disparities among non-Hispanic black and Hispanic women persisted across HR+/HER2- cases compared to non-Hispanic white women. Our findings suggest that while race/ethnicity and SES are correlated, each plays an independent role in contributing to disease among Luminal A tumors. Further study is needed to investigate how tumor biology, race/ethnicity, and socioeconomic disparities among HR+/HER2

  6. Optimal breast cancer screening strategies for older women: current perspectives

    Directory of Open Access Journals (Sweden)

    Braithwaite D

    2016-02-01

    Full Text Available Dejana Braithwaite,1 Joshua Demb,1 Louise M Henderson2 1Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, 2Department of Radiology, University of North Carolina, Chapel Hill, NC, USA Abstract: Breast cancer is a major cause of cancer-related deaths among older women, aged 65 years or older. Screening mammography has been shown to be effective in reducing breast cancer mortality in women aged 50–74 years but not among those aged 75 years or older. Given the large heterogeneity in comorbidity status and life expectancy among older women, controversy remains over screening mammography in this population. Diminished life expectancy with aging may decrease the potential screening benefit and increase the risk of harms. In this review, we summarize the evidence on screening mammography utilization, performance, and outcomes and highlight evidence gaps. Optimizing the screening strategy will involve separating older women who will benefit from screening from those who will not benefit by using information on comorbidity status and life expectancy. This review has identified areas related to screening mammography in older women that warrant additional research, including the need to evaluate emerging screening technologies, such as tomosynthesis among older women and precision cancer screening. In the absence of randomized controlled trials, the benefits and harms of continued screening mammography in older women need to be estimated using both population-based cohort data and simulation models. Keywords: aging, breast cancer, precision cancer screening

  7. EDIBLE VACCINES FROM GM CROPS: CURRENT STATUS AND FUTURE SCOPE

    Directory of Open Access Journals (Sweden)

    Doshi V

    2013-06-01

    take “food” rather than “drugs” when we are ill. This review attempts to discuss the current status and future of this new preventive modality.

  8. Analysis on Current Status and Plights of Translational Medicine

    Institute of Scientific and Technical Information of China (English)

    ZHAO Jin-wen; QIAN Feng

    2015-01-01

    Translational medicine, which is a new concept appearing in the field of international medical health in the past three or four years, forms a discipline of the system medicine (including systematic pathology, diagnosis and comprehensive treatment as well as pharmacology, etc) synchronizing with personalized medicine and predictable medicine. It is a branch of medical research trying to build a better bridge between the basic studies and the clinical medical treatment. It can promote the predicative, prognostic and personalized medicines by the evaluation and application of molecular markers, the individual therapies based on molecular subtypes and the evaluation and predication of therapeutic responses and prognosis. And its purpose is to build a direct connection between basic research and clinical practice so as to transform the knowledge and achievements of basic research into new therapeutic methods in clinic, which can be used to serve the clinic and solve clinical problems. Nevertheless, the study on translational medicine is limited, and there are few review articles about the progress of translational medicine in English. With the development of innovative and new technology, the therapeutic methods become more accurate and diverse, and the translational medicine will make outstanding advances and provide more space for the future treatment of various diseases so as to better serve the clinical practices and the patients. In addition, except the outstanding achievements, there are still multiple plights in the translational medicine research. Therefore, this study aimed to review the current status and the present problems in translational medicine, hoping to expand the study outcomes in China to the whole world.

  9. CURRENT STATUS OF INDIVIDUAL DOSIMETRIC MONITORING IN UKRAINE.

    Science.gov (United States)

    Chumak, V; Deniachenko, N; Makarovska, O; Mihailescu, L-C; Prykhodko, A; Voloskyi, V; Vanhavere, F

    2016-09-01

    About 50 000 workers are being occupationally exposed to radiation in Ukraine. Individual dosimetric monitoring (IDM) is provided by 77 dosimetry services and laboratories of very different scale with a number of monitored workers ranging from several persons to ∼9000. In the present work, the current status of personal dosimetry in Ukraine was studied. The First National Intercomparison (FNI) of the IDM labs was accompanied by a survey of the laboratory operation in terms of coverage, types of dosimetry provided, instrumentation and methodologies used, metrological support, data recording, etc. Totally, 34 laboratories responded to the FNI call, and 18 services with 19 different personal dosimetry systems took part in the intercomparison exercise providing 24 dosimeters each for blind irradiation to photons of 6 different qualities (ISO N-series X-rays, S-Cs and S-Co sources) in a dose range of 5-60 mSv. Performance of the dosimetry labs was evaluated according to ISO 14146 criteria of matching trumpet curves with H0 = 0.2 mSv. The test revealed that 8 of the 19 systems meet ISO 14146 criteria in full, 5 other labs show marginal performance and 6 laboratories demonstrated catastrophic quality of dosimetric results. Altogether, 18 participating labs provide dosimetric monitoring to 37 477 workers (about three-fourths of all occupationally exposed workers), usually on monthly (nuclear industry) or quarterly (rest of applications) basis. Of this number, 20 664 persons (55 %) receive completely adequate individual monitoring, and the number of personnel receiving IDM of inadequate quality counts 3054 persons. PMID:26979804

  10. CURRENT STATUS AND POLICY IMPLICATIONS FOR FOSTERING SOCIAL ENTREPRENEUR

    Directory of Open Access Journals (Sweden)

    Yoon-Doo Kim

    2012-01-01

    Full Text Available In this study, problems in current status of social entrepreneurs in Korea were examined and further policy issues for them were suggested as well. For the methodology, the study analyzed the drawbacks and policy implication of fostering social entrepreneurs through Focus Group Interview (FGI on analysis of present condition of incubating social entrepreneur and programs for it. First, it should escape from personnel expense-centered one and convert to ecosystem-centered or division-centered project in the direction of the government for fostering social entrepreneurs, putting emphasis on follow-up management and evaluation. Second, it must suggest a standard model for social entrepreneur promotion project. In other words, the projects with low performance should be reduced and education models appropriate for new circumstances and changes must be adopted through not only programs standardized in divisions, categories and local provinces, but also appointing expert instructors and project evaluation. Third, it’s necessary to propose specific guideline for detailed education operation according to education trainee and objectives of social entrepreneur. Fourth, it is needed to have more various contents development and distribution by strengthening support for specialized foundation, management and case studies related to fostering social entrepreneurs. Finally, it is even more required to spread awareness on social economics relating to programs for fostering social entrepreneur. With the long-term perspective, it is needed to render policy and specialization for fostering Korean-model social entrepreneurs, which is able to raise competent social entrepreneurs suitable for each stage of growth such as sourcing, incubation and launching social entrepreneurs.

  11. Livestock in biomedical research: history, current status and future prospective.

    Science.gov (United States)

    Polejaeva, Irina A; Rutigliano, Heloisa M; Wells, Kevin D

    2016-01-01

    Livestock models have contributed significantly to biomedical and surgical advances. Their contribution is particularly prominent in the areas of physiology and assisted reproductive technologies, including understanding developmental processes and disorders, from ancient to modern times. Over the past 25 years, biomedical research that traditionally embraced a diverse species approach shifted to a small number of model species (e.g. mice and rats). The initial reasons for focusing the main efforts on the mouse were the availability of murine embryonic stem cells (ESCs) and genome sequence data. This powerful combination allowed for precise manipulation of the mouse genome (knockouts, knockins, transcriptional switches etc.) leading to ground-breaking discoveries on gene functions and regulation, and their role in health and disease. Despite the enormous contribution to biomedical research, mouse models have some major limitations. Their substantial differences compared with humans in body and organ size, lifespan and inbreeding result in pronounced metabolic, physiological and behavioural differences. Comparative studies of strategically chosen domestic species can complement mouse research and yield more rigorous findings. Because genome sequence and gene manipulation tools are now available for farm animals (cattle, pigs, sheep and goats), a larger number of livestock genetically engineered (GE) models will be accessible for biomedical research. This paper discusses the use of cattle, goats, sheep and pigs in biomedical research, provides an overview of transgenic technology in farm animals and highlights some of the beneficial characteristics of large animal models of human disease compared with the mouse. In addition, status and origin of current regulation of GE biomedical models is also reviewed.

  12. Current Status of Soil-transmitted Nematode Infection in China

    Institute of Scientific and Technical Information of China (English)

    YING-DAN CHEN; LIN-HUA TANG; LONG-QI XU

    2008-01-01

    Objective To Carry out national surveys for ascertaining the current status and trends of soil-transmitted nematode infections in China,providing scientific basis for forther developing control strategies.Methods In 1988-1992(hereinafter abbreriated as "survey in 1990"),a stratified cluster random sampling method was used in the survey.In 2001-2004(hereinafter abbreriated as "survey in 2003"),in order to compare with the survey in 1990,two-characteristic stratified cluster random sampling method was used and 687 investigation spots were sampled from the 2848 spots selected in the survey in 1990.Kato-Katz thick smear method was used to examine the eggs of soil-transmitted nematodes in fecal samples. Results The prevalence rates were 53.6% and 19.6% for soil-transmitted nematodes,14.6%and 6.120% for hookworms,44.6% and 12.7% for Ascaris lumbricoides,17.4% and 4.630% for Trichuris trichiura in survey 1990 and survey 2003,respectively.The prevalence rates of soil-transmitted nematodes were higher in 13 provinces than the average level in China in the survey in 1990.and higher in 8 provinces than the average level in the survey in 2003.The prevalence of hookworms,Ascaris lumbricoides,Trichurls trichiura and the overall prevalence of soft-transmitted nematodes were higher in females than in males.It is estimated from the results of survey in 2003 that the number of persons with soil-transmitted nematode infections in the country is about 129 million,less than that in the survey in 1990. Conclusion The prevalence of soil-transmitted nematodes has declined considerably but is still relatively high in some provinces and autonomous regions.Control activities and socioeconomic development may have contributed to the decreased prevalence.

  13. Current status of the nuclear matter incompressibility coefficient

    International Nuclear Information System (INIS)

    We review the current status of the incompressibility coefficient of symmetric nuclear matter, Knm, as deduced from experimental data on excitation cross section, σ(E), of the isoscalar giant monopole resonance (ISGMR) and the isoscalar giant dipole resonance (ISGDR), by inelastic α-particle scattering, using the nonrelativistic and relativistic mean-field based random phase approximation (RPA). We will discuss the following problems: (1) Self-consistent (non-relativistic) Hartree-Fock (HF)-based RPA calculations and the need to carry out detailed and accurate calculations of the strength function distributions, S(E), and the transition densities, pt, of the isoscalar giant resonance within the HF-RPA theory. We will present results of our investigation concerning, (i) the consequences of violation of self-consistency in common applications of HF-based RPA on S(E) and p, of isoscalar giant resonances, and (ii) the effects of the spurious state mixing (SSM) on properties of the ISGDR. (2) The relation between the strength function S(E) and the excitation cross section a(E) of the isoscalar giant resonances (the ISGMR and the ISGDR, in particular) obtained by alpha-scattering. Here we present results of accurate microscopic calculations for S(E) and for σ(E), obtained within the folding-model distorted-wave-Born approximation with transition densities pt(r ) obtained from HF-RPA calculations. We provide an explanation for the discrepancy between theory and experiment concerning S(E) of the ISGDR. (3) The apparent discrepancy of about 20 % in the value of Knm as predicted by the relativistic and the non-relativistic models. Our investigation suggests that this discrepancy is mainly due to the different values of the symmetry energy coefficient employed in the relativistic and the non-relativistic models

  14. The current status of forensic science laboratory accreditation in Europe.

    Science.gov (United States)

    Malkoc, Ekrem; Neuteboom, Wim

    2007-04-11

    Forensic science is gaining some solid ground in the area of effective crime prevention, especially in the areas where more sophisticated use of available technology is prevalent. All it takes is high-level cooperation among nations that can help them deal with criminality that adopts a cross-border nature more and more. It is apparent that cooperation will not be enough on its own and this development will require a network of qualified forensic laboratories spread over Europe. It is argued in this paper that forensic science laboratories play an important role in the fight against crime. Another, complimentary argument is that forensic science laboratories need to be better involved in the fight against crime. For this to be achieved, a good level of cooperation should be established and maintained. It is also noted that harmonization is required for such cooperation and seeking accreditation according to an internationally acceptable standard, such as ISO/IEC 17025, will eventually bring harmonization as an end result. Because, ISO/IEC 17025 as an international standard, has been a tool that helps forensic science laboratories in the current trend towards accreditation that can be observed not only in Europe, but also in the rest of the world of forensic science. In the introduction part, ISO/IEC 17025 states that "the acceptance of testing and calibration results between countries should be facilitated if laboratories comply with this international standard and if they obtain accreditation from bodies which have entered into mutual recognition agreements with equivalent bodies in other countries using this international standard." Furthermore, it is emphasized that the use of this international standard will assist in the harmonization of standards and procedures. The background of forensic science cooperation in Europe will be explained by using an existing European forensic science network, i.e. ENFSI, in order to understand the current status of forensic

  15. Support for international agricultural research: current status and future challenges.

    Science.gov (United States)

    Zeigler, Robert S; Mohanty, Samarendu

    2010-11-30

    The success of the first Green Revolution in the form of abundant food supplies and low prices over the past two decades has diverted the world's attention from agriculture to other pressing issues. This has resulted in lower support for the agricultural research work primarily undertaken by the 15 research centers of the Consultative Group on International Agricultural Research (CGIAR). The total support in real dollars for most of the last three decades has been more or less flat although the number of centers increased from 4 to 15. However, since 2000, the funding situation has improved for the CGIAR centers, with almost all the increase coming from grants earmarked for specific research projects. Even for some centers such as the International Rice Research Institute (IRRI), the downward trend continued as late as 2006 with the budget in real dollars reaching the 1978 level of support. The recent food crisis has renewed the call for a second Green Revolution by revitalizing yield growth to feed the world in the face of growing population and a shrinking land base for agricultural use. The slowdown in yield growth because of decades of neglect in agricultural research and infrastructure development has been identified as the underlying reason for the recent food crisis. For the second Green Revolution to be successful, the CGIAR centers will have to play a complex role by expanding productivity in a sustainable manner with fewer resources. Thus, it is crucial to examine the current structure of support for the CGIAR centers and identify the challenges ahead in terms of source and end use of funds for the success of the second Green Revolution. The objective of this paper is to provide a historical perspective on the support to the CGIAR centers and to examine the current status of funding, in particular, the role of project-specific grants in rebuilding capacity of these centers. The paper will also discuss the nature of the support (unrestricted vs. project

  16. 20 CFR 404.120 - How we determine currently insured status.

    Science.gov (United States)

    2010-04-01

    ... 20 Employees' Benefits 2 2010-04-01 2010-04-01 false How we determine currently insured status... § 404.120 How we determine currently insured status. (a) What the period is for determining currently... not counted as part of the 13-quarter period. We do not count as part of the 13-quarter period...

  17. 21 CFR 210.1 - Status of current good manufacturing practice regulations.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 4 2010-04-01 2010-04-01 false Status of current good manufacturing practice... SERVICES (CONTINUED) DRUGS: GENERAL CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL § 210.1 Status of current good manufacturing practice...

  18. Policies for second generation biofuels: current status and future challenges

    Energy Technology Data Exchange (ETDEWEB)

    Egger, Haakan; Greaker, Mads; Potter, Emily

    2011-07-01

    Current state-of-the-art knowledge concludes that green house gas (GHG) emissions must be controlled and reduced within the next 30-40 years. The transport sector contributes almost a fifth of the current global emissions, and its share is likely to increase in the future. The US and a number of European countries have therefore introduced various support schemes for research and development (RandD) of low emission fuels that can potentially replace the current fossil fuels. One such alternative is biofuels. The advantage of biofuels are that it is easy to introduce into the transport sector. On the other hand, recent research papers question whether the supply of feedstock is sufficient, and to what extent biofuels lead to GHG emission reductions. This report reviews the current status of second generation biofuels. Second generation biofuels are made from cellulose, which according to our survey of the literature, is in more abundant supply than the first generation biofuels feedstocks. Furthermore, it seems to have the potential to reduce GHG emissions from the transport sector without leading to devastating land use changes, which recent critique has held against first generation biofuels. Given that governments have decided to support RandD of low emission fuels, we ask the following questions: Should second generation biofuels receive RandD support to the same extent as other low emission fuels like hydrogen? How should support schemes for second generation biofuels be designed? Second generation biofuels can be divided according to the production process into thermo-chemical and bio-chemical. With respect to the thermo-chemical process the potential for cost reductions seems to be low. On the other hand, ethanol made from cellulose using the biochemical conversion process is far from a ripe technology. Expert reports point to several potential technological breakthroughs which may reduce costs substantially. Hence, cellulosic ethanol, should receive direct

  19. Current status on performance of CT colonography and clinical indications

    International Nuclear Information System (INIS)

    CT colonography (CTC) is a robust and reliable imaging test of the colon. Accuracy for the detection of colorectal cancer (CRC) is as high as conventional colonoscopy (CC). Identification of polyp is size dependent, with large lesions (≥10 mm) accurately detected and small lesions (6–9 mm) identified with moderate to good sensitivity. Recent studies show good sensitivity for the identification of nonpolypoid (flat) lesions as well. Current CTC indications include the evaluation of patients who had undergone a previous incomplete CC or those who are unfit for CC (elderly and frail individuals, patients with underlying severe clinical conditions, or with contraindication to sedation). CTC can also be efficiently used in the assessment of diverticular disease (excluding patients with acute diverticulitis, where the exam should be postponed), before laparoscopic surgery for CRC (to have an accurate localization of the lesion), in the evaluation of colonic involvement in the case of deep pelvic endometriosis (replacing barium enema). CTC is also a safe procedure in patients with colostomy. For CRC screening, CTC should be considered an opportunistic screening test (not available for population, or mass screening) to be offered to asymptomatic average-risk individuals, of both genders, starting at age 50. The use in individuals with positive family history should be discussed with the patient first. Absolute contraindication is to propose CTC for surveillance of genetic syndromes and chronic inflammatory bowel diseases (in particular, ulcerative colitis). The use of CTC in the follow-up after surgery for CRC is achieving interesting evidences despite the fact that literature data are still relatively weak in terms of numerosity of the studied populations. In patients who underwent previous polypectomy CTC cannot be recommended as first test because debate is still open. It is desirable that in the future CTC would be the first-line and only diagnostic test for

  20. Current status on performance of CT colonography and clinical indications

    Energy Technology Data Exchange (ETDEWEB)

    Laghi, Andrea, E-mail: andrea.laghi@uniroma1.it [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Polo Pontino, I.C.O.T. Hospital, Via Franco Faggiana 43, 04100 Latina (Italy); Rengo, Marco [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Polo Pontino, I.C.O.T. Hospital, Via Franco Faggiana 43, 04100 Latina (Italy); Graser, Anno [InstitutfürKlinische Radiologie, Klinikumder Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, 81377 München (Germany); Iafrate, Franco [Department of Radiological Sciences, Oncology and Pathology Sapienza – Università di Roma, Policlinico Umberto I, Viale Regina Elena 324, 00161 Rome (Italy)

    2013-08-15

    CT colonography (CTC) is a robust and reliable imaging test of the colon. Accuracy for the detection of colorectal cancer (CRC) is as high as conventional colonoscopy (CC). Identification of polyp is size dependent, with large lesions (≥10 mm) accurately detected and small lesions (6–9 mm) identified with moderate to good sensitivity. Recent studies show good sensitivity for the identification of nonpolypoid (flat) lesions as well. Current CTC indications include the evaluation of patients who had undergone a previous incomplete CC or those who are unfit for CC (elderly and frail individuals, patients with underlying severe clinical conditions, or with contraindication to sedation). CTC can also be efficiently used in the assessment of diverticular disease (excluding patients with acute diverticulitis, where the exam should be postponed), before laparoscopic surgery for CRC (to have an accurate localization of the lesion), in the evaluation of colonic involvement in the case of deep pelvic endometriosis (replacing barium enema). CTC is also a safe procedure in patients with colostomy. For CRC screening, CTC should be considered an opportunistic screening test (not available for population, or mass screening) to be offered to asymptomatic average-risk individuals, of both genders, starting at age 50. The use in individuals with positive family history should be discussed with the patient first. Absolute contraindication is to propose CTC for surveillance of genetic syndromes and chronic inflammatory bowel diseases (in particular, ulcerative colitis). The use of CTC in the follow-up after surgery for CRC is achieving interesting evidences despite the fact that literature data are still relatively weak in terms of numerosity of the studied populations. In patients who underwent previous polypectomy CTC cannot be recommended as first test because debate is still open. It is desirable that in the future CTC would be the first-line and only diagnostic test for

  1. 早期非小细胞肺癌立体定向消融放疗现状%Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage Non-small Cell Lung Cancer

    Institute of Scientific and Technical Information of China (English)

    石安辉; 朱广迎

    2016-01-01

    目前比较立体定向消融放疗(stereotactic ablative radiotherapy, SABR)与手术治疗早期非小细胞肺癌(non-small cell lung cancer, NSCLC)的随机研究证据尚不多,高水平的循证医学证据更是缺乏。尽管STARS和ROSEL两项随机研究结果荟萃分析显示SABR较手术耐受性更好,生存不劣于手术,但是目前仍仅推荐拒绝手术或不可手术的早期NSCLC首选SABR,期待着正在进行的随机研究VALOR(Veterans Affairs Lung Cancer Surgery or Stereotactic Ra-diotherapy in the US)和SABRTooth(SABRTooth study in the United Kingdom)的结果。许多回顾性的研究和病例对照研究显示了SABR治疗的安全性和有效性(局部控制率达90%以上,5年生存率达70%),但是由于肿瘤分期定义、如何决定可否手术及手术患者采用手术方式(开胸或胸腔镜辅助)等不同,很难比较SABR和手术的优劣,尽管大部分结论是两种方法疗效相似,但难以成为循证医学证据,因此争论热点是哪一种方法更安全、创伤更小。本文将就以上争论热点进行述评。%High level evidence from randomized studies comparing stereotactic ablative radiotherapy (SABR) to surgery is lacking. Although the results of pooled analysis of two randomized trials for STARS and ROSEL showed that SABR is better tolerated and might lead to better overall survival than surgery for operable clinical stage I non-small cell lung cancer (NSCLC), SABR, however, is only recommended as a preferred treatment option for early stage NSCLC patients who cannot or will not undergo surgery. We, therefore, are waiting for the results of the ongoing randomized studies [Veterans af-fairs lung cancer surgery or stereotactic radiotherapy in the US (VALOR) and the SABRTooth study in the United Kingdom (SABRTooths)]. Many retrospective and case control studies showed that SABR is safe and effective (local control rate higher than 90%, 5 years survival rate

  2. Race/Ethnicity, Gender, Weight Status, and Colorectal Cancer Screening

    Directory of Open Access Journals (Sweden)

    Heather Bittner Fagan

    2011-01-01

    The literature on colorectal cancer (CRC screening is contradictory regarding the impact of weight status on CRC screening. This study was intended to determine if CRC screening rates among 2005 National Health Interview Survey (NHIS respondent racial/ethnic and gender subgroups were influenced by weight status. Methods. Univariable and multivariable logistic regression analyses were performed to determine if CRC screening use differed significantly among obese, overweight, and normal-weight individuals in race/ethnic and gender subgroups. Results. Multivariable analyses showed that CRC screening rates did not differ significantly for individuals within these subgroups who were obese or overweight as compared to their normal-weight peers. Conclusion. Weight status does not contribute to disparities in CRC screening in race/ethnicity and gender subgroups.

  3. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

    Institute of Scientific and Technical Information of China (English)

    2008-01-01

    This article is to offer a concise review on the use of cytoreductive surgery (CRS) plus intraperitoneal hyperthermic chemotherapy (IPHC) for the treatment of peritoneal carcinomatosis (PC). Traditionally, PC was treated with systemic chemotherapy alone with very poor response and a median survival of less than 6 mo. With the establishment of several phase studies, a new trend has been developed toward the use of CRS plus IPHC as a standard method for treating selected patients with PC, in whom sufficient cytoreduction could be achieved. In spite of the need for more high quality phase studies, there is now a consensus among many surgical oncology experts throughout the world about the use of this new treatment strategy as standard care for colorectal cancer patients with PC. This review summarizes the current status and possible progress in future.

  4. Current therapy of small cell lung cancer

    DEFF Research Database (Denmark)

    Sorensen, M; Lassen, U; Hansen, H H

    1998-01-01

    This article reviews the most important recent clinical trials on the treatment of small cell lung cancer (SCLC). Two randomized studies addressing the timing of thoracic radiotherapy in limited stage SCLC are discussed. In the smaller of the two studies (n = 103), a survival benefit was associated...... with initial versus delayed radiotherapy. No survival differences in the larger study of the two studies were detected, which compared alternating with sequential delivery of radiotherapy (n = 335). The optimal way to deliver radiotherapy still must be defined. Two small, randomized studies on dose intensity...

  5. Assessment of the current status of basic nuclear data compilations

    International Nuclear Information System (INIS)

    Topics discussed include: the status of mass-chain evaluations, remote terminal access, other US Nuclear Data Network publications, formats and procedures subcommittee report, keyword follow-up (Phys. Rev. C), and atomic data and nuclear data tables

  6. Current Status and Prediction on Development of PE Market

    Institute of Scientific and Technical Information of China (English)

    Yu Jiao

    2003-01-01

    This article comprehensively analyzes the status of market demand/supply and import/export volumes of PE in the world and in China, and predicts the future development trends in the fields of PE production and consumption.

  7. The current status of utilization of research reactors in China

    International Nuclear Information System (INIS)

    Seminars on utilization of research reactors were held to enhance experience exchanging among institutes and universities in China. The status of CARR (China Advanced Research Reactor) project is briefly described. The progress in BNCT program in China is introduced. (author)

  8. Total antioxidant status in women with breast cancer

    International Nuclear Information System (INIS)

    Objective: To measure the concentration of total antioxidant status (TAS) in women with breast cancer. Methodology: This is a case control study conducted in Al-Salam Hospital and Department of Pharmacology in Mosul Medical College. Twenty women having histologically confirmed breast cancer and twenty age-matched healthy volunteer women participated in the study. Serum total antioxidant status (TAS) was measured in both groups. Results: Mean TAS of the patient group (0.91 +- 0.32 mmol/l) was significantly lower (P<0.001) than that of the control group (1.82 +- 0.14 mmol/l). Conclusion: The present study demonstrated that women with breast cancer have a low level of TAS as compared to those of healthy women. It further emphasizes the growing concern that oxidative damage may occur in those patients that exhaust the antioxidant defense of the body leading to a low levels of TAS. Administration of antioxidant supplements such as a combination of vitamins A, C and E are necessary in women at high risk of developing breast cancer or after surgery or with anticancer drugs. (author)

  9. Socioeconomic status and patterns of care in lung cancer

    International Nuclear Information System (INIS)

    This retrospective study aims to explore any associations between socioeconomic factors and lung cancer management and outcome in the Australian setting. The study population consisted of patients newly diagnosed with lung cancer in 1996 who were living in the Northern Sydney Area Health Service (NSAHS) or South Western Sydney Area Health Service (SWSAHS). These two Area Health Services differ in socioeconomic profiles based on socioeconomic indexes for areas (SEIFA), median income, education level and unemployment rate. Data on patient demographics, tumour characteristics, management details, recurrence and survival were collected, and the patterns of care were analysed. Socioeconomic status indicators of the two Area Health Services were imputed from the Australian Bureau of Statistics data. There were 270 and 256 new cases of lung cancer identified in NSAHS and SWSAHS respectively. Patients in NSAHS were slightly older (median age 73 versus 68 years) and there was less male predominance. The stage distributions and performance status of the two cohorts were similar. There were no significant differences in the utilisation rates of different treatment modalities between the two areas: radiotherapy (54% in NSAHS and 55% in SWSAHS), chemotherapy (34% and 25%), surgery (26% and 21%) and no treatment (22% and 25%). The 5-year overall survival was slightly in favour of NSAHS (10.5% and 7.4%), but did not reach statistical significance. Despite differences in socioeconomic profiles between the two area health services, patients with lung cancer had similar patterns of care and survival

  10. Current Status of the Problem of Cosmological Variability of Fundamental Physical Constants

    Science.gov (United States)

    Varshslovich, D.A.; Ivanchik, A.V.; Orlov, A.V.; Potekhin, A.Y.; Petitjean, P.

    We review the current status of the problem of cosmological variability of fundamental physical constants, provided by modern laboratory experiments, Oklo phenomena analysis, and especially astronomical observations.

  11. Transrectal Ultrasound Guided Prostate Biopsy: Current Status and Controversy

    Energy Technology Data Exchange (ETDEWEB)

    Hwang, Sung Il; Lee, Hak Jong; Hong, Sung Kyu; Lee, Sang Eun [Seoul National University Bundang Hospital, Seongnam (Korea, Republic of); Kim, Seung Hyup; Cho, Jeong Yeon [Seoul National University Hospital, Seoul (Korea, Republic of)

    2007-09-15

    In Korea, the incidence of prostate cancer in 2002 was sixth among the malignancies diagnosed in men, but it was the most rapidly increasing cancer. As many prostate cancers are indistinguishable from normal prostate tissue as determined on an ultrasound examination, the randomized systematic transrectal ultrasound guided prostate biopsy is the gold standard for the detection of prostate cancer. Indications for a TRUS guided prostate biopsy including an elevated level of prostate specific antigen (PSA) and an abnormal digital rectal exam, as well as patient preparation and procedure techniques including anesthesia are reviewed in this report. This report also considers controversies about a prostate biopsy such as the ideal number of biopsy cores, usefulness of PSA derivatives, effective methods for local anesthesia, and the use of patient preparation questionnaires covering topics such as the paucity of anticoagulants and the use of antibiotics and enemas

  12. Current status and future perspectives of robotic surgery and laparoscopic surgery for gastric cancer%手术机器人系统和腹腔镜微创外科技术在胃癌治疗中的应用

    Institute of Scientific and Technical Information of China (English)

    江志伟; 黎介寿

    2012-01-01

    腹腔镜外科在胃癌治疗中面临着两大困难,即D2淋巴结清扫及全腹腔镜下的消化道重建.而手术机器人系统具有图像立体三维、放大10倍、有7个自由度关节的器械和医生工作体位舒适等优点,有利于行胃癌D2淋巴结清扫及消化道吻合重建,增强微创手术的优势,拓展微创外科在胃癌治疗中的适应证.在加速康复外科理念下开展微创手术治疗胃癌,必将有利于促进患者的快速康复.%Laparoscopic gastrectomy has not become a common procedure for gastric cancer due to the difficulties of performing D2 lymphadenectomy and reconstruction of digestive tract by the conventional laparoscopic instruments.The da Vinci system provides 3D visualization,enhanced magnification,and seven degrees of freedom of the instruments to suture and knot in the narrow surgical space,so it can perform totally robotic gastrectomy with D2 lymphadenectomy and robot-sewing anastomosis for reconstruction.Application of robotic system can expand the indications of minimally invasive surgery in treatment of gastric cancer.Combination fast-track surgery to optimize the perioperative management with the technique of minimally invasive surgery can enhance the recovery of surgical gastric cancer patients.

  13. Chemopreventive Herbal Anti-Oxidants: Current Status and Future Perspectives

    OpenAIRE

    Patel, Rachana; Garg, Rachana; Erande, Suvarna; B. Maru, Girish

    2007-01-01

    Cancer chemoprevention is fast becoming a lucrative approach for controlling cancer. Carcinogenesis being a complex multi-step, multi-factorial process, a number of chemopreventive interventions can be employed. These strategies are generally directed against two broad events of carcinogenesis viz., initiation and promotion/progression. Anti-initiation interventions principally involve inhibition of carcinogen activation, scavenging of free radicals and reactive carcinogen metabolites along w...

  14. Indus-2 Synchrotron Radiation Source: current status and utilization

    International Nuclear Information System (INIS)

    Indus Synchrotron Radiation complex at Raja Ramanna Centre for Advanced Technology at Indore, India houses two synchrotron radiation sources: Indus-1 and Indus-2. Indus-1 is a 450 MeV source emitting in VUV/ soft x-ray region and operating at 100 mA since 1999. Indus-2 is designed for 2.5 GeV, 300 mA operation and is operating at 2 GeV and 100 mA since March 2010 in 24x7 mode and a beam lifetime of about 22 hrs has been achieved. Operation at 2.5 GeV and 100 mA has recently been demonstrated with the addition of in-house developed solid state RF amplifiers. Indus-2 can accommodate 21 bending magnet (BM) and 5 insertion device (ID) beamlines. Sixteen BM beamlines have been planned and six BM beamlines namely i) Angle Dispersive XRD ii) Energy dispersive XRD iii) Energy dispersive EXAFS iv) Soft and deep x-ray lithography v) X-ray fluorescence micro-probe and vi) X-ray photoelectron spectroscopy beamlines have been commissioned. These are being used by researchers from different universities, national institutes and laboratories for carrying out several investigations. Two more beamlines namely 'Grazing incidence x-ray scattering' and 'Protein crystallography' are nearing commissioning. A number of materials research related problems have been investigated using these beamlines and several papers have already been published. Here we will report on the current status of the source, details of the beamlines already operational, beamlines to be commissioned soon and several up-gradation schemes that are being planned. Five IDs consisting of two soft x-ray planar undulators, one superconducting wavelength shifter / wiggler, one APPLE II soft x-ray helical undulator and one hard x-ray undulator will be installed during the next few years. Three new ID based beamli-nes for Atomic and Molecular physics, Angle integrated / Angle resolved PES and Magnetic Circular Dichroism experiments will be commissioned.

  15. Current Status of the New Antiepileptic Drugs in Chronic Pain

    Science.gov (United States)

    Sidhu, Harpreet S.; Sadhotra, Akshay

    2016-01-01

    Antiepileptic drugs (AEDs) are extensively used worldwide to treat a wide range of disorders other than epilepsy, such as neuropathic pain, migraine, and bipolar disorder. Due to this situation more than 20 new third-generation AEDs have been introduced in the market recently. The future design of new AEDs must also have potential to help in the non-epileptic disorders. The wide acceptance of second generation AEDs for the management of various non-epileptic disorders has caused the emergence of generics in the market. The wide use of approved AEDs outside epilepsy is based on both economic and scientific reasons. Bipolar disorders, migraine prophylaxis, fibromyalgia, and neuropathic pain represent the most attractive indication expansion opportunities for anticonvulsant developers, providing blockbuster revenues. Strong growth in non-epilepsy conditions will see Pfizer’s Lyrica become the market leading brand by 2018. In this review, we mainly focus on the current status of new AEDs in the treatment of chronic pain and migraine prophylaxis. AEDs have a strong analgesic potential and this is demonstrated by the wide use of carbamazepine in trigeminal neuralgia and sodium valproate in migraine prophylaxis. At present, data on the new AEDs for non-epileptic conditions are inconclusive. Not all AEDs are effective in the management of neuropathic pain and migraine. Only those AEDs whose mechanisms of action are match with pathophysiology of the disease, have potential to show efficacy in non-epileptic disorder. For this better understanding of the pathophysiology of the disease and mechanisms of action of new AEDs are essential requirement before initiating pre-clinical and clinical trials. Many new AEDs show good results in the animal model and open-label studies but fail to provide strong evidence at randomized, placebo-controlled trials. The final decision regarding the clinical efficacy of the particular AEDs in a specific non-epileptic disorder should be

  16. Current Trends in Treatment of Status Epilepticus and Refractory Status Epilepticus.

    Science.gov (United States)

    Betjemann, John P

    2015-12-01

    Status epilepticus is a heterogeneous disorder with varied definitions and presentations. Taken together, all forms of status epilepticus carry significant morbidity and mortality, much of which is dictated by the underlying etiology. Generalized convulsive status epilepticus, which represents a common form, is a true neurologic emergency that requires emergent management. Treatment focuses on stabilizing the patient and aggressive medical management to achieve the timely termination of seizures. For other forms of status epilepticus including nonconvulsive and focal status epilepticus, the goal remains early seizure termination, but the use of intravenous medications should be weighed against the risks associated with these therapies. The diagnostic evaluation of status epilepticus is guided by the patient's history and should be broad, including a screen for toxins, electrolytes, structural abnormalities, and central nervous system infectious and autoimmune/inflammatory etiologies. Considerable research is still needed to improve our understanding of the mechanisms, consequences, and therapy of status epilepticus.

  17. Weight status and body image perceptions in adolescents: current perspectives.

    Science.gov (United States)

    Voelker, Dana K; Reel, Justine J; Greenleaf, Christy

    2015-01-01

    Adolescence represents a pivotal stage in the development of positive or negative body image. Many influences exist during the teen years including transitions (eg, puberty) that affect one's body shape, weight status, and appearance. Weight status exists along a spectrum between being obese (ie, where one's body weight is in the 95th percentile for age and gender) to being underweight. Salient influences on body image include the media, which can target adolescents, and peers who help shape beliefs about the perceived body ideal. Internalization of and pressures to conform to these socially prescribed body ideals help to explain associations between weight status and body image. The concepts of fat talk and weight-related bullying during adolescence greatly contribute to an overemphasis on body weight and appearance as well as the development of negative body perceptions and dissatisfaction surrounding specific body parts. This article provides an overview of the significance of adolescent development in shaping body image, the relationship between body image and adolescent weight status, and the consequences of having a negative body image during adolescence (ie, disordered eating, eating disorders, and dysfunctional exercise). Practical implications for promoting a healthy weight status and positive body image among adolescents will be discussed. PMID:26347007

  18. Weight status and body image perceptions in adolescents: current perspectives.

    Science.gov (United States)

    Voelker, Dana K; Reel, Justine J; Greenleaf, Christy

    2015-01-01

    Adolescence represents a pivotal stage in the development of positive or negative body image. Many influences exist during the teen years including transitions (eg, puberty) that affect one's body shape, weight status, and appearance. Weight status exists along a spectrum between being obese (ie, where one's body weight is in the 95th percentile for age and gender) to being underweight. Salient influences on body image include the media, which can target adolescents, and peers who help shape beliefs about the perceived body ideal. Internalization of and pressures to conform to these socially prescribed body ideals help to explain associations between weight status and body image. The concepts of fat talk and weight-related bullying during adolescence greatly contribute to an overemphasis on body weight and appearance as well as the development of negative body perceptions and dissatisfaction surrounding specific body parts. This article provides an overview of the significance of adolescent development in shaping body image, the relationship between body image and adolescent weight status, and the consequences of having a negative body image during adolescence (ie, disordered eating, eating disorders, and dysfunctional exercise). Practical implications for promoting a healthy weight status and positive body image among adolescents will be discussed.

  19. MELiSSA Food Characterization general approach and current status

    Science.gov (United States)

    Weihreter, Martin; Chaerle, Laury; Secco, Benjamin; Molders, Katrien; van der Straeten, Dominique; Duliere, Eric; Pieters, Serge; Maclean, Heather; Dochain, Denis; Quinet, Muriel; Lutts, Stanley; Graham, Thomas; Stasiak, Michael; Rondeau Vuk, Theresa; Zheng, Youbin; Dixon, Mike; Laniau, Martine; Larreture, Alain; Timsit, Michel; Aronne, Giovanna; Barbieri, Giancarlo; Buonomo, Roberta; Veronica; Paradiso, Roberta; de Pascale, Stafania; Galbiati, Massimo; Troia, A. R.; Nobili, Matteo; Bucchieri, Lorenzo; Page, Valérie; Feller, Urs; Lasseur, Christophe

    . Available MELiSSA closed environment crop growth data were used to develop a first photosynthetic model representing the basic carbon fixation mechanisms. This model will be further elaborated in the course of this study to predict yield, oxygen production and transpi-ration. As an ultimate goal the model is intended to simulate the composition of the different plant organs (root, shoot, fruit/seed or tuber) for each crop under various conditions. For the validation of this model an extensive amount of data sets are needed. Current plant growth bench test setups will provide part of the required data. To gain more precise and detailed datasets, a highly closed plant growth chamber (Plant Characterization Unit, PCU) is under development. The PCU will provide accurate mass balances for carbon, water, oxygen and other elements with statistical reliability. This reliability is achieved through a high degree of closure and environment homogeneity. The PCU will also provide data for the above described plant characterization studies. The general work approach, the current status and future steps will be illustrated.

  20. Assessment of the current status of basic nuclear data compilations

    International Nuclear Information System (INIS)

    The Panel on Basic Nuclear Data Compilations met at the National Nuclear Data Center at Brookhaven National Laboratory (BNL). All 7 panel members were present, together with 17 other individuals with various responsibilities and interests in the US Nuclear Data Network (USNDN). Status reports were presented to the panel by the five US evaluation centers, located at Brookhaven (BNL), Idaho Falls (INEL), Berkeley (LBL), Oak Ridge (ORNL), and the University of Pennsylvania. The reports from the centers outlined the status of their mass chain evaluations and of a number of other projects related to this work; these areas are discussed in more detail in this report

  1. [Development of antituberculous drugs: current status and future prospects].

    Science.gov (United States)

    Tomioka, Haruaki; Namba, Kenji

    2006-12-01

    and drug regimens for anti-TB chemotherapy. There are a number of difficulties in drug-design for the development of new drug formulations with increased potential for antimycobacterial effects, excellent pharmacokinetics, and tolerability. It should be emphasized that the most urgent goal of chemotherapy of TB and MAC infections, especially that associated with HIV infection, is to develop highly active, low-cost drugs which can be used not only in industrialized countries but also in developing countries, since the incidences of AIDS-associated intractable TB and MAC infections are rapidly increasing in the latter. We strongly wish a great advance of fundametal and practical studies in developing such kinds of new anti-TB drugs in the near future. 1. Prospects for non-clinical or clinical development of new antituberculous drugs in relation to corporate strategy: Kenji NAMBA (New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd.) Tuberculosis (TB) remains one of the deadliest threats to public health. No new anti-TB drugs have been brought into the clinic in the past 40 years. Current non-clinical works with progressed technology and Global Alliance for TB Drug Development, a non-profit organization established in 2000, accelerate research and development of faster-acting anti-TB compounds. We reviewed the status of new types of compounds which are being developed as anti-TB drug, such as diarylquinoline (TMC 207), nitroimidazole (PA-824 and OPC-67683), and moxifloxacin (MFLX). We also discussed the best clinical development plans for new-TB drugs in relation to corporate strategy. 2. Exploring novel drug targets through the chemical genomics approach and its possible application to the development of anti-tuberculosis drugs: Yorimasa SUWA (Reverse Proteomics Research Institute Co., Ltd.), Yohji SUZUKI (Teijin Ltd.) Recently, chemical genomics approach has been focused as an emerging technology for the drug discovery. In advance to a very large scale

  2. A current global view of environmental and occupational cancers.

    Science.gov (United States)

    Yang, Mihi

    2011-07-01

    This review is focused on current information of avoidable environmental pollution and occupational exposure as causes of cancer. Approximately 2% to 8% of all cancers are thought to be due to occupation. In addition, occupational and environmental cancers have their own characteristics, e.g., specific chemicals and cancers, multiple factors, multiple causation and interaction, or latency period. Concerning carcinogens, asbestos/silica/wood dust, soot/polycyclic aromatic hydrocarbons [benzo(a) pyrene], heavy metals (arsenic, chromium, nickel), aromatic amines (4-aminobiphenyl, benzidine), organic solvents (benzene or vinyl chloride), radiation/radon, or indoor pollutants (formaldehyde, tobacco smoking) are mentioned with their specific cancers, e.g., lung, skin, and bladder cancers, mesothelioma or leukemia, and exposure routes, rubber or pigment manufacturing, textile, painting, insulation, mining, and so on. In addition, nanoparticles, electromagnetic waves, and climate changes are suspected as future carcinogenic sources. Moreover, the aspects of environmental and occupational cancers are quite different between developing and developed countries. The recent follow-up of occupational cancers in Nordic countries shows a good example for developed countries. On the other hand, newly industrializing countries face an increased burden of occupational and environmental cancers. Developing countries are particularly suffering from preventable cancers in mining, agriculture, or industries without proper implication of safety regulations. Therefore, industrialized countries are expected to educate and provide support for developing countries. In addition, citizens can encounter new environmental and occupational carcinogen nominators such as nanomaterials, electromagnetic wave, and climate exchanges. As their carcinogenicity or involvement in carcinogenesis is not clearly unknown, proper consideration for them should be taken into account. For these purposes, new

  3. Tumor suppressors status in cancer cell line Encyclopedia.

    Science.gov (United States)

    Sonkin, Dmitriy; Hassan, Mehedi; Murphy, Denis J; Tatarinova, Tatiana V

    2013-08-01

    Tumor suppressors play a major role in the etiology of human cancer, and typically achieve a tumor-promoting effect upon complete functional inactivation. Bi-allelic inactivation of tumor suppressors may occur through genetic mechanisms (such as loss of function mutation, copy number (CN) loss, or loss of heterozygosity (LOH)), epigenetic mechanisms (such as promoter methylation or histone modification), or a combination of the two. We report systematically derived status of 69 known or putative tumor suppressors, across 799 samples of the Cancer Cell Line Encyclopedia. In order to generate such resource we constructed a novel comprehensive computational framework for the assessment of tumor suppressor functional "status". This approach utilizes several orthogonal genomic data types, including mutation data, copy number, LOH and expression. Through correlation with additional data types (compound sensitivity and gene set activity) we show that this integrative method provides a more accurate assessment of tumor suppressor status than can be inferred by expression, copy number, or mutation alone. This approach has the potential for a more realistic assessment of tumor suppressor genes for both basic and translational oncology research.

  4. Current status on marine litter indicators in Nordic waters

    DEFF Research Database (Denmark)

    Strand, Jakob; Tairova, Zhanna; Magnusson, Kerstin;

    Status for project on Marine litter in the Nordic waters. This includes a review of Nordic studies on marine litter indicators. Various studies as part of either research or existing monitoring have provided information on occurrence of marine litter in Nordic waters from Baltic Sea to the Arctic....

  5. Current Status and Challenges in Wind Energy Assessment

    DEFF Research Database (Denmark)

    Gryning, Sven-Erik; Badger, Jake; Hahmann, Andrea N.;

    2014-01-01

    Here we discuss the status and challenges in the development of atlases for the assessment of the regional and global wind resources. The text more specifically describes a methodology that is under development at DTU Wind Energy in Denmark. As the wind assessment is based on mesoscale modelling,...

  6. ACRF Instrumentation Status: New, Current, and Future March 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-03-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  7. ACRF Instrumentation Status: New, Current, and Future October 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-10-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  8. ACRF Instrumentation Status: New, Current, and Future May 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  9. ACRF Instrumentation Status: New, Current, and Future June 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-06-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  10. ACRF Instrumentation Status: New, Current, and Future May 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-04-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  11. ACRF Instrumentation Status: New, Current, and Future - March 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-04-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  12. ACRF Instrumentation Status: New, Current, and Future July 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-07-01

    The purpose of this report is to provide a concise but comprehensive overview of ACRF instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) SBIR instrument development.

  13. ACRF Instrumentation Status: New, Current, and Future - February 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-03-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  14. ACRF Instrumentation Status: New, Current, and Future February 2007

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2007-02-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development

  15. ACRF Instrumentation Status: New, Current, and Future January 2007

    Energy Technology Data Exchange (ETDEWEB)

    Liljegren, JC

    2007-01-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development.

  16. KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine | Office of Cancer Genomics

    Science.gov (United States)

    Decitabine, a cancer therapeutic that inhibits DNA methylation, produces variable antitumor response rates in patients with solid tumors that might be leveraged clinically with identification of a predictive biomarker. In this study, we profiled the response of human ovarian, melanoma, and breast cancer cells treated with decitabine, finding that RAS/MEK/ERK pathway activation and DNMT1 expression correlated with cytotoxic activity. Further, we showed that KRAS genomic status predicted decitabine sensitivity in low-grade and high-grade serous ovarian cancer cells.

  17. Weight status and body image perceptions in adolescents: current perspectives

    Directory of Open Access Journals (Sweden)

    Voelker DK

    2015-08-01

    Full Text Available Dana K Voelker,1 Justine J Reel,2 Christy Greenleaf3 1West Virginia University, College of Physical Activity and Sport Sciences, Morgantown, WV, 2University of North Carolina Wilmington, College of Health and Human Services, Wilmington, NC, 3University of Wisconsin–Milwaukee, College of Health Sciences, Milwaukee, WI, USA Abstract: Adolescence represents a pivotal stage in the development of positive or negative body image. Many influences exist during the teen years including transitions (eg, puberty that affect one’s body shape, weight status, and appearance. Weight status exists along a spectrum between being obese (ie, where one’s body weight is in the 95th percentile for age and gender to being underweight. Salient influences on body image include the media, which can target adolescents, and peers who help shape beliefs about the perceived body ideal. Internalization of and pressures to conform to these socially prescribed body ideals help to explain associations between weight status and body image. The concepts of fat talk and weight-related bullying during adolescence greatly contribute to an overemphasis on body weight and appearance as well as the development of negative body perceptions and dissatisfaction surrounding specific body parts. This article provides an overview of the significance of adolescent development in shaping body image, the relationship between body image and adolescent weight status, and the consequences of having a negative body image during adolescence (ie, disordered eating, eating disorders, and dysfunctional exercise. Practical implications for promoting a healthy weight status and positive body image among adolescents will be discussed. Keywords: adolescence, eating disorders, obesity, bullying, puberty, physical activity

  18. Current and emerging treatments for pancreatic cancer.

    Science.gov (United States)

    Regine, W F; John, W J; Mohiuddin, M

    1997-10-01

    The worldwide annual pancreatic cancer death rate equals its estimated annual incidence. Surgery has been considered the only curative modality for this disease, but only 5 to 15% of patients are candidates for potentially curative resection. Evidence that postoperative adjuvant treatment improves outcome has been limited to a single randomised trial of a well tolerated split-course chemoradiation regimen. More intensive regimens have since been developed and are associated with, at best, a modest improvement in patient outcome. The potentially significant morbidity associated with pancreaticoduodenectomy, which can compromise the delivery of postoperative adjuvant chemoradiation, has led to the development of preoperative adjuvant ('neoadjuvant') chemoradiation in these patients. Although experience suggests that such an approach is feasible, its ultimate impact awaits further evaluation. Combined modality therapy has produced the most promising results in patients with unresectable or locally advanced disease. However, only modest improvements in median survival and minimal increases in long term survival have so far been achieved. This observation has encouraged many investigators to devise innovative methods of delivering therapy, including radioisotope implantation and intraoperative radiation therapy (IORT). Combined modality therapy with radioisotope implantation appears to have the greatest potential for improving local control and survival in these patients. IORT may be associated with lower morbidity than radioisotope implantation, but its impact may be limited by the radiobiological disadvantage associated with single dose boost therapy. Although new radiosensitising drugs are being tested, the problem of distant metastasis remains significant. New chemotherapeutic agents such as gemcitabine appear to have the potential to produce better results than those achieved over the last 35 years with fluorouracil. Investigations into the optimal integration of

  19. Current status of robotic training in the UK – a trainees perspective

    Directory of Open Access Journals (Sweden)

    Kaite E Chan

    2014-02-01

    Full Text Available The validation of robotic surgery in a growing number of operative procedures has increased its acceptance nationwide and its usage is becoming widespread. Training needs to reflect this fast paced environment to ensure that surgeons continue to progress competently and safely. Current surgical training in the UK is validated through the Intercollegiate Surgical Curriculum Programme (ISCP with progression assessed through an Annual Review of Curriculum Progress (ARCP. There has been some resistance to this since its introduction and many trainees remain dissatisfied with this programme. Training in robotic surgery is currently focused through fellowships with little regular exposure to urology trainees at more junior levels. Robotic simulation provides a useful adjunct to training for both technical and non-technical skills. Its usage is particularly valuable to more inexperienced trainees but may be of limited benefit in those with more advanced skills. Training programmes such as the fundamental skills in robotic surgery (FSRS have been created to facilitate robotic training and it is likely that the future of robotic surgery training will include a combination of theoretical learning, training programmes and fellowship training.-------------------------------------------------------Cite this article as: Chan KE, Vasdev N. Current status of robotic training in the UK – a trainees perspective. Int J Cancer Ther Oncol 2014; 2(1:02013.DOI: http://dx.doi.org/10.14319/ijcto.0201.3

  20. Epidemiology and current status of esophageal cancer in Huai'an city,from 2009 to 2011%2009-2011年淮安市食管癌流行病学与治疗现状分析

    Institute of Scientific and Technical Information of China (English)

    王志敏; 杜云翔; 山顺林; 单鹄声; 闻旭阳; 林浩; 潘恩春

    2013-01-01

    目的:对淮安市2009-2011年食管癌发病、死亡及治疗情况进行分析,为食管癌的综合防治提供依据.方法:利用淮安市肿瘤登记处收集的淮安市2009-2011年食管癌发病及死亡数据,计算发病率、标化发病率,死亡率和标化死亡率潜在减寿年数,分析食管癌高发的流行病学特征.结果:淮安地区2009-2011年食管癌粗发病率为62.91/10万,标化率为49.92/10万,居淮安市恶性肿瘤发病第1位,其粗化率和标化率在城市和农村不同性别之间均处于较高水平,男女性粗发病率在≥45岁逐渐升高,在75~<80岁达到最高峰.食管癌粗死亡率为46.75/10万,标化率为36.87/10万,居淮安市恶性肿瘤死亡第1位,在<45岁男、女性死亡率均处于较低水平,≥45岁逐渐上升,在75~<80岁达到最高峰.全市食管癌潜在减寿年数(YPLL)为45 678人年,平均潜在减寿年数(AYLL)为6.21人年.接受手术治疗者比例为28.70%(1 815/6 323),接受放疗者为49.44%(3 126/6 323).结论:淮安地区食管癌发病率和死亡率均处于较高水平,男女性别比较大,在食管癌高发地区应进一步加大人群防治的力度以巩固防治效果.%OBJECTIVE:To investigate the incidence and mortality of esophageal cancer in Huai'an Area from 2009 to 2011,providing a basis for its comprehensive prevention and treatment. METHODS: The data about the incidence and mortality of esophageal cancer were provided by Huai'an Cancer Registry,and the incidence and mortality rates,standardized rates and potential years of life lost (PYLL) were calculated and the epidemiological characteristics of the disease was analyzed. RESULTS: The crude and standardized incidence rates were 62. 91/105 and 49. 92/105 , respectively, both of which were high in urban and rural areas of Huai'an,and in males and females. The incidence increased in people aged ≥ 45 years old,reaching the peak at the ages of 75 — 80. The crude and standardized mortality

  1. The current status and future directions of myxoma virus, a master in immune evasion.

    Science.gov (United States)

    Spiesschaert, Bart; McFadden, Grant; Hermans, Katleen; Nauwynck, Hans; Van de Walle, Gerlinde R

    2011-01-01

    Myxoma virus (MYXV) gained importance throughout the twentieth century because of the use of the highly virulent Standard Laboratory Strain (SLS) by the Australian government in the attempt to control the feral Australian population of Oryctolagus cuniculus (European rabbit) and the subsequent illegal release of MYXV in Europe. In the European rabbit, MYXV causes a disease with an exceedingly high mortality rate, named myxomatosis, which is passively transmitted by biting arthropod vectors. MYXV still has a great impact on European rabbit populations around the world. In contrast, only a single cutaneous lesion, restricted to the point of inoculation, is seen in its natural long-term host, the South-American Sylvilagus brasiliensis and the North-American S. Bachmani. Apart from being detrimental for European rabbits, however, MYXV has also become of interest in human medicine in the last two decades for two reasons. Firstly, due to the strong immune suppressing effects of certain MYXV proteins, several secreted virus-encoded immunomodulators (e.g. Serp-1) are being developed to treat systemic inflammatory syndromes such as cardiovascular disease in humans. Secondly, due to the inherent ability of MYXV to infect a broad spectrum of human cancer cells, the live virus is also being developed as an oncolytic virotherapeutic to treat human cancer. In this review, an update will be given on the current status of MYXV in rabbits as well as its potential in human medicine in the twenty-first century. PMID:21658227

  2. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

    Science.gov (United States)

    Smith, Robert A; Manassaram-Baptiste, Deana; Brooks, Durado; Doroshenk, Mary; Fedewa, Stacey; Saslow, Debbie; Brawley, Otis W; Wender, Richard

    2015-01-01

    Each year, the American Cancer Society (ACS) publishes a summary of its guidelines for early cancer detection along with a report on data and trends in cancer screening rates and select issues related to cancer screening. In this issue of the journal, we summarize current ACS cancer screening guidelines. The latest data on utilization of cancer screening from the National Health Interview Survey (NHIS) also is described, as are several issues related to screening coverage under the Affordable Care Act, including the expansion of the Medicaid program.

  3. ACRF Instrumentation Status: New, Current, and Future - September 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-10-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  4. ACRF Instrumentation Status: New, Current, and Future - July 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  5. ACRF Instrumentation Status: New, Current, and Future - November 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-12-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  6. ACRF Instrumentation Status: New, Current, and Future - August 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-09-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  7. ACRF Instrumentation Status: New, Current, and Future - October 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-10-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  8. Current Status & Development Trend of VSAT Market in China

    Institute of Scientific and Technical Information of China (English)

    Xu Nutu

    2006-01-01

    @@ 1. General Status of VSAT Market Development in China 1)Development History Development in China The history of the application of satellite communication in China is not too long and it was dated from the early seventies of the 20th century. In 1973, approved by Chinese government,Ministry of Posts and Telecommunications purchased satellite earth equipment from foreign country and constructed 3 stations in Shanghai and Beijing.

  9. ACRF Instrumentation Status: New, Current, and Future - June 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  10. ACRF Instrumentation Status: New, Current, and Future - December 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-01-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  11. ACRF Instrumentation Status: New, Current, and Future - May 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  12. ACRF Instrumentation Status: New, Current, and Future - January 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-03-02

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  13. ACRF Instrumentation Status: New, Current, and Future September 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-09-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  14. ACRF Instrumentation Status: New, Current, and Future July 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-07-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  15. ACRF Instrumentation Status: New, Current, and Future August 2006

    Energy Technology Data Exchange (ETDEWEB)

    JC Liljegren

    2006-08-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Program Climate Research Facility instrumentation status. The report is divided into four sections: (1) new instrumentation in the process of being acquired and deployed, (2) existing instrumentation and progress on improvements or upgrades, (3) proposed future instrumentation, and (4) Small Business Innovation Research instrument development. New information is highlighted in blue text.

  16. ACRF Instrumentation Status: New, Current, and Future February 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-02-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  17. ACRF Instrumentation Status: New, Current, and Future - April 2008

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2008-05-01

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  18. ACRF Instrumentation Status: New, Current, and Future March 2009

    Energy Technology Data Exchange (ETDEWEB)

    JW Voyles

    2009-03-15

    The purpose of this report is to provide a concise but comprehensive overview of Atmospheric Radiation Measurement Climate Research Facility instrumentation status. The report is divided into the following five sections: (1) new instrumentation in the process of being acquired and deployed, (2) field campaigns, (3) existing instrumentation and progress on improvements or upgrades, (4) proposed future instrumentation, and (5) Small Business Innovation Research instrument development.

  19. Current status of combined chemo-radiotherapy for locally advanced non-small cell lung cancer%局部晚期非小细胞肺癌同期放化疗研究进展

    Institute of Scientific and Technical Information of China (English)

    吕冬婕; 韩春; 王澜

    2009-01-01

    放化综合治疗是局部晚期非小细胞肺癌(NSCLC)的基本治疗策略.近期研究表明同期放化疗在生存率等方面优于序贯治疗,已成为局部晚期NSCLC的标准治疗模式,但是尚无具体放化结合模式指导临床治疗.为了进一步提高治疗疗效,目前临床研究主要集中于以下几个方面:同期放化治疗加入诱导或巩固化疗、同期放化疗中放疗分割方式的改变、同期放化疗中化疗方式及方案的选择、同期放化疗加入分子靶向治疗.%Combination of chemotherapy and radiotherapy is foundational treatment approach for locally advanced non- small cell lung cancer (NSCLC) patients. Concomitant chemo-radiotherapy have been demons-trated to be better than sequential chemoradiotherapy in survival rate, and it is considered as a standard approach in patients with locally advanced NSCLC. However, the chemo-radiotherapy regimens remain uncert-ain. The main clinical researches aiming at improving the survival rate of locally advanced NSCLC patients are the addition of induction or consolidation, the alteration of radiation fractionation, the alteration of chemo schema and the inte- gration of molecularly targeted therapies combining with concurrent chemo-radiotherapy.

  20. Tiagabine: efficacy and safety in partial seizures – current status

    Directory of Open Access Journals (Sweden)

    Jürgen Bauer

    2008-09-01

    Full Text Available Jürgen Bauer, Déirdre Cooper-MahkornDepartment of Epileptology, Bonn University Hospital, GermanyAbstract: Tiagabine hydrochloride (TGB is a selective gamma-aminobutyric acid (GABA reuptake inhibitor. TGB is effective as an add-on medication in adults and children 12 years and older in the treatment of partial seizures. Results of nonrandomized add-on trials with TGB show treatment success with seizure reduction of at least 50% in 33% to 46% of patients. In newly diagnosed patients with partial epilepsy, TGB monotherapy was as effective as carbamazepine. Comedication with TGB elevates the risk of nonconvulsive status (7.8% vs 2.7% without TGB. The most common side effects include dizziness/lightheadedness, asthenia/lack of energy and somnolence. TGB has no negative effects on cognition; it does not increase the risk of fractures or rash. TGB may interfere with color perception. TGB presents an intermediate risk for depression in patients with epilepsy (approximately 4%. Regarding the risk of overdose, 96–680 mg TGB (mean 224 mg caused seizures or coma. TGB is an antiepileptic drug exhibiting a specific anticonvulsive mechanism of action, the efficacy of which is relatively low when used in comedication. Critical side effects, such as the induction of nonconvulsive status epilepticus, further limit its use.Keywords: epilepsy, tiagabine, antiepileptic drugs, status epilepticus, pharmacotherapy

  1. Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.

    Directory of Open Access Journals (Sweden)

    Hellmuth A Meyer

    Full Text Available Selenium (Se is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP serves as the major Se transport protein in blood and as reliable biomarker of Se status in marginally supplied individuals. Among the different malignancies, renal cancer is characterized by a high mortality rate. In this study, we aimed to analyze the Se status in renal cell cancer (RCC patients and whether it correlates to cancer-specific mortality. To this end, serum samples of RCC patients (n = 41 and controls (n = 21 were retrospectively analyzed. Serum Se and SePP concentrations were measured by X-ray fluorescence and an immunoassay, respectively. Clinical and survival data were compared to serum Se and SePP concentrations as markers of Se status by receiver operating characteristic (ROC curve and Kaplan-Meier and Cox regression analyses. In our patients, higher tumor grade and tumor stage at diagnosis correlated to lower SePP and Se concentrations. Kaplan-Meier analyses indicated that low Se status at diagnosis (SePP<2.4 mg/l, bottom tertile of patient group was associated with a poor 5-year survival rate of 20% only. We conclude that SePP and Se concentrations are of prognostic value in RCC and may serve as additional diagnostic biomarkers identifying a Se deficit in kidney cancer patients potentially affecting therapy regimen. As poor Se status was indicative of high mortality odds, we speculate that an adjuvant Se supplementation of Se-deficient RCC patients might be beneficial in order to stabilize their selenoprotein expression hopefully prolonging their survival. However, this assumption needs to be rigorously tested in prospective clinical trials.

  2. Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients.

    Science.gov (United States)

    Meyer, Hellmuth A; Endermann, Tobias; Stephan, Carsten; Stoedter, Mette; Behrends, Thomas; Wolff, Ingmar; Jung, Klaus; Schomburg, Lutz

    2012-01-01

    Selenium (Se) is an essential trace element for selenoprotein biosynthesis. Selenoproteins have been implicated in cancer risk and tumor development. Selenoprotein P (SePP) serves as the major Se transport protein in blood and as reliable biomarker of Se status in marginally supplied individuals. Among the different malignancies, renal cancer is characterized by a high mortality rate. In this study, we aimed to analyze the Se status in renal cell cancer (RCC) patients and whether it correlates to cancer-specific mortality. To this end, serum samples of RCC patients (n = 41) and controls (n = 21) were retrospectively analyzed. Serum Se and SePP concentrations were measured by X-ray fluorescence and an immunoassay, respectively. Clinical and survival data were compared to serum Se and SePP concentrations as markers of Se status by receiver operating characteristic (ROC) curve and Kaplan-Meier and Cox regression analyses. In our patients, higher tumor grade and tumor stage at diagnosis correlated to lower SePP and Se concentrations. Kaplan-Meier analyses indicated that low Se status at diagnosis (SePP<2.4 mg/l, bottom tertile of patient group) was associated with a poor 5-year survival rate of 20% only. We conclude that SePP and Se concentrations are of prognostic value in RCC and may serve as additional diagnostic biomarkers identifying a Se deficit in kidney cancer patients potentially affecting therapy regimen. As poor Se status was indicative of high mortality odds, we speculate that an adjuvant Se supplementation of Se-deficient RCC patients might be beneficial in order to stabilize their selenoprotein expression hopefully prolonging their survival. However, this assumption needs to be rigorously tested in prospective clinical trials. PMID:23056383

  3. Microbiological aspects of biofuel production: Current status and future directions

    Directory of Open Access Journals (Sweden)

    Mostafa S. Elshahed

    2010-04-01

    Full Text Available Biofuel research is currently an area of immense interest due to the increase in global energy demand by emerging economies and the recent increases in global oil prices. Multiple approaches are currently being researched for the use of microorganisms in the production of various biofuel (e.g. alcohols, hydrogen, biodiesel, and biogas from multiple starting materials. This review provides a brief overview on the research currently underway on laboratory and industrial scales in the area of biofuels, with specific emphasis on the economic viability of various approaches currently being utilized.

  4. Cancer survivorship research: a review of the literature and summary of current NCI-designated cancer center projects.

    Science.gov (United States)

    Harrop, J Phil; Dean, Julie A; Paskett, Electra D

    2011-10-01

    The number of cancer survivors and the amount of cancer survivorship research have grown substantially during the past three decades. This article provides a review of interventional and observational cancer survivorship research efforts as well as a summary of current cancer survivorship research projects being conducted by National Cancer Institute-designated cancer centers in an effort to identify areas that need further attention.

  5. CURRENT STATUS OF ADVACATE PROCESS FOR FLUE GAS DESULFURIZATION

    Science.gov (United States)

    The following report discusses current bench- and pilot-plant advances in preparation of ADVAnced siliCATE (ADVACATE) calcium silicate sorbentsfor flue gas desulfurization. It also discusses current bench- and pilot-plant advances in sorbent preparation. Fly ash was ground in a l...

  6. Biofuel production from microalgae as feedstock: current status and potential.

    Science.gov (United States)

    Han, Song-Fang; Jin, Wen-Biao; Tu, Ren-Jie; Wu, Wei-Min

    2015-06-01

    Algal biofuel has become an attractive alternative of petroleum-based fuels in the past decade. Microalgae have been proposed as a feedstock to produce biodiesel, since they are capable of mitigating CO2 emission and accumulating lipids with high productivity. This article is an overview of the updated status of biofuels, especially biodiesel production from microalgae including fundamental research, culture selection and engineering process development; it summarizes research on mathematical and life cycle modeling on algae growth and biomass production; and it updates global efforts of research and development and commercialization attempts. The major challenges are also discussed.

  7. The proton ''spin contents'': Current status ampersand perspectives

    International Nuclear Information System (INIS)

    The present status of the phenomenological and theoretical interpretation of the EMC result on the polarized deep elastic scattering is reviewed. We focus our discussion on the possibility of a significant gluonic contribution to the proton spin via the axial anomaly. We contrast the variant perspectives on this question: the viewpoint that stresses the interpretation in terms of the parton distributions vs the one that concentrates on the matrix elements of local operators. Some remarks concerning the validity of OZI rule for the strange quark are also included. 53 refs

  8. Current status and prospects of U.S. nuclear industry

    International Nuclear Information System (INIS)

    The status of the U.S. nuclear enterprise is considered followed by a summary of the advanced light water reactor program. Several selected national policy issues are discussed which include high level nuclear waste management, disposition of excess weapons plutonium, and economic deregulation and competition. A summary of the following three technical issues: (1) plant aging and license renewal, (2) regulatory guidance being developed for digital instrumentation and control systems in nuclear power plants, and (3) risk-informed performance based regulation is provided. A rather philosophical perspective on the topic of safety and compliance is also provided

  9. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.

    Science.gov (United States)

    Smith, Robert A; Brooks, Durado; Cokkinides, Vilma; Saslow, Debbie; Brawley, Otis W

    2013-01-01

    Each year the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection, a report on data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, current ACS cancer screening guidelines are summarized, as are updated guidelines on cervical cancer screening and lung cancer screening with low-dose helical computed tomography. The latest data on the use of cancer screening from the National Health Interview Survey also are described, as are several issues related to screening coverage under the Patient Protection and Affordable Care Act of 2010.

  10. Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area.

    Science.gov (United States)

    Rashid, Haroon; Alam, Khursheed; Afroze, Dil; Yousuf, Adfar; Banday, Manzoor; Kawoosa, Fizalah

    2016-01-01

    Gastric cancer (GC) is the fourth most prevalant cancer and the second leading cause of cancer-related mortality worldwide. As in other cancers gastric carcinogenesis is multifactorial involving environmental, genetic and epigenetic components. Epigenetic silencing due to hypermethylation of tumour suppressor genes is one of the key events in gastric carcinogenesis. This study was aimed to analyse the hypermethylation status of the E-Cadherin (CDH1) gene promoter in GCs in the ethnic Kashmiri population. In this study a total of 80 GC patients were recruited. Hypermethylation in tumour tissue was detected by methylation specific PCR (MS-PCR). Hypermethylation of CDH1 promoter was observed in 52 (65%) of gastric carcinoma cases which was significantly much higher than adjacent normal tissue [p≤0.0001]. Further the frequency of CDH1 promoter methylation was significantly different with intestinal and diffuse types of gastric cancer [55.7% vs 82.1%; CDH1 hypermethylation [P≤0.05]. Thus the current data indicate a vital role of epigenetic alteration of CDH1 in the causation and development of gastric cancer, particularly of diffuse type, in our population.

  11. Current strategies for the prevention of breast cancer

    Directory of Open Access Journals (Sweden)

    Advani P

    2014-05-01

    Full Text Available Pooja Advani, Alvaro Moreno-AspitiaDepartment of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USAAbstract: Due to the high incidence of breast cancer in the United States, optimal strategies for its prevention are imperative. This entails identification of women who are at an increased risk for breast cancer and an integrative approach that includes effective screening methods as well as nutritional, pharmacologic, and surgical management. Several breast cancer risk-assessment tools, such as the Gail and Claus models, can help clinicians determine the quantitative risk of breast cancer. The role of selective estrogen receptor modulators, such as tamoxifen and raloxifene, for the prevention of breast cancer has been well established. Several other agents, such as aromatase inhibitors, are currently being investigated. The potential adverse effects of these chemopreventive agents, which include an impact on the quality of life, must be discussed with the patient before deciding on this approach. Additionally, breast cancer risk factors have been identified over the years; some of them are modifiable, but others are not. Although there is no conclusive evidence to suggest the protective role of specific dietary components, alcohol consumption and obesity are associated with an increased breast cancer risk; thus lifestyle changes can lead to a lower risk of developing breast cancer. Surgical approaches, including bilateral risk-reduction mastectomy and salpingo-oophorectomy, are usually limited to women with a hereditary predisposition to development of breast cancer. The objective of this review is to summarize the various approaches directed at reducing the incidence of breast cancer.Keywords: chemoprevention, tamoxifen, raloxifene, prophylactic surgery

  12. Nitriding and Nitrocarburizing; Current Status and Future Challenges

    DEFF Research Database (Denmark)

    Somers, Marcel A. J.

    This contribution addresses the current understanding of gaseous nitriding and nitrocarburizing. Aspects of thermodynamics, kinetics and microstructure development in iron and heat treatable steel will be explained. In these materials the nitrided/ nitrocarburized case can be subdivided...

  13. Medicinal Use of Cannabis: History and Current Status

    Directory of Open Access Journals (Sweden)

    Harold Kalant

    2001-01-01

    Full Text Available OBJECTIVE: To provide an overview of the history and pharmacology of cannabis in relation to current scientific knowledge concerning actual and potential therapeutic uses of cannabis preparations and pure cannabinoids.

  14. Status of high transport current ROEBEL assembled coated conductor cables

    Energy Technology Data Exchange (ETDEWEB)

    Goldacker, Wilfried; Frank, Antje; Kudymow, Andrej; Heller, Reinhard; Kling, Andrea; Terzieva, Stanimira; Schmidt, Curt [Forschungszentrum Karlsruhe, Institut fuer Technische Physik, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-Leopoldshafen (Germany)], E-mail: Wilfried.Goldacker@itp.fzk.de

    2009-03-15

    Assembling coated conductors (CC) into flat ROEBEL bars (RACC cable) was introduced in 2005 by the authors as a practicable method of reaching high transport currents in a low AC loss cable, which is a cable design suited for application in windings. The transport current of 1.02 kA in self-field at 77 K achieved so far, however, is still too low for several applications in electrical machinery such as larger transformers and generators/motors. A new cable concept for further increased currents was presented just recently. The goal of the new design was primarily to demonstrate the possibility of strongly increased transport currents without changing the important cable features for low AC losses. such as, for example, the transposition length of the strands. We present detailed investigations of the properties of this progressed cable design, which has threefold layered strands, an unchanged transposition pitch of 18.8 cm and finally the application of 45 coated conductors in the cable. A 1.1 m long sample (equivalent to six transposition lengths) was prepared from commercial Cu stabilized coated conductors purchased from Superpower. The measured new record DC transport current of the cable was 2628 A at 77 K in self-field (5 {mu}V cm{sup -1} criterion). The use of three slightly different current carrying batches of strand material ({+-} 10%) was a special feature of the cable, which allowed for interesting investigations of current redistribution effects in the cable, by monitoring a representative strand of each batch during the critical current measurement. Although current redistribution effects showed a complex situation, the behaviour of the cable was found to be absolutely stable under all operational conditions, even above the critical current. The high self-field degradation of the critical current reached the order of 60% at 77 K, and could be modelled satisfactory with calculations based on a proven Biot-Savart-law approach, adapted to the specific

  15. International tourism demand in Macedonia: Current status and estimation

    OpenAIRE

    Biljana Petrevska

    2013-01-01

    The paper aims to investigate current international tourism demand in Macedonia, as well as to make an attempt to forecast it in a short-term horizon by 2014. For this purpose, the past and current patterns are based on stylized facts obtained from secondary data spreading over a sample period from 2000-2011. Furthermore, the estimation of future trends is based on Box-Jenkins methodology. Several alternative specifications were introduced and upon the outcomes of standard indicators for accu...

  16. Functional magnetic resonance imaging in cervical cancer: Current evidence and future directions

    Directory of Open Access Journals (Sweden)

    Sayan Kundu

    2012-01-01

    Full Text Available Carcinoma cervix is one of the most common cancers amongst Indian women. Though treatment strategies continue to evolve, there are no established predictive biomarkers of prognosis or therapeutic response. Novel imaging techniques using magnetic resonance (MR and positron emission tomography (PET can facilitate time resolved spatial evaluation of biological characteristics (perfusion, permeability, cellularity, proliferation, oxygenation, and apoptosis thereby serving as early surrogate biomarkers for prognosis and therapeutic response. Several of these imaging modalities such as dynamic contrast-enhanced MRI (DCE-MRI, diffusion-weighted MRI (DW-MRI, MR spectroscopy (MRS and fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET are now being evaluated for gynecological oncology, with the majority of work being performed on cervical tumors. PUBMED database was searched for this review from January 1966 till February 2011. This review examines the basic principles of functional MR imaging for cervical cancer and its current status as a diagnostic and predictive biomarker for cervical cancer.

  17. Breast cancer stem cells: current advances and clinical implications.

    Science.gov (United States)

    Luo, Ming; Clouthier, Shawn G; Deol, Yadwinder; Liu, Suling; Nagrath, Sunitha; Azizi, Ebrahim; Wicha, Max S

    2015-01-01

    There is substantial evidence that many cancers, including breast cancer, are driven by a population of cells that display stem cell properties. These cells, termed cancer stem cells (CSCs) or tumor initiating cells, not only drive tumor initiation and growth but also mediate tumor metastasis and therapeutic resistance. In this chapter, we summarize current advances in CSC research with a major focus on breast CSCs (BCSCs). We review the prevailing methods to isolate and characterize BCSCs and recent evidence documenting their cellular origins and phenotypic plasticity that enables them to transition between mesenchymal and epithelial-like states. We describe in vitro and clinical evidence that these cells mediate metastasis and treatment resistance in breast cancer, the development of novel strategies to isolate circulating tumor cells (CTCs) that contain CSCs and the use of patient-derived xenograft (PDX) models in preclinical breast cancer research. Lastly, we highlight several signaling pathways that regulate BCSC self-renewal and describe clinical implications of targeting these cells for breast cancer treatment. The development of strategies to effectively target BCSCs has the potential to significantly improve the outcomes for patients with breast cancer.

  18. Status and Advances of RGD Molecular Imaging in Lung Cancer

    Directory of Open Access Journals (Sweden)

    Ning YUE

    2014-12-01

    Full Text Available Lung cancer has been one of the most common and the highest mortality rates malignant tumors at home and abroad. Sustained angiogenesis was not only the characteristic of malignant tumors, but also the foundation of tumor proliferation, invasion, recurrence and metastasis, it was also one of the hot spots of treatments in lung cancer biology currently. Integrins played an important part in tumor angiogenesis. Arg-Gly-Asp (RGD peptides could combine with integrins specifically, and the application of radionuclide-labeled RGD molecular probes enabled imaging of tumor blood vessels to reflect its changes. The lung cancer imaging of RGD peptides at home and abroad in recent years was reviewed in this article.

  19. The MiMeS Project: Overview and Current Status

    CERN Document Server

    Wade, G A; Bohlender, D A; Bouret, J -C; Cohen, D; Duez, V; Gagné, M; Grunhut, J; Henrichs, H F; Hill, N; Kochukhov, O; Mathis, S; Neiner, C; Oksala, M; Owocki, S; Petit, V; Shultz, M; Rivinius, T; Townsend, R; Vink, J S

    2010-01-01

    The Magnetism in Massive Stars (MiMeS) Project is a consensus collaboration among many of the foremost international researchers of the physics of hot, massive stars, with the basic aim of understanding the origin, evolution and impact of magnetic fields in these objects. At the time of writing, MiMeS Large Programs have acquired over 950 high-resolution polarised spectra of about 150 individual stars with spectral types from B5-O4, discovering new magnetic fields in a dozen hot, massive stars. The quality of this spectral and magnetic mat\\'eriel is very high, and the Collaboration is keen to connect with colleagues capable of exploiting the data in new or unforeseen ways. In this paper we review the structure of the MiMeS observing programs and report the status of observations, data modeling and development of related theory.

  20. Targeting to the hair follicles: current status and potential.

    Science.gov (United States)

    Wosicka, Hanna; Cal, Krzysztof

    2010-02-01

    The pilosebaceous unit is a complex structure that undergoes a specific growth cycle and comprises a few important drug targeting sites. For example, drugs can be targeted to the bulge region with stem cells or to the sebaceous glands. Interest in pilosebaceous units is directed towards their utilization as reservoirs for localized therapy and also as a transport pathway for systemic drug delivery. Improved investigative methods, such as differential stripping, are being developed in order to determine follicular penetration. This article reviews relevant aspects of effective follicle-targeting formulations and delivery systems as well as the activity status of hair follicles, and variations in follicle size and distribution throughout various body regions. Each of these factors strongly affects follicular permeation. We provide examples of improved penetration of particle-based formulations and of a size-dependent manner of follicular penetration. Contradictions are also discussed, indicating the need for detailed future investigations.

  1. Current status of Clonorchis sinensis and clonorchiasis in China.

    Science.gov (United States)

    Lai, De-Hua; Hong, Xiao-Kun; Su, Bi-Xiu; Liang, Chi; Hide, Geoff; Zhang, Xiaoli; Yu, Xinbing; Lun, Zhao-Rong

    2016-01-01

    The oriental liver fluke, Clonorchis sinensis, a pathogen causing clonorchiasis, is of major socio-economic importance in East Asia, including China, Korea and Vietnam. This parasite is now recognized as a biocarcinogen strongly linked to cholangiocarcinoma in humans. Here, we describe the status of clonorchiasis in China, where it has been estimated that more than 15 million patients are affected. This paper also summarizes the major advances in the field of clonorchiasis research during last decade, including diagnosis techniques, pathogenesis and genome/transcriptome/proteome studies in the last years. We strongly hope that our work can stimulate the governments of the countries or regions where clonorchiasis is endemic to pay more attention to this disease and establish related guidelines to prevent and control it. PMID:26740359

  2. Captive breeding of pangolins: current status, problems and future prospects.

    Science.gov (United States)

    Hua, Liushuai; Gong, Shiping; Wang, Fumin; Li, Weiye; Ge, Yan; Li, Xiaonan; Hou, Fanghui

    2015-01-01

    Pangolins are unique placental mammals with eight species existing in the world, which have adapted to a highly specialized diet of ants and termites, and are of significance in the control of forest termite disaster. Besides their ecological value, pangolins are extremely important economic animals with the value as medicine and food. At present, illegal hunting and habitat destruction have drastically decreased the wild population of pangolins, pushing them to the edge of extinction. Captive breeding is an important way to protect these species, but because of pangolin's specialized behaviors and high dependence on natural ecosystem, there still exist many technical barriers to successful captive breeding programs. In this paper, based on the literatures and our practical experience, we reviewed the status and existing problems in captive breeding of pangolins, including four aspects, the naturalistic habitat, dietary husbandry, reproduction and disease control. Some recommendations are presented for effective captive breeding and protection of pangolins. PMID:26155072

  3. Targeting to the hair follicles: current status and potential.

    Science.gov (United States)

    Wosicka, Hanna; Cal, Krzysztof

    2010-02-01

    The pilosebaceous unit is a complex structure that undergoes a specific growth cycle and comprises a few important drug targeting sites. For example, drugs can be targeted to the bulge region with stem cells or to the sebaceous glands. Interest in pilosebaceous units is directed towards their utilization as reservoirs for localized therapy and also as a transport pathway for systemic drug delivery. Improved investigative methods, such as differential stripping, are being developed in order to determine follicular penetration. This article reviews relevant aspects of effective follicle-targeting formulations and delivery systems as well as the activity status of hair follicles, and variations in follicle size and distribution throughout various body regions. Each of these factors strongly affects follicular permeation. We provide examples of improved penetration of particle-based formulations and of a size-dependent manner of follicular penetration. Contradictions are also discussed, indicating the need for detailed future investigations. PMID:20060268

  4. Filtered neutron beams at the FMRB - review and current status

    International Nuclear Information System (INIS)

    A review is presented of our experience with filtered neutron beams installed in beam tubes of the Research and Measurement Reactor Braunschweig since 1976: Desing of the filters and measurement of the beam parameters are reported and an outline of the research work done with the beams is given. The present status of the irradiation facility, which consists of 5 beams (144 keV, 24.5 keV, 2 keV, 0.2 keV and thermal neutrons), is described in some detail to allow understanding of the physical as well as the technical prerequisites for performing calibrations of neutron measuring instruments. An appendix contains the actual beam parameters. (orig.)

  5. HappyFace - current status and future development plans

    International Nuclear Information System (INIS)

    The HappyFace Project is a meta-monitoring tool, which is allow to monitor the Grid sites of the Worldwide LHC Computing Grid (WLCG). It can also be used for any (complex) computing system, e.g. local or distributed computing resources. HappyFace provides fast access to all relevant monitoring sites and gets a complete overview about the status of all available sites on one page. It has an automatic querying system, a lot of testing modules can be plugged in and also the ability to design and add new modules is available. The project had been written in Python and PHP, but in the 3rd version of HappyFace the source code is fully migrated to Python and the web output uses only HTML templates, which makes it simpler.

  6. Current Status of the GRACE Follow-On Mission

    Science.gov (United States)

    Watkins, Michael; Flechtner, Frank; Webb, Frank; Landerer, Felix; Grunwald, Ludwig

    2016-04-01

    The GRACE Follow-On Mission has now advanced to the Assembly and Test Phase with the delivery of essentially all satellite subsystems and science instruments. As of the time of this abstract submission, the team continues to plan launch in 2017. The project team is conducting tests of satellite and instrument operation and performance and putting together updated simulations of expected performance on-orbit, including intersatellite ranging (both microwave and laser), accelerometer, thermal variability and deformation, and other errors. In addition, all required ground analysis software of the Science Data System is in development and testing at JPL, The UTCSR, and GFZ, in preparation for fully integrated end-to-end (international) testing from Level-1 through Level-3 data in the coming year. In this presentation, we will provide the detailed status of project integration and test, the latest simulations of science performance, and schedule for remaining project milestones.

  7. Small modular reactors: current status, economic aspects and licensing

    International Nuclear Information System (INIS)

    Interest for nuclear energy had resurgence since the beginning of the new century. This was a consequence of the new world conditions and needs: increasing energy demands (mainly from developing countries), awareness of the importance of energetic security and the necessity of limiting carbon emissions. In this nuclear boom, Small Modular Reactors (SMRs) develop and start to consolidate as a viable option for the present energy market. Their modular characteristics, lower initial capital cost, passive safety features and their niche applications, situate them as a technology with various advantages. The following study will present and analysis that will help to comprehend the SMRs present status. Information will show planned reactors, reactors in construction and in operation, advantages and challenges of their implementation, relevant economic aspects and important licensing factors that need to be highlighted. The analysis showed that the SMR technology is still in an initial stage that could reach and important development point in the next ten years. In this period, many of the reactors that are in design stage or that are through their licensing process might be constructed and could be getting ready for a commercial status. On the other hand, it has been observed that there are two main economic factors that need to be considered for any SMRs implementation project. First, the costs (initial, operation, maintenance, fuel and decommissioning) and second their possible niche market applications. Additionally, it has been noted that the licensing process is one of the greatest challenges for SMR general development. Licensing is mainly related to topic such as Emergency Planning Zone, first-of-a-kind engineering, passive safety features, proliferation resistance, multiple module designs and staffing. Previous information will serve as a base for carrying out a feasibility assessment analysis for SMR in Mexico. This part will be the last section of the project

  8. Small modular reactors: current status, economic aspects and licensing

    Energy Technology Data Exchange (ETDEWEB)

    Zimbron E, E. [Instituto Tecnologico de Estudios Superiores de Monterrey, Campus Santa Fe, Av. Carlos Lazo No. 100, Santa Fe, 01389 Mexico D. F. (Mexico); Puente E, F., E-mail: erick.zimbron@gmail.com [ININ, Direccion de Investigacion Cientifica, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico)

    2014-10-15

    Interest for nuclear energy had resurgence since the beginning of the new century. This was a consequence of the new world conditions and needs: increasing energy demands (mainly from developing countries), awareness of the importance of energetic security and the necessity of limiting carbon emissions. In this nuclear boom, Small Modular Reactors (SMRs) develop and start to consolidate as a viable option for the present energy market. Their modular characteristics, lower initial capital cost, passive safety features and their niche applications, situate them as a technology with various advantages. The following study will present and analysis that will help to comprehend the SMRs present status. Information will show planned reactors, reactors in construction and in operation, advantages and challenges of their implementation, relevant economic aspects and important licensing factors that need to be highlighted. The analysis showed that the SMR technology is still in an initial stage that could reach and important development point in the next ten years. In this period, many of the reactors that are in design stage or that are through their licensing process might be constructed and could be getting ready for a commercial status. On the other hand, it has been observed that there are two main economic factors that need to be considered for any SMRs implementation project. First, the costs (initial, operation, maintenance, fuel and decommissioning) and second their possible niche market applications. Additionally, it has been noted that the licensing process is one of the greatest challenges for SMR general development. Licensing is mainly related to topic such as Emergency Planning Zone, first-of-a-kind engineering, passive safety features, proliferation resistance, multiple module designs and staffing. Previous information will serve as a base for carrying out a feasibility assessment analysis for SMR in Mexico. This part will be the last section of the project

  9. Current treatment for colorectal cancer metastatic to the liver

    NARCIS (Netherlands)

    Cromheecke, M; de Jong, KP; Hoekstra, HJ

    1999-01-01

    Surgery is currently the only available treatment option which offers the potential for cure for patients with liver metastases from colorectal cancer. Of those who undergo a potentially curative operation for their primary tumour but subsequently recur, almost 80% will develop evidence of metastati

  10. Current issues in the targeted therapy of advanced colorectal cancer.

    NARCIS (Netherlands)

    Knijn, N.; Tol, J.; Punt, C.J.A.

    2010-01-01

    Currently used cytotoxic drugs in the treatment of advanced colorectal cancer (ACC) are primarily the fluoropyrimidines, irinotecan, and oxaliplatin. The introduction of targeted therapy has increased the therapeutic arsenal. Two classes of monoclonal antibodies have been approved for clinical use i

  11. Genetic Analyses in Health Laboratories: Current Status and Expectations

    Science.gov (United States)

    Finotti, Alessia; Breveglieri, Giulia; Borgatti, Monica; Gambari, Roberto

    Genetic analyses performed in health laboratories involve adult patients, newborns, embryos/fetuses, pre-implanted pre-embryos, pre-fertilized oocytes and should meet the major medical needs of hospitals and pharmaceutical companies. Recent data support the concept that, in addition to diagnosis and prognosis, genetic analyses might lead to development of personalized therapy. Novel frontiers in genetic testing involve the development of single cell analyses and non-invasive assays, including those able to predict outcome of cancer pathologies by looking at circulating tumor cells, DNA, mRNA and microRNAs. In this respect, PCR-free diagnostics appears to be one of the most interesting and appealing approaches.

  12. Current status of the hydrogeology for the WIPP

    International Nuclear Information System (INIS)

    The current efforts to define the hydraulic system at the proposed WIPP site are described. These efforts are directed toward further refinement of the field data and conducting specific tests to determine the isotropy of the media and the appropriateness of their representation as porous or as fractured systems

  13. Business Education at Catholic Universities: Current Status and Future Directions

    Science.gov (United States)

    Porth, Stephen J.; McCall, John J.; DiAngelo, Joseph A.

    2009-01-01

    Is business education at Catholic colleges and universities different than business education at secular institutions? This study assesses the current state of business education at Catholic colleges and universities based on a national survey of business school deans and faculty members and an audit of business unit web sites. Results suggest…

  14. San Juan Fracture Characterization Project: Status and current results

    Energy Technology Data Exchange (ETDEWEB)

    Majer, E.L.; Daley, T.M.; Myer, L.R.; Nihei, K.; Queen, J.; Sinton, J.; Murphy, J.; Fortuna, M.; Lynn, H.B.; Imhoff, M.A.; Wilson, R.

    2001-02-26

    The overall objectives of this report are to extend current state-of-the-art 3-D imaging to extract the optimal information for fracture quantification and to develop next generation capability in fracture imaging for true 3-D imaging of the static and dynamic fracture properties.

  15. Current status in the therapy of liver diseases.

    Science.gov (United States)

    Uhl, Philipp; Fricker, Gert; Haberkorn, Uwe; Mier, Walter

    2014-01-01

    Hepatic diseases, like viral hepatitis, autoimmune hepatitis, hereditary hemochromatosis, non-alcoholic fatty liver disease (NAFLD) and Wilson's disease, play an important role in the development of liver cirrhosis and, hence, hepatocellular carcinoma. In this review, the current treatment options and the molecular mechanisms of action of the drugs are summarized. Unfortunately, the treatment options for most of these hepatic diseases are limited. Since hepatitis B (HBV) and C (HCV) infections are the most common causes of liver cirrhosis and hepatocellular carcinoma, they are the focus of the development of new drugs. The current treatment of choice for HBV/HCV infection is an interferon-based combination therapy with oral antiviral drugs, like nucleos(t)ide analogues, which is associated with improving the therapeutic success and also preventing the development of resistances. Currently, two new protease inhibitors for HCV treatment are expected (deleobuvir, faldaprevir) and together with the promising drug, daclatasvir (NS5A-inhibitor, currently in clinical trials), adequate therapy is to be expected in due course (circumventing the requirement of interferon with its side-effects), while in contrast, efficient HBV therapeutics are still lacking. In this respect, entry inhibitors, like Myrcludex B, the lead substance of the first entry inhibitor for HBV/HDV (hepatitis D) infection, provide immense potential. The pharmacokinetics and the mechanism of action of Myrcludex B are described in detail.

  16. Income Inequality and Health Status in the United States: Evidence from the Current Population Survey.

    Science.gov (United States)

    Mellor, Jennifer M.; Milyo, Jeffrey

    2002-01-01

    Current Population Survey data on self-reported health status and income for the general population and those in poverty were analyzed. No consistent association was found between income inequality and individual health status. Previous findings of such an association were attributed to ecological fallacy or failure to control for individual…

  17. Breast cancer pain management - A review of current & novel therapies

    Directory of Open Access Journals (Sweden)

    Aanchal Satija

    2014-01-01

    Full Text Available Breast cancer is one of the most prevalent cancers amongst women in the world. Unfortunately, even after adequate treatment, some patients experience severe pain either due to disease progression or due to treatment related side effects. The persistent pain causes a negative physical and psychosocial impact on patients′ lives. Current rational pain management is patient-centred and requires a thorough psychological assessment. Usually adequate analgesia is achieved by adopting the WHO′s three step analgesic ladder. As the disease progresses, the pain experienced by the patient also increases. This necessitates the administration of opioids and adjuvant analgesics to the breast cancer patients experiencing severe pain. However, opioid use is associated with intolerable side effects like constipation, nausea, vomiting, fear of dependence, and tolerance. Concomitant medications are required to combat these unacceptable side effects. Adjuvant analgesics need to be added to provide adequate and satisfactory analgesia. These factors worsen the psychological state of patients and deteriorate their quality of life. Hence, there is a need to develop therapeutic modalities to provide adequate analgesia with minimum side effects. This review article focuses on the current treatments available for cancer pain management, their limitations, and novel targets and non-pharmacological measures under investigation which have the potential to produce a radical change in pain management measures for the breast cancer patients.

  18. Current Status of Acanthamoeba in Iran: A Narrative Review Article.

    Directory of Open Access Journals (Sweden)

    Maryam Niyyati

    2015-06-01

    Full Text Available Free-living amoebae belonging to the genus Acanthamoeba have an environmental distribution. Amoebic keratitis due to these protozoan parasites continue to rise in Iran and worldwide. In Iran, there are various researches regarding both morphological and molecular identification of Acanthamoeba spp. in environmental and clinical samples. However, there is no thorough review about Acanthamoeba genotypes and their distribution in environmental sources such as water, dust and biofilm in Iran. Besides, according to increasing cases of Amoebic keratitis in the region awareness regarding the pathogenic potential of these sight-threatening amoebae is of utmost importance.We conducted a thorough review based on the database sources such as MEDLINE, PubMed and Google scholar. No restrictions were placed on study date, study design or language of publication. We searched all valuable and relevant information considering the occurrence of the Acanthamoeba in both environmental and clinical samples.According to our thorough review Acanthamoeba belonging to T4 genotype is the most prevalent type strain in environmental and clinical samples in several regions in Iran and worldwide, however, there are reports regarding Acanthamoeba belonging to other genotypes such as T2, T3, T5, T6 and T11 and the mentioned point could leads us to more researches with the goal of presenting the real genotype dominance of Acanthamoeba and related disease in the country.Overall, the present review will focus on present status of genotypes of Acanthamoeba in Iran during recent years.

  19. Current status of demonstration for stationary fuel cell in Korea

    Energy Technology Data Exchange (ETDEWEB)

    Park, D.R. [Korea Gas Co., Ansan (Korea, Republic of). Research and Development Div.

    2009-07-01

    In 2006, the Korean Government launched the Residential Fuel Cell Monitoring Project to address the barriers to the widespread commercialization of fuel cells for residential power generation (RPG). This presentation reviewed the status on the development and dissemination of the residential fuel cell in Korea, with particular reference to a domestically developed proton exchange membrane (PEM) fuel cell for RPG. The purpose of the project was to find a commercial product that is suitable to Korean life style and to solve reliability issues regarding grid connection. The paper showed that although residential fuel cell systems are available in Korea, their capital cost remains high and system durability is not sufficient. This large-scale demonstration test project for residential fuel cell systems was launched in an effort to reduce the cost to levels that are acceptable for wide scale use. A total of 210 unit were tested in order to evaluate the technical level and to investigate the problems that must be solved for mass market introduction.

  20. Ultra-Rapid Opioid Detoxification: Current Status and Controversies

    Directory of Open Access Journals (Sweden)

    Singh J

    2004-07-01

    Full Text Available Opioid dependence is a major health problem and a cause of increasing concern to physicians and other health professionals worldwide. A crucial first step in intervention is detoxification. Recent trends in medical practice have seen the emergence of newer techniques that claim to accelerate the detoxification procedure and ensure prevention of relapse by rapid induction onto maintenance treatment with opioid antagonists such as naltrexone. This review delves into the theoretical and methodological aspects related to ultra-rapid opioid detoxification (opioid detoxification procedure using opioid antagonists, performed under general anaesthesia or heavy sedation and discusses the status of the same in light of the available evidence regarding its applicability, safety and effectiveness. Although useful in some respects (especially in completion rates for detoxification and subsequent induction onto naltrexone maintenance, the justification of this procedure lies in (a the resolution of the ethical conflicts surrounding the procedure and (b conduction of methodologically sound long-term studies to demonstrate greater efficacy over routine/standard detoxification procedures beyond the short-term detoxification period.

  1. Advanced fuel technology and performance: Current status and trends

    International Nuclear Information System (INIS)

    During the last years the Nuclear Fuel Cycle and Waste Management Division of the IAEA has been giving great attention to the collection, analysis and exchange of information in the field of reactor fuel technology. Most of these activities are being conducted in the framework of the International Working Group on Water Reactor Fuel Performance and Technology (IWGFPT). The purpose of this Advisory Group Meeting on Advanced Fuel Technology and Performance was to update and to continue the previous work, and to review the experience of advanced fuel technology, its performance with regard to all types of reactors and to outline the future trends on the basis of national experience and discussions during the meeting. As a result of the meeting a Summary Report was prepared which reflected the status of the advanced nuclear fuel technology up to 1990. The 10 papers presented by participants of this meeting are also published here. A separate abstract was prepared for each of these papers. Refs, figs and tabs

  2. The LHCf experiment at CERN: motivations and current status

    Energy Technology Data Exchange (ETDEWEB)

    D' Alessandro, R.; Adriani, O.; Bonechi, L. [Universita degli Studi di Firenze and INFN Sezione di Firenze, Firenze (Italy); Bongi, M. [INFN Sezione di Firenze, Firenze (Italy); Castellini, G. [IFAC-CNR and INFN Sezione di Firenze, Firenze (Italy); Faus, D.A. [IFIC, Centro Mixto CSIC-UVEG, Valencia (Spain); Fukui, K. [Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya (Japan); Grandi, M. [INFN Sezione di Firenze, Firenze (Italy); Haguenauer, M. [Ecole-Polytechnique, Paris (France); Itow, Y. [Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya (Japan); Kasahara, K. [Research Institute for Science and Engineering, Waseda University, Tokyo (Japan); Macina, D. [CERN, Geneva (Switzerland); Mase, T.; Masuda, K.; Matsubara, Y.; Menjo, H. [Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya (Japan); Mizuishi, M. [Research Institute for Science and Engineering, Waseda University, Tokyo (Japan); Muraki, Y. [Konan University, Kobe (Japan); Papini, P. [INFN Sezione di Firenze, Firenze (Italy); Perrot, A.L. [CERN, Geneva (Switzerland)

    2009-05-15

    LHCf is an experiment currently installed at CERN at the LHC complex. It consists of two small calorimeters each one placed 140 meters away from the ATLAS interaction point. Their purpose is to study forward production of neutral particles in proton-proton collisions at extremely low angles. The results will provide invaluable inputs to the many air-shower Monte Carlo codes currently used for modeling cosmic rays interactions in the Earth atmosphere. Depending on machine start up, data will be taken from 900 GeV in the centre of mass up to 14 TeV (laboratory equivalent collision energy of 10{sup 17}eV), thus covering an energy range up to and beyond the 'knee' of the cosmic ray spectrum.

  3. The LHCf experiment at CERN motivations and current status

    CERN Document Server

    D'Alessandro, R; Bonechi, L; Bongi, M; Castellini, G; Faus, D A; Fukui, K; Grandi, M; Haguenauer, M; Itow, Y; Kasahara, K; Macina, D; Mase, T; Masuda, K; Matsubara, Y; Menjo, H; Mizuishi, M; Muraki, Y; Papini, P; Perrot, A L; Ricciarini, S; Sako, T; Shimizu, Y; Taki, K; Tamura, T; Torii, S; Tricomi, A; Turner, W C; Velasco, J; Viciani, A; Yoshida, K

    2009-01-01

    LHCf is an experiment currently installed at CERN at the LHC complex. It consists of two small calorimeters each one placed 140 meters away from the ATLAS interaction point. Their purpose is to study forward production of neutral particles in proton-proton collisions at extremely low angles. The results will provide invaluable inputs to the many air-shower Monte Carlo codes currently used for modeling cosmic rays interactions in the Earth atmosphere. Depending on machine start up, data will be taken from 900 GeV in the centre of mass up to 14 TeV (laboratory equivalent collision energy of 1017eV), thus covering an energy range up to and beyond the “knee” of the cosmic ray spectrum.

  4. INTERNATIONAL TOURISM DEMAND IN MACEDONIA: CURRENT STATUS AND ESTIMATION

    Directory of Open Access Journals (Sweden)

    Biljana Petrevska

    2013-01-01

    Full Text Available The paper aims to investigate current international tourism demand in Macedonia, as well as to make an attempt to forecast it in a short-term horizon by 2014. For this purpose, the past and current patterns are based on stylized facts obtained from secondary data spreading over a sample period from 2000-2011. Furthermore, the estimation of future trends is based on Box-Jenkins methodology. Several alternative specifications were introduced and upon the outcomes of standard indicators for accuracy testing, the research identified the most appropriate one. According to projected values, moderate, but constant increase of international tourist arrivals is expected. The paper strongly recommends this empirical evidence in a line of mitigating the potential negative impacts as well as in preparation of tourism development plan in Macedonia. Finally, its contribution lies in the fact that it enriches poorly-developed empirical academic work within this scientific area in Macedonia.

  5. Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis.

    Science.gov (United States)

    Grant, William B; Boucher, Barbara J

    2009-09-01

    The ultraviolet-B (UVB)-vitamin D-cancer hypothesis was proposed in 1980. There have been numerous ecological, observational and other studies of the hypothesis. There are about 14 types of cancer for which it seems to apply: bladder, breast, colon, endometrial, esophageal, gallbladder, gastric, ovarian, pancreatic, rectal, renal and vulvar cancer and both Hodgkin's and non-Hodgkin's lymphoma. Nonetheless, the hypothesis has not yet been accepted by public health agencies. Some of the reasons for this include a distrust of ecological studies, some mistrust of observational studies, and the existence of just one positive randomized controlled trial, an analysis of a vitamin D and calcium supplementation study involving post-menopausal women in Nebraska. Paradigm shifts such as this generally take time, in part due to opposition from those content with the status quo. In this paper, results of ecological studies in the United States using summertime solar UVB as the index of vitamin D production, which is highly asymmetrical with respect to latitude, and indices for other cancer risk-modifying factors (air pollution, alcohol consumption, dietary iron and zinc, ethnic background, socioeconomic status, smoking and urban/rural residence) are discussed in terms of supporting the hypothesis. These studies were not considered while other ecological studies were examined in recent critiques of the hypothesis. While additional randomized controlled trials would, of course, be helpful, the current evidence seems to satisfy the criteria for causality as outlined by A. Bradford Hill. PMID:19667154

  6. EMDR and the anxiety disorders: exploring the current status

    OpenAIRE

    de, Jongh, Petra; Broeke, ten, C.J.M.

    2009-01-01

    Based on the assumptions of Shapiro's adaptive information-processing model, it could be argued that a large proportion of people suffering from an anxiety disorder would benefit from eye movement desensitization and reprocessing (EMDR). This article provides an overview of the current empirical evidence on the application of EMDR for the anxiety disorders spectrum other than posttraumatic stress disorder (PTSD). Reviewing the existing literature, it is disappointing to find that 20 years aft...

  7. Current status of clinical laser applications in periodontal therapy.

    Science.gov (United States)

    Aoki, Akira; Mizutani, Koji; Takasaki, Aristeo Atsushi; Sasaki, Katia Miyuki; Nagai, Shigeyuki; Schwarz, Frank; Yoshida, Itaru; Eguro, Toru; Zeredo, Jorge Luis; Izumi, Yuichi

    2008-01-01

    Periodontal disease is a chronic inflammatory disorder caused by bacterial infection. Laser treatment demonstrates specific characteristics that may be valuable in managing periodontal disease. In addition, lasers reduce stress and uncomfortable conditions for patients during and after treatment compared to other conventional tools. This article reviews the literature to describe the current clinical applications of lasers for gingival tissue management-including esthetic treatment, non-surgical and surgical periodontal pocket therapy, osseous surgery, and implant therapy.

  8. Current status of radiofrequency ablation of hepatocellular carcinoma

    OpenAIRE

    Rhim, Hyunchul; Lim, Hyo K.; Choi, Dongil

    2010-01-01

    Loco-regional treatments for hepatocellular carcinoma (HCC) are important alternatives to curative transplantation or resection. Among them, radiofrequency ablation (RFA) is accepted as the most popular technique showing excellent local tumor control and acceptable morbidity. The current role of RFA is well documented in the evidence-based practice guidelines of European Association of Study of Liver, American Association of Study of the Liver Disease and Japanese academic societies. Several ...

  9. Current status of Tc-99m production in Thailand

    Energy Technology Data Exchange (ETDEWEB)

    Charoen, Sakda [Office of Atomic Energy for Peace, Bangkok (Thailand)

    2003-03-01

    Technetium-99m is the workhorse of nuclear medicine and currently accounts for over 80% of all in vivo diagnostic procedures. In Thailand, Office of Atomic Energy for Peace (OAEP) had experiences in production of Technetium-99m by solvent extraction process and alternative technology for Technetium-99m generator based on zirconium molybdate and titanium molybdate gel generators were also studied. The paper describes past experiences and future plan of Technetium-99m production in Thailand. (author)

  10. Current status of stereoscopic 3D LCD TV technologies

    Science.gov (United States)

    Choi, Hee-Jin

    2011-06-01

    The year 2010 may be recorded as a first year of successful commercial 3D products. Among them, the 3D LCD TVs are expected to be the major one regarding the sales volume. In this paper, the principle of current stereoscopic 3D LCD TV techniques and the required flat panel display (FPD) technologies for the realization of them are reviewed. [Figure not available: see fulltext.

  11. Nitric oxide and phytohormone interactions: current status and perspectives

    OpenAIRE

    Luciano eFreschi

    2013-01-01

    Nitric oxide (NO) is currently considered a ubiquitous signal in plant systems, playing significant roles in a wide range of plant responses to environmental and endogenous cues. During the signaling events leading to these plant responses, NO frequently interacts with plant hormones and other endogenous molecules, at times originating remarkably complex signaling cascades. Accumulating evidence indicates that virtually all major classes of plant hormones may influence, at least to some degre...

  12. Nitric oxide and phytohormone interactions: current status and perspectives

    OpenAIRE

    Freschi, Luciano

    2013-01-01

    Nitric oxide (NO) is currently considered a ubiquitous signal in plant systems, playing significant roles in a wide range of responses to environmental and endogenous cues. During the signaling events leading to these plant responses, NO frequently interacts with plant hormones and other endogenous molecules, at times originating remarkably complex signaling cascades. Accumulating evidence indicates that virtually all major classes of plant hormones may influence, at least to some degree, the...

  13. Large Antenna Control Methods: Current Status and Future Trends

    Science.gov (United States)

    Rodriguez, G.; Lin, Y. H.; Milman, M. H.

    1985-01-01

    Current methods for control of large antennas, as well as future trends required for improved performance are addressed. Some of the target missions in which these methods would be used are: the Land Mobile Satellite System (LMSS) for communications; the Satellite Surveillance (SSS) for aircraft traffic control; the orbiting Very Long Baseline Interferometer (VLBI), or QUASAT, for radio astronomy; and the Large Deployable Reflector (LDR) for IR and submillimeter astronomy.

  14. Nuclear Medicine Therapy : Current Status and Future Prospects

    Directory of Open Access Journals (Sweden)

    S.M. Sharma

    1990-10-01

    Full Text Available Radioisotope therapy began in 1942 with the use of /sup 131/I for Graves disease and /sup 32/P for polycythemia vera. Local therapy with radioisotopes includes radiocolloids for malignant pleural and peritoneal effusions, intra-articular radiocolloids for chronic synovitis, intra-arterial radioactive microsphere for liver metastases, and intralymphatic administration for malignancies of the lymphatic system. The most widely practised use of radioisotopes for therapy is for the management of hyperthyroidism by /sup 131/I. Each school has developed its own treatment schedule for controlling the disease without producing too unacceptable an incidence of late hypothyroidism. /sup 131/I is also being used effectively for thyroid cancer, particularly at the Radiation Medicine Centre, BARC. There is hope that a new generation of radiolabelled compounds is round the corner for therapy. As in the case of radiopharmaceuticals for diagnosis, the shift has been from simple inorganic compounds to tailored organic ones. Radiolabelled monoclonal antibodies aimed against specific tumour antigens have already shown great promise. Another area of interest is the use of minute lipid spheroids (vesicles enclosing the radioactive drug which can be targeted to the tumour.

  15. WISM - A Wideband Instrument for Snow Measurement: Past Accomplishments, Current Status, and Path Forward

    Science.gov (United States)

    Bonds, Quenton; Racette, Paul; Durham, Tim (Principal Investigator)

    2016-01-01

    Presented are the prior accomplishments, current status and path forward for GSFC's Wideband Instrument for Snow Measurement (WISM). This work is a high level overview of the project, presented via Webinar to the IEEE young professionals.

  16. Personality disorders in the DSM-5: current status, lessons learned, and future challenges. Introduction.

    Science.gov (United States)

    Widiger, Thomas A; Krueger, Robert F

    2013-10-01

    Provides an introduction to a special section of Personality Disorders: Theory, Research, and Treatment. The purpose of this special section is to provide a discussion of the current status, lessons learned, and future challenges for the classification of personality disorders.

  17. Oral cancer prevention: current status and future promise

    Institute of Scientific and Technical Information of China (English)

    Li Mao

    2008-01-01

    @@ Head and neck carcinogenesis is a multistep process requiring the accumulation of multiple genetic alterations in epithelial cells. These alterations allow growth advantages over other cells and the development of malignant phenotypes.

  18. [Overview of current modalities of colorectal cancer screening].

    Science.gov (United States)

    Kajzrlíková, Ivana Mikoviny; Vítek, Petr

    2016-04-01

    There are one-step and two-steps programs for colorectal cancer screening. The aim of all screening examinations is to detect early stage of the disease in asymptomatic patient. The aim of this article is actual review of current screening modalities such as fecal occult blood test, flexible sigmoideoscopy, colonoscopy, CT colonography, capsule endoscopy, blood-based tests and stool DNA tests. Colonoscopy still remains the gold standard for detection of colorectal neoplasias. In majority of countries worldwide programs for colorectal cancer screening are based on immunochemical fecal occult blood test followed by colonoscopy when positive.

  19. Spent fuel management: Current status and prospects 1990

    International Nuclear Information System (INIS)

    Spent Fuel Management has always been one of the most important steps in the Nuclear Fuel Cycle and it still is one of the most vital and common problem for all countries. Projections for spent fuel arisings by the year 2010 range between 400,000 and 450,000 t of spent nuclear fuel. It is recognized that this fuel will either be stored and later disposed of in a deep geological repository (once-through fuel cycle) or stored and then reprocessed (closed fuel cycle). While some countries have concluded which choice they will make, others are applying the ''wait and see'' attitude. This continues to place great emphasis on short and long term storage technologies since much of the spent fuel will remain in storage in the next 20 years. The nuclear community recognizes the importance that design, technological, economic and material problems in spent fuel storage concepts and continues to encourage the international cooperation in such areas. This past year several nations have made decisions which impact on the projected storage volume (the Federal Republic of Germany has cancelled their reprocessing plant) and plan to contract the reprocessing with other nations. Argentina has delayed its reprocessing efforts. At the same time, while there are plans for recycle of plutonium in thermal reactors, the plans for its use in fast reactors have been delayed. These unforeseen changes reflect the constantly changing nature of the back-end of the fuel cycle and reinforce the importance of cooperation in these activities. The main objective of the Advisory Group on Spent Fuel Management is to review the world-wide situation in spent fuel management, to define the most important directions of national efforts and international cooperation, to exchange information on the present status and progress in performing the back-end of the nuclear fuel cycle and to elaborate recommendations for future Agency programmes in the field of spent fuel management. Refs, figs and tabs

  20. Decommissioning and demolition in the European Union. Current status

    International Nuclear Information System (INIS)

    The European Commission pursues the environmental and energy policy goals of limiting global warming to a maximum of 2 C and, therefore, reducing CO2 emissions by at least 20%. Nuclear power, with its present 30% contribution to the Community's electricity supply and the low CO2 emissions of the entire fuel cycle, makes an important contribution to an energy mix matching the 3 factors of competitiveness, security of supply, and sustainability. The decision to use nuclear power plants in their respective countries for electricity production is left to each member state. As of mid-2008, 146 nuclear power plants were in operation in the European Union, while 74 had been shut down permanently. Two nuclear power plants had been demolished completely, showing that the European Community is just at the beginning of the learning curve in this field. The importance of nuclear power plant decommissioning and demolition will increase in the future as replacement capacity in nuclear power generation will become necessary. The European Commission's activities in decommissioning and demolition date from the 1990s: The provisions about environmental impact assessment and the recommendations to apply Article 37 (potential impacts on water, soil and air) of the Euratom Treaty demand a description of decommissioning and demolition of nuclear power plants. In a ruling of 2002, the European Court of Justice assigns to the Community the required competences in the fields of nuclear safety and, consequently, also decommissioning and demolition. The financial provisions necessary for these activities are covered in the Electricity Directive within the framework of the rules for a common single market in 2003. After a first status report, the Commission published recommendations about financing decommissioning and demolition in 2006. (orig.)